The O
fish O
ingredient O
N3 B
- I
docosahexaenoic I
acid I
22 O
: O
6 O
n O
- O
3 O
( O
DHA B
) O
stimulates O
brain O
development O
. O

The O
main O
components O
in O
the O
oil O
were O
beta B
- I
caryophyllene I
( O
56 O
. O
87 O
% O
) O
, O
alpha B
- I
cadinol I
( O
12 O
. O
52 O
% O
) O
, O
8S B
, I
13 I
- I
cedran I
- I
diol I
( O
5 O
. O
41 O
% O
) O
, O
alpha B
- I
terpineol I
( O
3 O
. O
99 O
% O
) O
, O
beta B
- I
eudesmol I
( O
2 O
. O
54 O
% O
) O
, O
caryophyllene B
oxide I
( O
2 O
. O
51 O
% O
) O
and O
ethyl B
iso I
- I
allocholate I
( O
2 O
. O
03 O
% O
) O
along O
with O
beta B
- I
cubebene I
, O
gamma B
- I
cadinene I
, O
cubenol B
, O
1 B
, I
8 I
- I

Firstly O
, O
sustained O
release O
ketoprofen B
fine O
granules O
were O
developed O
by O
spray O
drying O
the O
aqueous O
dispersions O
composed O
of O
Eudragit B
RS I
- I
30D I
, O
Starch O
1500 O
and O
PEG B
6000 I
. O

The O
structures O
were O
elucidated O
based O
on O
( B
13 I
) I
C I
- O
and O
( B
1 I
) I
H I
- O
NMR O
as O
well O
as O
2D O
- O
NMR O
, O
IR O
and O
different O
MS O
spectra O
and O
the O
immunomodulation O
activity O
for O
compound O
1 O
was O
evaluated O
through O
lymphocyte O
proliferation O
assay O
, O
IL O
- O
2 O
assay O
, O
oxidative O
burst O
of O
phagocytic O
leukocytes O
and O
through O
their O
cytotoxicity O
on O
two O
cell O
lines O
. O

The O
two O
stressors O
were O
the O
myxozoan O
parasite O
, O
Tetracapsuloides O
bryosalmonae O
, O
which O
is O
the O
etiological O
agent O
of O
proliferative O
kidney O
disease O
( O
PKD O
) O
and O
a O
natural O
stressor O
to O
salmonid O
populations O
, O
and O
17 B
beta I
- I
estradiol I
( O
E2 O
) O
as O
prototype O
of O
estrogen B
- O
active O
chemical O
stressors O
in O
the O
aquatic O
environment O
. O

Isolation O
of O
a O
p B
- I
hydroxyphenyl I
anhydride I
from O
the O
leaves O
of O
Diphysa O
carthagenensisw O
. O

Diphysidione B
( O
1 O
) O
, O
a O
new O
p B
- I
hydroxyphenyl I
anhydride I
, O
and O
vitexin B
( O
2 O
) O
were O
isolated O
from O
the O
leaves O
of O
Diphysa O
carthagenensis O
. O

The O
structure O
of O
the O
new O
terpenoid B
was O
elucidated O
by O
comprehensive O
spectroscopic O
analysis O
including O
electron O
ionisation O
- O
mass O
spectra O
, O
( B
1 I
) I
H I
NMR O
, O
( B
13 I
) I
C I
NMR O
, O
distortionless O
enchancement O
by O
polarisation O
transfer O
, O
H B
, O
H B
correlation O
spectroscopy O
, O
heteronuclear O
multiple O
- O
quantum O
coherence O
and O
heteronuclear O
multiple O
- O
bond O
correlation O
. O

The O
structure O
of O
the O
new O
terpenoid B
was O
elucidated O
by O
comprehensive O
spectroscopic O
analysis O
including O
electron O
ionisation O
- O
mass O
spectra O
, O
( B
1 I
) I
H I
NMR O
, O
( B
13 I
) I
C I
NMR O
, O
distortionless O
enchancement O
by O
polarisation O
transfer O
, O
H B
, O
H B
correlation O
spectroscopy O
, O
heteronuclear O
multiple O
- O
quantum O
coherence O
and O
heteronuclear O
multiple O
- O
bond O
correlation O
. O

phytoconstituents O
alpha B
- I
amyrin I
acetate I
, O
beta B
- I
amyrin I
- I
beta I
- I
D I
- I
glucopyranoside I
and O
betulinic B
acid I
have O
been O
isolated O
from O
the O
stem O
bark O
of O
Morus O
alba O
L O
. O

In O
addition O
to O
that O
, O
significant O
increase O
in O
plasma O
high O
- O
density O
lipoprotein O
, O
hepatic O
phosphofructokinase O
and O
glucose B
- I
6 I
phosphate I
dehydrogenase O
was O
observed O
in O
STZ B
diabetic O
mice O
. O

The O
K B
( I
+ I
) I
- O
evoked O
[ B
( I
3 I
) I
H I
] I
GABA I
release O
was O
inhibited O
by O
the O
mGlu7 O
allosteric O
agonist O
N B
, I
N I
' I
- I
dibenzyhydryl I
- I
ethane I
- I
1 I
, I
2 I
- I
diamine I
dihydrochloride I
( O
AMN082 B
, O
0 O
. O
001 O
- O
10 O
mu O
M O
) O
, O
as O
well O
as O
by O
the O
group O
III O
mGlu O
receptor O
agonist O
l B
- I
( I
+ I
) I
- I
2 I
- I
amino I
- I
4 I
- I
phosphonobutyric I
acid I
[ O
( B
l I
) I
- I
AP4 I
, O
0 O
. O
01 O
- O
1 O
mM O
] O
. O

AMN082 B
also O
inhibited O
in O
a O
MMPIP B
- O
sensitive O
manner O
the O
K B
( I
+ I
) I
- O
evoked O
release O
of O
endogenous O
GABA B
. O

AMN082 B
- O
inhibitory O
effect O
was O
additive O
to O
that O
caused O
by O
( B
- I
) I
baclofen I
, O
but O
insensitive O
to O
the O
GABA B
( O
B O
) O
antagonist O
3 B
- I
[ I
[ I
( I
3 I
, I
4 I
- I
Dichlorophenyl I
) I
methyl I
] I
amino I
] I
propyl I
] I
diethoxymethyl I
) I
phosphinic I
acid I
( O
CGP52432 B
) O
. O

Conversely O
, O
( B
- I
) I
baclofen I
- O
induced O
inhibition O
of O
GABA B
exocytosis O
was O
insensitive O
to O
MMPIP B
. O

Finally O
, O
the O
forskolin B
- O
evoked O
[ B
( I
3 I
) I
H I
] I
GABA I
release O
was O
reduced O
by O
AMN082 B
or O
( B
- I
) I
baclofen I
but O
abolished O
when O
the O
two O
agonists O
were O
added O
concomitantly O
. O

Antiangiogenic O
effects O
of O
p B
- I
coumaric I
acid I
in O
human O
endothelial O
cells O
. O

p B
- I
Coumaric I
acid I
, O
a O
hydroxy B
derivative O
of O
cinnamic B
acid I
, O
has O
been O
known O
to O
possess O
antioxidant O
and O
anticancer O
activities O
. O

Despite O
its O
potential O
contribution O
to O
chemopreventive O
effects O
, O
the O
mechanism O
by O
which O
p B
- I
coumaric I
acid I
exerts O
its O
antiangiogenic O
actions O
remains O
elusive O
. O

In O
this O
study O
, O
we O
revealed O
that O
p B
- I
coumaric I
acid I
inhibited O
the O
sprouting O
of O
endothelial O
cells O
in O
rat O
aortic O
rings O
and O
inhibited O
the O
tube O
formation O
and O
migration O
of O
endothelial O
cells O
. O

We O
observed O
that O
p B
- I
coumaric I
acid I
could O
downregulate O
mRNA O
expression O
levels O
of O
the O
key O
angiogenic O
factors O
vascular O
endothelial O
growth O
factor O
and O
basic O
fibroblast O
growth O
factor O
. O

Also O
, O
we O
demonstrated O
that O
p B
- I
coumaric I
acid I
inhibited O
both O
the O
AKT O
and O
ERK O
signaling O
pathways O
, O
which O
are O
known O
to O
be O
crucial O
for O
angiogenesis O
. O

Using O
a O
mouse O
model O
, O
we O
also O
showed O
that O
p B
- I
coumaric I
acid I
effectively O
suppressed O
tumor O
growth O
in O
vivo O
by O
lowering O
hemoglobin O
contents O
. O

Collectively O
, O
these O
findings O
indicate O
that O
p B
- I
coumaric I
acid I
possesses O
potent O
anticancer O
properties O
due O
to O
the O
inhibition O
of O
angiogenesis O
in O
vivo O
. O

Water O
- O
insoluble O
drug O
ibuprofen B
was O
dispersed O
in O
deionized O
water O
, O
and O
then O
the O
ion O
- O
exchange O
fibers O
in O
OH B
( I
- I
) I
type O
was O
immersed O
in O
it O
. O

Feroniellides B
C I
- I
E I
, O
new O
apotirucallane B
triterpenoids I
from O
the O
stem O
bark O
of O
Feroniella O
lucida O
. O

Bioassay O
- O
directed O
isolation O
of O
Feroniella O
lucida O
stem O
bark O
yielded O
three O
new O
apotirucallane B
triterpenoids I
named O
feroniellides B
C I
- I
E I
. O

Of O
triterpenoids B
examined O
, O
feroniellides B
D I
and I
E I
revealed O
anticancer O
activity O
against O
KB O
and O
HeLa O
cells O
with O
IC50 O
values O
in O
range O
of O
3 O
. O
4 O
- O
14 O
. O
2 O
micro O
g O
mL O
( O
- O
1 O
) O
, O
which O
are O
significantly O
more O
potent O
than O
feroniellides B
A I
- I
C I
( O
IC50 O
25 O
. O
5 O
- O
60 O
. O
0 O
micro O
g O
mL O
( O
- O
1 O
) O
) O
. O

Of O
triterpenoids B
examined O
, O
feroniellides B
D I
and I
E I
revealed O
anticancer O
activity O
against O
KB O
and O
HeLa O
cells O
with O
IC50 O
values O
in O
range O
of O
3 O
. O
4 O
- O
14 O
. O
2 O
micro O
g O
mL O
( O
- O
1 O
) O
, O
which O
are O
significantly O
more O
potent O
than O
feroniellides B
A I
- I
C I
( O
IC50 O
25 O
. O
5 O
- O
60 O
. O
0 O
micro O
g O
mL O
( O
- O
1 O
) O
) O
. O

The O
present O
investigation O
suggests O
that O
an O
isovalerate B
moiety O
in O
feroniellides B
D I
and I
E I
is O
possibly O
associated O
with O
exerting O
cytotoxicity O
against O
cancer O
cells O
. O

The O
structure O
of O
tsukubachelin B
B I
( O
1 O
) O
comprises O
6 O
mol O
of O
amino B
acids I
, O
including O
2 O
mol O
of O
serine B
and O
1 O
mol O
each O
of O
ornithine B
, O
N B
- I
alpha I
- I
methyl I
- I
N I
- I
delta I
- I
hydroxy I
- I
N I
- I
delta I
- I
formylornithine I
, O
N B
- I
alpha I
- I
methyl I
- I
N I
- I
delta I
- I
hydroxyornithine I
, O
and O
cyclic B
N I
- I
hydroxyornithine I
. O

Its O
structure O
and O
absolute O
configurations O
were O
established O
on O
the O
basis O
of O
spectral O
data O
, O
particularly O
by O
the O
use O
of O
1D O
NMR O
, O
2D O
shift O
- O
correlated O
NMR O
pulse O
sequences O
( O
( B
1 I
) I
H I
- O
( B
1 I
) I
H I
COSY O
, O
HSQC O
, O
HMBC O
and O
ROESY O
) O
and O
CD O
spectra O
. O

Its O
structure O
and O
absolute O
configurations O
were O
established O
on O
the O
basis O
of O
spectral O
data O
, O
particularly O
by O
the O
use O
of O
1D O
NMR O
, O
2D O
shift O
- O
correlated O
NMR O
pulse O
sequences O
( O
( B
1 I
) I
H I
- O
( B
1 I
) I
H I
COSY O
, O
HSQC O
, O
HMBC O
and O
ROESY O
) O
and O
CD O
spectra O
. O

In O
contrast O
, O
administration O
of O
the O
5HT2AR O
antagonist O
MDL B
11 I
, I
939 I
( O
0 O
. O
5 O
mg O
/ O
kg O
, O
i O
. O
p O
. O
) O
delayed O
the O
acquisition O
of O
extinction O
of O
fear O
memory O
. O

Here O
, O
we O
used O
two O
compounds O
, O
Compound O
44 O
[ O
6 B
, I
6 I
- I
dimethyl I
- I
3 I
- I
( I
3 I
- I
hydroxypropyl I
) I
thio I
- I
1 I
- I
( I
thiazol I
- I
2 I
- I
yl I
) I
- I
6 I
, I
7 I
- I
dihydro I
- I
2 I
- I
benzothiophen I
- I
4 I
( I
5H I
) I
- I
one I
] O
and O
Compound O
6 O
[ O
methyl B
3 I
, I
5 I
- I
diphenylpyridazine I
- I
4 I
- I
carboxylate I
] O
, O
with O
functional O
activity O
as O
potentiators O
of O
gamma B
- I
aminobutyric I
acid I
at O
GABA B
( O
A O
) O
alpha O
5 O
receptors O
, O
to O

dissociation O
( O
ETD O
) O
tandem O
mass O
spectrometry O
using O
fluoranthene B
anion I
- I
radical I
as O
an O
electron O
donor O
. O

In O
silico O
electron O
transfer O
to O
the O
precursor O
dications O
, O
( O
GtK B
+ O
2H B
) O
( O
2 O
+ O
) O
, O
( O
AtK B
+ O
2H B
) O
( O
2 O
+ O
) O
, O
and O
( O
AtR B
+ O
2H B
) O
( O
2 O
+ O
) O
, O
formed O
zwitterionic O
intermediates O
containing O
thioenol B
anion I
- I
radical I
and O
ammonium B
cation I
groups O
that O
were O
local O
energy O
minima O
on O
the O
potential O
energy O
surface O
of O
the O
ground O
electronic O
state O
. O

The O
zwitterions O
underwent O
facile O
isomerization O
by O
N B
- O
terminal O
ammonium B
proton O
migration O
to O
the O
thioenol B
anion I
- I
radical I
group O
forming O
aminothioketyl B
intermediates O
. O

Reaction O
of O
HOD B
( I
+ I
) I
with O
CO B
was O
studied O
over O
the O
collision O
energy O
( O
E O
( O
col O
) O
) O
range O
between O
0 O
. O
18 O
and O
2 O
. O
87 O
eV O
, O
for O
HOD B
( I
+ I
) I
in O
its O
ground O
state O
and O
with O
one O
quantum O
in O
each O
of O
its O
vibrational O
modes O
: O
( O
001 O
) O
- O
- O
predominantly O
OH B
stretch O
; O
( O
010 O
) O
- O
- O
bend O
, O
and O
( O
100 O
) O
- O
- O
predominately O
OD B
stretch O
. O

Reaction O
of O
HOD B
( I
+ I
) I
with O
CO B
was O
studied O
over O
the O
collision O
energy O
( O
E O
( O
col O
) O
) O
range O
between O
0 O
. O
18 O
and O
2 O
. O
87 O
eV O
, O
for O
HOD B
( I
+ I
) I
in O
its O
ground O
state O
and O
with O
one O
quantum O
in O
each O
of O
its O
vibrational O
modes O
: O
( O
001 O
) O
- O
- O
predominantly O
OH B
stretch O
; O
( O
010 O
) O
- O
- O
bend O
, O
and O
( O
100 O
) O
- O
- O
predominately O
OD B
stretch O
. O

The O
dominant O
reactions O
are O
near O
- O
thermoneutral O
proton O
and O
deuteron B
transfer O
, O
generating O
HCO B
( I
+ I
) I
and O
DCO B
( I
+ I
) I
product O
ions O
by O
a O
predominantly O
direct O
mechanism O
. O

The O
dominant O
reactions O
are O
near O
- O
thermoneutral O
proton O
and O
deuteron B
transfer O
, O
generating O
HCO B
( I
+ I
) I
and O
DCO B
( I
+ I
) I
product O
ions O
by O
a O
predominantly O
direct O
mechanism O
. O

The O
HCO B
( I
+ I
) I
and O
DCO B
( I
+ I
) I
channels O
occur O
with O
a O
combined O
efficiency O
of O
76 O
% O
for O
ground O
state O
HOD B
( I
+ I
) I
at O
our O
lowest O
E O
( O
col O
) O
, O
increasing O
to O
94 O
% O
for O
E O
( O
col O
) O
around O
0 O
. O
33 O
eV O
, O
then O
falling O
at O
high O
E O
( O
col O
) O
to O
~ O
40 O
% O
. O

The O
HCO B
( I
+ I
) I
and O
DCO B
( I
+ I
) I
channels O
occur O
with O
a O
combined O
efficiency O
of O
76 O
% O
for O
ground O
state O
HOD B
( I
+ I
) I
at O
our O
lowest O
E O
( O
col O
) O
, O
increasing O
to O
94 O
% O
for O
E O
( O
col O
) O
around O
0 O
. O
33 O
eV O
, O
then O
falling O
at O
high O
E O
( O
col O
) O
to O
~ O
40 O
% O
. O

The O
HCO B
( I
+ I
) I
and O
DCO B
( I
+ I
) I
channels O
occur O
with O
a O
combined O
efficiency O
of O
76 O
% O
for O
ground O
state O
HOD B
( I
+ I
) I
at O
our O
lowest O
E O
( O
col O
) O
, O
increasing O
to O
94 O
% O
for O
E O
( O
col O
) O
around O
0 O
. O
33 O
eV O
, O
then O
falling O
at O
high O
E O
( O
col O
) O
to O
~ O
40 O
% O
. O

The O
HCO B
( I
+ I
) I
and O
DCO B
( I
+ I
) I
channels O
have O
a O
complicated O
dependence O
on O
the O
HOD B
( I
+ I
) I
vibrational O
state O
. O

The O
HCO B
( I
+ I
) I
and O
DCO B
( I
+ I
) I
channels O
have O
a O
complicated O
dependence O
on O
the O
HOD B
( I
+ I
) I
vibrational O
state O
. O

The O
HCO B
( I
+ I
) I
and O
DCO B
( I
+ I
) I
channels O
have O
a O
complicated O
dependence O
on O
the O
HOD B
( I
+ I
) I
vibrational O
state O
. O

Excitation O
of O
the O
OH B
or O
OD B
stretch O
modes O
enhances O
H B
( I
+ I
) I
or O
D B
( I
+ I
) I
transfer O
, O
respectively O
, O
and O
inhibits O
D B
( I
+ I
) I
or O
H B
( I
+ I
) I
transfer O
. O

Excitation O
of O
the O
OH B
or O
OD B
stretch O
modes O
enhances O
H B
( I
+ I
) I
or O
D B
( I
+ I
) I
transfer O
, O
respectively O
, O
and O
inhibits O
D B
( I
+ I
) I
or O
H B
( I
+ I
) I
transfer O
. O

Excitation O
of O
the O
OH B
or O
OD B
stretch O
modes O
enhances O
H B
( I
+ I
) I
or O
D B
( I
+ I
) I
transfer O
, O
respectively O
, O
and O
inhibits O
D B
( I
+ I
) I
or O
H B
( I
+ I
) I
transfer O
. O

Excitation O
of O
the O
OH B
or O
OD B
stretch O
modes O
enhances O
H B
( I
+ I
) I
or O
D B
( I
+ I
) I
transfer O
, O
respectively O
, O
and O
inhibits O
D B
( I
+ I
) I
or O
H B
( I
+ I
) I
transfer O
. O

Bend O
excitation O
preferentially O
enhances O
H B
( I
+ I
) I
transfer O
, O
with O
no O
effect O
on O
D B
( I
+ I
) I
transfer O
. O

Bend O
excitation O
preferentially O
enhances O
H B
( I
+ I
) I
transfer O
, O
with O
no O
effect O
on O
D B
( I
+ I
) I
transfer O
. O

There O
is O
no O
coupling O
of O
energy O
initially O
in O
any O
HOD B
( I
+ I
) I
vibrational O
mode O
to O
recoil O
velocity O
of O
either O
of O
the O
product O
ions O
, O
even O
at O
low O
E O
( O
col O
) O
where O
vibrational O
excitation O
doubles O
or O
triples O
the O
energy O
available O
to O
products O
. O

HOCO B
( I
+ I
) I
+ O
D B
and O
DOCO B
( I
+ I
) I
+ O
H B
products O
are O
also O
observed O
, O
but O
as O
minor O
channels O
despite O
being O
barrierless O
and O
exoergic O
. O

HOCO B
( I
+ I
) I
+ O
D B
and O
DOCO B
( I
+ I
) I
+ O
H B
products O
are O
also O
observed O
, O
but O
as O
minor O
channels O
despite O
being O
barrierless O
and O
exoergic O
. O

To O
assess O
the O
potential O
use O
of O
these O
compounds O
in O
the O
treatment O
of O
ADHD O
, O
we O
examined O
the O
effects O
of O
a O
well O
- O
characterized O
benztropine B
analog O
, O
AHN B
2 I
- I
005 I
, O
on O
performance O
of O
rats O
in O
a O
PFC O
- O
dependent O
delayed O
- O
alternation O
task O
of O
spatial O
working O
memory O
. O

Similar O
to O
that O
seen O
with O
all O
drugs O
currently O
approved O
for O
ADHD O
, O
AHN B
2 I
- I
005 I
dose O
- O
dependently O
improved O
performance O
in O
this O
task O
. O

Despite O
the O
selectivity O
of O
this O
compound O
for O
the O
DA O
transporter O
, O
additional O
microdialysis O
studies O
demonstrated O
that O
a O
cognition O
- O
enhancing O
dose O
of O
AHN B
2 I
- I
005 I
that O
lacked O
locomotor O
activating O
effects O
increased O
extracellular O
levels O
of O
both O
DA O
and O
NE O
in O
the O
PFC O
. O

AHN B
2 I
- I
005 I
produced O
a O
larger O
increase O
in O
extracellular O
DA O
in O
the O
nucleus O
accumbens O
, O
although O
the O
magnitude O
of O
this O
was O
well O
below O
that O
seen O
with O
motor O
activating O
doses O
of O
psychostimulants O
. O

These O
studies O
provide O
a O
strong O
rationale O
for O
future O
research O
focused O
on O
the O
neural O
mechanisms O
contributing O
to O
the O
cognition O
- O
enhancing O
actions O
and O
the O
potential O
clinical O
utility O
of O
AHN B
2 I
- I
005 I
and O
related O
compounds O
. O

Using O
neuroblastoma O
- O
derived O
Neuro O
- O
2a O
cells O
to O
investigate O
the O
function O
of O
ARIP1 O
, O
we O
found O
that O
overexpression O
of O
ARIP1 O
down O
- O
regulated O
the O
activin O
A O
- O
induced O
signal O
transduction O
and O
significantly O
decreased O
the O
voltage O
- O
gated O
Na B
( I
+ I
) I
current O
( O
I O
( O
Na B
) O
) O
. O

In O
this O
study O
, O
we O
investigated O
the O
protection O
by O
chrysin B
, O
apigenin B
, O
and O
luteolin B
against O
tert B
- I
butyl I
hydroperoxide I
( O
tBHP B
) O
- O
induced O
oxidative O
stress O
and O
the O
possible O
mechanisms O
involved O
in O
rat O
primary O
hepatocytes O
. O

Vitamin B
D I
binding O
protein O
is O
a O
key O
determinant O
of O
25 B
- I
hydroxyvitamin I
D I
levels O
in O
infants O
and O
toddlers O
. O

Circulating O
25 B
- I
hydroxyvitamin I
D I
( O
25 B
- I
OHD I
) O
levels O
vary O
among O
human O
populations O
. O

Omega B
- I
3 I
PUFA I
intake O
was O
assessed O
using O
an O
interviewer O
- O
administered O
food O
frequency O
questionnaire O
. O

In O
contrast O
, O
HgCl B
( I
2 I
) I
caused O
a O
concentration O
- O
dependent O
decline O
of O
viable O
leukocytes O
and O
especially O
of O
activated O
T O
cells O
. O

1 O
. O
Six O
healthy O
male O
subjects O
were O
given O
a O
single O
dose O
of O
500 O
mg O
of O
[ B
14C I
] I
PTZ601 I
( O
mean O
radioactivity O
79 O
. O
2 O
mu O
Ci O
) O
by O
intravenous O
( O
IV O
) O
infusion O
over O
1 O
h O
, O
and O
observed O
for O
5 O
days O
post O
- O
dose O
during O
which O
pharmacokinetic O
( O
PK O
) O
samples O
were O
collected O
. O

Pregnant O
ApoE O
( O
- O
/ O
- O
) O
mice O
were O
given O
drinking O
water O
containing O
85 O
mg O
/ O
l O
NaAsO B
( I
2 I
) I
( O
49 O
ppm O
arsenic B
) O
from O
gestation O
day O
( O
GD O
) O
8 O
to O
18 O
. O

Release O
from O
the O
gland O
of O
the O
reproductive O
hormones O
luteinising O
hormone O
and O
follicle O
- O
stimulating O
hormone O
is O
regulated O
primarily O
by O
hypothalamically O
- O
derived O
gonadotrophin B
- I
releasing I
hormone I
( O
GnRH B
) O
, O
although O
other O
releasing O
factors O
( O
RF O
) O
have O
been O
postulated O
to O
exist O
. O

Herein O
, O
a O
flexible O
and O
conductive O
CNT O
/ O
TiO B
( I
2 I
) I
core O
/ O
shell O
heterostructure O
film O
is O
reported O
, O
with O
aligned O
and O
interconnected O
CNTs O
wrapped O
in O
a O
continuous O
TiO B
( I
2 I
) I
coating O
. O

Herein O
, O
a O
flexible O
and O
conductive O
CNT O
/ O
TiO B
( I
2 I
) I
core O
/ O
shell O
heterostructure O
film O
is O
reported O
, O
with O
aligned O
and O
interconnected O
CNTs O
wrapped O
in O
a O
continuous O
TiO B
( I
2 I
) I
coating O
. O

Without O
using O
additional O
transparent O
conducting O
oxide B
( O
TCO O
) O
substrates O
, O
this O
unique O
feature O
of O
the O
film O
boosts O
the O
incident O
photon O
- O
to O
- O
electron O
conversion O
efficiency O
to O
32 O
% O
, O
outperforming O
TiO B
( I
2 I
) I
nanoparticle O
electrodes O
fabricated O
on O
TCO O
substrates O
. O

We O
address O
these O
hypotheses O
by O
initially O
examining O
the O
exposure O
effects O
of O
ozone B
( O
O B
( I
3 I
) I
) O
and O
/ O
or O
particulate O
matter O
( O
PM O
) O
on O
cardiac O
function O
in O
C57Bl O
/ O
6J O
( O
B6 O
) O
mice O
. O

Separate O
groups O
of O
mice O
underwent O
3 O
consecutive O
days O
of O
the O
same O
exposure O
sequence O
for O
3h O
each O
consisting O
of O
the O
following O
: O
( O
1 O
) O
6h O
of O
filtered O
air O
( O
FAFA O
) O
, O
( O
2 O
) O
O B
( I
3 I
) I
then O
FA O
( O
O B
( I
3 I
) I
FA O
) O
, O
( O
3 O
) O
FA O
then O
carbon B
black I
( O
FACB O
) O
, O
or O
( O
4 O
) O
O B
( I
3 I
) I
then O
CB O
. O

Separate O
groups O
of O
mice O
underwent O
3 O
consecutive O
days O
of O
the O
same O
exposure O
sequence O
for O
3h O
each O
consisting O
of O
the O
following O
: O
( O
1 O
) O
6h O
of O
filtered O
air O
( O
FAFA O
) O
, O
( O
2 O
) O
O B
( I
3 I
) I
then O
FA O
( O
O B
( I
3 I
) I
FA O
) O
, O
( O
3 O
) O
FA O
then O
carbon B
black I
( O
FACB O
) O
, O
or O
( O
4 O
) O
O B
( I
3 I
) I
then O
CB O
. O

Separate O
groups O
of O
mice O
underwent O
3 O
consecutive O
days O
of O
the O
same O
exposure O
sequence O
for O
3h O
each O
consisting O
of O
the O
following O
: O
( O
1 O
) O
6h O
of O
filtered O
air O
( O
FAFA O
) O
, O
( O
2 O
) O
O B
( I
3 I
) I
then O
FA O
( O
O B
( I
3 I
) I
FA O
) O
, O
( O
3 O
) O
FA O
then O
carbon B
black I
( O
FACB O
) O
, O
or O
( O
4 O
) O
O B
( I
3 I
) I
then O
CB O
. O

For O
example O
, O
O B
( I
3 I
) I
FA O
exposure O
led O
to O
reductions O
in O
both O
end O
- O
systolic O
and O
end O
- O
diastolic O
left O
ventricular O
( O
LV O
) O
volumes O
, O
whereas O
FACB O
exposure O
led O
an O
increase O
in O
end O
- O
diastolic O
LV O
volume O
. O

These O
same O
cardiac O
compensatory O
changes O
were O
largely O
abolished O
in O
Nppa O
KO O
mice O
following O
O B
( I
3 I
) I
FA O
or O
FACB O
exposure O
. O

These O
results O
suggest O
that O
cardiac O
functional O
changes O
in O
response O
to O
air O
pollution O
exposure O
are O
strongly O
dependent O
on O
the O
pollutant O
constituents O
, O
especially O
related O
to O
O B
( I
3 I
) I
and O
/ O
or O
PM O
. O

A438079 B
did O
not O
directly O
affect O
JNK O
activation O
induced O
by O
tert B
- I
butyl I
hydroperoxide I
and O
GSH B
depletion O
. O

Induction O
of O
apoptosis O
in O
human O
ovarian O
cancer O
cells O
by O
new O
anticancer O
compounds O
, O
epothilone B
A I
and I
B I
. O

These O
systems O
were O
investigated O
in O
vivo O
for O
skin O
penetration O
, O
skin O
irritation O
, O
and O
the O
ability O
to O
knockdown O
glyceraldehyde B
3 I
- I
phosphate I
dehydrogenase O
( O
GAPDH O
) O
protein O
levels O
in O
animal O
models O
. O

Gallic B
acid I
and O
p B
- I
cumaric I
acid I
were O
identified O
for O
Ayval O
i O
k O
and O
Domat O
at O
each O
period O
of O
ripening O
, O
respectively O
. O

In O
addition O
, O
gallic B
acid I
, O
p B
- I
cumaric I
acid I
, O
sinapinic B
and I
apigenin I
acids I
were O
detected O
in O
Gemlik O
olive O
fruit O
. O

In O
addition O
, O
gallic B
acid I
, O
p B
- I
cumaric I
acid I
, O
sinapinic B
and I
apigenin I
acids I
were O
detected O
in O
Gemlik O
olive O
fruit O
. O

Two O
- O
dimensional O
rotating O
- O
frame O
nuclear O
Overhauser O
effect O
spectroscopy O
( O
2D O
ROESY O
) O
( B
1 I
) I
H I
NMR O
analyses O
show O
that O
the O
A O
ring O
of O
rutin B
was O
the O
part O
of O
the O
molecule O
that O
most O
likely O
inserted O
into O
the O
cavity O
of O
HP B
- I
beta I
- I
CD I
, O
thus O
forming O
a O
supramolecular O
inclusion O
complex O
. O

Direct O
- O
acting O
CB1 O
agonists O
, O
including O
Delta B
( I
9 I
) I
- I
tetrahydrocannabinol I
, O
WIN B
55 I
, I
212 I
[ O
R B
- I
( I
1 I
) I
- I
[ I
2 I
, I
3 I
- I
dihydro I
- I
5 I
- I
methyl I
- I
3 I
- I
[ I
( I
morpholinyl I
) I
methyl I
] I
pyrrolo I
[ I
1 I
, I
2 I
, I
3 I
- I
de I
] I
- I
1 I
, I
4 I
- I
benzoxazinyl I
] I
- I
( I
1 I
- I
naphthalenyl I
) I
methanone I
mesylate I
] O
, O
AM2389 B
[ O
9 B
beta I
- I
hydroxy I
- I
3 I
- I
( I
1 I
- I
hexyl I

In O
further O
studies O
, O
the O
diuretic O
effects O
of O
the O
CB1 O
agonist O
AM4054 B
were O
similar O
in O
male O
and O
female O
rats O
, O
displayed O
a O
relatively O
rapid O
onset O
to O
action O
, O
and O
were O
dose O
- O
dependently O
antagonized O
by O
30 O
minutes O
pretreatment O
with O
rimonabant B
, O
but O
not O
by O
the O
vanilloid B
receptor O
type O
I O
antagonist O
capsazepine B
, O
nor O
were O
the O
effects O
of O
WIN B
55 I
, I
212 I
antagonized O
by O
the O
CB2 O
antagonist O
AM630 B
[ O
( B
6 I
- I
iodo I
- I
2 I
- I
methyl I
- I
1 I
- I
[ I
2 I
- I
( I
4 I
- I
morpholinyl I
) I
ethyl I
] I
- I

Attention O
is O
regulated O
, O
at O
least O
in O
part O
, O
by O
the O
prefrontal O
cortex O
( O
PFC O
) O
, O
a O
brain O
area O
in O
which O
pathology O
of O
gamma B
- I
aminobutyric I
acid I
( O
GABA B
) O
neurons O
has O
been O
consistently O
observed O
in O
post O
- O
mortem O
analysis O
of O
the O
brains O
of O
people O
with O
schizophrenia O
. O

In O
this O
study O
, O
we O
performed O
live O
imaging O
analyses O
of O
Neuro O
- O
2a O
cells O
expressing O
SCAT3 O
, O
a O
caspase O
- O
3 O
cleavage O
peptide O
sequence O
linking O
two O
fluorescent O
proteins O
; O
enhanced O
cyan O
fluorescence O
protein O
( O
ECFP O
) O
and O
Venus O
, O
to O
determine O
whether O
sodium B
arsenite I
( O
NaAsO B
( I
2 I
) I
; O
0 O
, O
1 O
, O
5 O
, O
or O
10 O
mu O
M O
) O
affects O
both O
neurite O
outgrowth O
and O
/ O
or O
induces O
apoptosis O
with O
the O
same O
doses O
and O
in O
the O
same O
cell O
cultures O
. O

We O
observed O
that O
the O
area O
ratio O
of O
neurite O
to O
cell O
body O
in O
SCAT3 O
- O
expressing O
cells O
was O
significantly O
reduced O
by O
5 O
and O
10 O
mu O
M O
NaAsO B
( I
2 I
) I
, O
but O
not O
by O
1 O
mu O
M O
, O
although O
the O
emission O
ratio O
of O
ECFP O
to O
Venus O
, O
an O
endpoint O
of O
caspase O
- O
3 O
activity O
, O
was O
not O
changed O
. O

However O
, O
cytological O
assay O
using O
apoptotic O
and O
necrotic O
markers O
resulted O
in O
that O
apoptosis O
, O
but O
not O
necrosis O
, O
was O
significantly O
induced O
in O
Neuro O
- O
2a O
cells O
when O
NaAsO B
( I
2 I
) I
exposure O
continued O
after O
the O
significant O
effects O
of O
NaAsO B
( I
2 I
) I
on O
neurite O
outgrowth O
were O
found O
by O
live O
imaging O
. O

However O
, O
cytological O
assay O
using O
apoptotic O
and O
necrotic O
markers O
resulted O
in O
that O
apoptosis O
, O
but O
not O
necrosis O
, O
was O
significantly O
induced O
in O
Neuro O
- O
2a O
cells O
when O
NaAsO B
( I
2 I
) I
exposure O
continued O
after O
the O
significant O
effects O
of O
NaAsO B
( I
2 I
) I
on O
neurite O
outgrowth O
were O
found O
by O
live O
imaging O
. O

These O
results O
suggested O
that O
neurite O
outgrowth O
was O
suppressed O
by O
NaAsO B
( I
2 I
) I
prior O
to O
NaAsO B
( I
2 I
) I
- O
induced O
apoptosis O
. O

These O
results O
suggested O
that O
neurite O
outgrowth O
was O
suppressed O
by O
NaAsO B
( I
2 I
) I
prior O
to O
NaAsO B
( I
2 I
) I
- O
induced O
apoptosis O
. O

Next O
, O
we O
examined O
the O
effects O
of O
NaAsO B
( I
2 I
) I
on O
cytoskeletal O
gene O
expression O
in O
Neuro O
- O
2a O
cells O
. O

NaAsO B
( I
2 I
) I
increased O
the O
mRNA O
levels O
of O
the O
light O
and O
medium O
subunits O
of O
neurofilament O
and O
decreased O
the O
mRNA O
levels O
of O
tau O
and O
tubulin O
in O
a O
dose O
- O
dependent O
manner O
; O
no O
significant O
effect O
was O
found O
in O
the O
mRNA O
levels O
of O
the O
heavy O
subunit O
of O
neurofilament O
, O
microtubule O
- O
associated O
protein O
2 O
, O
or O
actin O
. O

The O
changes O
in O
cytoskeletal O
gene O
expression O
are O
likely O
responsible O
for O
the O
inhibitory O
effects O
of O
NaAsO B
( I
2 I
) I
on O
neurite O
outgrowth O
. O

Several O
series O
of O
45 O
acetophenone B
derivatives O
bearing O
various O
alkyl B
or O
benzyl B
substituents O
were O
conveniently O
synthesized O
and O
their O
structures O
characterized O
by O
( B
1 I
) I
H I
and O
( B
13 I
) I
C I
NMR O
spectroscopy O
, O
HRMS O
and O
single O
- O
crystal O
X O
- O
ray O
analysis O
. O

Several O
series O
of O
45 O
acetophenone B
derivatives O
bearing O
various O
alkyl B
or O
benzyl B
substituents O
were O
conveniently O
synthesized O
and O
their O
structures O
characterized O
by O
( B
1 I
) I
H I
and O
( B
13 I
) I
C I
NMR O
spectroscopy O
, O
HRMS O
and O
single O
- O
crystal O
X O
- O
ray O
analysis O
. O

RSV B
targets O
and O
activates O
the O
NAD B
( I
+ I
) I
- O
dependent O
protein O
deacetylase O
SIRT1 O
; O
in O
turn O
, O
SIRT1 O
induces O
an O
intracellular O
antioxidative O
mechanism O
by O
inducing O
mitochondrial O
superoxide B
dismutase O
( O
SOD2 O
) O
. O

Then O
, O
the O
effect O
of O
UVA O
- O
irradiation O
over O
NCTC2544 O
cells O
treated O
with O
increasing O
concentrations O
of O
15 O
compounds O
including O
photoallergens O
( O
benzophenone B
, O
4 B
- I
ter I
- I
butyl I
- I
4 I
- I
methoxy I
- I
dibenzoylmethane I
, I
2 I
- I
ethylexyl I
- I
p I
- I
methoxycinnamate I
, O
ketoprofen B
, O
6 B
- I
methylcumarin I
) O
; O
photoirritant O
and O
photoallergen O
( O
4 B
- I
aminobenzoic I
acid I
, O
chlorpromazine B
, O
promethazine B
) O
; O
photoirritants O
( O
acridine B
, O

Immunohistochemical O
analysis O
also O
revealed O
that O
LPS O
- O
induced O
lipocalin O
- O
2 O
is O
expressed O
by O
brain O
endothelial O
cells O
and O
is O
partly O
co O
- O
localised O
with O
cyclooxygenase O
- O
2 O
( O
Cox O
- O
2 O
) O
, O
the O
rate O
- O
limiting O
enzyme O
for O
the O
production O
of O
inflammatory O
induced O
prostaglandin B
E I
( I
2 I
) I
( O
PGE B
( I
2 I
) I
) O
, O
which O
is O
the O
key O
mediator O
of O
fever O
. O

Our O
findings O
suggest O
that O
IL O
- O
6 O
influences O
the O
expression O
of O
lipocalin O
- O
2 O
, O
which O
in O
turn O
may O
be O
involved O
in O
the O
control O
of O
the O
formation O
of O
Cox O
- O
2 O
, O
and O
hence O
central O
PGE B
( I
2 I
) I
- O
production O
. O

Dye O
- O
sensitized O
solar O
cells O
( O
DSSCs O
) O
based O
on O
hierarchical O
rutile O
TiO B
( I
2 I
) I
flower O
clusters O
prepared O
by O
a O
facile O
, O
one O
- O
pot O
hydrothermal O
process O
exhibit O
a O
high O
efficiency O
. O

Complex O
yet O
appealing O
rutile O
TiO B
( I
2 I
) I
flower O
films O
are O
, O
for O
the O
first O
time O
, O
directly O
hydrothermally O
grown O
on O
a O
transparent O
conducting O
fluorine B
- I
doped I
tin I
oxide I
( O
FTO B
) O
substrate O
. O

Notably O
, O
the O
small O
lattice O
mismatch O
between O
the O
FTO B
substrate O
and O
rutile O
TiO B
( I
2 I
) I
renders O
the O
epitaxial O
growth O
of O
a O
compact O
rutile O
TiO B
( I
2 I
) I
layer O
on O
the O
FTO B
glass O
. O

Notably O
, O
the O
small O
lattice O
mismatch O
between O
the O
FTO B
substrate O
and O
rutile O
TiO B
( I
2 I
) I
renders O
the O
epitaxial O
growth O
of O
a O
compact O
rutile O
TiO B
( I
2 I
) I
layer O
on O
the O
FTO B
glass O
. O

Intriguingly O
, O
these O
TiO B
( I
2 I
) I
flower O
clusters O
can O
then O
be O
exploited O
as O
photoanodes O
to O
produce O
DSSCs O
, O
yielding O
a O
power O
conversion O
efficiency O
of O
2 O
. O
94 O
% O
despite O
their O
rutile O
nature O
, O
which O
is O
further O
increased O
to O
4 O
. O
07 O
% O
upon O
the O
TiCl B
( I
4 I
) I
treatment O
. O

Intriguingly O
, O
these O
TiO B
( I
2 I
) I
flower O
clusters O
can O
then O
be O
exploited O
as O
photoanodes O
to O
produce O
DSSCs O
, O
yielding O
a O
power O
conversion O
efficiency O
of O
2 O
. O
94 O
% O
despite O
their O
rutile O
nature O
, O
which O
is O
further O
increased O
to O
4 O
. O
07 O
% O
upon O
the O
TiCl B
( I
4 I
) I
treatment O
. O

Thus O
, O
the O
aim O
of O
this O
study O
is O
to O
investigate O
the O
effects O
of O
aluminum B
trichloride I
( O
AlCl B
( I
3 I
) I
) O
on O
CYPS O
in O
rats O
. O

Forty O
male O
Wistar O
rats O
( O
5weeks O
old O
) O
weighing O
110 O
- O
120g O
were O
randomly O
allocated O
and O
orally O
exposed O
to O
0 O
, O
64 O
. O
18 O
, O
128 O
. O
36 O
and O
256 O
. O
72mg O
/ O
kg O
body O
weight O
( O
BW O
) O
AlCl B
( I
3 I
) I
in O
drinking O
water O
for O
120days O
. O

The O
results O
revealed O
that O
exposure O
to O
AlCl B
( I
3 I
) I
inhibited O
the O
microsomal O
CYP450 O
dependent O
enzyme O
system O
of O
liver O
. O

Our O
findings O
suggest O
that O
long O
term O
daily O
exposure O
of O
AlCl B
( I
3 I
) I
exerts O
the O
suppressive O
effects O
and O
thus O
may O
cause O
dysfunction O
of O
hepatic O
CYP450 O
dependent O
enzyme O
system O
of O
rat O
. O

Based O
on O
the O
acute O
diarrhea O
after O
the O
ingestion O
of O
a O
single O
oral O
dose O
of O
monobasic O
( O
NaH2PO B
( I
4 I
) I
) O
and O
dibasic O
( O
Na2HPO B
( I
4 I
) I
) O
monophosphates B
in O
adults O
, O
a O
do O
not O
consume O
concentration O
of O
600 O
mg O
PO B
( I
4 I
) I
/ O
L O
can O
be O
derived O
. O

Based O
on O
the O
acute O
diarrhea O
after O
the O
ingestion O
of O
a O
single O
oral O
dose O
of O
monobasic O
( O
NaH2PO B
( I
4 I
) I
) O
and O
dibasic O
( O
Na2HPO B
( I
4 I
) I
) O
monophosphates B
in O
adults O
, O
a O
do O
not O
consume O
concentration O
of O
600 O
mg O
PO B
( I
4 I
) I
/ O
L O
can O
be O
derived O
. O

Based O
on O
the O
acute O
diarrhea O
after O
the O
ingestion O
of O
a O
single O
oral O
dose O
of O
monobasic O
( O
NaH2PO B
( I
4 I
) I
) O
and O
dibasic O
( O
Na2HPO B
( I
4 I
) I
) O
monophosphates B
in O
adults O
, O
a O
do O
not O
consume O
concentration O
of O
600 O
mg O
PO B
( I
4 I
) I
/ O
L O
can O
be O
derived O
. O

H B
- O
TiO B
( I
2 I
) I
@ O
MnO B
( I
2 I
) I
/ O
/ O
H B
- O
TiO B
( I
2 I
) I
@ O
C B
core O
- O
shell O
nanowires O
for O
high O
performance O
and O
flexible O
asymmetric O
supercapacitors O
. O

H B
- O
TiO B
( I
2 I
) I
@ O
MnO B
( I
2 I
) I
/ O
/ O
H B
- O
TiO B
( I
2 I
) I
@ O
C B
core O
- O
shell O
nanowires O
for O
high O
performance O
and O
flexible O
asymmetric O
supercapacitors O
. O

H B
- O
TiO B
( I
2 I
) I
@ O
MnO B
( I
2 I
) I
/ O
/ O
H B
- O
TiO B
( I
2 I
) I
@ O
C B
core O
- O
shell O
nanowires O
for O
high O
performance O
and O
flexible O
asymmetric O
supercapacitors O
. O

A O
flexible O
solid O
- O
state O
asymmetric O
supercapacitor O
device O
with O
H B
- O
TiO B
( I
2 I
) I
@ O
MnO B
( I
2 I
) I
core O
- O
shell O
NWs O
as O
the O
positive O
electrode O
and O
H B
- O
TiO B
( I
2 I
) I
@ O
C B
core O
- O
shell O
NWs O
as O
the O
negative O
electrode O
is O
developed O
. O

A O
flexible O
solid O
- O
state O
asymmetric O
supercapacitor O
device O
with O
H B
- O
TiO B
( I
2 I
) I
@ O
MnO B
( I
2 I
) I
core O
- O
shell O
NWs O
as O
the O
positive O
electrode O
and O
H B
- O
TiO B
( I
2 I
) I
@ O
C B
core O
- O
shell O
NWs O
as O
the O
negative O
electrode O
is O
developed O
. O

A O
flexible O
solid O
- O
state O
asymmetric O
supercapacitor O
device O
with O
H B
- O
TiO B
( I
2 I
) I
@ O
MnO B
( I
2 I
) I
core O
- O
shell O
NWs O
as O
the O
positive O
electrode O
and O
H B
- O
TiO B
( I
2 I
) I
@ O
C B
core O
- O
shell O
NWs O
as O
the O
negative O
electrode O
is O
developed O
. O

There O
are O
limited O
data O
on O
the O
sub O
- O
lethal O
physiological O
effects O
of O
titanium B
dioxide I
nanoparticles O
( O
TiO B
( I
2 I
) I
NPs O
) O
in O
adult O
fishes O
, O
and O
the O
consequences O
of O
TiO B
( I
2 I
) I
NP O
exposure O
on O
reproductive O
success O
are O
also O
unclear O
. O

There O
are O
limited O
data O
on O
the O
sub O
- O
lethal O
physiological O
effects O
of O
titanium B
dioxide I
nanoparticles O
( O
TiO B
( I
2 I
) I
NPs O
) O
in O
adult O
fishes O
, O
and O
the O
consequences O
of O
TiO B
( I
2 I
) I
NP O
exposure O
on O
reproductive O
success O
are O
also O
unclear O
. O

This O
study O
aimed O
to O
examine O
the O
sub O
- O
lethal O
effects O
of O
a O
14 O
- O
d O
aqueous O
TiO B
( I
2 I
) I
( O
TiO B
( I
2 I
) I
NP O
, O
0 O
. O
1 O
or O
1 O
. O
0 O
mg O
l O
( O
- O
1 O
) O
; O
TiO B
( I
2 I
) I
bulk O
, O
1 O
. O
0 O
mg O
l O
( O
- O
1 O
) O
) O
exposure O
on O
the O
physiology O
and O
reproductive O
health O
of O
zebrafish O
. O

This O
study O
aimed O
to O
examine O
the O
sub O
- O
lethal O
effects O
of O
a O
14 O
- O
d O
aqueous O
TiO B
( I
2 I
) I
( O
TiO B
( I
2 I
) I
NP O
, O
0 O
. O
1 O
or O
1 O
. O
0 O
mg O
l O
( O
- O
1 O
) O
; O
TiO B
( I
2 I
) I
bulk O
, O
1 O
. O
0 O
mg O
l O
( O
- O
1 O
) O
) O
exposure O
on O
the O
physiology O
and O
reproductive O
health O
of O
zebrafish O
. O

This O
study O
aimed O
to O
examine O
the O
sub O
- O
lethal O
effects O
of O
a O
14 O
- O
d O
aqueous O
TiO B
( I
2 I
) I
( O
TiO B
( I
2 I
) I
NP O
, O
0 O
. O
1 O
or O
1 O
. O
0 O
mg O
l O
( O
- O
1 O
) O
; O
TiO B
( I
2 I
) I
bulk O
, O
1 O
. O
0 O
mg O
l O
( O
- O
1 O
) O
) O
exposure O
on O
the O
physiology O
and O
reproductive O
health O
of O
zebrafish O
. O

Then O
, O
during O
a O
21 O
- O
d O
post O
exposure O
recovery O
period O
, O
effects O
of O
the O
TiO B
( I
2 I
) I
exposure O
on O
reproductive O
success O
were O
evaluated O
. O

Whole O
body O
Ti B
concentrations O
increased O
significantly O
in O
fish O
exposed O
to O
both O
the O
1 O
. O
0 O
mg O
l O
( O
- O
1 O
) O
TiO B
( I
2 I
) I
NP O
and O
bulk O
TiO B
( I
2 I
) I
compared O
to O
controls O
, O
but O
concentrations O
returned O
to O
control O
levels O
by O
the O
end O
of O
the O
recovery O
period O
. O

Whole O
body O
Ti B
concentrations O
increased O
significantly O
in O
fish O
exposed O
to O
both O
the O
1 O
. O
0 O
mg O
l O
( O
- O
1 O
) O
TiO B
( I
2 I
) I
NP O
and O
bulk O
TiO B
( I
2 I
) I
compared O
to O
controls O
, O
but O
concentrations O
returned O
to O
control O
levels O
by O
the O
end O
of O
the O
recovery O
period O
. O

No O
change O
in O
erythrocyte O
counts O
were O
observed O
, O
but O
there O
was O
a O
two O
- O
fold O
decline O
in O
leukocyte O
counts O
in O
all O
TiO B
( I
2 I
) I
treatment O
groups O
relative O
to O
time O
- O
matched O
controls O
. O

Whole O
body O
electrolyte O
and O
trace O
metal O
profiles O
were O
not O
affected O
by O
exposure O
to O
TiO B
( I
2 I
) I
, O
and O
there O
were O
no O
changes O
in O
Na B
( I
+ I
) I
K B
( I
+ I
) I
- O
ATPase O
activity O
in O
brain O
, O
gill O
or O
liver O
tissues O
. O

Whole O
body O
electrolyte O
and O
trace O
metal O
profiles O
were O
not O
affected O
by O
exposure O
to O
TiO B
( I
2 I
) I
, O
and O
there O
were O
no O
changes O
in O
Na B
( I
+ I
) I
K B
( I
+ I
) I
- O
ATPase O
activity O
in O
brain O
, O
gill O
or O
liver O
tissues O
. O

Whole O
body O
electrolyte O
and O
trace O
metal O
profiles O
were O
not O
affected O
by O
exposure O
to O
TiO B
( I
2 I
) I
, O
and O
there O
were O
no O
changes O
in O
Na B
( I
+ I
) I
K B
( I
+ I
) I
- O
ATPase O
activity O
in O
brain O
, O
gill O
or O
liver O
tissues O
. O

Total O
glutathione B
( O
GSH B
) O
levels O
in O
brain O
, O
gill O
and O
liver O
tissues O
were O
higher O
in O
fish O
exposed O
to O
TiO B
( I
2 I
) I
NP O
( O
both O
0 O
. O
1 O
and O
1 O
. O
0 O
mg O
l O
( O
- O
1 O
) O
) O
compared O
to O
bulk O
TiO B
( I
2 I
) I
and O
control O
fish O
. O

Total O
glutathione B
( O
GSH B
) O
levels O
in O
brain O
, O
gill O
and O
liver O
tissues O
were O
higher O
in O
fish O
exposed O
to O
TiO B
( I
2 I
) I
NP O
( O
both O
0 O
. O
1 O
and O
1 O
. O
0 O
mg O
l O
( O
- O
1 O
) O
) O
compared O
to O
bulk O
TiO B
( I
2 I
) I
and O
control O
fish O
. O

At O
the O
end O
of O
the O
14 O
- O
d O
exposure O
adult O
zebrafish O
were O
able O
to O
reproduce O
; O
however O
, O
the O
cumulative O
number O
of O
viable O
embryos O
produced O
was O
lower O
in O
fish O
exposed O
to O
1 O
. O
0 O
mg O
l O
( O
- O
1 O
) O
TiO B
( I
2 I
) I
( O
both O
NP O
and O
bulk O
) O
by O
the O
end O
of O
the O
21 O
- O
d O
recovery O
period O
. O

Overall O
, O
this O
study O
showed O
limited O
toxicity O
of O
bulk O
or O
nano O
scale O
TiO B
( I
2 I
) I
during O
the O
exposure O
; O
however O
reproduction O
was O
affected O
in O
both O
bulk O
and O
NP O
1 O
. O
0 O
mg O
l O
( O
- O
1 O
) O
groups O
. O

Buspirone B
and O
its O
major O
metabolites O
1 B
- I
( I
2 I
- I
pyrimidinyl I
) I
piperazine I
and O
6 B
' I
- I
hydroxybuspirone I
were O
determined O
using O
a O
newly O
validated O
UPLC O
- O
MS O
/ O
MS O
method O
. O

Single O
dose O
and O
7 O
- O
day O
AC O
administration O
at O
0 O
. O
125mg O
/ O
kg O
had O
no O
effect O
on O
CYP3A O
activity O
since O
no O
change O
in O
the O
formation O
of O
1 B
- I
( I
2 I
- I
pyrimidinyl I
) I
piperazine I
and O
6 B
' I
- I
hydroxybuspirone I
. O

The O
aim O
of O
the O
present O
study O
was O
to O
assess O
whether O
lactational O
exposure O
to O
polychlorinated B
biphenyl I
- I
153 I
( O
PCB B
- I
153 I
) O
, O
dichlorodiphenyldich B
( O
DDE B
) O
, O
or O
hexachlorobenzene B
( O
HCB B
) O
as O
estimated O
with O
a O
physiologically O
based O
pharmacokinetic O
( O
PBPK O
) O
model O
, O
is O
associated O
with O
decrements O
in O
mental O
and O
psychomotor O
development O
scores O
of O
the O
Bayley O
Scales O
of O
Infant O
Development O
( O
BSID O
) O
test O
in O
children O
aged O
around O
14 O
- O
months O
of O
a O
subsample O
( O
N O
= O

The O
theoretical O
calculation O
successfully O
predicted O
the O
experimental O
observation O
that O
the O
monomodal O
- O
poly B
( I
dimethyl I
siloxane I
) I
( O
PDMS B
) O
- O
brush O
- O
grafted O
TiO B
( I
2 I
) I
nanoparticles O
can O
only O
be O
well O
dispersed O
within O
a O
small O
molecular O
weight O
silicone B
matrix O
. O

Utilizing O
a O
bimodal O
grafted O
polymer O
brush O
design O
, O
with O
densely O
grafted O
short O
brushes O
to O
shield O
particle O
surfaces O
and O
sparsely O
grafted O
long O
brushes O
that O
favor O
the O
entanglement O
with O
matrix O
chains O
, O
we O
dispersed O
TiO B
( I
2 I
) I
nanoparticles O
in O
high O
molecular O
weight O
commercial O
silicone B
matrices O
and O
successfully O
prepared O
thick O
( O
about O
5 O
mm O
) O
transparent O
high O
- O
refractive O
- O
index O
TiO B
( I
2 I
) I
/ O
silicone B
nanocomposites O
. O

Utilizing O
a O
bimodal O
grafted O
polymer O
brush O
design O
, O
with O
densely O
grafted O
short O
brushes O
to O
shield O
particle O
surfaces O
and O
sparsely O
grafted O
long O
brushes O
that O
favor O
the O
entanglement O
with O
matrix O
chains O
, O
we O
dispersed O
TiO B
( I
2 I
) I
nanoparticles O
in O
high O
molecular O
weight O
commercial O
silicone B
matrices O
and O
successfully O
prepared O
thick O
( O
about O
5 O
mm O
) O
transparent O
high O
- O
refractive O
- O
index O
TiO B
( I
2 I
) I
/ O
silicone B
nanocomposites O
. O

Male O
Sprague O
- O
Dawley O
rats O
were O
exposed O
to O
either O
sham O
or O
IH O
( O
cycles O
between O
21 O
% O
O B
( I
2 I
) I
/ O
0 O
% O
CO B
( I
2 I
) I
and O
5 O
% O
O B
( I
2 I
) I
/ O
5 O
% O
CO B
( I
2 I
) I
) O
conditions O
for O
7 O
h O
/ O
day O
for O
14 O
or O
21 O
days O
. O

Male O
Sprague O
- O
Dawley O
rats O
were O
exposed O
to O
either O
sham O
or O
IH O
( O
cycles O
between O
21 O
% O
O B
( I
2 I
) I
/ O
0 O
% O
CO B
( I
2 I
) I
and O
5 O
% O
O B
( I
2 I
) I
/ O
5 O
% O
CO B
( I
2 I
) I
) O
conditions O
for O
7 O
h O
/ O
day O
for O
14 O
or O
21 O
days O
. O

Male O
Sprague O
- O
Dawley O
rats O
were O
exposed O
to O
either O
sham O
or O
IH O
( O
cycles O
between O
21 O
% O
O B
( I
2 I
) I
/ O
0 O
% O
CO B
( I
2 I
) I
and O
5 O
% O
O B
( I
2 I
) I
/ O
5 O
% O
CO B
( I
2 I
) I
) O
conditions O
for O
7 O
h O
/ O
day O
for O
14 O
or O
21 O
days O
. O

Male O
Sprague O
- O
Dawley O
rats O
were O
exposed O
to O
either O
sham O
or O
IH O
( O
cycles O
between O
21 O
% O
O B
( I
2 I
) I
/ O
0 O
% O
CO B
( I
2 I
) I
and O
5 O
% O
O B
( I
2 I
) I
/ O
5 O
% O
CO B
( I
2 I
) I
) O
conditions O
for O
7 O
h O
/ O
day O
for O
14 O
or O
21 O
days O
. O

Ethanol B
levels O
reached O
in O
circulation O
during O
moderate O
- O
to O
- O
heavy O
alcohol B
intoxication O
( O
50 O
- O
100 O
mM O
) O
modify O
Ca B
( I
2 I
+ I
) I
- O
and O
voltage O
- O
gated O
K B
( I
+ I
) I
( O
BK O
) O
channel O
steady O
- O
state O
activity O
, O
eventually O
altering O
both O
physiology O
and O
behavior O
. O

In O
contrast O
, O
50 O
- O
100 O
mM O
ethanol B
failed O
to O
alter O
the O
steady O
- O
state O
activities O
of O
Na B
( I
+ I
) I
/ O
Cl B
( I
- I
) I
- O
gated O
rslo2 O
, O
H B
( I
+ I
) I
- O
gated O
mslo3 O
, O
and O
an O
mslo1 O
/ O
3 O
chimera O
engineered O
by O
joining O
the O
mslo1 O
region O
encompassing O
the O
N B
terminus O
to O
S6 O
with O
the O
mslo3 O
cytosolic O
tail O
domain O
( O
CTD O
) O
. O

In O
contrast O
, O
50 O
- O
100 O
mM O
ethanol B
failed O
to O
alter O
the O
steady O
- O
state O
activities O
of O
Na B
( I
+ I
) I
/ O
Cl B
( I
- I
) I
- O
gated O
rslo2 O
, O
H B
( I
+ I
) I
- O
gated O
mslo3 O
, O
and O
an O
mslo1 O
/ O
3 O
chimera O
engineered O
by O
joining O
the O
mslo1 O
region O
encompassing O
the O
N B
terminus O
to O
S6 O
with O
the O
mslo3 O
cytosolic O
tail O
domain O
( O
CTD O
) O
. O

In O
contrast O
, O
50 O
- O
100 O
mM O
ethanol B
failed O
to O
alter O
the O
steady O
- O
state O
activities O
of O
Na B
( I
+ I
) I
/ O
Cl B
( I
- I
) I
- O
gated O
rslo2 O
, O
H B
( I
+ I
) I
- O
gated O
mslo3 O
, O
and O
an O
mslo1 O
/ O
3 O
chimera O
engineered O
by O
joining O
the O
mslo1 O
region O
encompassing O
the O
N B
terminus O
to O
S6 O
with O
the O
mslo3 O
cytosolic O
tail O
domain O
( O
CTD O
) O
. O

Collectively O
, O
data O
indicate O
that O
the O
slo O
family O
canonical O
design O
, O
which O
combines O
a O
transmembrane O
6 O
( O
TM6 O
) O
voltage O
- O
gated O
K B
( I
+ I
) I
channel O
( O
K B
( O
V O
) O
) O
core O
with O
CTDs O
that O
empower O
the O
channel O
with O
ion O
- O
sensing O
, O
does O
not O
necessarily O
render O
ethanol B
sensitivity O
. O

Rather O
, O
a O
CTD O
containing O
Ca B
( I
2 I
+ I
) I
- O
sensing O
regulator O
of O
conductance O
for O
K B
( I
+ I
) I
domains O
seems O
to O
be O
critical O
to O
bestow O
K B
( O
V O
) O
structures O
, O
whether O
of O
TM2 O
( O
MthK O
) O
or O
TM6 O
( O
slo1 O
) O
, O
with O
sensitivity O
to O
intoxicating O
ethanol B
levels O
. O

N B
- I
Methyl I
- I
anthraniloyl I
modification O
at O
the O
3 B
' I
- I
OH I
of O
the O
2 B
' I
- I
deoxyribose I
leads O
to O
ligands O
( O
mant O
- O
deoxy O
- O
ATP B
[ O
dATP O
] O
, O
mant O
- O
deoxy O
- O
ADP B
) O
with O
inverse O
agonist O
activity O
. O

N B
- I
Methyl I
- I
anthraniloyl I
modification O
at O
the O
3 B
' I
- I
OH I
of O
the O
2 B
' I
- I
deoxyribose I
leads O
to O
ligands O
( O
mant O
- O
deoxy O
- O
ATP B
[ O
dATP O
] O
, O
mant O
- O
deoxy O
- O
ADP B
) O
with O
inverse O
agonist O
activity O
. O

Toxicokinetic O
study O
and O
absolute O
oral O
bioavailability O
of O
deoxynivalenol B
, O
T B
- I
2 I
toxin I
and O
zearalenone B
in O
broiler O
chickens O
. O

For O
deoxynivalenol B
a O
bolus O
of O
0 O
. O
75mg O
/ O
kg O
BW O
was O
administered O
, O
for O
T B
- I
2 I
toxin I
0 O
. O
02mg O
/ O
kg O
BW O
and O
for O
zearalenone B
0 O
. O
3mg O
/ O
kg O
BW O
. O

Volumes O
of O
distribution O
were O
recorded O
, O
i O
. O
e O
. O
4 O
. O
99 O
, O
0 O
. O
14 O
and O
22 O
. O
26L O
/ O
kg O
for O
deoxynivalenol B
, O
T B
- I
2 I
toxin I
and O
zearalenone B
, O
respectively O
. O

Total O
body O
clearance O
was O
0 O
. O
12 O
, O
0 O
. O
03 O
and O
0 O
. O
48L O
/ O
minkg O
for O
deoxynivalenol B
, O
T B
- I
2 I
toxin I
and O
zearalenone B
, O
respectively O
. O

After O
IV O
administration O
, O
T B
- I
2 I
toxin I
had O
the O
shortest O
elimination O
half O
- O
life O
( O
3 O
. O
9min O
) O
, O
followed O
by O
deoxynivalenol B
( O
27 O
. O
9min O
) O
and O
zearalenone B
( O
31 O
. O
8min O
) O
. O

The O
synthetic O
H2S B
donors O
reviewed O
include O
, O
GYY4137 B
; O
cysteine B
analogs O
; O
S B
- I
propyl I
cysteine I
, O
S B
- I
allyl I
cysteine I
, O
S B
- I
propargyl I
cysteine I
, O
and O
N B
- I
acetyl I
cysteine I
. O

The O
synthetic O
H2S B
donors O
reviewed O
include O
, O
GYY4137 B
; O
cysteine B
analogs O
; O
S B
- I
propyl I
cysteine I
, O
S B
- I
allyl I
cysteine I
, O
S B
- I
propargyl I
cysteine I
, O
and O
N B
- I
acetyl I
cysteine I
. O

The O
synthetic O
H2S B
donors O
reviewed O
include O
, O
GYY4137 B
; O
cysteine B
analogs O
; O
S B
- I
propyl I
cysteine I
, O
S B
- I
allyl I
cysteine I
, O
S B
- I
propargyl I
cysteine I
, O
and O
N B
- I
acetyl I
cysteine I
. O

The O
synthetic O
H2S B
donors O
reviewed O
include O
, O
GYY4137 B
; O
cysteine B
analogs O
; O
S B
- I
propyl I
cysteine I
, O
S B
- I
allyl I
cysteine I
, O
S B
- I
propargyl I
cysteine I
, O
and O
N B
- I
acetyl I
cysteine I
. O

Concentrations O
of O
inorganic O
arsenic B
, O
as O
sum O
of O
arsenite B
( O
As B
( I
III I
) I
) O
and O
arsenate B
( O
As B
( I
V I
) I
) O
were O
determined O
in O
600 O
composite O
samples O
by O
using O
inductively O
coupled O
plasma O
mass O
spectrometry O
. O

Concentrations O
of O
inorganic O
arsenic B
, O
as O
sum O
of O
arsenite B
( O
As B
( I
III I
) I
) O
and O
arsenate B
( O
As B
( I
V I
) I
) O
were O
determined O
in O
600 O
composite O
samples O
by O
using O
inductively O
coupled O
plasma O
mass O
spectrometry O
. O

Synthesis O
and O
chiral O
recognition O
of O
nickel B
( I
II I
) I
macrocyclic O
complex O
with O
( B
R I
) I
- I
naphthylethyleneamin I
pendant O
groups O
and O
its O
self O
- O
assembled O
framework O
. O

The O
complex O
was O
found O
to O
have O
a O
square O
- O
planar O
coordination O
environment O
for O
the O
nickel B
( I
II I
) I
ion O
. O

We O
investigated O
the O
influence O
of O
TCDD B
on O
prostate O
cancer O
cells O
( O
PC O
- O
3 O
) O
and O
non O
- O
tumor O
prostate O
cells O
( O
PNT1A O
) O
on O
5 B
alpha I
- I
dihydrotestosterone I
- O
activated O
ARs O
containing O
CAG O
repeats O
within O
normal O
length O
range O
( O
16 O
, O
22 O
, O
and O
28 O
) O
. O

Therefore O
, O
in O
this O
study O
, O
the O
effects O
of O
rosemary O
on O
the O
activation O
of O
nuclear O
factor O
kappa O
beta O
( O
NF O
- O
kB O
) O
and O
mitogen O
- O
activated O
protein O
kinases O
( O
MAPKs O
) O
, O
the O
expression O
of O
inducible O
nitric B
oxide I
synthase O
( O
iNOS O
) O
and O
cyclooxygenase O
- O
2 O
( O
COX O
- O
2 O
) O
, O
and O
the O
production O
of O
nitric B
oxide I
( O
NO B
) O
, O
prostaglandin B
E I
( I
2 I
) I
( O
PGE B
( I
2 I
) I
) O
, O
and O
cytokine O
in O
lipopolysaccharide O
( O
LPS O
) O
- O
stimulated O

LPS O
- O
induced O
production O
of O
PGE B
( I
2 I
) I
and O
tumour O
necrosis O
factor O
- O
alpha O
( O
TNF O
- O
alpha O
) O
were O
blocked O
by O
rosemary O
. O

In O
the O
present O
study O
, O
we O
have O
determined O
the O
NMR O
structure O
of O
EW29Ch O
in O
the O
sugar B
- O
free O
state O
and O
performed O
( B
15 I
) I
N I
relaxation O
experiments O
for O
EW29Ch O
in O
both O
the O
sugar B
- O
free O
state O
and O
the O
lactose B
- O
bound O
states O
. O

By O
contrast O
, O
the O
( B
15 I
) I
N I
relaxation O
experiments O
revealed O
a O
conformational O
exchange O
at O
the O
alpha O
sugar B
- O
binding O
site O
in O
the O
sugar B
- O
free O
state O
, O
which O
was O
suppressed O
in O
the O
lactose B
- O
bound O
state O
. O

Their O
anticholinesterase O
activity O
was O
carried O
out O
by O
the O
Ellman O
assay O
against O
both O
enzymes O
, O
acetylcholinesterase O
( O
AChE O
) O
and O
butyrylcholinesteras O
, O
and O
diterpene O
sclareol B
exhibited O
fairly O
good O
activity O
against O
both O
the O
enzymes O
while O
the O
two O
triterpenoids O
oleanolic B
and I
ursolic I
acids I
exhibited O
selective O
activity O
against O
AChE O
. O

The O
key O
technologies O
of O
this O
device O
involve O
controlling O
the O
O B
( I
2 I
) I
content O
and O
the O
temperature O
of O
SO B
( I
2 I
) I
as O
well O
as O
the O
quantification O
of O
sulfur B
in O
SF O
. O

The O
key O
technologies O
of O
this O
device O
involve O
controlling O
the O
O B
( I
2 I
) I
content O
and O
the O
temperature O
of O
SO B
( I
2 I
) I
as O
well O
as O
the O
quantification O
of O
sulfur B
in O
SF O
. O

This O
device O
can O
reduce O
the O
possibility O
of O
reaction O
between O
bioactive O
compounds O
and O
sulfur B
/ O
sulfurous B
acid I
, O
as O
well O
as O
control O
the O
limitation O
of O
SO B
( I
2 I
) I
residues O
. O

Nine O
new O
steroidal B
glycosides I
, O
named O
as O
stauntosides B
C I
- I
K I
( O
2 O
, O
5 O
, O
7 O
- O
10 O
, O
13 O
, O
14 O
, O
and O
16 O
) O
, O
along O
with O
seven O
known O
compounds O
( O
1 O
, O
3 O
, O
4 O
, O
6 O
, O
11 O
, O
12 O
, O
and O
15 O
) O
were O
isolated O
from O
the O
95 O
% O
ethanol B
extract O
of O
the O
roots O
of O
Cynanchum O
stauntonii O
. O

Sir2 O
is O
an O
evolutionarily O
conserved O
NAD B
( I
+ I
) I
- O
dependent O
deacetylase O
which O
has O
been O
shown O
to O
play O
a O
critical O
role O
in O
glucose B
and O
fat O
metabolism O
. O

The O
use O
of O
2D O
INADEQUATE O
and O
( B
15 I
) I
N I
NMR O
for O
the O
unambiguous O
structure O
elucidation O
of O
the O
reaction O
products O
is O
discussed O
in O
this O
manuscript O
. O

How O
is O
( B
68 I
) I
Ga I
labeling O
of O
macrocyclic O
chelators O
influenced O
by O
metal O
ion O
contaminants O
in O
( B
68 I
) I
Ge I
/ O
( B
68 I
) I
Ga I
generator O
eluates O
? O

How O
is O
( B
68 I
) I
Ga I
labeling O
of O
macrocyclic O
chelators O
influenced O
by O
metal O
ion O
contaminants O
in O
( B
68 I
) I
Ge I
/ O
( B
68 I
) I
Ga I
generator O
eluates O
? O

How O
is O
( B
68 I
) I
Ga I
labeling O
of O
macrocyclic O
chelators O
influenced O
by O
metal O
ion O
contaminants O
in O
( B
68 I
) I
Ge I
/ O
( B
68 I
) I
Ga I
generator O
eluates O
? O

To O
assess O
the O
influence O
of O
Zn B
( I
2 I
+ I
) I
, O
Cu B
( I
2 I
+ I
) I
, O
Fe B
( I
3 I
+ I
) I
, O
Al B
( I
3 I
+ I
) I
, O
Ti B
( I
IV I
) I
, O
and O
Sn B
( I
IV I
) I
on O
incorporation O
of O
( B
68 I
) I
Ga I
( I
3 I
+ I
) I
into O
pendant O
- O
arm O
macrocyclic O
chelators O
, O
the O
( B
68 I
) I
Ga I
labeling O
of O
1 B
, I
4 I
, I
7 I
- I
triazacyclononane I
- I
1 I
, I
4 I
, I
7 I
- I
triacetic I
acid I
( O
NOTA B
) O
, O
1 B
, I
4 I
, I
7 I
, I
10 I
- I
tetraazacyclododecan I
- I

To O
assess O
the O
influence O
of O
Zn B
( I
2 I
+ I
) I
, O
Cu B
( I
2 I
+ I
) I
, O
Fe B
( I
3 I
+ I
) I
, O
Al B
( I
3 I
+ I
) I
, O
Ti B
( I
IV I
) I
, O
and O
Sn B
( I
IV I
) I
on O
incorporation O
of O
( B
68 I
) I
Ga I
( I
3 I
+ I
) I
into O
pendant O
- O
arm O
macrocyclic O
chelators O
, O
the O
( B
68 I
) I
Ga I
labeling O
of O
1 B
, I
4 I
, I
7 I
- I
triazacyclononane I
- I
1 I
, I
4 I
, I
7 I
- I
triacetic I
acid I
( O
NOTA B
) O
, O
1 B
, I
4 I
, I
7 I
, I
10 I
- I
tetraazacyclododecan I
- I

To O
assess O
the O
influence O
of O
Zn B
( I
2 I
+ I
) I
, O
Cu B
( I
2 I
+ I
) I
, O
Fe B
( I
3 I
+ I
) I
, O
Al B
( I
3 I
+ I
) I
, O
Ti B
( I
IV I
) I
, O
and O
Sn B
( I
IV I
) I
on O
incorporation O
of O
( B
68 I
) I
Ga I
( I
3 I
+ I
) I
into O
pendant O
- O
arm O
macrocyclic O
chelators O
, O
the O
( B
68 I
) I
Ga I
labeling O
of O
1 B
, I
4 I
, I
7 I
- I
triazacyclononane I
- I
1 I
, I
4 I
, I
7 I
- I
triacetic I
acid I
( O
NOTA B
) O
, O
1 B
, I
4 I
, I
7 I
, I
10 I
- I
tetraazacyclododecan I
- I

The O
( B
68 I
) I
Ga I
labeling O
yield O
for O
carboxylate B
- O
type O
chelators O
NOTA B
and O
DOTA B
is O
decreased O
at O
lower O
metal O
ion O
contaminant O
concentrations O
compared O
with O
phosphinate B
- O
type O
chelators O
TRAP B
and O
NOPO B
. O

The O
latter O
are O
able O
to O
rapidly O
exchange O
coordinated O
Zn B
( I
II I
) I
with O
( B
68 I
) I
Ga I
( I
3 I
+ I
) I
, O
as O
confirmed O
by O
mass O
spectrometry O
and O
( B
31 I
) I
P I
NMR O
spectroscopy O
. O

The O
latter O
are O
able O
to O
rapidly O
exchange O
coordinated O
Zn B
( I
II I
) I
with O
( B
68 I
) I
Ga I
( I
3 I
+ I
) I
, O
as O
confirmed O
by O
mass O
spectrometry O
and O
( B
31 I
) I
P I
NMR O
spectroscopy O
. O

( B
68 I
) I
Ga I
labeling O
of O
Zn B
( I
II I
) I
complexes O
of O
TRAP B
and O
NOPO B
proceeds O
as O
efficient O
as O
labeling O
of O
neat O
NOTA B
; O
this O
applies O
also O
to O
the O
corresponding O
peptide O
conjugates O
of O
these O
chelators O
. O

( B
68 I
) I
Ga I
labeling O
of O
Zn B
( I
II I
) I
complexes O
of O
TRAP B
and O
NOPO B
proceeds O
as O
efficient O
as O
labeling O
of O
neat O
NOTA B
; O
this O
applies O
also O
to O
the O
corresponding O
peptide O
conjugates O
of O
these O
chelators O
. O

This O
behavior O
results O
in O
substantially O
improved O
selectivity O
for O
Ga B
( I
3 I
+ I
) I
and O
, O
therefore O
, O
in O
more O
robust O
and O
reliable O
( B
68 I
) I
Ga I
labeling O
procedures O
. O

In O
addition O
, O
none O
of O
the O
investigated O
chelators O
binds O
( B
68 I
) I
Ge I
, O
rendering O
post O
- O
labeling O
purification O
protocols O
, O
for O
example O
, O
solid O
- O
phase O
extraction O
, O
a O
reliable O
means O
of O
removal O
of O
( B
68 I
) I
Ge I
contamination O
from O
( B
68 I
) I
Ga I
radiopharmaceuticals O
. O

In O
addition O
, O
none O
of O
the O
investigated O
chelators O
binds O
( B
68 I
) I
Ge I
, O
rendering O
post O
- O
labeling O
purification O
protocols O
, O
for O
example O
, O
solid O
- O
phase O
extraction O
, O
a O
reliable O
means O
of O
removal O
of O
( B
68 I
) I
Ge I
contamination O
from O
( B
68 I
) I
Ga I
radiopharmaceuticals O
. O

In O
addition O
, O
none O
of O
the O
investigated O
chelators O
binds O
( B
68 I
) I
Ge I
, O
rendering O
post O
- O
labeling O
purification O
protocols O
, O
for O
example O
, O
solid O
- O
phase O
extraction O
, O
a O
reliable O
means O
of O
removal O
of O
( B
68 I
) I
Ge I
contamination O
from O
( B
68 I
) I
Ga I
radiopharmaceuticals O
. O

Using O
an O
embryo O
- O
larval O
bioassay O
, O
embryos O
were O
either O
treated O
with O
1000 O
pptr O
( O
parts O
- O
per O
- O
trillion O
, O
pg O
/ O
mL O
) O
17 B
alpha I
- I
ethynylestradiol I
( O
EE2 B
) O
alone O
from O
6h O
post O
fertilization O
( O
hpf O
) O
to O
4 O
days O
post O
fertilization O
( O
dpf O
) O
, O
or O
pre O
- O
treated O
with O
dioxin O
( O
4 O
- O
5 O
hpf O
) O
prior O
to O
EE2 B
. O

From O
6 O
. O
5 O
to O
16 O
. O
5 O
day O
post O
coitus O
( O
dpc O
) O
, O
pregnant O
mice O
were O
given O
oral O
doses O
of O
17 B
alpha I
- I
ethynylestradiol I
( O
EE O
, O
0 O
. O
2mg O
/ O
kg O
/ O
day O
) O
, O
BPA B
( O
5 O
or O
50mg O
/ O
kg O
/ O
day O
) O
, O
or O
OP O
( O
3 O
, O
12 O
, O
or O
48 O
mg O
/ O
kg O
/ O
day O
) O
dissolved O
in O
corn O
oil O
. O

They O
suggest O
that O
, O
contrary O
to O
the O
commonly O
accepted O
mechanism O
, O
the O
attacking O
O B
( I
2 I
) I
is O
not O
incorporated O
as O
an O
active O
site O
ligand O
but O
, O
rather O
, O
acts O
as O
an O
electron O
acceptor O
. O

Our O
findings O
offer O
new O
ways O
toward O
the O
understanding O
of O
O B
( I
2 I
) I
inactivation O
and O
O B
( I
2 I
) I
tolerance O
in O
NiFe B
hydrogenases O
. O

Our O
findings O
offer O
new O
ways O
toward O
the O
understanding O
of O
O B
( I
2 I
) I
inactivation O
and O
O B
( I
2 I
) I
tolerance O
in O
NiFe B
hydrogenases O
. O

This O
study O
was O
designed O
to O
evaluate O
the O
potential O
effects O
of O
puerarin B
( O
PR O
) O
, O
an O
effective O
isoflavonoid B
compound O
purified O
from O
Pueraria O
lobata O
, O
in O
treating O
hepatic O
fibrosis O
( O
HF O
) O
rats O
induced O
by O
carbon B
tetrachloride I
( O
CCl B
( I
4 I
) I
, O
2 O
mL O
kg O
( O
- O
1 O
) O
d O
( O
- O
1 O
) O
) O
. O

These O
findings O
demonstrate O
that O
puerarin B
successfully O
reverses O
hepatotoxicity O
in O
CCl B
( I
4 I
) I
- O
induced O
HF O
rats O
via O
the O
underlying O
mechanisms O
of O
regulating O
serum O
enzymes O
and O
attenuating O
TNF O
- O
alpha O
/ O
NF O
- O
kappa O
B O
pathway O
for O
anti O
- O
inflammation O
response O
, O
as O
well O
as O
improving O
metabolic O
function O
in O
liver O
tissue O
. O

Methanol B
extracts O
of O
aerial O
parts O
( O
GAA O
) O
and O
roots O
( O
GAR O
) O
of O
G O
. O
asclepiadea O
at O
doses O
of O
100 O
, O
200 O
, O
and O
400mg O
/ O
kg O
b O
. O
w O
. O
were O
orally O
administered O
to O
Wistar O
rats O
once O
daily O
for O
7 O
days O
before O
they O
were O
treated O
with O
CCl B
( I
4 I
) I
. O

In O
CCl B
( I
4 I
) I
treated O
animals O
, O
GAA O
and O
GAR O
significantly O
decreased O
levels O
of O
serum O
transaminases O
, O
alkaline O
phosphatase O
and O
total O
bilirubin B
, O
and O
increased O
the O
level O
of O
total O
protein O
. O

Treatment O
with O
the O
extracts O
resulted O
in O
a O
significant O
increase O
in O
the O
levels O
of O
catalase O
, O
superoxide B
dismutase O
and O
reduced B
glutathione I
, O
accompanied O
with O
a O
marked O
reduction O
in O
the O
levels O
of O
malondialdehyde B
, O
as O
compared O
to O
CCl B
( I
4 I
) I
treated O
group O
. O

The O
histopathological O
studies O
confirmed O
protective O
effects O
of O
extracts O
against O
CCl B
( I
4 I
) I
- O
induced O
liver O
injuries O
. O

The O
aim O
of O
the O
present O
study O
was O
to O
assess O
the O
effect O
of O
two O
hydroxylated B
BDE I
- I
47 I
metabolites O
, O
5 B
- I
OH I
- I
BDE I
- I
47 I
and O
6 B
- I
OH I
- I
BDE I
- I
47 I
, O
on O
steroidogenesis O
in O
the O
ovary O
. O

a I
, I
j I
] I
xanthenes I
- I
3 I
, I
11 I
- I
dicarboxylic I
acid I
, O
were O
synthesized O
, O
and O
the O
structures O
of O
which O
were O
characterized O
by O
( B
1 I
) I
H I
- O
NMR O
, O
( B
13 I
) I
C I
- O
NMR O
, O
high O
resolution O
( O
HR O
) O
- O
MS O
, O
and O
IR O
spectra O
. O

NADH B
and O
Krebs O
cycle O
intermediates O
were O
decreased O
, O
whereas O
NAD B
( I
+ I
) I
was O
increased O
. O

Delta B
9 I
- I
tetrahydrocannabinol I
impairs O
the O
inflammatory O
response O
to O
influenza O
infection O
: O
role O
of O
antigen O
- O
presenting O
cells O
and O
the O
cannabinoid O
receptors O
1 O
and O
2 O
. O

Two O
alginate O
- O
mAb1 O
sustained O
release O
formulations O
were O
developed O
by O
an O
internal O
gelation O
technique O
using O
CaCO B
( I
3 I
) I
and O
CaHPO B
( I
4 I
) I
as O
calcium B
sources O
for O
physical O
cross O
- O
linking O
. O

Two O
alginate O
- O
mAb1 O
sustained O
release O
formulations O
were O
developed O
by O
an O
internal O
gelation O
technique O
using O
CaCO B
( I
3 I
) I
and O
CaHPO B
( I
4 I
) I
as O
calcium B
sources O
for O
physical O
cross O
- O
linking O
. O

The O
CaCO B
( I
3 I
) I
formulation O
provided O
a O
stable O
pH O
- O
environment O
, O
optimally O
suited O
for O
pH O
- O
sensitive O
proteins O
. O

CaHPO B
( I
4 I
) I
led O
to O
a O
lower O
pH O
and O
stronger O
alginate O
- O
mAb1 O
interactions O
. O

The O
CaHPO B
( I
4 I
) I
cross O
- O
linked O
alginate O
released O
mAb1 O
over O
a O
period O
of O
10 O
- O
15 O
days O
. O

The O
neural O
network O
underlying O
the O
ability O
of O
5 B
- I
HT I
( O
1A O
) O
agonists O
to O
treat O
cognitive O
impairments O
of O
schizophrenia O
likely O
includes O
dopamine B
, O
glutamate B
, O
and O
gamma B
- I
aminobutyric I
acid I
neurons O
. O

Proton O
magnetic O
resonance O
spectroscopy O
( O
( B
1 I
) I
H I
MRS O
) O
enables O
the O
observation O
of O
brain O
function O
in O
vivo O
. O

( B
1 I
) I
H I
MRS O
measures O
have O
been O
found O
to O
be O
abnormal O
in O
psychotic O
disorders O
such O
as O
schizophrenia O
. O

Here O
we O
specifically O
review O
the O
influence O
exerted O
by O
antipsychotic O
drugs O
on O
brain O
metabolism O
, O
as O
detected O
by O
( B
1 I
) I
H I
MRS O
. O

The O
above O
results O
were O
reviewed O
according O
to O
the O
most O
recent O
theories O
in O
the O
field O
accounting O
for O
the O
impact O
of O
antipsychotics O
( B
1 I
) I
HMRS I
measures O
. O

Biochemical O
and O
molecular O
mechanisms O
of O
N B
- I
acetyl I
cysteine I
and O
silymarin O
- O
mediated O
protection O
against O
maneb O
- O
and O
paraquat B
- O
induced O
hepatotoxicity O
in O
rats O
. O

N B
- I
acetyl I
cysteine I
( O
NAC B
) O
, O
a O
glutathione B
( O
GSH B
) O
precursor O
and O
silymarin O
( O
SIL O
) O
, O
a O
naturally O
occurring O
antioxidant O
, O
encounter O
oxidative O
stress O
- O
mediated O
cellular O
damage O
. O

Field O
- O
effect O
transistors O
are O
fabricated O
from O
thin O
films O
of O
Ag B
- I
doped I
PbSe I
nanocrystals O
to O
analyze O
the O
influence O
of O
electronically O
active O
impurities O
on O
electrical O
transport O
in O
this O
important O
material O
for O
nanocrystal O
applications O
. O

Korean O
red O
ginseng O
ameliorates O
acute O
3 B
- I
nitropropionic I
acid I
- O
induced O
cochlear O
damage O
in O
mice O
. O

3 B
- I
Nitropropionic I
acid I
( O
3 B
- I
NP I
) O
, O
a O
mitochondrial O
toxin O
, O
has O
been O
reported O
to O
induce O
an O
acute O
cochlear O
damage O
. O

Sodium B
dodecyl I
benzene I
sulfonate I
( O
SDBS B
) O
and O
cetyl B
trimethyl I
ammonium I
chloride I
( O
CTAC B
) O
are O
two O
kinds O
of O
surfactants O
widely O
applied O
in O
various O
industries O
. O

Sodium B
dodecyl I
benzene I
sulfonate I
( O
SDBS B
) O
and O
cetyl B
trimethyl I
ammonium I
chloride I
( O
CTAC B
) O
are O
two O
kinds O
of O
surfactants O
widely O
applied O
in O
various O
industries O
. O

In O
faeces O
, O
darexaban B
was O
the O
major O
drug O
- O
related O
component O
, O
and O
N B
- I
demethyl I
darexaban I
( O
M5 O
) O
was O
detected O
as O
a O
minor O
metabolite O
. O

A O
minor O
metabolic O
fate O
involved O
oxidation O
by O
cytochrome O
P450 O
to O
yield O
monohydroxylated O
metabolites O
M1 O
and O
M3 O
and O
des B
- I
ethyl I
ertugliflozin I
( O
M2 O
) O
, O
which O
accounted O
for O
~ O
5 O
. O
2 O
% O
of O
the O
dose O
in O
excreta O
. O

Fullerene B
nanoparticles O
( O
nC B
( I
60 I
) I
) O
in O
aqueous O
environments O
can O
significantly O
enhance O
the O
transport O
of O
hydrophobic O
organic O
contaminants O
by O
serving O
as O
a O
contaminant O
carrier O
. O

In O
the O
present O
study O
, O
the O
authors O
examine O
the O
effect O
of O
the O
solvent O
- O
exchange O
process O
on O
nC B
( I
60 I
) I
aggregate O
formation O
and O
, O
subsequently O
, O
on O
nC B
( I
60 I
) I
' O
s O
contaminant O
- O
mobilizing O
capability O
. O

In O
the O
present O
study O
, O
the O
authors O
examine O
the O
effect O
of O
the O
solvent O
- O
exchange O
process O
on O
nC B
( I
60 I
) I
aggregate O
formation O
and O
, O
subsequently O
, O
on O
nC B
( I
60 I
) I
' O
s O
contaminant O
- O
mobilizing O
capability O
. O

A O
series O
of O
nC B
( I
60 I
) I
samples O
were O
prepared O
using O
a O
modified O
toluene B
- O
water O
solvent O
- O
exchange O
method O
through O
the O
inclusion O
of O
a O
secondary O
organic O
solvent O
in O
the O
phase O
transfer O
of O
molecular O
C B
( I
60 I
) I
in O
toluene B
to O
nC B
( I
60 I
) I
in O
water O
. O

A O
series O
of O
nC B
( I
60 I
) I
samples O
were O
prepared O
using O
a O
modified O
toluene B
- O
water O
solvent O
- O
exchange O
method O
through O
the O
inclusion O
of O
a O
secondary O
organic O
solvent O
in O
the O
phase O
transfer O
of O
molecular O
C B
( I
60 I
) I
in O
toluene B
to O
nC B
( I
60 I
) I
in O
water O
. O

A O
series O
of O
nC B
( I
60 I
) I
samples O
were O
prepared O
using O
a O
modified O
toluene B
- O
water O
solvent O
- O
exchange O
method O
through O
the O
inclusion O
of O
a O
secondary O
organic O
solvent O
in O
the O
phase O
transfer O
of O
molecular O
C B
( I
60 I
) I
in O
toluene B
to O
nC B
( I
60 I
) I
in O
water O
. O

The O
involvement O
of O
a O
secondary O
solvent O
in O
the O
phase O
transfer O
process O
had O
only O
small O
effects O
on O
the O
particle O
size O
and O
distribution O
, O
zeta O
potential O
, O
and O
mobility O
of O
the O
nC B
( I
60 I
) I
products O
but O
significantly O
influenced O
the O
capability O
of O
nC B
( I
60 I
) I
to O
enhance O
the O
transport O
of O
2 B
, I
2 I
' I
, I
5 I
, I
5 I
' I
- I
polychlorinated I
biphenyl I
( O
PCB B
) O
in O
a O
saturated O
sandy O
soil O
column O
, O
regardless O
of O
whether O
the O
secondary O
solvent O
was O
water O
- O
miscible O
or O
non O
- O
water O
- O
miscible O
. O

The O
involvement O
of O
a O
secondary O
solvent O
in O
the O
phase O
transfer O
process O
had O
only O
small O
effects O
on O
the O
particle O
size O
and O
distribution O
, O
zeta O
potential O
, O
and O
mobility O
of O
the O
nC B
( I
60 I
) I
products O
but O
significantly O
influenced O
the O
capability O
of O
nC B
( I
60 I
) I
to O
enhance O
the O
transport O
of O
2 B
, I
2 I
' I
, I
5 I
, I
5 I
' I
- I
polychlorinated I
biphenyl I
( O
PCB B
) O
in O
a O
saturated O
sandy O
soil O
column O
, O
regardless O
of O
whether O
the O
secondary O
solvent O
was O
water O
- O
miscible O
or O
non O
- O
water O
- O
miscible O
. O

The O
two O
groups O
of O
secondary O
solvents O
appear O
to O
affect O
the O
aggregation O
properties O
of O
nC B
( I
60 I
) I
in O
water O
via O
different O
mechanisms O
. O

In O
general O
, O
nC B
( I
60 I
) I
products O
made O
with O
a O
secondary O
water O
- O
miscible O
solvent O
have O
stronger O
capabilities O
to O
enhance O
PCB B
transport O
. O

Taken O
together O
, O
the O
results O
indicate O
that O
according O
to O
formation O
conditions O
and O
solvent O
constituents O
, O
nC B
( I
60 I
) I
will O
vary O
significantly O
in O
its O
interactions O
with O
organic O
contaminants O
, O
specifically O
as O
related O
to O
adsorption O
or O
desorption O
as O
well O
as O
transport O
in O
porous O
media O
. O

This O
study O
aimed O
to O
describe O
the O
pathologies O
in O
gill O
, O
gut O
, O
liver O
, O
kidney O
, O
brain O
and O
muscle O
of O
juvenile O
rainbow O
trout O
, O
Oncorhynchus O
mykiss O
, O
exposed O
in O
triplicate O
to O
either O
a O
control O
( O
no O
added O
Cu B
) O
, O
20 O
or O
100 O
mu O
g O
l O
( O
- O
1 O
) O
of O
either O
dissolved O
Cu B
( O
as O
CuSO B
( I
4 I
) I
) O
or O
Cu B
- O
NPs O
( O
mean O
primary O
particle O
size O
of O
87 O
+ O
/ O
- O
27 O
nm O
) O
in O
a O
semi O
- O
static O
waterborne O
exposure O
regime O
. O

All O
treatments O
caused O
organ O
injuries O
, O
and O
the O
kinds O
of O
pathologies O
observed O
with O
Cu B
- O
NPs O
were O
broadly O
of O
the O
same O
type O
as O
CuSO B
( I
4 I
) I
including O
: O
hyperplasia O
, O
aneurisms O
, O
and O
necrosis O
in O
the O
secondary O
lamellae O
of O
the O
gills O
; O
swelling O
of O
goblet O
cells O
, O
necrosis O
in O
the O
mucosa O
layer O
and O
vacuole O
formation O
in O
the O
gut O
; O
hepatitis O
- O
like O
injury O
and O
cells O
with O
pyknotic O
nuclei O
in O
the O
liver O
; O
damage O
to O
the O
epithelium O
of O
some O
renal O
tubules O
and O
increased O
Bowman O
' O
s O
space O
in O
the O
kidney O
. O

Overall O
the O
data O
showed O
that O
pathology O
from O
CuSO B
( I
4 I
) I
and O
Cu B
- O
NPs O
were O
of O
similar O
types O
, O
but O
there O
were O
some O
material O
- O
type O
effects O
in O
the O
severity O
or O
incidence O
of O
injuries O
with O
Cu B
- O
NPs O
causing O
more O
injury O
in O
the O
intestine O
, O
liver O
and O
brain O
than O
the O
equivalent O
concentration O
of O
CuSO B
( I
4 I
) I
by O
the O
end O
of O
the O
experiment O
, O
but O
in O
the O
gill O
and O
muscle O
CuSO B
( I
4 I
) I
caused O
more O
pathology O
. O

Overall O
the O
data O
showed O
that O
pathology O
from O
CuSO B
( I
4 I
) I
and O
Cu B
- O
NPs O
were O
of O
similar O
types O
, O
but O
there O
were O
some O
material O
- O
type O
effects O
in O
the O
severity O
or O
incidence O
of O
injuries O
with O
Cu B
- O
NPs O
causing O
more O
injury O
in O
the O
intestine O
, O
liver O
and O
brain O
than O
the O
equivalent O
concentration O
of O
CuSO B
( I
4 I
) I
by O
the O
end O
of O
the O
experiment O
, O
but O
in O
the O
gill O
and O
muscle O
CuSO B
( I
4 I
) I
caused O
more O
pathology O
. O

Overall O
the O
data O
showed O
that O
pathology O
from O
CuSO B
( I
4 I
) I
and O
Cu B
- O
NPs O
were O
of O
similar O
types O
, O
but O
there O
were O
some O
material O
- O
type O
effects O
in O
the O
severity O
or O
incidence O
of O
injuries O
with O
Cu B
- O
NPs O
causing O
more O
injury O
in O
the O
intestine O
, O
liver O
and O
brain O
than O
the O
equivalent O
concentration O
of O
CuSO B
( I
4 I
) I
by O
the O
end O
of O
the O
experiment O
, O
but O
in O
the O
gill O
and O
muscle O
CuSO B
( I
4 I
) I
caused O
more O
pathology O
. O

BMS B
- I
763534 I
accelerated O
the O
dissociation O
of O
( B
125 I
) I
I I
- O
o O
- O
CRF O
from O
rat O
frontal O
cortex O
membrane O
CRF O
( O
1 O
) O
receptors O
consistent O
with O
a O
negative O
allosteric O
modulation O
of O
CRF O
binding O
. O

Furthermore O
, O
the O
level O
of O
prostaglandin B
E I
( I
2 I
) I
( O
PGE B
( I
2 I
) I
) O
was O
determined O
in O
LPS O
- O
induced O
RAW264 O
. O
7 O
macrophages O
. O

The O
results O
indicate O
that O
1 O
) O
the O
U O
value O
can O
affect O
the O
calculated O
energetic O
result O
significantly O
, O
not O
only O
the O
absolute O
adsorption O
energy O
but O
also O
the O
trend O
in O
adsorption O
energy O
; O
2 O
) O
CO B
can O
directly O
react O
with O
surface O
lattice O
oxygen B
atoms O
( O
O B
( O
2f O
) O
/ O
O B
( O
3f O
) O
) O
to O
form O
CO B
( I
2 I
) I
via O
the O
Mars O
- O
van O
Krevelen O
reaction O
mechanism O
on O
both O
( O
110 O
) O
- O
B O
and O
( O
111 O
) O
- O
B O
; O
3 O
) O
pre O
- O
adsorbed O
molecular O
O B
( I
2 I
) I
can O
enhance O
CO B
oxidation O
through O
the O
channel O
in O
which O
it O
directly O
reacts O
with O
molecular O
CO B
to O
form O
CO B
( I
2 I
) I
[ O
O B

The O
results O
indicate O
that O
1 O
) O
the O
U O
value O
can O
affect O
the O
calculated O
energetic O
result O
significantly O
, O
not O
only O
the O
absolute O
adsorption O
energy O
but O
also O
the O
trend O
in O
adsorption O
energy O
; O
2 O
) O
CO B
can O
directly O
react O
with O
surface O
lattice O
oxygen B
atoms O
( O
O B
( O
2f O
) O
/ O
O B
( O
3f O
) O
) O
to O
form O
CO B
( I
2 I
) I
via O
the O
Mars O
- O
van O
Krevelen O
reaction O
mechanism O
on O
both O
( O
110 O
) O
- O
B O
and O
( O
111 O
) O
- O
B O
; O
3 O
) O
pre O
- O
adsorbed O
molecular O
O B
( I
2 I
) I
can O
enhance O
CO B
oxidation O
through O
the O
channel O
in O
which O
it O
directly O
reacts O
with O
molecular O
CO B
to O
form O
CO B
( I
2 I
) I
[ O
O B

The O
results O
indicate O
that O
1 O
) O
the O
U O
value O
can O
affect O
the O
calculated O
energetic O
result O
significantly O
, O
not O
only O
the O
absolute O
adsorption O
energy O
but O
also O
the O
trend O
in O
adsorption O
energy O
; O
2 O
) O
CO B
can O
directly O
react O
with O
surface O
lattice O
oxygen B
atoms O
( O
O B
( O
2f O
) O
/ O
O B
( O
3f O
) O
) O
to O
form O
CO B
( I
2 I
) I
via O
the O
Mars O
- O
van O
Krevelen O
reaction O
mechanism O
on O
both O
( O
110 O
) O
- O
B O
and O
( O
111 O
) O
- O
B O
; O
3 O
) O
pre O
- O
adsorbed O
molecular O
O B
( I
2 I
) I
can O
enhance O
CO B
oxidation O
through O
the O
channel O
in O
which O
it O
directly O
reacts O
with O
molecular O
CO B
to O
form O
CO B
( I
2 I
) I
[ O
O B

( I
2 I
) I
( O
a O
) O
+ O
CO B
( O
g O
) O
- O
- O
> O
CO B
( I
2 I
) I
( O
g O
) O
+ O
O B
( O
a O
) O
] O
on O
( O
110 O
) O
- O
A O
/ O
( O
111 O
) O
- O
A O
; O
4 O
) O
CO B
oxidation O
is O
a O
structure O
- O
sensitive O
reaction O
, O
and O
the O
activation O
energy O
of O
CO B
oxidation O
follows O
the O
order O
of O
Co B
( I
3 I
) I
O I
( I
4 I
) I
( O
111 O
) O
- O
A O
( O
0 O
. O
78 O
eV O
) O
> O
Co B
( I
3 I
) I
O I
( I
4 I
) I
( O
111 O
) O
- O
B O
( O
0 O
. O
68 O
eV O
) O
> O
Co B
( I
3 I
) I
O I
( I
4 I
) I
( O
110 O
) O
- O
A O
( O
0 O
. O
51 O
eV O
) O
> O
Co B

Thus O
, O
some O
deviations O
of O
the O
experimental O
points O
with O
respect O
the O
H O
- O
H O
profiles O
can O
be O
attributed O
to O
specific O
interactions O
between O
the O
buffering O
electrolyte O
and O
the O
drug O
due O
to O
the O
hydrotrophic O
character O
of O
citric B
and I
lactic I
acids I
. O

Intergrowth O
of O
two O
partially O
miscible O
phases O
of O
BiFeO B
( I
3 I
) I
and O
BiMnO B
( I
3 I
) I
gives O
a O
new O
class O
of O
room O
- O
temperature O
multiferroic O
phase O
, O
Bi B
( I
3 I
) I
Fe I
( I
2 I
) I
Mn I
( I
2 I
) I
O I
( I
10 I
+ I
delta I
) I
, O
which O
has O
a O
unique O
supercell O
( O
SC O
) O
structure O
. O

Intergrowth O
of O
two O
partially O
miscible O
phases O
of O
BiFeO B
( I
3 I
) I
and O
BiMnO B
( I
3 I
) I
gives O
a O
new O
class O
of O
room O
- O
temperature O
multiferroic O
phase O
, O
Bi B
( I
3 I
) I
Fe I
( I
2 I
) I
Mn I
( I
2 I
) I
O I
( I
10 I
+ I
delta I
) I
, O
which O
has O
a O
unique O
supercell O
( O
SC O
) O
structure O
. O

These O
results O
open O
up O
a O
new O
avenue O
for O
exploring O
room O
- O
temperature O
single O
- O
phase O
multiferroic O
thin O
films O
by O
controlling O
the O
phase O
mixing O
of O
two O
perovskite B
BiRO B
( I
3 I
) I
( O
R O
= O
Cr B
, O
Mn B
, O
Fe B
, O
Co B
, O
Ni B
) O
materials O
. O

The O
microsomal O
enzyme O
17 B
beta I
- I
hydroxysteroid I
dehydrogenase O
3 O
faces O
the O
cytoplasm O
and O
uses O
NADPH B
generated O
by O
glucose B
- I
6 I
- I
phosphate I
dehydrogenase O
. O

Recent O
studies O
proposed O
a O
functional O
coupling O
between O
17 B
beta I
- I
hydroxysteroid I
dehydrogenase O
3 O
( O
17 O
beta O
- O
HSD3 O
) O
- O
dependent O
testosterone O
formation O
and O
11 B
beta I
- I
hydroxysteroid I
dehydrogenase O
1 O
( O
11 O
beta O
- O
HSD1 O
) O
- O
mediated O
interconversion O
of O
glucocorticoids O
through O
competition O
for O
the O
luminal O
pyridine B
nucleotide I
pool O
. O

Recent O
studies O
proposed O
a O
functional O
coupling O
between O
17 B
beta I
- I
hydroxysteroid I
dehydrogenase O
3 O
( O
17 O
beta O
- O
HSD3 O
) O
- O
dependent O
testosterone O
formation O
and O
11 B
beta I
- I
hydroxysteroid I
dehydrogenase O
1 O
( O
11 O
beta O
- O
HSD1 O
) O
- O
mediated O
interconversion O
of O
glucocorticoids O
through O
competition O
for O
the O
luminal O
pyridine B
nucleotide I
pool O
. O

To O
test O
this O
hypothesis O
, O
we O
used O
human O
embryonic O
kidney O
- O
293 O
cells O
transfected O
with O
17 O
beta O
- O
HSD3 O
and O
/ O
or O
11 O
beta O
- O
HSD1 O
, O
in O
the O
absence O
or O
presence O
of O
hexose B
- I
6 I
- I
phosphate I
dehydrogenase O
that O
generates O
reduced O
nicotinamide B
adenine I
dinucleotide I
phosphate I
( O
NADPH B
) O
in O
the O
endoplasmic O
reticulum O
and O
determined O
enzyme O
activities O
. O

Electronic O
transition O
moments O
of O
6 B
- I
methyl I
isoxanthopterin I
- O
- O
a O
fluorescent O
analogue O
of O
the O
nucleic O
acid O
base O
guanine B
. O

We O
studied O
the O
orientations O
and O
magnitudes O
of O
the O
electric O
dipole O
transition O
moments O
( O
EDTMs O
) O
of O
6 B
- I
methyl I
isoxanthopterin I
( O
6 B
- I
MI I
) O
, O
a O
fluorescent O
analogue O
of O
guanine B
that O
has O
been O
particularly O
useful O
in O
biological O
studies O
. O

Sub O
- O
threshold O
doses O
of O
PGE B
( I
2 I
) I
( O
4 O
ng O
/ O
paw O
) O
or O
dopamine B
( O
0 O
. O
4 O
mu O
g O
/ O
paw O
) O
, O
that O
do O
not O
induce O
hyperalgesia O
by O
themselves O
, O
when O
injected O
just O
following O
alpha B
beta I
meATP I
or O
carrageenan O
in O
rats O
treated O
with O
dexamethasone B
induced O
hyperalgesia O
, O
which O
is O
prevented O
by O
A317491 B
or O
treatment O
with O
periganglionar O
( O
DRG O
- O
L5 O
) O
injections O
of O
ODN O
- O
antisense O
, O
against O
P2X3 O
receptor O
. O

Furthermore O
, O
because O
PKC O
epsilon O
translocation O
induces O
an O
increase O
of O
neuronal O
susceptibility O
to O
inflammatory O
mediators O
, O
this O
study O
demonstrates O
that O
alpha B
beta I
meATP I
in O
peripheral O
tissue O
increases O
the O
expression O
of O
PKC O
epsilon O
in O
cell O
membranes O
of O
DRG O
- O
L5 O
, O
and O
in O
contrast O
, O
the O
administration O
of O
PKC O
epsilon O
translocation O
inhibitor O
( O
1 O
mu O
g O
/ O
paw O
) O
in O
peripheral O
tissue O
45 O
min O
before O
alpha B
beta I
meATP I
, O
prevented O
the O
hyperalgesia O
induced O
by O
sub O
- O
threshold O
dose O
of O
PGE B
( I
2 I
) I
( O
4 O
ng O
/ O
paw O
) O
. O

Furthermore O
, O
it O
consists O
of O
fatty B
acid I
alkyl I
esters I
( O
FAAS B
) O
which O
have O
a O
great O
influence O
on O
biodiesel O
fuel O
properties O
and O
in O
the O
storage O
lifetime O
of O
biodiesel O
itself O
. O

The O
complete O
distribution O
of O
surface O
and O
bulk O
silanols B
, O
and O
of O
isolated O
, O
geminal B
and I
vicinal I
silanols I
for O
all O
these O
materials O
is O
presented O
. O

It O
catalyzes O
the O
hydration O
of O
carbon B
dioxide I
( O
CO B
( I
2 I
) I
) O
to O
bicarbonate B
( O
HCO B
( I
3 I
) I
- I
) O
and O
the O
corresponding O
dehydration O
of O
HCO B
( I
3 I
) I
- I
in O
acidic O
medium O
with O
regeneration O
of O
CO B
( I
2 I
) I
. O

It O
catalyzes O
the O
hydration O
of O
carbon B
dioxide I
( O
CO B
( I
2 I
) I
) O
to O
bicarbonate B
( O
HCO B
( I
3 I
) I
- I
) O
and O
the O
corresponding O
dehydration O
of O
HCO B
( I
3 I
) I
- I
in O
acidic O
medium O
with O
regeneration O
of O
CO B
( I
2 I
) I
. O

On O
the O
other O
hand O
, O
the O
phenyl B
moiety O
of O
phenol B
was O
found O
to O
lay O
in O
the O
hydrophobic O
part O
of O
the O
CA O
active O
site O
, O
where O
CO B
( I
2 I
) I
, O
the O
physiologic O
substrate O
of O
the O
CAs O
, O
binds O
in O
the O
precatalytic O
complex O
, O
explaining O
thus O
the O
behavior O
of O
phenol B
as O
a O
unique O
CO B
( I
2 I
) I
competitive O
inhibitor O
. O

On O
the O
other O
hand O
, O
the O
phenyl B
moiety O
of O
phenol B
was O
found O
to O
lay O
in O
the O
hydrophobic O
part O
of O
the O
CA O
active O
site O
, O
where O
CO B
( I
2 I
) I
, O
the O
physiologic O
substrate O
of O
the O
CAs O
, O
binds O
in O
the O
precatalytic O
complex O
, O
explaining O
thus O
the O
behavior O
of O
phenol B
as O
a O
unique O
CO B
( I
2 I
) I
competitive O
inhibitor O
. O

Supramolecular O
hydrogels O
with O
reverse O
thermal O
gelation O
properties O
from O
( B
oligo I
) I
tyrosine I
containing O
block O
copolymers O
. O

Novel O
block O
copolymers O
comprising O
poly B
( I
ethylene I
glycol I
) I
( O
PEG B
) O
and O
an O
oligo B
( I
tyrosine I
) I
block O
were O
synthesized O
in O
different O
compositions O
by O
N B
- I
carboxyanhydride I
( O
NCA B
) O
polymerization O
. O

2 O
. O
The O
oxidase O
activity O
affording O
5 B
- I
OH I
- I
BP I
- I
3 I
was O
inhibited O
by O
SKF B
525 I
- I
A I
and O
ketoconazole B
, O
and O
partly O
by O
quinidine B
and O
sulfaphenazole B
. O

The O
oxidase O
activity O
affording O
2 B
, I
4 I
- I
diOH I
- I
BP I
was O
inhibited O
by O
SKF B
525 I
- I
A I
, O
ketoconazole B
and O
alpha B
- I
naphthoflavone I
, O
and O
partly O
by O
sulfaphenazole B
. O

Green O
asymmetric O
synthesis O
: O
beta B
- I
amino I
alcohol I
- O
catalyzed O
direct O
asymmetric O
aldol B
reactions O
in O
aqueous O
micelles O
. O

A O
family O
of O
cheap O
and O
easily O
accessible O
beta B
- I
amino I
alcohols I
, O
obtained O
in O
one O
step O
from O
naturally O
occurring O
amino B
acids I
, O
was O
shown O
to O
successfully O
catalyze O
the O
asymmetric O
aldol B
reaction O
between O
a O
series O
of O
ketones B
and O
aromatic B
aldehydes I
. O

These O
aldol B
reactions O
furnished O
the O
corresponding O
beta B
- I
hydroxy I
ketones I
with O
up O
to O
93 O
% O
isolated O
yield O
and O
89 O
% O
ee O
. O

( B
S I
) I
- I
2 I
- I
phenylglycinol I
and O
Triton B
X I
- I
100 I
proved O
to O
be O
the O
best O
organocatalyst O
and O
surfactant O
, O
respectively O
. O

The O
in O
vivo O
antioxidant O
and O
antifibrotic O
properties O
of O
green O
tea O
( O
Camellia O
sinensis O
, O
Theaceae O
) O
were O
investigated O
with O
a O
study O
of O
carbon B
tetrachloride I
( O
CCl B
( I
4 I
) I
) O
- O
induced O
oxidative O
stress O
and O
hepatic O
fibrosis O
in O
male O
ICR O
mice O
. O

Oral O
administration O
of O
green O
tea O
extract O
at O
doses O
of O
125 O
, O
625 O
and O
1250 O
mg O
/ O
kg O
for O
8 O
weeks O
significantly O
reduced O
( O
p O
< O
0 O
. O
05 O
) O
the O
levels O
of O
thiobarbituric B
acid I
- O
reactive O
substances O
( O
TBARS O
) O
and O
protein O
carbonyls B
in O
the O
liver O
by O
at O
least O
28 O
% O
compared O
with O
that O
was O
induced O
by O
CCl B
( I
4 I
) I
( O
1 O
mL O
/ O
kg O
) O
in O
mice O
. O

Our O
study O
found O
that O
oral O
administration O
of O
green O
tea O
extract O
prevented O
CCl B
( I
4 I
) I
- O
induced O
hepatic O
fibrosis O
, O
as O
evidenced O
by O
a O
decreased O
hydroxyproline B
level O
in O
the O
liver O
and O
a O
reduced O
incidence O
of O
hepatic O
fibrosis O
by O
histological O
observations O
. O

These O
results O
indicate O
that O
green O
tea O
exhibits O
potent O
protective O
effects O
against O
CCl B
( I
4 I
) I
- O
induced O
oxidative O
stress O
and O
hepatic O
fibrosis O
in O
mice O
by O
inhibiting O
oxidative O
damage O
and O
increasing O
antioxidant O
enzyme O
activities O
. O

In O
addition O
, O
the O
phenolic B
content O
of O
the O
tea O
products O
was O
determined O
using O
the O
Folin B
- I
Ciocalteu I
phenol I
reagent O
. O

A O
simple O
multiresidue O
analytical O
method O
is O
developed O
for O
the O
simultaneous O
determination O
of O
carbendazim B
( O
CB O
) O
, O
thiabendazole B
( O
TB O
) O
, O
and O
6 B
- I
benzyl I
aminopurine I
( O
6 B
- I
BA I
) O
in O
bean O
sprouts O
. O

The O
CPF B
group O
also O
exhibited O
increased O
levels O
of O
dopamine B
metabolism O
in O
the O
hippocampus O
and O
decreased O
levels O
of O
gamma B
- I
aminobutyric I
acid I
( O
GABA B
) O
and O
glutamate B
in O
the O
striatum O
compared O
to O
the O
vehicle O
group O
. O

All O
rats O
were O
exposed O
to O
no O
, O
chronic O
low O
or O
chronic O
low O
with O
pulsatile O
high O
17 B
beta I
- I
estradiol I
( O
E2 O
) O
replacement O
. O

Photochemical O
properties O
and O
activity O
of O
water O
- O
soluble O
polymer O
/ O
c B
( I
60 I
) I
nanohybrids O
for O
photodynamic O
therapy O
. O

Water O
- O
soluble O
star O
- O
like O
poly B
( I
vinyl I
alcohol I
) I
/ O
C B
( I
60 I
) I
and O
poly B
{ I
[ I
poly I
( I
ethylene I
glycol I
) I
acrylate I
] I
- I
co I
- I
( I
vinyl I
acetate I
) I
} I
/ O
C B
( I
60 I
) I
nanohybrids O
are O
prepared O
by O
grafting O
macroradicals O
onto O
C B
( I
60 I
) I
and O
are O
assessed O
as O
photosensitizers O
for O
photodynamic O
therapy O
. O

Water O
- O
soluble O
star O
- O
like O
poly B
( I
vinyl I
alcohol I
) I
/ O
C B
( I
60 I
) I
and O
poly B
{ I
[ I
poly I
( I
ethylene I
glycol I
) I
acrylate I
] I
- I
co I
- I
( I
vinyl I
acetate I
) I
} I
/ O
C B
( I
60 I
) I
nanohybrids O
are O
prepared O
by O
grafting O
macroradicals O
onto O
C B
( I
60 I
) I
and O
are O
assessed O
as O
photosensitizers O
for O
photodynamic O
therapy O
. O

Water O
- O
soluble O
star O
- O
like O
poly B
( I
vinyl I
alcohol I
) I
/ O
C B
( I
60 I
) I
and O
poly B
{ I
[ I
poly I
( I
ethylene I
glycol I
) I
acrylate I
] I
- I
co I
- I
( I
vinyl I
acetate I
) I
} I
/ O
C B
( I
60 I
) I
nanohybrids O
are O
prepared O
by O
grafting O
macroradicals O
onto O
C B
( I
60 I
) I
and O
are O
assessed O
as O
photosensitizers O
for O
photodynamic O
therapy O
. O

The O
advantages O
of O
both O
nanohybrids O
are O
encountered O
in O
a O
third O
one O
, O
poly B
[ I
( I
N I
- I
vinylpyrrolidone I
) I
- I
co I
- I
( I
vinyl I
acetate I
) I
] I
/ O
C B
( I
60 I
) I
, O
which O
has O
linear O
grafts O
without O
hydroxyl B
groups O
, O
and O
shows O
a O
better O
photodynamic O
activity O
. O

We O
measured O
the O
mRNA O
expressions O
of O
steroidogenesis O
genes O
: O
steroidogenic O
acute O
regulatory O
protein O
( O
StAR O
) O
, O
3 B
beta I
- I
hydroxysteroid I
dehydrogenase O
( O
3 O
beta O
- O
HSD O
) O
, O
cytochrome O
- O
P450 O
( O
CYP O
) O
11A1 O
, O
insulin O
- O
like O
factor O
3 O
( O
INSL O
- O
3 O
) O
, O
CYP17A1 O
, O
inhibin O
- O
alpha O
( O
INH O
- O
alpha O
) O
, O
androgen B
receptor O
( O
AR O
) O
, O
estrogen B
receptor O
- O
alpha O
( O
ER O
- O
alpha O
) O
, O
and O
luteinising O
hormone O
receptor O
( O
LHR O
) O
in O
isolated O
ILCs O

First O
, O
we O
examined O
the O
expression O
of O
genes O
encoding O
proteins O
associated O
with O
progesterone B
biosynthesis O
: O
steroidogenic O
acute O
regulatory O
protein O
( O
STAR O
) O
; O
a O
side O
chain O
cleavage O
enzyme O
( O
CYP11A1 O
) O
; O
and O
3 B
beta I
- I
hydroxysteroid I
dehydrogenase O
/ O
ketosteroid B
isomerase O
( O
HSD3B O
) O
. O

Next O
, O
we O
examined O
expression O
of O
genes O
encoding O
five O
progesterone B
metabolizing O
enzymes O
: O
the O
3 B
- I
keto I
and I
20 I
- I
ketosteroid I
reductases O
( O
AKR1C1 O
- O
AKR1C3 O
) O
and O
5 O
alpha O
- O
reductases O
( O
SRD5A1 O
and O
SRD5A2 O
) O
; O
and O
the O
opposing O
20 B
alpha I
- I
hydroxysteroid I
dehydrogenase O
( O
HSD17B2 O
) O
. O

Gonadotrophin B
- I
inhibitory I
hormone I
( O
GnIH B
) O
plays O
an O
important O
role O
in O
regulating O
of O
reproduction O
in O
teleosts O
. O

In O
vivo O
studies O
showed O
that O
vitamins B
B1 I
and I
B6 I
( O
10 O
or O
100 O
mg O
/ O
kg O
) O
reduced O
urinary O
mutagens O
from O
NOR B
( O
P O
< O
0 O
. O
001 O
) O
or O
NLX B
( O
P O
< O
0 O
. O
02 O
) O
either O
free O
or O
beta O
- O
glucoronidase O
- O
conjugates O
. O

Two O
- O
dimensional O
( O
2D O
) O
atomic O
crystals O
, O
such O
as O
graphene B
and O
transition B
- I
metal I
dichalcogenides I
, O
have O
emerged O
as O
a O
new O
class O
of O
materials O
with O
remarkable O
physical O
properties O
. O

In O
contrast O
to O
graphene B
, O
monolayer O
MoS B
( I
2 I
) I
is O
a O
non O
- O
centrosymmetric O
material O
with O
a O
direct O
energy O
gap O
. O

Here O
we O
report O
the O
spectroscopic O
identification O
in O
a O
monolayer O
MoS B
( I
2 I
) I
field O
- O
effect O
transistor O
of O
tightly O
bound O
negative O
trions O
, O
a O
quasiparticle O
composed O
of O
two O
electrons O
and O
a O
hole O
. O

Crystalline O
sodium B
superoxide I
( O
NaO B
( I
2 I
) I
) O
forms O
in O
a O
one O
- O
electron O
transfer O
step O
as O
a O
solid O
discharge O
product O
. O

Solid O
- O
state O
( B
13 I
) I
C I
magic O
- O
angle O
spinning O
( O
MAS O
) O
NMR O
spectroscopy O
is O
used O
to O
investigate O
the O
structure O
of O
the O
Cu B
( I
II I
) I
- O
based O
metal O
- O
organic O
frameworks O
( O
MOFs O
) O
, O
HKUST O
- O
1 O
and O
STAM O
- O
1 O
, O
and O
the O
structural O
changes O
occurring O
within O
these O
MOFs O
upon O
activation O
( O
dehydration O
) O
. O

Solid O
- O
state O
( B
13 I
) I
C I
magic O
- O
angle O
spinning O
( O
MAS O
) O
NMR O
spectroscopy O
is O
used O
to O
investigate O
the O
structure O
of O
the O
Cu B
( I
II I
) I
- O
based O
metal O
- O
organic O
frameworks O
( O
MOFs O
) O
, O
HKUST O
- O
1 O
and O
STAM O
- O
1 O
, O
and O
the O
structural O
changes O
occurring O
within O
these O
MOFs O
upon O
activation O
( O
dehydration O
) O
. O

However O
, O
interactions O
between O
nuclei O
and O
unpaired O
electrons O
in O
paramagnetic O
systems O
( O
e O
. O
g O
. O
, O
Cu B
( I
II I
) I
- O
based O
MOFs O
) O
pose O
a O
considerable O
challenge O
, O
not O
only O
for O
spectral O
acquisition O
, O
but O
also O
in O
the O
assignment O
and O
interpretation O
of O
the O
spectral O
resonances O
. O

Here O
, O
we O
exploit O
the O
rapid O
T O
( O
1 O
) O
relaxation O
of O
these O
materials O
to O
obtain O
( B
13 I
) I
C I
NMR O
spectra O
using O
a O
spin O
- O
echo O
pulse O
sequence O
at O
natural O
abundance O
levels O
, O
and O
employ O
frequency O
- O
stepped O
acquisition O
to O
ensure O
uniform O
excitation O
of O
resonances O
over O
a O
wide O
frequency O
range O
. O

We O
then O
utilise O
selective O
( B
13 I
) I
C I
isotopic O
labelling O
of O
the O
organic O
linker O
molecules O
to O
enable O
an O
unambiguous O
assignment O
of O
NMR O
spectra O
of O
both O
MOFs O
for O
the O
first O
time O
. O

Hybrid O
furoxanyl B
N I
- I
acylhydrazone I
derivatives O
as O
hits O
for O
the O
development O
of O
neglected O
diseases O
drug O
candidates O
. O

Here O
we O
report O
on O
the O
design O
and O
preparation O
of O
forty O
hybrid O
furoxanyl B
N I
- I
acylhydrazones I
and O
on O
their O
activity O
on O
Mycobacterium O
tuberculosis O
, O
H37Rv O
and O
MDR O
strains O
, O
Trypanosoma O
cruzi O
, O
and O
Leishmania O
amazonensis O
. O

Furoxanyl B
N I
- I
acylhydrazone I
( B
E I
) I
- I
2 I
- I
methyl I
- I
N I
' I
- I
( I
4 I
- I
phenyl I
- I
3 I
- I
furoxanylmethylidene I
) I
- I
4H I
- I
imidazo I
[ I
1 I
, I
2 I
- I
a I
] I
pyridine I
- I
3 I
- I
carbohydrazide I
15 O
was O
ten O
- O
fold O
more O
potent O
against O
T O
. O
cruzi O
Amastigotes O
than O
the O
standard O
drug O
nifurtimox O
. O

Herein O
, O
the O
present O
article O
reports O
the O
novel O
multifunctional O
Fe B
( I
3 I
) I
O I
( I
4 I
) I
@ O
Ag B
/ O
SiO B
( I
2 I
) I
/ O
Au B
core O
- O
shell O
microspheres O
that O
display O
long O
- O
range O
plasmon O
transfer O
of O
Ag B
to O
Au B
leading O
to O
enhanced O
Raman O
scattering O
. O

As O
a O
result O
, O
Fe B
( I
3 I
) I
O I
( I
4 I
) I
@ O
Ag B
/ O
SiO B
( I
2 I
) I
/ O
Au B
microspheres O
have O
the O
best O
enhancement O
effect O
in O
the O
Raman O
active O
research O
by O
using O
Rhodamine B
- I
b I
( O
RdB B
) O
as O
a O
probe O
molecule O
. O

PET O
probe O
discovery O
using O
in O
situ O
click O
chemistry O
uses O
( B
19 I
) I
F I
- O
bearing O
fragments O
as O
( B
18 I
) I
F I
surrogates O
. O

PET O
probe O
discovery O
using O
in O
situ O
click O
chemistry O
uses O
( B
19 I
) I
F I
- O
bearing O
fragments O
as O
( B
18 I
) I
F I
surrogates O
. O

Key O
reactions O
in O
the O
synthesis O
include O
desymmetrization O
of O
the O
bis B
( I
dimethylamide I
) I
unit O
of O
tartaric B
acid I
, O
Zn B
( I
BH I
( I
4 I
) I
) I
( I
2 I
) I
- O
mediated O
anti O
- O
selective O
reduction O
, O
and O
a O
Horner O
- O
Wadsworth O
- O
Emmons O
olefination O
. O

These O
nanostructural O
changes O
are O
confirmed O
by O
cryo O
- O
transmission O
electron O
microscopy O
( O
cryo O
- O
TEM O
) O
, O
and O
the O
photoisomerization O
of O
trans B
- I
ACA I
and O
cis B
- I
ACA I
is O
verified O
by O
( B
1 I
) I
H I
NMR O
. O

Synthesis O
and O
HIV O
- O
1 O
inhibitory O
activities O
of O
dicaffeoyl B
and I
digalloyl I
esters I
of O
quinic B
acid I
derivatives O
. O

Protective O
effect O
of O
70 O
% O
ethanolic O
extract O
of O
Lindera O
obtusiloba O
Blume O
on O
tert B
- I
butyl I
hydroperoxide I
- O
induced O
oxidative O
hepatotoxicity O
in O
rats O
. O

LOE O
prevented O
tert B
- I
butyl I
hydroperoxide I
( O
t B
- I
BHP I
) O
- O
induced O
oxidative O
damage O
in O
HepG2 O
cells O
. O

We O
found O
ADP B
- O
ribosylating O
activity O
for O
the O
SCO5461 O
protein O
product O
through O
its O
co O
- O
incubation O
with O
guanosine B
and O
NAD B
( I
+ I
) I
, O
which O
resulted O
in O
the O
formation O
of O
N B
( I
2 I
) I
- I
( I
ADP I
- I
ribos I
- I
1 I
- I
yl I
) I
- I
guanosine I
( O
( B
ar2 I
) I
Guo I
) O
, O
with O
a O
K O
( O
m O
) O
value O
of O
110 O
mu O
M O
. O

We O
found O
ADP B
- O
ribosylating O
activity O
for O
the O
SCO5461 O
protein O
product O
through O
its O
co O
- O
incubation O
with O
guanosine B
and O
NAD B
( I
+ I
) I
, O
which O
resulted O
in O
the O
formation O
of O
N B
( I
2 I
) I
- I
( I
ADP I
- I
ribos I
- I
1 I
- I
yl I
) I
- I
guanosine I
( O
( B
ar2 I
) I
Guo I
) O
, O
with O
a O
K O
( O
m O
) O
value O
of O
110 O
mu O
M O
. O

17 B
beta I
- I
Estradiol I
( O
E O
( O
2 O
) O
) O
protects O
several O
non O
- O
reproductive O
tissues O
from O
apoptosis O
, O
including O
skeletal O
muscle O
. O

In O
addition O
, O
the O
red O
variety O
possessed O
higher O
antioxidant O
capacity O
as O
exemplified O
by O
the O
( B
* I
) I
OH I
scavenging O
abilities O
, O
Fe B
( I
2 I
+ I
) I
chelating O
ability O
, O
and O
inhibition O
of O
Fe B
( I
2 I
+ I
) I
- O
induced O
pancreatic O
lipid O
peroxidation O
in O
vitro O
. O

Inhibitory O
effects O
of O
metachromins B
L I
- I
Q I
and O
its O
related O
analogs O
against O
receptor O
tyrosine B
kinases O
EGFR O
and O
HER2 O
. O

Inhibitory O
effects O
of O
metachromins B
L I
- I
Q I
( O
1 O
- O
6 O
) O
, O
sesquiterpenoid B
quinones I
with O
an O
amino B
acid I
residue O
, O
and O
their O
related O
analogs O
( O
7 O
- O
18 O
) O
prepared O
from O
metachromins B
A O
( O
19 O
) O
and O
C O
( O
20 O
) O
against O
receptor O
tyrosine B
kinases O
EGFR O
and O
HER2 O
were O
investigated O
. O

Two O
analogs O
11 O
and O
12 O
showed O
relatively O
stronger O
inhibitory O
activity O
against O
EGFR O
, O
while O
metachromins B
L I
- I
Q I
( O
1 O
- O
6 O
) O
and O
seven O
analogs O
( O
8 O
, O
10 O
, O
11 O
, O
and O
15 O
- O
18 O
) O
showed O
inhibitory O
activities O
against O
HER2 O
. O

In O
the O
case O
of O
capreomycin B
oleate I
, O
both O
instruments O
, O
mini O
and O
nano O
spray O
- O
dryer O
, O
were O
suitable O
to O
maintain O
a O
high O
ion O
- O
paired O
content O
, O
while O
for O
capreomycin B
linoleate I
and I
linolenate I
, O
mini O
spray O
- O
dryer O
was O
the O
most O
appropriate O
instrument O
. O

Capreomycin B
oleate I
and I
linoleate I
showed O
the O
same O
efficacy O
of O
capreomycin B
sulfate I
against O
M O
. O
tuberculosis O
, O
while O
capreomycin B
linolenate I
showed O
a O
reduced O
efficacy O
, O
even O
though O
strain O
growth O
was O
inhibited O
at O
10 O
( O
- O
4 O
) O
mycobacterial O
inoculum O
. O

In O
addition O
, O
we O
tested O
the O
sensitivity O
of O
Wistar O
rats O
to O
17 B
beta I
- I
estradiol I
by O
immature O
uterotrophic O
assay O
, O
and O
no O
obvious O
uterotrophic O
response O
was O
observed O
in O
the O
rats O
given O
doses O
up O
to O
100 O
mu O
g O
/ O
kg O
body O
weight O
. O

Silent O
information O
regulator O
2 O
( O
Sir2 O
) O
enzymes O
or O
sirtuins O
are O
a O
family O
of O
NAD B
( I
+ I
) I
- O
dependent O
protein O
N B
( I
epsilon I
) I
- I
acetyl I
- I
lysine I
( O
AcK B
) O
deacetylases O
. O

Placental O
growth O
hormone O
( O
PGH O
) O
, O
estrogens B
( O
primarily O
17 B
beta I
- I
estradiol I
) O
, O
cortisol B
, O
and O
progesterone B
have O
the O
potential O
to O
modulate O
CYP3A O
activity O
. O

Ligand O
- O
exchange O
reactions O
of O
copper B
( I
I I
) I
precursors O
( O
[ B
Cu I
( I
CH I
( I
3 I
) I
CN I
) I
( I
4 I
) I
] I
BF I
( I
4 I
) I
, O
CuCl B
) O
with O
a O
panel O
of O
bis B
( I
azolyl I
) I
borates I
or O
poly B
( I
pyrazolyl I
) I
methanes I
and O
a O
tertiary B
monodentate I
phosphine I
( O
PTA B
= O
1 B
, I
3 I
, I
5 I
- I
triaza I
- I
7 I
- I
phosphaadamantane I
, O
PCN B
= O
tris B
( I
cyanoethyl I
) I
phosphine I
) O
produced O
two O
series O
of O
heteroleptic O
, O

either O
' O
2 O
+ O
1 O
+ O
1 O
' O
- O
or O
' O
3 O
+ O
1 O
' O
- O
type O
complexes O
, O
which O
have O
been O
characterized O
by O
elemental O
analysis O
, O
FT O
- O
IR O
, O
ESI O
- O
MS O
and O
multinuclear O
( B
31 I
) I
P I
and O
( B
1 I
) I
H I
NMR O
. O

either O
' O
2 O
+ O
1 O
+ O
1 O
' O
- O
or O
' O
3 O
+ O
1 O
' O
- O
type O
complexes O
, O
which O
have O
been O
characterized O
by O
elemental O
analysis O
, O
FT O
- O
IR O
, O
ESI O
- O
MS O
and O
multinuclear O
( B
31 I
) I
P I
and O
( B
1 I
) I
H I
NMR O
. O

First O
, O
the O
nanosized O
PSQ B
particles O
were O
prepared O
by O
the O
hydrolysis O
- O
condensation O
reaction O
of O
gamma B
- I
methacryloxypropyl I
trimethoxysilane I
( O
MPTS B
) O
in O
ethanol B
medium O
. O

Here O
we O
report O
the O
functionalization O
of O
monodisperse O
iron B
oxide I
nanoparticles O
( O
NPs O
) O
with O
commercially O
available O
functional O
acids O
containing O
multiple O
double O
bonds O
such O
as O
linolenic B
( I
LLA I
) I
and I
linoleic I
( I
LEA I
) I
acids I
or O
pyridine B
moieties O
such O
as O
6 B
- I
methylpyridine I
- I
2 I
- I
carboxylic I
acid I
, O
isonicotinic B
acid I
, O
3 B
- I
hydroxypicolinic I
acid I
, O
and O
6 B
- I
( I
1 I
- I
piperidinyl I
) I
pyridine I
- I
3 I
- I
carboxlic I
acid I
( O
PPCA B
) O
. O

Furthermore O
, O
the O
concentrations O
of O
the O
ligands O
17 B
beta I
- I
estradiol I
, O
testosterone B
and O
corticosterone B
were O
measured O
. O

A O
multiscale O
investigation O
was O
carried O
out O
to O
study O
the O
dark O
and O
light O
- O
enhanced O
bactericidal O
mechanisms O
of O
poly B
( I
phenylene I
ethynylene I
) I
( O
PPE B
) O
- O
based O
cationic O
conjugated O
polyelectrolytes O
( O
CPEs O
) O
and O
oligo B
- I
phenylene I
ethynylenes I
( O
OPEs B
) O
. O

This O
is O
in O
sharp O
contrast O
to O
many O
III O
- O
V O
nanowires O
on O
silicon B
which O
are O
observed O
to O
stem O
from O
thin O
SiN B
( I
x I
) I
, O
SiO B
( I
2 I
) I
, O
or O
SiO B
( I
2 I
) I
/ O
Si B
openings O
. O

This O
is O
in O
sharp O
contrast O
to O
many O
III O
- O
V O
nanowires O
on O
silicon B
which O
are O
observed O
to O
stem O
from O
thin O
SiN B
( I
x I
) I
, O
SiO B
( I
2 I
) I
, O
or O
SiO B
( I
2 I
) I
/ O
Si B
openings O
. O

This O
is O
in O
sharp O
contrast O
to O
many O
III O
- O
V O
nanowires O
on O
silicon B
which O
are O
observed O
to O
stem O
from O
thin O
SiN B
( I
x I
) I
, O
SiO B
( I
2 I
) I
, O
or O
SiO B
( I
2 I
) I
/ O
Si B
openings O
. O

A O
comparative O
study O
of O
the O
rotational O
dynamics O
of O
PF6 B
( I
- I
) I
anions O
in O
the O
crystals O
and O
liquid O
states O
of O
1 B
- I
butyl I
- I
3 I
- I
methylimidazolium I
hexafluorophosphate I
: O
results O
from O
31P B
NMR O
spectroscopy O
. O

The O
rotational O
dynamics O
of O
the O
hexafluorophosphate B
anion O
( O
PF B
( I
6 I
) I
( I
- I
) I
) O
in O
the O
crystalline O
and O
liquid O
states O
of O
the O
archetypal O
room O
temperature O
ionic O
liquid O
( O
RTIL O
) O
1 B
- I
butyl I
- I
3 I
- I
methylimidazolium I
hexafluorophosphate I
( O
[ B
C I
( I
4 I
) I
mim I
] I
PF I
( I
6 I
) I
) O
are O
investigated O
using O
( B
31 I
) I
P I
NMR O
spectroscopy O
line O
shape O
analyses O
and O
spin O
- O
lattice O
relaxation O
time O
measurements O
. O

Hydrophobic O
carbon B
nanotubes O
( O
CNTs O
) O
and O
hydrophilic O
nanofilaments O
such O
as O
oxidized O
CNTs O
, O
Pd B
nanowires O
( O
NWs O
) O
, O
and O
MnO B
( I
2 I
) I
NWs O
are O
transformed O
from O
wires O
to O
rings O
by O
a O
general O
methodology O
. O

Large O
polystyrene B
particles O
stabilized O
by O
poly B
( I
acrylic I
acid I
) I
( O
PAA B
) O
( O
L O
- O
PS B
( I
PAA I
) I
) O
( O
as O
the O
core O
) O
and O
small O
polystyrene B
particles O
stabilized O
by O
poly B
( I
vinyl I
pyrrolidone I
) I
( O
PVP B
) O
( O
S O
- O
PS B
( I
PVP I
) I
) O
( O
as O
the O
corona O
) O
were O
successfully O
used O
to O
prepare O
raspberry O
- O
like O
particles O
by O
a O
heterocoagulation O
technique O
utilizing O
the O
hydrogen B
bonding O
interaction O
between O
PAA B
and O
PVP B
. O

Large O
polystyrene B
particles O
stabilized O
by O
poly B
( I
acrylic I
acid I
) I
( O
PAA B
) O
( O
L O
- O
PS B
( I
PAA I
) I
) O
( O
as O
the O
core O
) O
and O
small O
polystyrene B
particles O
stabilized O
by O
poly B
( I
vinyl I
pyrrolidone I
) I
( O
PVP B
) O
( O
S O
- O
PS B
( I
PVP I
) I
) O
( O
as O
the O
corona O
) O
were O
successfully O
used O
to O
prepare O
raspberry O
- O
like O
particles O
by O
a O
heterocoagulation O
technique O
utilizing O
the O
hydrogen B
bonding O
interaction O
between O
PAA B
and O
PVP B
. O

The O
coverage O
of O
L O
- O
PS B
( I
PAA I
) I
by O
S O
- O
PS B
( I
PVP I
) I
could O
be O
controlled O
by O
adding O
PVP B
homopolymer O
to O
the O
L O
- O
PS B
( I
PAA I
) I
dispersion O
and O
by O
changing O
the O
molecular O
weight O
of O
the O
stabilizers O
. O

The O
coverage O
of O
L O
- O
PS B
( I
PAA I
) I
by O
S O
- O
PS B
( I
PVP I
) I
could O
be O
controlled O
by O
adding O
PVP B
homopolymer O
to O
the O
L O
- O
PS B
( I
PAA I
) I
dispersion O
and O
by O
changing O
the O
molecular O
weight O
of O
the O
stabilizers O
. O

The O
coverage O
of O
L O
- O
PS B
( I
PAA I
) I
by O
S O
- O
PS B
( I
PVP I
) I
could O
be O
controlled O
by O
adding O
PVP B
homopolymer O
to O
the O
L O
- O
PS B
( I
PAA I
) I
dispersion O
and O
by O
changing O
the O
molecular O
weight O
of O
the O
stabilizers O
. O

Moreover O
, O
the O
heterocoagulation O
of O
large O
poly B
( I
methyl I
methacrylate I
) I
particles O
stabilized O
by O
PAA B
( O
L O
- O
PMMA B
( I
PAA I
) I
) O
and O
S O
- O
PS B
( I
PVP I
) I
particles O
was O
also O
accomplished O
, O
resulting O
in O
the O
formation O
of O
L O
- O
PMMA B
( I
PAA I
) I
- O
core O
/ O
S O
- O
PS B
( I
PVP I
) I
- O
corona O
raspberry O
- O
like O
composite O
particles O
. O

Moreover O
, O
the O
heterocoagulation O
of O
large O
poly B
( I
methyl I
methacrylate I
) I
particles O
stabilized O
by O
PAA B
( O
L O
- O
PMMA B
( I
PAA I
) I
) O
and O
S O
- O
PS B
( I
PVP I
) I
particles O
was O
also O
accomplished O
, O
resulting O
in O
the O
formation O
of O
L O
- O
PMMA B
( I
PAA I
) I
- O
core O
/ O
S O
- O
PS B
( I
PVP I
) I
- O
corona O
raspberry O
- O
like O
composite O
particles O
. O

Moreover O
, O
the O
heterocoagulation O
of O
large O
poly B
( I
methyl I
methacrylate I
) I
particles O
stabilized O
by O
PAA B
( O
L O
- O
PMMA B
( I
PAA I
) I
) O
and O
S O
- O
PS B
( I
PVP I
) I
particles O
was O
also O
accomplished O
, O
resulting O
in O
the O
formation O
of O
L O
- O
PMMA B
( I
PAA I
) I
- O
core O
/ O
S O
- O
PS B
( I
PVP I
) I
- O
corona O
raspberry O
- O
like O
composite O
particles O
. O

Moreover O
, O
the O
heterocoagulation O
of O
large O
poly B
( I
methyl I
methacrylate I
) I
particles O
stabilized O
by O
PAA B
( O
L O
- O
PMMA B
( I
PAA I
) I
) O
and O
S O
- O
PS B
( I
PVP I
) I
particles O
was O
also O
accomplished O
, O
resulting O
in O
the O
formation O
of O
L O
- O
PMMA B
( I
PAA I
) I
- O
core O
/ O
S O
- O
PS B
( I
PVP I
) I
- O
corona O
raspberry O
- O
like O
composite O
particles O
. O

Generation O
of O
B B
- I
doped I
graphene I
nanoplatelets O
using O
a O
solution O
process O
and O
their O
supercapacitor O
applications O
. O

This O
is O
the O
first O
report O
on O
the O
production O
of O
B B
- I
doped I
graphene I
nanoplatelets O
from O
a O
solution O
process O
and O
on O
the O
use O
of O
B B
- I
doped I
graphene I
materials O
in O
supercapacitors O
. O

This O
is O
the O
first O
report O
on O
the O
production O
of O
B B
- I
doped I
graphene I
nanoplatelets O
from O
a O
solution O
process O
and O
on O
the O
use O
of O
B B
- I
doped I
graphene I
materials O
in O
supercapacitors O
. O

Freeze O
- O
fracture O
transmission O
electron O
microscopy O
( O
FF O
- O
TEM O
) O
images O
and O
( B
1 I
) I
H I
NMR O
measurements O
supported O
this O
speculation O
. O

We O
report O
the O
direct O
measurement O
of O
the O
Dirac O
point O
, O
the O
Fermi O
level O
, O
and O
the O
work O
function O
of O
graphene B
by O
performing O
internal O
photoemission O
measurements O
on O
a O
graphene B
/ O
SiO B
( I
2 I
) I
/ O
Si B
structure O
with O
a O
unique O
optical O
- O
cavity O
enhanced O
test O
structure O
. O

A O
complete O
electronic O
band O
alignment O
at O
the O
graphene B
/ O
SiO B
( I
2 I
) I
/ O
Si B
interfaces O
is O
accurately O
established O
. O

The O
observation O
of O
enhanced O
photoemission O
from O
a O
one O
- O
atom O
thick O
graphene B
layer O
was O
possible O
by O
taking O
advantage O
of O
the O
constructive O
optical O
interference O
in O
the O
SiO B
( I
2 I
) I
cavity O
. O

At O
the O
flat O
band O
condition O
, O
the O
Fermi O
level O
was O
extracted O
and O
found O
to O
reside O
3 O
. O
3 O
eV O
+ O
/ O
- O
0 O
. O
05 O
eV O
below O
the O
bottom O
of O
the O
SiO B
( I
2 I
) I
conduction O
band O
. O

When O
combined O
with O
the O
shift O
of O
the O
Fermi O
level O
from O
the O
Dirac O
point O
, O
we O
are O
able O
to O
ascertain O
the O
position O
of O
the O
Dirac O
point O
at O
3 O
. O
6 O
eV O
+ O
/ O
- O
0 O
. O
05 O
eV O
with O
respect O
to O
the O
bottom O
of O
the O
SiO B
( I
2 I
) I
conduction O
band O
edge O
, O
yielding O
a O
work O
function O
of O
4 O
. O
5 O
eV O
+ O
/ O
- O
0 O
. O
05 O
eV O
which O
is O
in O
an O
excellent O
agreement O
with O
theory O
. O

CAs O
were O
passively O
encapsulated O
with O
323 O
mOs O
kg O
( O
- O
1 O
) O
into O
1 B
, I
2 I
- I
dipalmitoyl I
- I
sn I
- I
glycero I
- I
3 I
- I
phosphocholine I
/ O
1 B
, I
2 I
- I
distearoyl I
- I
sn I
- I
glycero I
- I
3 I
- I
phosphocholine I
/ O
1 B
, I
2 I
- I
dipalmitoyl I
- I
sn I
- I
glycero I
- I
3 I
- I
phosphodiglycerol I
50 O
/ O
20 O
/ O
30 O
( O
mol O
/ O
mol O
) O
TSL O
( O
DPPG B
( I
2 I
) I
- O
TSL O
) O

Anodic O
TiO B
( I
2 I
) I
nanotubes O
with O
different O
structures O
, O
doping O
agents O
, O
and O
decorations O
have O
been O
studied O
in O
order O
to O
improve O
energy O
conversion O
and O
storage O
efficiencies O
such O
as O
in O
dye O
sensitized O
solar O
cells O
, O
solar O
fuels O
, O
and O
electrochemical O
supercapacitors O
. O

However O
, O
the O
top O
surface O
modification O
of O
TiO B
( I
2 I
) I
nanotubes O
has O
never O
been O
addressed O
. O

In O
this O
study O
, O
anodic O
TiO B
( I
2 I
) I
nanotubes O
have O
been O
selectively O
closed O
by O
high O
energy O
focused O
ion O
beams O
and O
re O
- O
opened O
by O
low O
energy O
focused O
ion O
beams O
. O

Under O
a O
30 O
kV O
Ga B
( I
+ I
) I
beam O
, O
TiO B
( I
2 I
) I
nanotubes O
are O
closed O
with O
a O
65 O
nm O
shield O
layer O
covering O
the O
top O
entrance O
when O
the O
ion O
dose O
is O
larger O
than O
1 O
. O
2 O
x O
10 O
( O
17 O
) O
ions O
per O
cm O
( O
2 O
) O
; O
under O
a O
5 O
kV O
Ga B
( I
+ I
) I
beam O
, O
the O
shield O
layer O
is O
removed O
and O
the O
closed O
tubes O
are O
re O
- O
opened O
. O

Under O
a O
30 O
kV O
Ga B
( I
+ I
) I
beam O
, O
TiO B
( I
2 I
) I
nanotubes O
are O
closed O
with O
a O
65 O
nm O
shield O
layer O
covering O
the O
top O
entrance O
when O
the O
ion O
dose O
is O
larger O
than O
1 O
. O
2 O
x O
10 O
( O
17 O
) O
ions O
per O
cm O
( O
2 O
) O
; O
under O
a O
5 O
kV O
Ga B
( I
+ I
) I
beam O
, O
the O
shield O
layer O
is O
removed O
and O
the O
closed O
tubes O
are O
re O
- O
opened O
. O

Under O
a O
30 O
kV O
Ga B
( I
+ I
) I
beam O
, O
TiO B
( I
2 I
) I
nanotubes O
are O
closed O
with O
a O
65 O
nm O
shield O
layer O
covering O
the O
top O
entrance O
when O
the O
ion O
dose O
is O
larger O
than O
1 O
. O
2 O
x O
10 O
( O
17 O
) O
ions O
per O
cm O
( O
2 O
) O
; O
under O
a O
5 O
kV O
Ga B
( I
+ I
) I
beam O
, O
the O
shield O
layer O
is O
removed O
and O
the O
closed O
tubes O
are O
re O
- O
opened O
. O

An O
ion O
- O
induced O
viscous O
flow O
model O
has O
been O
proposed O
to O
explain O
the O
influence O
of O
Ga B
( I
+ I
) I
ion O
beam O
flux O
, O
substrate O
temperature O
, O
initial O
tube O
diameter O
, O
ion O
beam O
dwell O
time O
, O
and O
the O
incidence O
angle O
of O
the O
ion O
beam O
. O

Vibrational O
absorption O
( O
VA O
) O
and O
vibrational O
circular O
dichroism O
( O
VCD O
) O
spectra O
of O
methyl B
mandelate I
, O
a O
prototype O
chiral O
molecule O
, O
in O
a O
series O
of O
organic O
solvents O
, O
namely O
methanol B
( O
MeOH B
- I
d I
( I
4 I
) I
) O
, O
dimethyl B
sulfoxide I
( O
DMSO B
- I
d I
( I
6 I
) I
) O
, O
and O
chloroform B
( O
CDCl B
( I
3 I
) I
) O
, O
have O
been O
measured O
in O
the O
finger O
print O
region O
from O
1800 O
to O
1150 O
cm O
( O
- O
1 O
) O
. O

The O
spectral O
changes O
evident O
in O
the O
vibrational O
spectra O
of O
the O
3M O
membranes O
can O
be O
associated O
with O
two O
major O
phenomena O
: O
( O
1 O
) O
dissociation O
of O
the O
proton O
from O
the O
sulfonic B
acid I
groups O
even O
in O
the O
presence O
of O
small O
amounts O
of O
water O
; O
and O
( O
2 O
) O
changes O
in O
the O
conformation O
or O
the O
degree O
of O
crystallinity O
of O
the O
poly B
( I
tetrafluoroethylene I
) I
hydrophobic O
domains O
both O
as O
a O
function O
of O
EW O
and O
membrane O
water O
content O
. O

The O
resultant O
microbattery O
based O
on O
self O
- O
aligned O
LiFePO B
( I
4 I
) I
nanoforests O
of O
shell O
- O
core O
- O
shell O
structure O
, O
with O
precise O
arrangement O
of O
various O
auxiliary O
material O
layers O
including O
a O
central O
nanometric O
metal O
core O
as O
direct O
electronic O
pathway O
to O
current O
collector O
, O
delivers O
excellent O
energy O
density O
and O
stable O
cycling O
stability O
only O
rivaled O
by O
the O
best O
Li B
- O
ion O
batteries O
of O
conventional O
configurations O
, O
while O
providing O
rate O
performance O
per O
foot O
- O
print O
and O
on O
- O
site O
manufacturability O
unavailable O
from O
the O
latter O
. O

Here O
we O
report O
on O
the O
chemical O
synthesis O
, O
CO B
releasing O
properties O
, O
cytotoxicity O
profile O
and O
pharmacological O
activities O
of O
four O
novel O
structurally O
related O
iron B
- I
allyl I
carbonyls I
. O

We O
designed O
a O
function O
- O
oriented O
hybrid O
material O
consisting O
of O
silver B
vanadium I
oxide I
( O
beta O
- O
AgVO B
( I
3 I
) I
) O
nanowires O
modified O
with O
uniform O
Ag B
nanoparticles O
and O
multi O
- O
walled O
carbon B
nanotubes O
( O
CNTs O
) O
as O
a O
high O
- O
performance O
cathode O
material O
for O
LIBs O
. O

The O
Ag B
nanoparticles O
which O
precipitated O
automatically O
in O
the O
synthetic O
process O
act O
as O
a O
bridge O
between O
the O
beta O
- O
AgVO B
( I
3 I
) I
nanowires O
and O
CNTs O
, O
creating O
a O
self O
- O
bridged O
network O
structure O
. O

The O
Ag B
particles O
at O
the O
junction O
of O
the O
nanowires O
and O
CNTs O
facilitate O
electron O
transport O
from O
the O
CNTs O
to O
the O
nanowires O
, O
and O
thereby O
improve O
the O
electrical O
conductivity O
of O
the O
beta O
- O
AgVO B
( I
3 I
) I
nanowires O
and O
the O
composite O
. O

The O
improved O
performance O
of O
the O
composite O
arises O
from O
its O
unique O
nanosized O
beta O
- O
AgVO B
( I
3 I
) I
nanowires O
with O
short O
diffusion O
pathway O
for O
lithium B
ions O
, O
efficient O
electron O
collection O
and O
transfer O
in O
the O
presence O
of O
Ag B
nanoparticles O
, O
together O
with O
excellent O
electrical O
conductivity O
of O
CNTs O
. O

To O
find O
out O
which O
metabolites O
in O
serum O
are O
effective O
for O
the O
diagnosis O
of O
MS O
, O
we O
utilized O
metabolic O
profiling O
using O
proton O
nuclear O
magnetic O
resonance O
spectroscopy O
( O
( B
1 I
) I
H I
- O
NMR O
) O
. O

Chiral O
compounds O
have O
characteristic O
CD O
spectra O
in O
the O
UV O
- O
visible O
region O
, O
where O
Ag B
( I
55 I
) I
shows O
optical O
absorption O
but O
SCH B
( I
3 I
) I
does O
not O
; O
revealing O
that O
highly O
degenerated O
molecular O
- O
like O
electronic O
states O
of O
Ag B
( I
55 I
) I
are O
modified O
by O
the O
presence O
of O
the O
molecule O
inducing O
optical O
activity O
. O

Chiral O
compounds O
have O
characteristic O
CD O
spectra O
in O
the O
UV O
- O
visible O
region O
, O
where O
Ag B
( I
55 I
) I
shows O
optical O
absorption O
but O
SCH B
( I
3 I
) I
does O
not O
; O
revealing O
that O
highly O
degenerated O
molecular O
- O
like O
electronic O
states O
of O
Ag B
( I
55 I
) I
are O
modified O
by O
the O
presence O
of O
the O
molecule O
inducing O
optical O
activity O
. O

Chiral O
compounds O
have O
characteristic O
CD O
spectra O
in O
the O
UV O
- O
visible O
region O
, O
where O
Ag B
( I
55 I
) I
shows O
optical O
absorption O
but O
SCH B
( I
3 I
) I
does O
not O
; O
revealing O
that O
highly O
degenerated O
molecular O
- O
like O
electronic O
states O
of O
Ag B
( I
55 I
) I
are O
modified O
by O
the O
presence O
of O
the O
molecule O
inducing O
optical O
activity O
. O

Surfactant O
- O
Assisted O
Assembly O
of O
Fullerene B
( O
C B
( I
60 I
) I
) O
Nanorods O
and O
Nanotubes O
Formed O
at O
a O
Liquid O
- O
Liquid O
Interface O
. O

Herein O
we O
report O
the O
surfactant O
- O
triggered O
assembly O
of O
fullerene B
( O
C B
( I
60 I
) I
) O
into O
3D O
flowerlike O
microcrystals O
at O
the O
liquid O
- O
liquid O
interface O
. O

C B
( I
60 I
) I
crystals O
were O
grown O
using O
a O
liquid O
- O
liquid O
interfacial O
precipitation O
( O
LLIP O
) O
method O
by O
layering O
surfactant O
solution O
in O
butanol B
with O
a O
saturated O
solution O
of O
C B
( I
60 I
) I
in O
benzene B
. O

C B
( I
60 I
) I
crystals O
were O
grown O
using O
a O
liquid O
- O
liquid O
interfacial O
precipitation O
( O
LLIP O
) O
method O
by O
layering O
surfactant O
solution O
in O
butanol B
with O
a O
saturated O
solution O
of O
C B
( I
60 I
) I
in O
benzene B
. O

In O
the O
LLIP O
method O
, O
it O
is O
suggested O
that O
the O
crystal O
formation O
mechanism O
is O
driven O
by O
supersaturation O
related O
to O
the O
low O
C B
( I
60 I
) I
solubility O
in O
alcohol O
. O

We O
found O
that O
the O
dimensions O
of O
the O
synthesized O
C B
( I
60 I
) I
flowers O
depend O
on O
the O
concentration O
and O
surfactant O
type O
. O

In O
the O
absence O
of O
surfactant O
( O
i O
. O
e O
. O
, O
in O
the O
butanol B
/ O
benzene B
system O
) O
, O
1D O
C B
( I
60 I
) I
nanowhiskers O
( O
nanorods O
) O
and O
C B
( I
60 I
) I
nanotubes O
( O
diameter O
400 O
nm O
- O
2 O
mu O
m O
and O
length O
5 O
- O
20 O
mu O
m O
) O
are O
obtained O
. O

In O
the O
absence O
of O
surfactant O
( O
i O
. O
e O
. O
, O
in O
the O
butanol B
/ O
benzene B
system O
) O
, O
1D O
C B
( I
60 I
) I
nanowhiskers O
( O
nanorods O
) O
and O
C B
( I
60 I
) I
nanotubes O
( O
diameter O
400 O
nm O
- O
2 O
mu O
m O
and O
length O
5 O
- O
20 O
mu O
m O
) O
are O
obtained O
. O

However O
, O
when O
surfactants O
are O
incorporated O
into O
the O
system O
flowerlike O
microcrystals O
consisting O
of O
C B
( I
60 I
) I
nanotubes O
are O
observed O
. O

To O
the O
best O
of O
our O
knowledge O
, O
this O
is O
the O
first O
example O
of O
the O
surfactant O
- O
assisted O
assembly O
of O
C B
( I
60 I
) I
crystals O
. O

X O
- O
ray O
diffraction O
( O
XRD O
) O
and O
transmission O
electron O
microscopy O
( O
TEM O
) O
measurements O
have O
shown O
that O
fullerene B
flowers O
have O
a O
hexagonal O
structure O
with O
cell O
dimensions O
of O
a O
= O
2 O
. O
539 O
nm O
and O
c O
= O
1 O
. O
021 O
nm O
, O
which O
differ O
from O
that O
of O
pristine O
C B
( I
60 I
) I
. O

Mixtures O
of O
flower O
- O
shaped O
C B
( I
60 I
) I
crystals O
and O
free O
- O
standing O
C B
( I
60 I
) I
nanotubes O
are O
found O
in O
the O
0 O
. O
1 O
% O
C B
( I
12 I
) I
G I
( I
2 I
) I
/ O
butanol B
system O
. O

Mixtures O
of O
flower O
- O
shaped O
C B
( I
60 I
) I
crystals O
and O
free O
- O
standing O
C B
( I
60 I
) I
nanotubes O
are O
found O
in O
the O
0 O
. O
1 O
% O
C B
( I
12 I
) I
G I
( I
2 I
) I
/ O
butanol B
system O
. O

Flower O
- O
shaped O
C B
( I
60 I
) I
microcrystals O
are O
also O
observed O
with O
anionic O
surfactants O
cetyltrimethylammoni B
bromide I
( O
CTAB B
) O
and O
cetyltrimethylammoni B
chloride I
( O
CTAC B
) O
. O

C B
( I
60 I
) I
flowers O
obtained O
from O
0 O
. O
01 O
% O
CTAB B
and O
0 O
. O
01 O
% O
CTAC B
also O
exhibit O
hexagonal O
structures O
with O
cell O
dimensions O
of O
a O
= O
2 O
. O
329 O
nm O
and O
c O
= O
1 O
. O
273 O
nm O
, O
a O
= O
2 O
. O
459 O
nm O
and O
c O
= O
0 O
. O
938 O
nm O
, O
respectively O
. O

Our O
C B
( I
60 I
) I
flowers O
exhibit O
intense O
photoluminescence O
( O
PL O
) O
and O
a O
blue O
- O
shifted O
PL O
intensity O
maximum O
compared O
to O
the O
same O
parameters O
for O
pristine O
C B
( I
60 I
) I
, O
demonstrating O
the O
potential O
to O
control O
the O
optoelectronic O
properties O
of O
fullerene B
- O
based O
nanostructures O
. O

Our O
C B
( I
60 I
) I
flowers O
exhibit O
intense O
photoluminescence O
( O
PL O
) O
and O
a O
blue O
- O
shifted O
PL O
intensity O
maximum O
compared O
to O
the O
same O
parameters O
for O
pristine O
C B
( I
60 I
) I
, O
demonstrating O
the O
potential O
to O
control O
the O
optoelectronic O
properties O
of O
fullerene B
- O
based O
nanostructures O
. O

In O
recent O
studies O
an O
enhancement O
of O
the O
ionic O
conductivity O
was O
indeed O
observed O
in O
micro O
- O
/ O
nanoscaled O
Y B
( I
2 I
) I
O I
( I
3 I
) I
- O
stabilised O
ZrO B
( I
2 I
) I
( O
YSZ B
) O
composites O
and O
hetero O
multilayers O
of O
thin O
films O
. O

In O
order O
to O
obtain O
independent O
information O
on O
the O
role O
of O
heterophase O
boundaries O
for O
fast O
transport O
in O
strained O
solid O
electrolytes O
, O
systematic O
measurements O
of O
the O
( B
18 I
) I
O I
- O
tracer O
diffusion O
coefficient O
in O
nanoscaled O
YSZ B
/ O
Y B
( I
2 I
) I
O I
( I
3 I
) I
multilayers O
were O
performed O
. O

The O
electronic O
structure O
of O
the O
Fe B
- O
O B
( I
2 I
) I
center O
in O
oxy O
- O
hemoglobin O
and O
oxy O
- O
myoglobin O
is O
a O
long O
- O
standing O
issue O
in O
the O
field O
of O
bioinorganic O
chemistry O
. O

Here O
, O
iron B
L O
- O
edge O
X O
- O
ray O
absorption O
spectroscopy O
, O
interpreted O
using O
a O
valence O
bond O
configuration O
interaction O
multiplet O
model O
, O
is O
applied O
to O
directly O
probe O
the O
electronic O
structure O
of O
the O
iron B
in O
the O
biomimetic O
Fe B
- O
O B
( I
2 I
) I
heme B
complex O
[ B
Fe I
( I
pfp I
) I
( I
1 I
- I
MeIm I
) I
O I
( I
2 I
) I
] I
( O
pfp B
( O
" O
picket B
fence I
porphyrin I
" O
) O
= O
meso B
- I
tetra I
( I
alpha I
, I
alpha I
, I
alpha I
, I
alpha I
- I
o I
- I
pivalamidophenyl I
) I
porphyrin I
or O
TpivPP B
) O
. O

The O
L O
- O
edge O
spectrum O
of O
[ B
Fe I
( I
pfp I
) I
( I
1 I
- I
MeIm I
) I
O I
( I
2 I
) I
] I
is O
further O
compared O
to O
those O
of O
[ B
Fe I
( I
II I
) I
( I
pfp I
) I
( I
1 I
- I
MeIm I
) I
( I
2 I
) I
] I
, O
[ B
Fe I
( I
II I
) I
( I
pfp I
) I
] I
, O
and O
[ B
Fe I
( I
III I
) I
( I
tpp I
) I
( I
ImH I
) I
( I
2 I
) I
] I
Cl I
( O
tpp B
= O
meso B
- I
tetraphenylporphyrin I
) O
which O
have O
Fe B
( I
II I
) I
S O
= O
0 O
, O
Fe B
( I
II I
) I
S O
= O
1 O
, O
and O
Fe B
( I
III I
) I
S O

The O
L O
- O
edge O
spectrum O
of O
[ B
Fe I
( I
pfp I
) I
( I
1 I
- I
MeIm I
) I
O I
( I
2 I
) I
] I
is O
further O
compared O
to O
those O
of O
[ B
Fe I
( I
II I
) I
( I
pfp I
) I
( I
1 I
- I
MeIm I
) I
( I
2 I
) I
] I
, O
[ B
Fe I
( I
II I
) I
( I
pfp I
) I
] I
, O
and O
[ B
Fe I
( I
III I
) I
( I
tpp I
) I
( I
ImH I
) I
( I
2 I
) I
] I
Cl I
( O
tpp B
= O
meso B
- I
tetraphenylporphyrin I
) O
which O
have O
Fe B
( I
II I
) I
S O
= O
0 O
, O
Fe B
( I
II I
) I
S O
= O
1 O
, O
and O
Fe B
( I
III I
) I
S O

The O
L O
- O
edge O
spectrum O
of O
[ B
Fe I
( I
pfp I
) I
( I
1 I
- I
MeIm I
) I
O I
( I
2 I
) I
] I
is O
further O
compared O
to O
those O
of O
[ B
Fe I
( I
II I
) I
( I
pfp I
) I
( I
1 I
- I
MeIm I
) I
( I
2 I
) I
] I
, O
[ B
Fe I
( I
II I
) I
( I
pfp I
) I
] I
, O
and O
[ B
Fe I
( I
III I
) I
( I
tpp I
) I
( I
ImH I
) I
( I
2 I
) I
] I
Cl I
( O
tpp B
= O
meso B
- I
tetraphenylporphyrin I
) O
which O
have O
Fe B
( I
II I
) I
S O
= O
0 O
, O
Fe B
( I
II I
) I
S O
= O
1 O
, O
and O
Fe B
( I
III I
) I
S O

The O
Fe B
- O
O B
( I
2 I
) I
pfp B
site O
is O
experimentally O
determined O
to O
have O
both O
significant O
sigma O
- O
donation O
and O
a O
strong O
pi O
- O
interaction O
of O
the O
O B
( I
2 I
) I
with O
the O
iron B
, O
with O
the O
latter O
having O
implications O
with O
respect O
to O
the O
spin O
polarization O
of O
the O
ground O
state O
. O

The O
Fe B
- O
O B
( I
2 I
) I
pfp B
site O
is O
experimentally O
determined O
to O
have O
both O
significant O
sigma O
- O
donation O
and O
a O
strong O
pi O
- O
interaction O
of O
the O
O B
( I
2 I
) I
with O
the O
iron B
, O
with O
the O
latter O
having O
implications O
with O
respect O
to O
the O
spin O
polarization O
of O
the O
ground O
state O
. O

As O
advanced O
electrodes O
for O
direct O
alcohol B
fuel O
cells O
, O
graphene B
- O
Pd B
and O
graphene B
- O
Pt B
composites O
with O
a O
trace O
of O
SnO B
( I
2 I
) I
have O
been O
successfully O
synthesized O
by O
a O
modified O
electroless O
plating O
technique O
. O

Finally O
, O
graphene B
oxide I
was O
reduced O
to O
graphene B
by O
further O
adding O
NaBH B
( I
4 I
) I
. O

Compared O
to O
other O
carbon B
- O
( O
e O
. O
g O
. O
, O
Vulcan B
XC I
- I
72R I
) O
supported O
Pd B
and O
Pt B
, O
the O
resultant O
graphene B
- O
Pd B
and O
Pt B
composites O
exhibit O
better O
electrocatalytic O
activity O
and O
long O
- O
term O
stability O
toward O
alcohol B
electrooxidation O
. O

Additionally O
, O
a O
trace O
amount O
of O
SnO B
( I
2 I
) I
formed O
around O
active O
catalysts O
may O
also O
be O
beneficial O
to O
the O
enhancement O
of O
electrochemical O
activity O
. O

The O
C B
- I
H I
bonds O
of O
precise O
location O
of O
inert O
polymer O
surfaces O
were O
readily O
transferred O
to O
bromoalkyl B
initiator O
, O
followed O
by O
ATRP O
of O
2 B
- I
( I
dimethylamino I
) I
ethyl I
methacrylate I
( O
DMAEMA B
) O
and O
glycidyl B
methacrylate I
( O
GMA B
) O
, O
respectively O
, O
to O
produce O
the O
resultant O
patterned O
BOPP O
- O
g O
- O
P B
( I
DMAEMA I
) I
and O
BOPP O
- O
g O
- O
P B
( I
GMA I
) I
films O
. O

The O
C B
- I
H I
bonds O
of O
precise O
location O
of O
inert O
polymer O
surfaces O
were O
readily O
transferred O
to O
bromoalkyl B
initiator O
, O
followed O
by O
ATRP O
of O
2 B
- I
( I
dimethylamino I
) I
ethyl I
methacrylate I
( O
DMAEMA B
) O
and O
glycidyl B
methacrylate I
( O
GMA B
) O
, O
respectively O
, O
to O
produce O
the O
resultant O
patterned O
BOPP O
- O
g O
- O
P B
( I
DMAEMA I
) I
and O
BOPP O
- O
g O
- O
P B
( I
GMA I
) I
films O
. O

The O
epoxy B
groups O
of O
the O
P B
( I
GMA I
) I
microdomains O
can O
be O
aminated O
for O
covalently O
coupling O
IgG O
, O
while O
the O
P B
( I
DMAEMA I
) I
microdomains O
were O
used O
for O
immobilizing O
IgG O
via O
electronic O
interactions O
. O

The O
epoxy B
groups O
of O
the O
P B
( I
GMA I
) I
microdomains O
can O
be O
aminated O
for O
covalently O
coupling O
IgG O
, O
while O
the O
P B
( I
DMAEMA I
) I
microdomains O
were O
used O
for O
immobilizing O
IgG O
via O
electronic O
interactions O
. O

Leukotriene B
A I
( I
4 I
) I
hydrolase O
( O
LTA O
( O
4 O
) O
H O
) O
is O
a O
cystolic O
enzyme O
that O
stereospecifically O
catalyzes O
the O
transformation O
of O
LTA B
( I
4 I
) I
to O
LTB B
( I
4 I
) I
. O

Leukotriene B
A I
( I
4 I
) I
hydrolase O
( O
LTA O
( O
4 O
) O
H O
) O
is O
a O
cystolic O
enzyme O
that O
stereospecifically O
catalyzes O
the O
transformation O
of O
LTA B
( I
4 I
) I
to O
LTB B
( I
4 I
) I
. O

LTB B
( I
4 I
) I
is O
a O
known O
pro O
- O
inflammatory O
mediator O
. O

The O
benzofuran B
series O
demonstrated O
reduced O
mouse O
and O
human O
whole O
blood O
LTB B
( I
4 I
) I
levels O
in O
vitro O
and O
led O
to O
the O
identification O
one O
analog O
for O
advanced O
profiling O
. O

OlfGST O
pi O
and O
rho O
exhibited O
thiol B
oxidoreductase O
activity O
toward O
2 B
- I
hydroxyethyl I
disulfide I
( O
2 B
- I
HEDS I
) O
and O
conjugated O
4 B
- I
hydroxynonenal I
( O
HNE B
) O
, O
a O
toxic O
aldehyde B
with O
neurodegenerative O
properties O
. O

The O
synthesised O
compounds O
' O
structures O
were O
confirmed O
by O
IR O
, O
Mass O
spectrometry O
, O
( B
1 I
) I
H I
NMR O
, O
( B
13 I
) I
C I
NMR O
and O
HRMS O
spectral O
data O
. O

The O
synthesised O
compounds O
' O
structures O
were O
confirmed O
by O
IR O
, O
Mass O
spectrometry O
, O
( B
1 I
) I
H I
NMR O
, O
( B
13 I
) I
C I
NMR O
and O
HRMS O
spectral O
data O
. O

Two O
of O
these O
are O
new O
compounds O
, O
designated O
as O
chonglouoside B
SL I
- I
7 I
( O
1 O
) O
and O
chonglouoside B
SL I
- I
8 I
( O
2 O
) O
. O

Two O
of O
these O
are O
new O
compounds O
, O
designated O
as O
chonglouoside B
SL I
- I
7 I
( O
1 O
) O
and O
chonglouoside B
SL I
- I
8 I
( O
2 O
) O
. O

The O
electrochemical O
reduction O
of O
benzoic B
acid I
in O
the O
presence O
and O
absence O
of O
hydrogen B
( O
H B
( I
2 I
) I
) O
has O
been O
investigated O
using O
a O
10 O
mu O
m O
diameter O
platinum B
microelectrode O
in O
four O
different O
room O
temperature O
ionic O
liquids O
( O
RTILs O
) O
, O
namely O
[ B
C I
( I
4 I
) I
mim I
] I
[ I
NTf I
( I
2 I
) I
] I
, O
[ B
C I
( I
4 I
) I
mpyrr I
] I
[ I
NTf I
( I
2 I
) I
] I
, O
[ B
C I
( I
4 I
) I
mim I
] I
[ I
OTf I
] I
and O
[ B
C I
( I
4 I
) I
mim I
] I
[ I
BF I
( I
4 I
) I
] I
, O
versus O
Ag B
/ O
Ag B
( I

In O
all O
cases O
, O
reductive O
voltammetry O
is O
observed O
, O
and O
is O
suggested O
to O
occur O
via O
a O
CE O
mechanism O
in O
which O
dissociation O
of O
benzoic B
acid I
is O
followed O
by O
electron O
transfer O
to O
H B
( I
+ I
) I
ultimately O
forming O
adsorbed O
hydrogen B
. O

In O
all O
cases O
, O
reductive O
voltammetry O
is O
observed O
, O
and O
is O
suggested O
to O
occur O
via O
a O
CE O
mechanism O
in O
which O
dissociation O
of O
benzoic B
acid I
is O
followed O
by O
electron O
transfer O
to O
H B
( I
+ I
) I
ultimately O
forming O
adsorbed O
hydrogen B
. O

Probing O
the O
structural O
, O
electronic O
and O
magnetic O
properties O
of O
multicenter O
Fe B
2 I
S I
2 I
0 O
/ O
- O
, O
Fe B
3 I
S I
4 I
0 O
/ O
- O
and O
Fe B
4 I
S I
4 I
0 O
/ O
- O
clusters O
. O

Probing O
the O
structural O
, O
electronic O
and O
magnetic O
properties O
of O
multicenter O
Fe B
2 I
S I
2 I
0 O
/ O
- O
, O
Fe B
3 I
S I
4 I
0 O
/ O
- O
and O
Fe B
4 I
S I
4 I
0 O
/ O
- O
clusters O
. O

Probing O
the O
structural O
, O
electronic O
and O
magnetic O
properties O
of O
multicenter O
Fe B
2 I
S I
2 I
0 O
/ O
- O
, O
Fe B
3 I
S I
4 I
0 O
/ O
- O
and O
Fe B
4 I
S I
4 I
0 O
/ O
- O
clusters O
. O

This O
work O
studies O
the O
effect O
of O
packing O
cracked O
seasoned O
olives O
with O
NaCl B
, O
KCl B
, O
and O
CaCl B
( I
2 I
) I
mixture O
brines O
on O
their O
mineral O
nutrients O
and O
sensory O
attributes O
, O
using O
RSM O
methodology O
. O

After O
baking O
, O
mycelium O
- O
supplemented O
bread O
still O
contained O
substantial O
amounts O
of O
gamma B
- I
aminobutyric I
acid I
and O
ergothioneine B
( O
0 O
. O
23 O
- O
0 O
. O
86 O
and O
0 O
. O
79 O
- O
2 O
. O
10 O
mg O
/ O
g O
dry O
matter O
, O
respectively O
) O
. O

The O
aim O
of O
this O
study O
was O
to O
investigate O
the O
protective O
effect O
of O
2 B
, I
3 I
- I
dehydrosilybin I
( O
DHS B
) O
against O
carbon B
tetrachloride I
( O
CCl B
( I
4 I
) I
) O
- O
induced O
liver O
injury O
in O
rats O
. O

Administration O
of O
DHS B
significantly O
attenuated O
the O
levels O
of O
serum O
aspartate B
aminotransferase O
, O
alanine B
aminotransferase O
, O
and O
liver O
lipid O
peroxidation O
in O
CCl B
( I
4 I
) I
- O
treated O
rats O
. O

Moreover O
, O
we O
showed O
that O
DHS B
prevented O
DNA O
damage O
and O
decreased O
the O
protein O
levels O
of O
gamma O
- O
H2AX O
, O
which O
is O
a O
specific O
DNA O
damage O
marker O
, O
in O
CCl B
( I
4 I
) I
- O
treated O
rat O
livers O
. O

DHS O
also O
markedly O
increased O
the O
activity O
of O
antioxidant O
enzymes O
, O
such O
as O
superoxide B
dismutase O
, O
catalase O
, O
glutathione B
peroxidase O
, O
and O
glutathione O
reductase O
in O
CCl B
( I
4 I
) I
- O
treated O
rat O
livers O
. O

Furthermore O
, O
we O
found O
that O
DHS B
significantly O
inhibited O
the O
production O
of O
serum O
nitric B
oxide I
as O
well O
as O
the O
levels O
of O
serum O
IL O
- O
6 O
, O
IFN O
- O
gamma O
, O
and O
TNF O
- O
alpha O
in O
CCl B
( I
4 I
) I
- O
treated O
rats O
. O

Additionally O
, O
DHS B
significantly O
suppressed O
iNOS O
expression O
on O
the O
protein O
levels O
in O
CCl B
( I
4 I
) I
- O
treated O
rat O
livers O
. O

Collectively O
, O
the O
present O
study O
suggests O
that O
DHS B
protects O
the O
liver O
from O
CCl B
( I
4 I
) I
- O
induced O
hepatic O
damage O
via O
antioxidant O
and O
anti O
- O
inflammatory O
mechanisms O
. O

The O
electrocatalysis O
comprises O
redox O
regeneration O
of O
the O
electrochemically O
created O
ABTS B
( I
+ I
) I
radical O
either O
by O
Trolox B
( O
6 B
- I
hydroxy I
- I
2 I
, I
5 I
, I
7 I
, I
8 I
- I
tetramethychroman I
- I
2 I
- I
carboxylic I
acid I
) O
or O
by O
antioxidants O
present O
in O
studied O
oils O
. O

LC O
- O
ESI O
- O
MS O
studies O
corroborated O
the O
identities O
of O
four O
glucosides O
and O
seven O
aglycones O
, O
among O
them O
vanillin B
( O
5 O
. O
7 O
/ O
100 O
g O
) O
, O
4 B
- I
hydroxybenzyl I
alcohol I
( O
3 O
. O
6 O
/ O
100 O
g O
) O
, O
and O
anisyl B
alcohol I
( O
7 O
. O
1 O
/ O
100 O
g O
) O
were O
found O
in O
high O
concentrations O
. O

The O
chromatographic O
and O
spectral O
data O
revealed O
the O
presence O
of O
several O
simple O
phenolic B
acids I
, O
derivatives O
of O
both O
caffeic B
and I
benzoic I
acids I
, O
and O
flavonoids B
in O
the O
produced O
extracts O
. O

Highly O
selective O
separation O
of O
arsenite B
species O
[ O
As B
( I
III I
) I
] O
was O
achieved O
by O
chelation O
with O
sodium B
diethyldithiocarbama I
( O
DDTC B
) O
followed O
by O
dispersion O
with O
40 O
mg O
of O
1 B
- I
octyl I
- I
3 I
- I
methylimidazolium I
hexafluorophosphate I
( O
[ B
C I
( I
8 I
) I
mim I
] I
[ I
PF I
( I
6 I
) I
] I
) O
IL O
. O

Analyte O
extraction O
, O
retention O
and O
separation O
of O
IL O
phase O
were O
achieved O
with O
a O
packed O
microcolumn O
and O
As B
( I
III I
) I
was O
determined O
in O
eluent O
solution O
by O
electrothermal O
atomic O
absorption O
spectrometry O
( O
ETAAS O
) O
. O

Concentration O
of O
As B
( I
V I
) I
was O
deduced O
by O
the O
difference O
between O
total O
inorganic O
arsenic B
and O
As B
( I
III I
) I
. O

Concentration O
of O
As B
( I
V I
) I
was O
deduced O
by O
the O
difference O
between O
total O
inorganic O
arsenic B
and O
As B
( I
III I
) I
. O

Under O
optimal O
conditions O
, O
As B
( I
III I
) I
extraction O
efficiency O
was O
100 O
% O
and O
a O
sensitivity O
enhancement O
factor O
of O
46 O
was O
obtained O
with O
only O
4 O
. O
0 O
ml O
of O
sample O
The O
method O
was O
successfully O
applied O
for O
arsenic B
speciation O
studies O
in O
mono O
- O
varietal O
wines O
. O

Most O
of O
the O
esters B
and O
alcohols B
decreased O
whereas O
13 O
new O
compounds O
appear O
, O
mostly O
furans B
( O
furfural B
, O
2 B
- I
acetylfurane I
, O
5 B
- I
methyl I
furfural I
, O
mesifurane B
) O
and O
aldehydes B
( O
octanal B
, O
nonanal B
, O
decanal B
and O
benzaldeyhde B
) O
. O

The O
reaction O
to O
form O
ABTS B
( I
+ I
) I
in O
said O
solvent O
was O
essentially O
complete O
by O
eight O
hours O
, O
and O
this O
radical O
cation O
was O
stable O
for O
at O
least O
6 O
days O
; O
at O
room O
temperature O
, O
the O
ABTS B
( I
+ I
) I
solution O
remained O
within O
an O
allowable O
analytical O
range O
for O
up O
to O
13 O
h O
. O

The O
reaction O
to O
form O
ABTS B
( I
+ I
) I
in O
said O
solvent O
was O
essentially O
complete O
by O
eight O
hours O
, O
and O
this O
radical O
cation O
was O
stable O
for O
at O
least O
6 O
days O
; O
at O
room O
temperature O
, O
the O
ABTS B
( I
+ I
) I
solution O
remained O
within O
an O
allowable O
analytical O
range O
for O
up O
to O
13 O
h O
. O

Competitive O
displacement O
binding O
assays O
using O
t O
- O
BBN O
/ O
BVD15 O
- O
DO3A O
against O
( B
125 I
) I
I I
- O
Tyr B
( O
4 O
) O
- O
BBN O
yielded O
an O
IC O
( O
50 O
) O
value O
of O
18 O
+ O
/ O
- O
0 O
. O
7 O
nM O
for O
GRPR O
in O
T O
- O
47D O
cells O
, O
a O
human O
breast O
cancer O
cell O
line O
. O

A O
similar O
assay O
using O
t O
- O
BBN O
/ O
BVD15 O
- O
DO3A O
against O
porcine O
( B
125 I
) I
I I
- O
NPY O
showed O
IC O
( O
50 O
) O
values O
of O
80 O
+ O
/ O
- O
11 O
nM O
for O
Y1 O
receptor O
in O
MCF7 O
cells O
, O
another O
human O
breast O
cancer O
cell O
line O
. O

In O
addition O
, O
Neu2000 B
effectively O
scavenged O
hydroxyl B
radicals O
generated O
by O
iron B
( I
III I
) I
- I
ascorbate I
, O
reduced O
protein O
carbonyl B
formation O
mediated O
by O
hydroxyl B
radicals O
and O
peroxynitrite B
, O
and O
prevented O
glutathione B
oxidation O
caused O
by O
tert B
- I
butyl I
hydroperoxide I
in O
isolated O
mitochondria O
. O

Different O
effects O
were O
discovered O
: O
crambescins B
inhibited O
K B
( I
+ I
) I
currents O
with O
the O
following O
potency O
: O
NcrambA2 B
> O
CrambC1 B
> O
CrambA2 B
, O
while O
Cramb816 B
lacked O
an O
effect O
. O

Only O
CrambC1 B
and O
Cramb816 B
partially O
blocked O
Na B
( I
+ I
) I
total O
current O
. O

The O
iron B
bioavailability O
of O
fresh O
cheese O
fortified O
with O
either O
FGSG O
and O
with O
or O
without O
zinc B
and O
FGSG O
in O
aqueous O
solution O
and O
a O
water O
solution O
of O
ferrous B
ascorbate I
( O
reference O
dose O
) O
was O
studied O
using O
double O
radio B
iron I
( O
( B
55 I
) I
Fe I
and O
( B
59 I
) I
Fe I
) O
erythrocyte O
incorporation O
in O
15 O
male O
subjects O
. O

The O
iron B
bioavailability O
of O
fresh O
cheese O
fortified O
with O
either O
FGSG O
and O
with O
or O
without O
zinc B
and O
FGSG O
in O
aqueous O
solution O
and O
a O
water O
solution O
of O
ferrous B
ascorbate I
( O
reference O
dose O
) O
was O
studied O
using O
double O
radio B
iron I
( O
( B
55 I
) I
Fe I
and O
( B
59 I
) I
Fe I
) O
erythrocyte O
incorporation O
in O
15 O
male O
subjects O
. O

The O
characterized O
conformer O
has O
a O
hydrogen B
- O
bonding O
interaction O
between O
a O
hydrogen B
atom O
of O
one O
NH B
( I
3 I
) I
ligand O
and O
the O
carbonyl B
group O
of O
guanine B
. O

The O
use O
of O
Reamer O
Irrigator O
Aspirator O
( O
RIA O
) O
autograft O
harvest O
in O
the O
treatment O
of O
critical O
- O
sized O
iliac O
wing O
defects O
in O
sheep O
: O
investigation O
of O
dexamethasone B
and O
beta B
- I
tricalcium I
phosphate I
augmentation O
. O

A O
reamer O
bone O
graft O
alone O
, O
or O
after O
short O
term O
incubation O
in O
a O
dexamethasone B
enriched O
solution O
, O
and O
a O
reamer O
graft O
collected O
using O
beta B
- I
tricalcium I
phosphate I
( O
beta B
- I
TCP I
) O
granules O
in O
the O
filter O
of O
the O
RIA O
collection O
device O
were O
compared O
to O
autologous O
iliac O
wing O
graft O
. O

We O
synthesized O
copolymers O
composed O
of O
methyl B
methacrylate I
and O
2 B
- I
aminoethyl I
methacrylate I
with O
different O
protecting O
groups O
or O
ion O
- O
complexes O
on O
their O
amino B
groups O
, O
then O
dip O
- O
coated O
the O
copolymers O
onto O
a O
poly B
( I
methyl I
methacrylate I
) I
( O
PMMA B
) O
substrate O
. O

PvdQ O
is O
an O
acyl B
- I
homoserine I
lactone I
( O
AHL B
) O
acylase O
able O
to O
degrade O
the O
signal O
molecule O
of O
P O
. O
aeruginosa O
QS O
. O

In O
patients O
with O
ER O
+ O
tumors O
pharmacologic O
ovary O
suppression O
with O
gonadotropin B
- I
releasing I
hormone I
agonists O
in O
combination O
with O
standard O
adjuvant O
therapy O
is O
generally O
more O
effective O
than O
adjuvant O
chemotherapy O
alone O
. O

Tritiated B
amitriptyline I
was O
added O
to O
laboratory O
microcosms O
containing O
soils O
, O
and O
the O
metabolism O
of O
the O
extractable O
( B
3 I
) I
H I
was O
monitored O
during O
incubation O
at O
30 O
degrees O
C O
. O

Nortriptyline B
( O
N B
- I
desmethyl I
amitriptyline I
) O
and O
amitriptyline B
- I
N I
- I
oxide I
were O
identified O
as O
major O
transformation O
products O
in O
all O
three O
soils O
by O
high O
performance O
liquid O
chromatography O
with O
photodiode O
array O
detector O
and O
time O
- O
of O
- O
flight O
mass O
spectrometry O
( O
HPLC O
- O
TOF O
- O
MS O
/ O
UV O
) O
. O

It O
is O
found O
that O
the O
BolA O
- O
like O
dual O
ligands O
system O
exhibits O
significantly O
enhanced O
gene O
expression O
in O
both O
HeLa O
and O
293T O
cell O
lines O
, O
as O
compared O
with O
poly B
( I
ethylenimine I
) I
PEI B
. O

The O
structures O
were O
elucidated O
on O
the O
basis O
of O
1D O
and O
2D O
( B
1 I
) I
H I
and O
( B
13 I
) I
C I
NMR O
techniques O
, O
and O
in O
vitro O
immunomodulatory O
activity O
was O
evaluated O
by O
standard O
proliferation O
of O
human O
peripheral O
blood O
lymphocytes O
. O

The O
structures O
were O
elucidated O
on O
the O
basis O
of O
1D O
and O
2D O
( B
1 I
) I
H I
and O
( B
13 I
) I
C I
NMR O
techniques O
, O
and O
in O
vitro O
immunomodulatory O
activity O
was O
evaluated O
by O
standard O
proliferation O
of O
human O
peripheral O
blood O
lymphocytes O
. O

Central O
in O
this O
context O
is O
class O
III O
phosphatidylinositol B
3 O
- O
kinase O
, O
an O
evolutionarily O
conserved O
enzyme O
complex O
that O
phosphorylates O
phosphatidylinositol B
into O
phosphatidylinositol B
3 I
- I
phosphate I
. O

Phosphatidylinositol B
3 I
- I
phosphate I
recruits O
specific O
effector O
proteins O
, O
most O
of O
which O
contain O
FYVE O
or O
PX O
domains O
, O
to O
promote O
endocytosis O
, O
endosome O
fusion O
, O
endosome O
motility O
and O
endosome O
maturation O
, O
as O
well O
as O
cargo O
sorting O
to O
lysosomes O
, O
the O
biosynthetic O
pathway O
or O
the O
plasma O
membrane O
. O

Here O
we O
review O
the O
functions O
of O
key O
phosphatidylinositol B
3 I
- I
phosphate I
effectors O
in O
regulation O
of O
endocytic O
membrane O
dynamics O
and O
protein O
sorting O
. O

The O
structures O
of O
the O
regioisomers O
6 O
and O
7 O
were O
determined O
by O
2D O
( B
1 I
) I
H I
- O
( B
1 I
) I
H I
COSY O
, O
( B
1 I
) I
H I
- O
( B
13 I
) I
C I
HSQC O
and O
( B
1 I
) I
H I
- O
( B
13 I
) I
C I
HMBC O
experiments O
. O

The O
structures O
of O
the O
regioisomers O
6 O
and O
7 O
were O
determined O
by O
2D O
( B
1 I
) I
H I
- O
( B
1 I
) I
H I
COSY O
, O
( B
1 I
) I
H I
- O
( B
13 I
) I
C I
HSQC O
and O
( B
1 I
) I
H I
- O
( B
13 I
) I
C I
HMBC O
experiments O
. O

The O
structures O
of O
the O
regioisomers O
6 O
and O
7 O
were O
determined O
by O
2D O
( B
1 I
) I
H I
- O
( B
1 I
) I
H I
COSY O
, O
( B
1 I
) I
H I
- O
( B
13 I
) I
C I
HSQC O
and O
( B
1 I
) I
H I
- O
( B
13 I
) I
C I
HMBC O
experiments O
. O

The O
structures O
of O
the O
regioisomers O
6 O
and O
7 O
were O
determined O
by O
2D O
( B
1 I
) I
H I
- O
( B
1 I
) I
H I
COSY O
, O
( B
1 I
) I
H I
- O
( B
13 I
) I
C I
HSQC O
and O
( B
1 I
) I
H I
- O
( B
13 I
) I
C I
HMBC O
experiments O
. O

The O
structures O
of O
the O
regioisomers O
6 O
and O
7 O
were O
determined O
by O
2D O
( B
1 I
) I
H I
- O
( B
1 I
) I
H I
COSY O
, O
( B
1 I
) I
H I
- O
( B
13 I
) I
C I
HSQC O
and O
( B
1 I
) I
H I
- O
( B
13 I
) I
C I
HMBC O
experiments O
. O

The O
structures O
of O
the O
regioisomers O
6 O
and O
7 O
were O
determined O
by O
2D O
( B
1 I
) I
H I
- O
( B
1 I
) I
H I
COSY O
, O
( B
1 I
) I
H I
- O
( B
13 I
) I
C I
HSQC O
and O
( B
1 I
) I
H I
- O
( B
13 I
) I
C I
HMBC O
experiments O
. O

ChE O
activity O
was O
measured O
with O
acetylthiocholine B
as O
substrate O
and O
CES O
activity O
was O
measured O
with O
four O
substrates O
: O
p B
- I
nitrophenyl I
acetate I
, O
p B
- I
nitrophenyl I
butyrate I
, O
1 B
- I
and I
2 I
- I
naphthyl I
acetate I
. O

ChE O
activity O
was O
measured O
with O
acetylthiocholine B
as O
substrate O
and O
CES O
activity O
was O
measured O
with O
four O
substrates O
: O
p B
- I
nitrophenyl I
acetate I
, O
p B
- I
nitrophenyl I
butyrate I
, O
1 B
- I
and I
2 I
- I
naphthyl I
acetate I
. O

Absorption O
and O
secretion O
of O
fluoride B
increase O
at O
acid O
pH O
levels O
, O
possibly O
because O
of O
its O
non O
- O
ionized O
state O
at O
these O
pHs O
and O
/ O
or O
because O
of O
participation O
of O
a O
F B
( I
- I
) I
/ O
H B
( I
+ I
) I
cotransporter O
or O
a O
F B
( I
- I
) I
/ O
OH B
( I
- I
) I
antiporter O
. O

Absorption O
and O
secretion O
of O
fluoride B
increase O
at O
acid O
pH O
levels O
, O
possibly O
because O
of O
its O
non O
- O
ionized O
state O
at O
these O
pHs O
and O
/ O
or O
because O
of O
participation O
of O
a O
F B
( I
- I
) I
/ O
H B
( I
+ I
) I
cotransporter O
or O
a O
F B
( I
- I
) I
/ O
OH B
( I
- I
) I
antiporter O
. O

Absorption O
and O
secretion O
of O
fluoride B
increase O
at O
acid O
pH O
levels O
, O
possibly O
because O
of O
its O
non O
- O
ionized O
state O
at O
these O
pHs O
and O
/ O
or O
because O
of O
participation O
of O
a O
F B
( I
- I
) I
/ O
H B
( I
+ I
) I
cotransporter O
or O
a O
F B
( I
- I
) I
/ O
OH B
( I
- I
) I
antiporter O
. O

Absorption O
and O
secretion O
of O
fluoride B
increase O
at O
acid O
pH O
levels O
, O
possibly O
because O
of O
its O
non O
- O
ionized O
state O
at O
these O
pHs O
and O
/ O
or O
because O
of O
participation O
of O
a O
F B
( I
- I
) I
/ O
H B
( I
+ I
) I
cotransporter O
or O
a O
F B
( I
- I
) I
/ O
OH B
( I
- I
) I
antiporter O
. O

The O
results O
also O
suggest O
transcellular O
participation O
of O
mechanisms O
involved O
in O
transport O
of O
Cl B
( I
- I
) I
and O
of O
an O
active O
transport O
in O
the O
secretory O
direction O
. O

There O
were O
synthesized O
new O
types O
of O
ribbon O
type O
steroidal O
dimers O
derived O
from O
three O
types O
of O
steroidal O
skeletons O
( O
cholic B
acid I
, O
etienic B
acid I
, O
estrone B
) O
using O
Cu B
( I
I I
) I
catalyzed O
1 O
, O
3 O
- O
dipolar O
cycloaddition O
reaction O
. O

Herein O
, O
a O
method O
is O
reported O
for O
controlling O
the O
twinning O
structure O
of O
silver B
nanoparticles O
, O
and O
consequently O
their O
shape O
, O
via O
the O
plasmon O
- O
mediated O
synthesis O
, O
solely O
by O
varying O
the O
excitation O
wavelength O
between O
400 O
, O
450 O
, O
and O
500 O
nm O
, O
which O
modulates O
the O
rate O
of O
Ag B
( I
+ I
) I
reduction O
. O

The O
activities O
of O
superoxide B
dismutase O
, O
catalase O
, O
glutathione B
peroxidase O
, O
glutathione B
reductase O
and O
the O
levels O
of O
reduced B
glutathione I
, O
vitamins B
C I
and I
E I
in O
the O
liver O
and O
kidney O
of O
the O
animals O
decreased O
significantly O
( O
p O
< O
0 O
. O
05 O
) O
. O

Arundinols B
A I
- I
C I
and O
arundinones B
A I
and I
B I
from O
the O
plant O
endophytic O
fungus O
Microsphaeropsis O
arundinis O
. O

Arundinols B
A I
- I
C I
and O
arundinones B
A I
and I
B I
from O
the O
plant O
endophytic O
fungus O
Microsphaeropsis O
arundinis O
. O

Three O
new O
ent B
- I
eudesmane I
sesquiterpenoids I
, O
arundinols B
A I
- I
C I
( O
1 O
- O
3 O
) O
, O
one O
isochroman B
- I
1 I
- I
one I
, O
arundinone B
A I
( O
4 O
) O
, O
and O
a O
polyoxygenated B
benzofuran I
- I
3 I
( I
2H I
) I
- I
one I
dimer O
, O
arundinone B
B I
( O
5 O
) O
, O
were O
isolated O
from O
the O
extract O
of O
a O
plant O
endophytic O
fungus O
, O
Microsphaeropsis O
arundinis O
. O

Three O
new O
ent B
- I
eudesmane I
sesquiterpenoids I
, O
arundinols B
A I
- I
C I
( O
1 O
- O
3 O
) O
, O
one O
isochroman B
- I
1 I
- I
one I
, O
arundinone B
A I
( O
4 O
) O
, O
and O
a O
polyoxygenated B
benzofuran I
- I
3 I
( I
2H I
) I
- I
one I
dimer O
, O
arundinone B
B I
( O
5 O
) O
, O
were O
isolated O
from O
the O
extract O
of O
a O
plant O
endophytic O
fungus O
, O
Microsphaeropsis O
arundinis O
. O

SKF83959 B
( O
3 B
- I
methyl I
- I
6 I
- I
chloro I
- I
7 I
, I
8 I
- I
hydroxy I
- I
1 I
- I
[ I
3 I
- I
methylphenyl I
] I
- I
2 I
, I
3 I
, I
4 I
, I
5 I
- I
tetrahydro I
- I
1H I
- I
3 I
- I
benzazepine I
) O
, O
an O
atypical O
dopamine B
receptor O
- O
1 O
( O
D O
( O
1 O
) O
receptor O
) O
agonist O
, O
has O
shown O
many O
D O
( O
1 O
) O
receptor O
- O
independent O
effects O
, O
such O
as O
neuroprotection O
, O
blockade O
of O
Na B
( I
+ I
) I
channel O
, O
and O
promotion O
of O
spontaneous O
glutamate B
release O
, O
which O
resemble O
the O
effects O
of O

However O
, O
while O
there O
was O
no O
significant O
cytotoxic O
effect O
observed O
in O
the O
MTT B
( O
thiazolyl B
blue I
tetrazolium I
bromide I
) O
cell O
viability O
assay O
at O
this O
concentration O
, O
there O
was O
a O
corresponding O
change O
in O
cell O
morphology O
which O
may O
be O
related O
to O
the O
resulting O
antagonistic O
effect O
. O

Insertion O
of O
ER O
alpha O
was O
blocked O
by O
the O
ER O
antagonist O
ICI B
182 I
, I
780 I
or O
with O
the O
protein O
kinase O
C O
( O
PKC O
) O
pathway O
inhibitor O
bisindolylmaleimide B
( O
BIS B
) O
. O

FTIR O
spectra O
revealed O
that O
the O
addition O
of O
manganese B
oxide I
contributes O
the O
transformation O
of O
TeO B
( I
4 I
) I
trigonal O
bipyramids O
with O
bridging O
oxygen B
( O
BO O
) O
to O
TeO B
( I
3 I
) I
trigonal O
pyramids O
with O
non O
- O
bridging O
oxygen B
( O
NBO O
) O
. O

FTIR O
spectra O
revealed O
that O
the O
addition O
of O
manganese B
oxide I
contributes O
the O
transformation O
of O
TeO B
( I
4 I
) I
trigonal O
bipyramids O
with O
bridging O
oxygen B
( O
BO O
) O
to O
TeO B
( I
3 I
) I
trigonal O
pyramids O
with O
non O
- O
bridging O
oxygen B
( O
NBO O
) O
. O

Contractions O
were O
produced O
by O
electrical O
field O
stimulation O
of O
perivascular O
nerves O
( O
EFS O
) O
, O
norepinephrine B
( O
NE O
) O
, O
adenosine B
5 I
' I
- I
triphosphate I
( O
ATP B
) O
, O
high O
K B
( I
+ I
) I
solution O
and O
by O
calcium B
chloride I
( O
CaCl B
( I
2 I
) I
) O
in O
Ca B
( I
2 I
+ I
) I
- O
free O
and O
high O
K B
( I
+ I
) I
, O
Ca B
( I
2 I
+ I
) I
- O
free O
solution O
. O

Contractions O
were O
produced O
by O
electrical O
field O
stimulation O
of O
perivascular O
nerves O
( O
EFS O
) O
, O
norepinephrine B
( O
NE O
) O
, O
adenosine B
5 I
' I
- I
triphosphate I
( O
ATP B
) O
, O
high O
K B
( I
+ I
) I
solution O
and O
by O
calcium B
chloride I
( O
CaCl B
( I
2 I
) I
) O
in O
Ca B
( I
2 I
+ I
) I
- O
free O
and O
high O
K B
( I
+ I
) I
, O
Ca B
( I
2 I
+ I
) I
- O
free O
solution O
. O

Contractions O
were O
produced O
by O
electrical O
field O
stimulation O
of O
perivascular O
nerves O
( O
EFS O
) O
, O
norepinephrine B
( O
NE O
) O
, O
adenosine B
5 I
' I
- I
triphosphate I
( O
ATP B
) O
, O
high O
K B
( I
+ I
) I
solution O
and O
by O
calcium B
chloride I
( O
CaCl B
( I
2 I
) I
) O
in O
Ca B
( I
2 I
+ I
) I
- O
free O
and O
high O
K B
( I
+ I
) I
, O
Ca B
( I
2 I
+ I
) I
- O
free O
solution O
. O

Inhibitors O
of O
ATP B
- O
and O
voltage O
- O
sensitive O
K B
( I
+ I
) I
channels O
did O
not O
modify O
the O
effects O
of O
resveratrol B
. O

None O
of O
the O
antagonists O
of O
K B
( I
+ I
) I
channels O
affected O
the O
resveratrol B
inhibition O
of O
NE O
- O
evoked O
contractions O
and O
effect O
of O
high O
concentrations O
of O
resveratrol B
on O
the O
EFS O
- O
evoked O
contractions O
. O

Resveratrol B
more O
potently O
inhibited O
CaCl B
( I
2 I
) I
than O
potassium B
chloride I
contractions O
of O
RPV O
. O

Effect O
of O
major O
cations O
( O
Ca B
( I
2 I
+ I
) I
, O
Mg B
( I
2 I
+ I
) I
, O
Na B
( I
+ I
) I
, O
K B
( I
+ I
) I
) O
and O
anions O
( O
SO B
42 I
- I
, O
Cl B
( I
- I
) I
, O
NO B
3 I
- I
) O
on O
Ni B
accumulation O
and O
toxicity O
in O
aquatic O
plant O
( O
Lemna O
minor O
L O
. O
) O
: O
implications O
For O
Ni B
risk O
assessment O
. O

Effect O
of O
major O
cations O
( O
Ca B
( I
2 I
+ I
) I
, O
Mg B
( I
2 I
+ I
) I
, O
Na B
( I
+ I
) I
, O
K B
( I
+ I
) I
) O
and O
anions O
( O
SO B
42 I
- I
, O
Cl B
( I
- I
) I
, O
NO B
3 I
- I
) O
on O
Ni B
accumulation O
and O
toxicity O
in O
aquatic O
plant O
( O
Lemna O
minor O
L O
. O
) O
: O
implications O
For O
Ni B
risk O
assessment O
. O

Effect O
of O
major O
cations O
( O
Ca B
( I
2 I
+ I
) I
, O
Mg B
( I
2 I
+ I
) I
, O
Na B
( I
+ I
) I
, O
K B
( I
+ I
) I
) O
and O
anions O
( O
SO B
42 I
- I
, O
Cl B
( I
- I
) I
, O
NO B
3 I
- I
) O
on O
Ni B
accumulation O
and O
toxicity O
in O
aquatic O
plant O
( O
Lemna O
minor O
L O
. O
) O
: O
implications O
For O
Ni B
risk O
assessment O
. O

The O
effect O
of O
major O
cation O
activity O
( O
Ca B
( I
2 I
+ I
) I
, O
Mg B
( I
2 I
+ I
) I
, O
Na B
( I
+ I
) I
, O
K B
( I
+ I
) I
) O
on O
Ni B
toxicity O
, O
with O
dose O
expressed O
as O
exposure O
( O
total O
dissolved O
Ni B
concentration O
NiTot O
) O
or O
free O
Ni B
ion O
activity O
( O
in O
solution O
Ni B
( I
2 I
+ I
) I
) O
, O
or O
as O
tissue O
residue O
( O
Ni B
concentration O
in O
plant O
tissue O
NiTiss O
) O
to O
the O
aquatic O
plant O
Lemna O
minor O
L O
. O
was O
examined O
. O

The O
effect O
of O
major O
cation O
activity O
( O
Ca B
( I
2 I
+ I
) I
, O
Mg B
( I
2 I
+ I
) I
, O
Na B
( I
+ I
) I
, O
K B
( I
+ I
) I
) O
on O
Ni B
toxicity O
, O
with O
dose O
expressed O
as O
exposure O
( O
total O
dissolved O
Ni B
concentration O
NiTot O
) O
or O
free O
Ni B
ion O
activity O
( O
in O
solution O
Ni B
( I
2 I
+ I
) I
) O
, O
or O
as O
tissue O
residue O
( O
Ni B
concentration O
in O
plant O
tissue O
NiTiss O
) O
to O
the O
aquatic O
plant O
Lemna O
minor O
L O
. O
was O
examined O
. O

CMT4B O
results O
from O
mutations O
in O
either O
myotubularin O
- O
related O
protein O
2 O
( O
MTMR2 O
; O
CMT4B1 O
) O
or O
MTMR13 O
( O
CMT4B2 O
) O
, O
phosphoinositide O
( O
PI O
) O
3 O
- O
phosphatases O
that O
dephosphorylate O
phosphatidylinositol B
3 I
- I
phosphate I
( O
PtdIns3P B
) O
and O
PtdIns B
( I
3 I
, I
5 I
) I
P2 I
, O
lipids O
which O
regulate O
endo O
- O
lysosomal O
membrane O
traffic O
. O

Fourth O
generation O
PPI B
dendrimers O
, O
sialic B
acid I
conjugated O
PPI B
dendrimers O
( O
SPPI O
) O
, O
mannose B
conjugated O
PPI B
dendrimers O
( O
MPPI O
) O
and O
dual O
ligand O
system O
i O
. O
e O
. O
sialic B
acid I
conjugated O
- O
mannosylated B
PPI I
dendrimers O
( O
SMPPI O
) O
were O
synthesized O
and O
characterized O
by O
FT O
- O
IR O
and O
( B
1 I
) I
H I
NMR O
spectroscopies O
and O
were O
further O
confirmed O
by O
size O
exclusion O
chromatography O
and O
differential O
scanning O
calorimetry O
. O

Biodegradable O
core O
- O
shell O
nanoassemblies O
for O
the O
delivery O
of O
docetaxel B
and O
Zn B
( I
II I
) I
- O
phthalocyanine B
inspired O
by O
combination O
therapy O
for O
cancer O
. O

This O
finding O
suggests O
that O
PEI B
combined O
with O
liposomes O
and O
with O
slightly O
decreased O
numbers O
of O
primary B
amines I
may O
be O
an O
effective O
vaginally O
administrated O
antiviral O
drug O
, O
and O
secondary B
and I
tertiary I
amine I
residues O
of O
PEI B
may O
contribute O
to O
the O
inhibitory O
efficiency O
against O
viral O
infection O
. O

An O
aluminum B
complex O
based O
on O
an O
amino B
triphenolate I
ligand O
scaffold O
shows O
unprecedented O
high O
activity O
( O
initial O
TOFs O
up O
to O
36 O
, O
000 O
h O
( O
- O
1 O
) O
) O
, O
broad O
substrate O
scope O
, O
and O
functional O
group O
tolerance O
in O
the O
formation O
of O
highly O
functional O
organic B
carbonates I
prepared O
from O
epoxides B
and O
CO B
( I
2 I
) I
. O

Schisphenlignans B
A I
- I
E I
: O
five O
new O
dibenzocyclooctadien B
lignans I
from O
Schisandra O
sphenanthera O
. O

Five O
new O
dibenzocyclooctadien B
lignans I
, O
schisphenlignans B
A I
- I
E I
( O
1 O
- O
5 O
) O
, O
together O
with O
eight O
known O
ones O
, O
were O
isolated O
from O
the O
stems O
of O
Schisandra O
sphenanthera O
. O

Enhancing O
catalytic O
selectivity O
of O
supported O
metal O
nanoparticles O
with O
capping O
ligands O
is O
demonstrated O
using O
an O
Au B
/ O
SiO B
( I
2 I
) I
catalyst O
in O
liquid O
phase O
aerobic O
oxidation O
of O
benzyl B
alcohol I
. O

Chemisorption O
of O
an O
appropriate O
amount O
of O
polyvinylpyrrolidone B
on O
the O
Au B
/ O
SiO B
( I
2 I
) I
catalyst O
greatly O
enhances O
the O
benzaldehyde B
selectivity O
from O
43 O
% O
to O
~ O
100 O
% O
and O
its O
yield O
from O
4 O
. O
9 O
% O
to O
7 O
. O
2 O
% O
. O

Derivatives O
of O
the O
azamacrocycle O
cyclam B
that O
contain O
a O
pendant O
naphthalimide B
dye O
are O
inherently O
fluorescent O
when O
zinc B
( I
II I
) I
is O
coordinated O
. O

This O
ligand O
has O
been O
assembled O
by O
using O
a O
one O
- O
pot O
" O
double O
- O
click O
" O
strategy O
and O
complexed O
with O
copper B
( I
II I
) I
and O
zinc B
( I
II I
) I
. O

This O
ligand O
has O
been O
assembled O
by O
using O
a O
one O
- O
pot O
" O
double O
- O
click O
" O
strategy O
and O
complexed O
with O
copper B
( I
II I
) I
and O
zinc B
( I
II I
) I
. O

The O
zinc B
( I
II I
) I
complex O
is O
fluorescent O
, O
and O
its O
fluorescence O
output O
changes O
in O
the O
presence O
of O
avidin O
. O

The O
results O
are O
disappointing O
due O
to O
side O
reactions O
in O
the O
IL O
proper O
, O
and O
F B
( I
- I
) I
- O
mediated O
hydrolysis O
of O
the O
produced O
ester B
. O

( B
1 I
) I
H I
NMR O
spectroscopic O
analysis O
was O
applied O
successfully O
to O
monitor O
the O
optical O
purity O
of O
the O
crystalline O
salt O
while O
undertaking O
optical O
resolution O
. O

The O
polymer O
network O
slows O
down O
the O
Na B
( I
+ I
) I
/ O
H B
( I
+ I
) I
exchange O
between O
Bioglass O
and O
water O
used O
to O
leach O
salt O
particles O
to O
create O
pores O
within O
the O
scaffold O
. O

The O
polymer O
network O
slows O
down O
the O
Na B
( I
+ I
) I
/ O
H B
( I
+ I
) I
exchange O
between O
Bioglass O
and O
water O
used O
to O
leach O
salt O
particles O
to O
create O
pores O
within O
the O
scaffold O
. O

The O
accepted O
proton O
pumping O
stoichiometry O
was O
4 O
protons O
per O
2 O
electrons O
transferred O
( O
4H B
( I
+ I
) I
/ O
2e O
( O
- O
) O
) O
but O
it O
has O
been O
suggested O
that O
stoichiometry O
may O
be O
3H B
( I
+ I
) I
/ O
2e O
( O
- O
) O
based O
on O
the O
identification O
of O
only O
3 O
proton O
pumping O
units O
in O
the O
crystal O
structure O
and O
a O
revision O
of O
the O
previous O
experimental O
data O
. O

The O
accepted O
proton O
pumping O
stoichiometry O
was O
4 O
protons O
per O
2 O
electrons O
transferred O
( O
4H B
( I
+ I
) I
/ O
2e O
( O
- O
) O
) O
but O
it O
has O
been O
suggested O
that O
stoichiometry O
may O
be O
3H B
( I
+ I
) I
/ O
2e O
( O
- O
) O
based O
on O
the O
identification O
of O
only O
3 O
proton O
pumping O
units O
in O
the O
crystal O
structure O
and O
a O
revision O
of O
the O
previous O
experimental O
data O
. O

Measurement O
of O
proton O
pumping O
stoichiometry O
is O
challenging O
because O
, O
even O
in O
isolated O
mitochondria O
, O
it O
is O
difficult O
to O
measure O
the O
proton O
motive O
force O
while O
simultaneously O
measuring O
the O
redox O
potentials O
of O
the O
NADH B
/ O
NAD B
( I
+ I
) I
and O
ubiquinol B
/ O
ubiquinone B
pools O
. O

Here O
we O
employ O
a O
new O
method O
to O
quantify O
the O
proton O
motive O
force O
in O
living O
cells O
from O
the O
redox O
poise O
of O
the O
bc O
( O
1 O
) O
complex O
measured O
using O
multiwavelength O
cell O
spectroscopy O
and O
show O
that O
the O
correct O
stoichiometry O
for O
complex O
I O
is O
4H B
( I
+ I
) I
/ O
2e O
( O
- O
) O
in O
mouse O
and O
human O
cells O
at O
high O
and O
physiological O
proton O
motive O
force O
. O

Oral O
intubation O
with O
CA O
or O
RA O
alone O
for O
five O
days O
was O
conducted O
prior O
to O
treatment O
with O
a O
single O
dose O
of O
tert B
- I
butyl I
hydroperoxide I
( O
0 O
. O
5mmol O
/ O
kg O
b O
. O
w O
. O
, O
i O
. O
p O
. O
) O
, O
which O
led O
to O
a O
significant O
reduction O
of O
indicators O
of O
hepatic O
toxicity O
, O
such O
as O
aspartate B
aminotransferase O
, O
alanine B
aminotransferase O
, O
oxidized B
glutathione I
, O
lipid O
peroxidation O
and O
enzyme O
activities O
related O
to O
antioxidant O
such O
as O
catalase O
, O
glutathione B
peroxidase O
and O
superoxide B

Herein O
, O
we O
examined O
the O
optical O
properties O
of O
three O
Si B
QDs O
with O
increasing O
sigma O
- O
pi O
conjugation O
length O
: O
octyl B
- O
, O
( B
trimethylsilyl I
) I
vinyl I
- O
, O
and O
2 B
- I
phenylvinyl I
- O
capped O
Si B
QDs O
. O

( B
13 I
) I
C I
NMR O
spectra O
, O
DLS O
, O
and O
circular O
dichroism O
spectra O
were O
employed O
to O
study O
the O
mechanism O
of O
the O
sol O
- O
gel O
phase O
transition O
. O

Tricycloalternarenes B
F I
- I
H I
: O
three O
new O
mixed O
terpenoids B
produced O
by O
an O
endolichenic O
fungus O
Ulocladium O
sp O
. O
using O
OSMAC O
method O
. O

Aphagrandinoids B
A I
- I
D I
, O
cycloartane B
triterpenoids I
with O
antibacterial O
activities O
from O
Aphanamixis O
grandifolia O
. O

Three O
new O
cycloartane B
triterpenoids I
, O
aphagrandinoids B
A I
- I
C I
( O
1 O
- O
3 O
) O
, O
and O
a O
new O
natural O
product O
, O
aphagrandinoid B
D I
( O
4 O
) O
, O
together O
with O
a O
known O
compound O
, O
were O
isolated O
from O
the O
leaves O
and O
twigs O
of O
Aphanamixis O
grandifolia O
. O

However O
, O
other O
steroids B
, O
including O
Delta B
( I
5 I
) I
- I
androstenediol I
, O
5 B
alpha I
- I
androstanediol I
and O
27 B
- I
hydroxycholesterol I
, O
which O
have O
a O
saturated O
A O
ring O
containing O
a O
3 B
beta I
- I
hydroxyl I
and O
a O
C19 O
methyl B
group O
, O
also O
mediate O
physiological O
responses O
through O
binding O
to O
estrogen B
receptor O
- O
alpha O
( O
ER O
alpha O
) O
and O
ER O
beta O
. O

However O
, O
other O
steroids B
, O
including O
Delta B
( I
5 I
) I
- I
androstenediol I
, O
5 B
alpha I
- I
androstanediol I
and O
27 B
- I
hydroxycholesterol I
, O
which O
have O
a O
saturated O
A O
ring O
containing O
a O
3 B
beta I
- I
hydroxyl I
and O
a O
C19 O
methyl B
group O
, O
also O
mediate O
physiological O
responses O
through O
binding O
to O
estrogen B
receptor O
- O
alpha O
( O
ER O
alpha O
) O
and O
ER O
beta O
. O

alpha B
- I
Santonin I
derived O
new O
series O
of O
1 B
, I
2 I
, I
3 I
- I
triazoles I
synthesized O
through O
Azide B
- I
Alkyne I
Huisgen O
1 O
, O
3 O
- O
dipolar O
cycloaddition O
reaction O
between O
substituted O
aryl B
azide I
and O
a O
propargylated B
alpha I
- I
desmotrosantonin I
were O
bio O
- O
evaluated O
for O
their O
diminutive O
effect O
on O
ConA O
induced O
T O
- O
cell O
and O
LPS O
induced O
B O
- O
cell O
proliferation O
. O

In O
medicine O
, O
the O
use O
of O
silica B
nanoparticles O
( O
SiO B
( I
2 I
) I
NPs O
) O
offers O
new O
perspectives O
in O
biosensor O
, O
drug O
delivery O
and O
cancer O
therapy O
. O

However O
, O
questions O
about O
potential O
toxic O
and O
deleterious O
effects O
of O
SiO B
( I
2 I
) I
NPs O
have O
also O
been O
raised O
. O

The O
aim O
of O
this O
study O
was O
to O
investigate O
the O
induction O
of O
cytotoxicity O
, O
oxidative O
stress O
and O
apoptosis O
by O
SiO B
( I
2 I
) I
NPs O
( O
size O
15 O
nm O
) O
in O
human O
skin O
epithelial O
( O
A431 O
) O
and O
human O
lung O
epithelial O
( O
A549 O
) O
cells O
. O

SiO B
( I
2 I
) I
NPs O
( O
concentration O
range O
25 O
- O
200 O
micro O
g O
/ O
ml O
) O
induced O
dose O
- O
dependent O
cytotoxicity O
in O
both O
types O
of O
cells O
, O
which O
was O
demonstrated O
by O
cell O
viability O
( O
3 B
- I
( I
4 I
, I
5 I
- I
dimethylthiazol I
- I
2 I
- I
yl I
) I
- I
2 I
, I
5 I
- I
diphenyltetrazoliumb I
) O
and O
lactate B
dehydrogenase O
leakage O
assays O
. O

SiO B
( I
2 I
) I
NPs O
were O
also O
found O
to O
induce O
oxidative O
stress O
in O
a O
dose O
- O
dependent O
manner O
, O
indicated O
by O
depletion O
of O
glutathione B
and O
induction O
of O
reactive O
oxygen B
species O
( O
ROS O
) O
generation O
and O
lipid O
peroxidation O
. O

Quantitative O
real O
- O
time O
polymerase O
chain O
reaction O
analysis O
showed O
that O
following O
the O
exposure O
of O
cells O
to O
SiO B
( I
2 I
) I
NPs O
, O
the O
messenger O
RNA O
level O
of O
apoptotic O
genes O
( O
caspase O
- O
3 O
and O
caspase O
- O
9 O
) O
were O
upregulated O
in O
a O
dose O
- O
dependent O
manner O
. O

Moreover O
, O
activities O
of O
caspase O
- O
3 O
and O
caspase O
- O
9 O
enzymes O
were O
also O
significantly O
higher O
in O
both O
kinds O
of O
cells O
exposed O
to O
SiO B
( I
2 I
) I
NPs O
. O

This O
study O
suggested O
that O
SiO B
( I
2 I
) I
NPs O
induce O
cytotoxicity O
and O
apoptosis O
in O
A431 O
and O
A549 O
cells O
, O
which O
is O
likely O
to O
be O
mediated O
through O
ROS O
generation O
and O
oxidative O
stress O
. O

In O
this O
study O
, O
supercritical O
fluid O
extraction O
( O
SFE O
) O
with O
CO B
( I
2 I
) I
and O
hydrodistillation O
( O
HD O
) O
were O
compared O
as O
methods O
to O
isolate O
the O
essential O
oil O
from O
Cupressus O
sempervirens O
. O

Solphenazines B
A I
- I
F I
, O
glycosylated B
phenazines I
from O
Streptomyces O
sp O
. O
strain O
DL O
- O
93 O
. O

During O
a O
survey O
of O
actinobacteria O
known O
to O
suppress O
the O
growth O
of O
Streptomyces O
scabies O
( O
the O
causative O
agent O
of O
potato O
scab O
disease O
) O
in O
vivo O
, O
six O
new O
rhamnosylated O
alkaloids O
, O
the O
solphenazines B
A I
- I
F I
( O
1 O
- O
6 O
) O
, O
were O
isolated O
from O
a O
biological O
control O
strain O
of O
Streptomyces O
( O
DL O
- O
93 O
) O
. O

Oxygen B
( O
O B
( I
2 I
) I
) O
is O
a O
vital O
element O
. O

Shortage O
of O
O B
( I
2 I
) I
results O
in O
deranged O
metabolism O
and O
important O
changes O
in O
vascular O
tone O
with O
opposite O
effects O
on O
the O
systemic O
and O
pulmonary O
circulation O
. O

However O
, O
O B
( I
2 I
) I
therapy O
remains O
the O
most O
common O
therapy O
of O
hypoxemia O
, O
but O
it O
must O
be O
carefully O
tailored O
to O
relieve O
hypoxemia O
without O
provoking O
hyperoxia O
or O
hypercarbia O
. O

Then O
, O
the O
individual O
response O
to O
O B
( I
2 I
) I
as O
well O
as O
changing O
needs O
of O
O B
( I
2 I
) I
during O
sleep O
or O
exercise O
must O
be O
evaluated O
to O
provide O
the O
best O
O B
( I
2 I
) I
therapy O
. O

Then O
, O
the O
individual O
response O
to O
O B
( I
2 I
) I
as O
well O
as O
changing O
needs O
of O
O B
( I
2 I
) I
during O
sleep O
or O
exercise O
must O
be O
evaluated O
to O
provide O
the O
best O
O B
( I
2 I
) I
therapy O
. O

Then O
, O
the O
individual O
response O
to O
O B
( I
2 I
) I
as O
well O
as O
changing O
needs O
of O
O B
( I
2 I
) I
during O
sleep O
or O
exercise O
must O
be O
evaluated O
to O
provide O
the O
best O
O B
( I
2 I
) I
therapy O
. O

A O
thorough O
knowledge O
of O
the O
pathophysiological O
bases O
of O
hypoxemia O
and O
O B
( I
2 I
) I
storage O
and O
delivery O
devices O
is O
then O
mandatory O
to O
administer O
O B
( I
2 I
) I
therapy O
guaranteeing O
for O
optimal O
correction O
of O
hypoxemia O
and O
minimizing O
the O
risk O
of O
hyperoxia O
. O

A O
thorough O
knowledge O
of O
the O
pathophysiological O
bases O
of O
hypoxemia O
and O
O B
( I
2 I
) I
storage O
and O
delivery O
devices O
is O
then O
mandatory O
to O
administer O
O B
( I
2 I
) I
therapy O
guaranteeing O
for O
optimal O
correction O
of O
hypoxemia O
and O
minimizing O
the O
risk O
of O
hyperoxia O
. O

Consistent O
with O
this O
aim O
also O
is O
a O
careful O
scrutiny O
of O
instruments O
and O
procedures O
for O
monitoring O
the O
individual O
response O
to O
O B
( I
2 I
) I
over O
time O
. O

Thus O
, O
at O
variance O
from O
classical O
pharmacological O
therapy O
, O
performing O
O B
( I
2 I
) I
therapy O
requires O
a O
vast O
array O
of O
clinical O
and O
technical O
competences O
. O

The O
optimal O
integration O
of O
these O
competences O
is O
needed O
to O
optimize O
O B
( I
2 I
) I
therapy O
on O
individual O
bases O
. O

As O
the O
potential O
becomes O
more O
negative O
, O
the O
molecules O
move O
in O
an O
upward O
direction O
, O
with O
a O
speed O
that O
depends O
on O
the O
amount O
of O
dissolved O
H B
( I
2 I
) I
produced O
by O
water O
reduction O
. O

Shown O
is O
that O
this O
motion O
is O
controlled O
, O
in O
large O
part O
, O
by O
the O
change O
in O
the O
electrolyte O
density O
near O
the O
electrode O
due O
to O
dissolved O
H B
( I
2 I
) I
. O

The O
electrogenerated O
H B
( I
2 I
) I
was O
also O
shown O
to O
be O
able O
to O
reductively O
remove O
the O
thiol O
SAM O
from O
the O
Pt B
/ O
Ir B
particles O
that O
decorate O
the O
microelectrode O
glass O
sheath O
. O

The O
mechanical O
characteristics O
of O
human O
red O
blood O
cell O
( O
RBC O
) O
membrane O
change O
due O
to O
C B
( I
60 I
) I
nanoparticle O
( O
NP O
) O
infiltration O
have O
been O
investigated O
in O
the O
present O
work O
. O

Using O
experimental O
approaches O
, O
including O
optical O
tweezer O
( O
OT O
) O
stretching O
and O
atomic O
force O
microscopy O
( O
AFM O
) O
indentation O
, O
we O
found O
that O
RBCs O
in O
the O
presence O
of O
C B
( I
60 I
) I
NPs O
are O
softer O
than O
normal O
RBCs O
. O

The O
strain O
- O
stress O
relations O
of O
both O
normal O
and O
C B
( I
60 I
) I
infiltrated O
RBC O
membranes O
are O
extracted O
from O
the O
data O
of O
AFM O
indentation O
, O
from O
which O
we O
proved O
that O
C B
( I
60 I
) I
NP O
infiltration O
can O
affect O
the O
mechanical O
properties O
of O
RBC O
membrane O
and O
tend O
to O
weaken O
the O
tensile O
resistance O
of O
lipids O
bilayers O
. O

The O
strain O
- O
stress O
relations O
of O
both O
normal O
and O
C B
( I
60 I
) I
infiltrated O
RBC O
membranes O
are O
extracted O
from O
the O
data O
of O
AFM O
indentation O
, O
from O
which O
we O
proved O
that O
C B
( I
60 I
) I
NP O
infiltration O
can O
affect O
the O
mechanical O
properties O
of O
RBC O
membrane O
and O
tend O
to O
weaken O
the O
tensile O
resistance O
of O
lipids O
bilayers O
. O

Based O
on O
this O
model O
, O
the O
strain O
- O
stress O
relations O
of O
both O
normal O
and O
C B
( I
60 I
) I
infiltrated O
lipid O
bilayers O
are O
calculated O
with O
consideration O
of O
intermolecular O
interactions O
. O

The O
influence O
of O
C B
( I
60 I
) I
NP O
concentration O
on O
the O
mechanical O
properties O
of O
RBC O
membrane O
is O
successfully O
predicted O
. O

Higher O
concentrations O
of O
C B
( I
60 I
) I
NPs O
in O
the O
lipid O
bilayers O
will O
lead O
to O
increased O
damage O
to O
the O
cell O
membrane O
, O
implying O
that O
the O
dosage O
of O
C B
( I
60 I
) I
NPs O
should O
be O
controlled O
in O
medical O
applications O
. O

Higher O
concentrations O
of O
C B
( I
60 I
) I
NPs O
in O
the O
lipid O
bilayers O
will O
lead O
to O
increased O
damage O
to O
the O
cell O
membrane O
, O
implying O
that O
the O
dosage O
of O
C B
( I
60 I
) I
NPs O
should O
be O
controlled O
in O
medical O
applications O
. O

They O
are O
hydrazones B
, O
( B
thio I
) I
semicarbazones I
, O
and O
oximes B
of I
indenoindolones I
, O
and O
indenoindolols B
. O

Heterocycles O
as O
nonclassical O
bioisosteres O
of O
alpha B
- I
amino I
acids I
. O

Bioisosterism O
of O
alpha B
- I
amino I
acids I
is O
often O
accomplished O
by O
replacing O
the O
alpha B
- I
carboxylate I
with O
one O
of O
the O
many O
known O
carboxylic B
acid I
bioisosteres O
. O

However O
, O
bioisosterism O
of O
the O
whole O
alpha B
- I
amino I
acid I
moiety O
is O
accomplished O
with O
heterocyclic O
bioisosteres O
that O
often O
display O
an O
acidic O
function O
. O

In O
this O
Minireview O
, O
we O
summarized O
the O
reported O
heterocycles O
as O
nonclassical O
bioisosteres O
of O
alpha B
- I
amino I
acids I
, O
which O
include O
quinoxaline B
- I
2 I
, I
4 I
( I
1H I
) I
- I
dione I
, O
quinoxaline B
- I
2 I
, I
3 I
( I
1H I
) I
- I
dione I
and O
quinolin B
- I
2 I
( I
1H I
) I
- I
one I
, O
azagrevellin B
and O
azepine B
- O
derived O
structures O
. O

The O
binding O
mode O
of O
the O
crystalized O
bioisosteres O
were O
compared O
with O
those O
of O
the O
crystalized O
alpha B
- I
amino I
acids I
that O
bind O
in O
the O
same O
domain O
, O
and O
where O
no O
data O
on O
the O
crystal O
structure O
were O
available O
, O
the O
displacement O
studies O
of O
known O
orthosteric O
ligands O
were O
used O
. O

The O
reported O
bioisosteres O
share O
the O
following O
essential O
structural O
features O
for O
mimicking O
alpha B
- I
amino I
acids I
: O
an O
aromatic O
ring O
system O
joined O
to O
a O
lactam O
ring O
system O
with O
an O
acidic O
feature O
next O
to O
the O
lactam B
carbonyl I
, O
where O
this O
acidic O
feature O
together O
with O
the O
lactam B
carbonyl I
can O
mimic O
the O
alpha O
- O
carboxylate O
, O
and O
the O
lactam O
nitrogen O
together O
with O
the O
aromatic O
ring O
system O
can O
mimic O
the O
alpha B
- I
ammonium I
. O

The O
rhombohedral O
phase O
Ge B
( I
3 I
) I
Sb I
( I
8 I
) I
Te I
( I
6 I
) I
and O
Ge B
( I
2 I
) I
Sb I
( I
7 I
) I
Te I
( I
4 I
) I
NWs O
adopted O
an O
innovative O
structure O
; O
3Sb B
( I
2 I
) I
layers O
intercalated O
the O
Ge B
( I
3 I
) I
Sb I
( I
2 I
) I
Te I
( I
6 I
) I
and O
Ge B
( I
2 I
) I
Sb I
( I
1 I
) I
Te I
( I
4 I
) I
domains O
, O
respectively O
, O
producing O
3 O
. O
4 O
and O
2 O
. O
7 O
nm O
period O
slabs O
. O

Fundamental O
and O
Torsional O
Combination O
Bands O
of O
Two O
Isomers O
of O
the O
OCS B
- O
CO B
( I
2 I
) I
Complex O
in O
the O
CO B
( I
2 I
) I
nu O
( O
3 O
) O
Region O
. O

Fundamental O
and O
Torsional O
Combination O
Bands O
of O
Two O
Isomers O
of O
the O
OCS B
- O
CO B
( I
2 I
) I
Complex O
in O
the O
CO B
( I
2 I
) I
nu O
( O
3 O
) O
Region O
. O

Spectra O
of O
two O
isomers O
of O
the O
weakly O
bound O
complex O
OCS B
- O
CO B
( I
2 I
) I
are O
observed O
in O
the O
region O
of O
the O
CO B
( I
2 I
) I
nu O
( O
3 O
) O
fundamental O
vibration O
( O
~ O
2349 O
cm O
( O
- O
1 O
) O
) O
, O
using O
an O
infrared O
tunable O
diode O
laser O
to O
probe O
a O
pulsed O
supersonic O
slit O
- O
jet O
expansion O
. O

Spectra O
of O
two O
isomers O
of O
the O
weakly O
bound O
complex O
OCS B
- O
CO B
( I
2 I
) I
are O
observed O
in O
the O
region O
of O
the O
CO B
( I
2 I
) I
nu O
( O
3 O
) O
fundamental O
vibration O
( O
~ O
2349 O
cm O
( O
- O
1 O
) O
) O
, O
using O
an O
infrared O
tunable O
diode O
laser O
to O
probe O
a O
pulsed O
supersonic O
slit O
- O
jet O
expansion O
. O

Two O
bands O
are O
measured O
and O
analyzed O
for O
each O
isomer O
, O
the O
fundamental O
asymmetric O
stretch O
of O
the O
CO B
( I
2 I
) I
component O
and O
a O
combination O
band O
involving O
this O
fundamental O
plus O
the O
intermolecular O
out O
- O
of O
- O
plane O
torsional O
mode O
. O

The O
resulting O
torsional O
frequencies O
are O
found O
to O
be O
18 O
. O
8 O
and O
15 O
. O
9 O
cm O
( O
- O
1 O
) O
for O
isomers O
a O
and O
b O
of O
OCS B
- O
CO B
( I
2 I
) I
, O
respectively O
. O

The O
two O
epimers O
of O
1 O
were O
resolved O
through O
an O
acetonide B
reaction O
, O
and O
the O
absolute O
configurations O
of O
two O
derivatives O
were O
deduced O
by O
the O
analysis O
of O
their O
( B
13 I
) I
C I
NMR O
differences O
induced O
by O
gamma O
- O
gauche O
or O
steric O
effect O
. O

Based O
on O
it O
, O
the O
( B
13 I
) I
C I
NMR O
assignment O
of O
24R O
- O
1 O
and O
24S O
- O
1 O
was O
also O
established O
. O

The O
devices O
displayed O
an O
NH B
( I
3 I
) I
sensitivity O
of O
60 O
nM O
( O
or O
~ O
1 O
ppb O
) O
, O
which O
is O
comparable O
to O
small O
molecule O
aqueous O
solution O
detection O
using O
state O
- O
of O
- O
the O
- O
art O
SWCNT O
TFT O
sensors O
while O
concomitantly O
achieving O
6000 O
times O
higher O
chemical O
selectivity O
toward O
a O
variety O
of O
amine B
- O
containing O
analyte O
molecules O
over O
that O
of O
other O
small O
molecules O
. O

Unprecedented O
transformation O
of O
tetrathienoanthracen B
into O
pentacene B
on O
Ni B
( I
111 I
) I
. O

Our O
images O
reveal O
a O
sulfur B
abstraction O
and O
cyclization O
reaction O
that O
converts O
tetrathienoanthracen B
precursors O
into O
pentacene B
on O
the O
Ni B
( I
111 I
) I
surface O
. O

Four O
new O
jatropholane B
- O
type O
diterpenes B
( O
1 O
- O
4 O
) O
, O
named O
sikkimenoids B
A I
- I
D I
, O
were O
isolated O
from O
the O
aerial O
parts O
of O
Euphorbia O
sikkimensis O
. O

This O
study O
aimed O
to O
evaluate O
the O
NO B
specie O
generated O
by O
RuBPY B
as O
compared O
to O
NO B
released O
from O
sodium B
nitroprusside I
( O
SNP B
) O
and O
to O
study O
the O
cellular O
mechanisms O
specially O
focusing O
the O
activation O
of O
soluble O
guanylyl B
- O
cyclase O
( O
sGC O
) O
, O
K B
( I
+ I
) I
channels O
and O
the O
cell O
membrane O
hyperpolarization O
, O
which O
are O
the O
main O
targets O
for O
NO B
- O
inducing O
vascular O
relaxation O
. O

The O
cellular O
mechanisms O
of O
aorta O
relaxation O
were O
investigated O
using O
K B
( I
+ I
) I
channel O
blockers O
and O
sGC O
inhibitor O
. O

RuBPY B
released O
only O
radicalar B
NO I
( O
0 O
) O
and O
SNP B
released O
both O
NO B
( I
- I
) I
and O
NO B
( O
0 O
) O
. O

The O
concentration O
- O
effect O
curves O
for O
RuBPY B
- O
induced O
relaxation O
was O
shifted O
to O
the O
right O
by O
inhibition O
of O
sGC O
with O
ODQ B
and O
by O
the O
non O
- O
selective O
blockade O
of O
K B
( I
+ I
) I
channels O
with O
TEA B
. O

Taken O
together O
, O
our O
results O
indicate O
that O
the O
large O
amount O
of O
NO B
( O
0 O
) O
specie O
generated O
by O
RuBPY B
induces O
vasorelaxation O
due O
to O
activation O
of O
sGC O
, O
K B
( I
+ I
) I
channels O
sensitive O
to O
TEA B
, O
and O
cell O
membrane O
hyperpolarization O
. O

These O
results O
indicate O
that O
NO B
( O
0 O
) O
generated O
from O
RuBPY B
can O
also O
directly O
activate O
the O
K B
( I
+ I
) I
channels O
in O
an O
independent O
way O
of O
sGC O
. O

ZnO B
is O
a O
CO B
( I
2 I
) I
- O
selective O
steam O
reforming O
catalyst O
. O

Catalytic O
experiments O
in O
a O
batch O
as O
well O
as O
a O
flow O
reactor O
resulted O
in O
highly O
selective O
steam O
reforming O
, O
though O
at O
low O
specific O
activities O
, O
of O
formaldehyde B
and O
methanol B
over O
ZnO B
toward O
CO B
( I
2 I
) I
( O
selectivity O
of O
95 O
- O
99 O
. O
6 O
% O
) O
. O

Comparison O
of O
the O
behavior O
of O
ZnPd B
near O
- O
surface O
intermetallic O
phases O
, O
unsupported O
intermetallic O
ZnPd B
and O
supported O
ZnPd B
/ O
ZnO B
catalysts O
reveals O
that O
formaldehyde B
is O
formed O
from O
methanol B
in O
parallel O
with O
CO B
( I
2 I
) I
on O
the O
former O
, O
while O
on O
unsupported O
intermetallic O
ZnPd B
and O
ZnO B
- O
supported O
ZnPd B
, O
it O
is O
efficiently O
reacted O
toward O
CO B
( I
2 I
) I
, O
thus O
, O
a O
beneficial O
role O
of O
ZnO B
in O
oxidizing O
formaldehyde B
- O
derived O
intermediates O
toward O

Comparison O
of O
the O
behavior O
of O
ZnPd B
near O
- O
surface O
intermetallic O
phases O
, O
unsupported O
intermetallic O
ZnPd B
and O
supported O
ZnPd B
/ O
ZnO B
catalysts O
reveals O
that O
formaldehyde B
is O
formed O
from O
methanol B
in O
parallel O
with O
CO B
( I
2 I
) I
on O
the O
former O
, O
while O
on O
unsupported O
intermetallic O
ZnPd B
and O
ZnO B
- O
supported O
ZnPd B
, O
it O
is O
efficiently O
reacted O
toward O
CO B
( I
2 I
) I
, O
thus O
, O
a O
beneficial O
role O
of O
ZnO B
in O
oxidizing O
formaldehyde B
- O
derived O
intermediates O
toward O

CO B
( I
2 I
) I
is O
evident O
. O

Toxicity O
assessment O
on O
trophoblast O
cells O
for O
some O
environment O
polluting O
chemicals O
and O
17 B
beta I
- I
estradiol I
. O

Cells O
were O
exposed O
for O
24h O
to O
various O
concentrations O
( O
from O
0 O
. O
1 O
pM O
to O
1 O
mM O
) O
of O
atrazine B
( O
ATR B
) O
, O
diethylstilbestrol B
( O
DES B
) O
, O
para B
- I
nonylphenol I
( O
p B
- I
NP I
) O
, O
resveratrol B
( O
RES B
) O
and O
17 B
beta I
- I
estradiol I
( O
E2 O
) O
and O
assayed O
for O
cell O
viability O
and O
human O
beta O
- O
Chorionic O
Gonadotropin O
( O
beta O
- O
hCG O
) O
secretion O
. O

We O
use O
an O
electrochemical O
approach O
involving O
phenyl B
- I
diazonium I
salts I
to O
systematically O
probe O
electronic O
modification O
in O
MLG O
and O
BLG O
with O
increasing O
functionalization O
for O
the O
first O
time O
, O
obtaining O
the O
highest O
conversion O
values O
to O
date O
. O

For O
MLG O
, O
we O
find O
that O
band O
gap O
opening O
as O
measured O
during O
transport O
is O
linearly O
increased O
with O
respect O
to O
the O
I O
( O
D O
) O
/ O
I O
( O
G O
) O
ratio O
but O
remains O
below O
0 O
. O
1 O
meV O
in O
magnitude O
for O
SiO B
( I
2 I
) I
supported O
graphene B
. O

TF O
or O
Cort B
each O
increased O
insulin O
- O
stimulated O
lipogenesis O
, O
an O
effect O
resulting O
from O
increased O
lipogenic O
gene O
expression O
and O
enhanced O
insulin O
- O
stimulated O
dephosphorylation O
of O
acetyl B
- I
coenzyme I
A I
carboxylase O
. O

Cell O
death O
was O
induced O
at O
relatively O
low O
concentrations O
by O
perfluorooctyl B
sulfonate I
( O
PFOS B
) O
, O
perfluorooctane B
sulfonylamide I
( O
PFOSA B
) O
and O
the O
fluorotelomer B
alcohol I
1H B
, I
1H I
, I
2H I
, I
2H I
- I
perfluorodecanol I
( O
FTOH B
8 I
: I
2 I
) O
with O
EC O
( O
50 O
) O
- O
values O
of O
62 O
+ O
/ O
- O
7 O
. O
6 O
, O
13 O
+ O
/ O
- O
1 O
. O
8 O
and O
15 O
+ O
/ O
- O
4 O
. O
2 O
mu O
M O
( O
mean O
+ O
/ O
- O
SD O
) O
respectively O
. O

The O
influence O
of O
changes O
in O
the O
chain O
conformation O
on O
the O
( B
13 I
) I
C I
sigma O
( O
ii O
) O
NMR O
shielding O
parameters O
is O
shown O
. O

Moreover O
, O
a O
comparison O
of O
the O
experimental O
( B
13 I
) I
C I
NMR O
spectra O
with O
the O
spectra O
calculated O
using O
the O
M1 O
- O
M4 O
models O
strongly O
supports O
the O
data O
for O
the O
M4 O
model O
. O

The O
composition O
of O
55 O
samples O
of O
essential O
oil O
isolated O
from O
the O
aerial O
parts O
of O
wild O
growing O
Myrtus O
communis O
L O
. O
harvested O
in O
16 O
locations O
from O
East O
to O
West O
Algeria O
were O
investigated O
by O
GC O
( O
determination O
of O
retention O
indices O
) O
and O
( B
13 I
) I
C I
- O
NMR O
analyses O
. O

A O
cobalt B
chlorin I
complex O
( O
Co B
( I
II I
) I
( I
Ch I
) I
) O
efficiently O
and O
selectively O
catalyzed O
two O
- O
electron O
reduction O
of O
dioxygen B
( O
O B
( I
2 I
) I
) O
by O
one O
- O
electron O
reductants O
( O
ferrocene B
derivatives O
) O
to O
produce O
hydrogen B
peroxide I
( O
H B
( I
2 I
) I
O I
( I
2 I
) I
) O
in O
the O
presence O
of O
perchloric B
acid I
( O
HClO B
( I
4 I
) I
) O
in O
benzonitrile B
( O
PhCN B
) O
at O
298 O
K O
. O

A O
cobalt B
chlorin I
complex O
( O
Co B
( I
II I
) I
( I
Ch I
) I
) O
efficiently O
and O
selectively O
catalyzed O
two O
- O
electron O
reduction O
of O
dioxygen B
( O
O B
( I
2 I
) I
) O
by O
one O
- O
electron O
reductants O
( O
ferrocene B
derivatives O
) O
to O
produce O
hydrogen B
peroxide I
( O
H B
( I
2 I
) I
O I
( I
2 I
) I
) O
in O
the O
presence O
of O
perchloric B
acid I
( O
HClO B
( I
4 I
) I
) O
in O
benzonitrile B
( O
PhCN B
) O
at O
298 O
K O
. O

The O
two O
- O
electron O
reduction O
of O
O B
( I
2 I
) I
by O
1 B
, I
1 I
' I
- I
dibromoferrocene I
( O
Br B
( I
2 I
) I
Fc I
) O
was O
catalyzed O
by O
Co B
( I
II I
) I
( I
Ch I
) I
, O
whereas O
virtually O
no O
reduction O
of O
O B
( I
2 I
) I
occurred O
with O
Co B
( I
II I
) I
( I
OEP I
) I
. O

The O
two O
- O
electron O
reduction O
of O
O B
( I
2 I
) I
by O
1 B
, I
1 I
' I
- I
dibromoferrocene I
( O
Br B
( I
2 I
) I
Fc I
) O
was O
catalyzed O
by O
Co B
( I
II I
) I
( I
Ch I
) I
, O
whereas O
virtually O
no O
reduction O
of O
O B
( I
2 I
) I
occurred O
with O
Co B
( I
II I
) I
( I
OEP I
) I
. O

In O
addition O
, O
Co B
( I
II I
) I
( I
Ch I
) I
is O
more O
stable O
than O
Co B
( I
II I
) I
( I
OEP I
) I
, O
where O
the O
catalytic O
turnover O
number O
( O
TON O
) O
of O
the O
two O
- O
electron O
reduction O
of O
O B
( I
2 I
) I
catalyzed O
by O
Co B
( I
II I
) I
( I
Ch I
) I
exceeded O
30000 O
. O

The O
detailed O
kinetic O
studies O
have O
revealed O
that O
the O
rate O
- O
determining O
step O
in O
the O
catalytic O
cycle O
is O
the O
proton O
- O
coupled O
electron O
transfer O
reduction O
of O
O B
( I
2 I
) I
with O
the O
protonated O
Co B
( I
II I
) I
( I
Ch I
) I
( O
[ B
Co I
( I
II I
) I
( I
ChH I
) I
] I
( I
+ I
) I
) O
that O
is O
produced O
by O
facile O
electron O
- O
transfer O
reduction O
of O
[ B
Co I
( I
III I
) I
( I
ChH I
) I
] I
( I
2 I
+ I
) I
by O
ferrocene B
derivative O
in O
the O
presence O
of O
HClO B
( I
4 I
) I
. O

The O
detailed O
kinetic O
studies O
have O
revealed O
that O
the O
rate O
- O
determining O
step O
in O
the O
catalytic O
cycle O
is O
the O
proton O
- O
coupled O
electron O
transfer O
reduction O
of O
O B
( I
2 I
) I
with O
the O
protonated O
Co B
( I
II I
) I
( I
Ch I
) I
( O
[ B
Co I
( I
II I
) I
( I
ChH I
) I
] I
( I
+ I
) I
) O
that O
is O
produced O
by O
facile O
electron O
- O
transfer O
reduction O
of O
[ B
Co I
( I
III I
) I
( I
ChH I
) I
] I
( I
2 I
+ I
) I
by O
ferrocene B
derivative O
in O
the O
presence O
of O
HClO B
( I
4 I
) I
. O

The O
one O
- O
electron O
- O
reduction O
potential O
of O
[ B
Co I
( I
III I
) I
( I
Ch I
) I
] I
( I
+ I
) I
was O
positively O
shifted O
from O
0 O
. O
37 O
V O
( O
vs O
SCE O
) O
to O
0 O
. O
48 O
V O
by O
the O
addition O
of O
HClO B
( I
4 I
) I
due O
to O
the O
protonation O
of O
[ B
Co I
( I
III I
) I
( I
Ch I
) I
] I
( I
+ I
) I
. O

Such O
a O
positive O
shift O
of O
[ B
Co I
( I
III I
) I
( I
Ch I
) I
] I
( I
+ I
) I
by O
protonation O
resulted O
in O
enhancement O
of O
the O
catalytic O
reactivity O
of O
[ B
Co I
( I
III I
) I
( I
ChH I
) I
] I
( I
2 I
+ I
) I
for O
the O
two O
- O
electron O
reduction O
of O
O B
( I
2 I
) I
with O
a O
lower O
overpotential O
as O
compared O
with O
that O
of O
[ B
Co I
( I
III I
) I
( I
OEP I
) I
] I
( I
+ I
) I
. O

deoxysorbitol I
formation O
[ O
on O
post O
- O
transition B
metals I
( O
In B
, O
Sn B
, O
Sb B
, O
Pb B
, O
and O
Bi B
) O
, O
as O
well O
as O
Zn B
and O
Cd B
( O
d O
metals O
) O
] O
. O

DFT O
calculations O
show O
that O
mercaptopropionic B
acid I
( O
MPA B
) O
and O
cysteine B
( O
Cys B
) O
exhibit O
characteristic O
binding O
configurations O
on O
TiO B
( I
2 I
) I
surfaces O
. O

No O
significant O
difference O
was O
found O
between O
the O
groups O
with O
regard O
to O
perfluorooctane B
sulfonate I
( O
PFOS B
) O
, O
perfluorooctanoic B
acid I
( O
PFOA B
) O
, O
mono B
- I
ethylhexyl I
phthalate I
( O
MEHP B
) O
and O
di B
- I
( I
2 I
- I
ethylhexyl I
) I
phthalate I
( O
DEHP B
) O
concentrations O
. O

The O
chemical O
structure O
and O
electronic O
properties O
of O
two O
- O
dimensional O
( O
2D O
) O
carbon B
- O
supported O
TiO B
2 I
, O
TiO B
2 I
- I
graphdiyne I
, O
and O
TiO B
2 I
- I
graphene I
composites O
have O
been O
studied O
by O
first O
- O
principles O
density O
functional O
theory O
. O

The O
chemical O
structure O
and O
electronic O
properties O
of O
two O
- O
dimensional O
( O
2D O
) O
carbon B
- O
supported O
TiO B
2 I
, O
TiO B
2 I
- I
graphdiyne I
, O
and O
TiO B
2 I
- I
graphene I
composites O
have O
been O
studied O
by O
first O
- O
principles O
density O
functional O
theory O
. O

Visible O
light O
irradiation O
of O
a O
ruthenium B
( I
II I
) I
quinone B
- O
containing O
complex O
, O
[ B
( I
phen I
) I
( I
2 I
) I
Ru I
( I
phendione I
) I
] I
( I
2 I
+ I
) I
( O
1 O
( O
2 O
+ O
) O
) O
, O
where O
phendione B
= O
1 B
, I
10 I
- I
phenanthroline I
- I
5 I
, I
6 I
- I
dione I
, O
leads O
to O
DNA O
cleavage O
in O
an O
oxygen B
independent O
manner O
. O

In O
the O
absence O
of O
added O
salt O
, O
alternating O
adsorption O
of O
5 O
bilayers O
of O
protonated O
poly B
( I
allylamine I
) I
( O
PAH B
) O
and O
comb O
- O
like O
poly B
( I
2 I
- I
hydroxyethyl I
methacrylate I
) I
- I
graft I
- I
poly I
( I
acrylic I
acid I
) I
( O
PHEMA B
- I
g I
- I
PAA I
) O
leads O
to O
~ O
2 O
- O
fold O
thicker O
coatings O
than O
adsorption O
of O
PAH B
and O
linear O
PAA B
, O
and O
the O
difference O
in O
the O
thicknesses O
of O
the O
two O
coatings O
increases O
with O
the O
number O
of O
bilayers O
. O

Three O
new O
labdane B
diterpenoids I
, O
calomacrins B
A I
- I
C I
( O
1 O
- O
3 O
) O
, O
and O
a O
new O
diaryl B
butyrolactone I
- O
type O
lignan B
, O
calomacrol B
A I
( O
8 O
) O
, O
as O
well O
as O
four O
known O
labdane B
diterpenoids I
and O
six O
known O
lignans B
, O
were O
isolated O
from O
the O
twigs O
and O
leaves O
of O
Calocedrus O
macrolepis O
. O

Design O
, O
synthesis O
and O
anticancer O
properties O
of O
5 B
- I
arylbenzoxepins I
as O
conformationally O
restricted O
isocombretastatin B
A I
- I
4 I
analogs O
. O

Characterization O
of O
the O
complexes O
were O
achieved O
by O
IR O
and O
NMR O
( O
( B
1 I
) I
H I
and O
( B
13 I
) I
C I
) O
spectra O
and O
in O
addition O
, O
for O
2 O
and O
3 O
, O
by O
X O
- O
ray O
crystallography O
. O

Characterization O
of O
the O
complexes O
were O
achieved O
by O
IR O
and O
NMR O
( O
( B
1 I
) I
H I
and O
( B
13 I
) I
C I
) O
spectra O
and O
in O
addition O
, O
for O
2 O
and O
3 O
, O
by O
X O
- O
ray O
crystallography O
. O

Commercially O
- O
available O
5 O
- O
HT2C O
agonists O
( O
CP B
809101 I
, O
Ro B
60 I
- I
0175 I
, O
WAY B
161503 I
, O
mCPP B
, O
and O
1 B
- I
methylpsilocin I
) O
, O
novel O
4 B
- I
phenyl I
- I
2 I
- I
N I
, I
N I
- I
dimethyl I
- I
aminotetralin I
( O
PAT B
) O
- O
type O
5 O
- O
HT2C O
agonists O
( O
with O
5 O
- O
HT2A O
/ O
2B O
antagonist O
activity O
) O
, O
and O
antagonists O
selective O
for O
5 O
- O
HT2A O
( O
M100907 B
) O
, O
5 O
- O
HT2C O
( O
SB B
- I

A O
consistent O
effect O
of O
repeated O
exposure O
to O
3 B
, I
4 I
methylenedioxymetham I
( O
MDMA B
) O
is O
a O
decrease O
in O
the O
tissue O
levels O
of O
serotonin B
( O
5 B
- I
HT I
) O
. O

Overall O
it O
was O
found O
that O
styelsamine B
analogues O
were O
stronger O
DNA O
binders O
, O
with O
the O
natural O
products O
styelsamines B
B I
and I
D I
having O
particularly O
high O
affinity O
( O
K O
( O
app O
) O
5 O
. O
33 O
x O
10 O
( O
6 O
) O
and O
3 O
. O
64 O
x O
10 O
( O
6 O
) O
M O
( O
- O
1 O
) O
, O
respectively O
) O
. O

The O
colloidal O
particles O
consist O
of O
a O
solid O
polystyrene B
core O
and O
a O
cross O
- O
linked O
poly B
- I
N I
- I
( I
isopropylacrylamide I
) I
shell O
with O
embedded O
crystalline O
titanium B
dioxide I
( O
TiO B
( I
2 I
) I
) O
nanoparticles O
( O
d O
= O
6 O
+ O
/ O
- O
3 O
nm O
) O
. O

The O
TiO B
( I
2 I
) I
particles O
are O
generated O
in O
the O
carrier O
network O
by O
a O
sol O
- O
gel O
process O
at O
room O
temperature O
. O

By O
analyzing O
the O
image O
stacks O
, O
the O
obtained O
near O
- O
edge O
X O
- O
ray O
absorption O
fine O
structure O
( O
NEXAFS O
) O
spectra O
of O
our O
individual O
hybrid O
particles O
show O
clearly O
that O
our O
synthesis O
generates O
TiO B
( I
2 I
) I
in O
the O
anastase O
phase O
. O

Additionally O
, O
our O
spectromicroscopy O
method O
permits O
the O
determination O
of O
the O
density O
distribution O
of O
TiO B
( I
2 I
) I
in O
single O
carrier O
particles O
. O

This O
study O
highlights O
the O
first O
synthesis O
of O
flavopiridol B
and O
2 B
- I
methoxyestradiol I
glucosides I
and O
confirms O
the O
ability O
of O
OleD O
to O
glucosylate B
both O
aromatic O
and O
aliphatic O
nucleophiles O
. O

This O
was O
achieved O
by O
the O
addition O
of O
ethylene B
glycol I
diglycidyl I
ether I
( O
EGDE B
) O
into O
the O
cryogelation O
system O
. O

Epitaxial O
silicon B
dots O
self O
- O
assembled O
on O
aluminum B
nitride I
/ O
Si B
( I
111 I
) I
. O

Si B
nanoscale O
dots O
are O
synthesized O
on O
AlN B
/ O
Si B
( I
111 I
) I
by O
molecular O
beam O
epitaxy O
. O

Metal B
nitride I
( B
Ni I
( I
0 I
. I
33 I
) I
Co I
( I
0 I
. I
67 I
) I
) I
N I
nanoparticles O
are O
prepared O
by O
nitridation O
using O
NiCo B
( I
2 I
) I
O I
( I
4 I
) I
as O
a O
precursor O
material O
by O
heating O
at O
335 O
degrees O
C O
for O
2 O
h O
in O
flowing O
NH B
( I
3 I
) I
+ O
N B
( I
2 I
) I
gas O
and O
characterized O
by O
X O
- O
ray O
diffraction O
( O
XRD O
) O
, O
field O
emission O
- O
scanning O
electron O
microscopy O
( O
FE O
- O
SEM O
) O
, O
high O
resolution O
- O
transmission O
electron O
microscopy O
( O
HR O
- O
TEM O
) O
, O
along O
with O
selective O
area O
electron O
diffraction O
( O
SAED O
) O
and O
X O

Metal B
nitride I
( B
Ni I
( I
0 I
. I
33 I
) I
Co I
( I
0 I
. I
67 I
) I
) I
N I
nanoparticles O
are O
prepared O
by O
nitridation O
using O
NiCo B
( I
2 I
) I
O I
( I
4 I
) I
as O
a O
precursor O
material O
by O
heating O
at O
335 O
degrees O
C O
for O
2 O
h O
in O
flowing O
NH B
( I
3 I
) I
+ O
N B
( I
2 I
) I
gas O
and O
characterized O
by O
X O
- O
ray O
diffraction O
( O
XRD O
) O
, O
field O
emission O
- O
scanning O
electron O
microscopy O
( O
FE O
- O
SEM O
) O
, O
high O
resolution O
- O
transmission O
electron O
microscopy O
( O
HR O
- O
TEM O
) O
, O
along O
with O
selective O
area O
electron O
diffraction O
( O
SAED O
) O
and O
X O

Functional O
imaging O
with O
( B
111 I
) I
Indium I
- O
octreotide O
with O
single O
photon O
emission O
computed O
tomography O
( O
octreo O
- O
SPECT O
or O
SPECT O
/ O
CT O
) O
, O
and O
( B
18 I
) I
fluorodeoxyglucose I
positron O
emission O
tomography O
/ O
CT O
( O
FDG O
- O
PET O
/ O
CT O
) O
were O
performed O
, O
followed O
by O
anatomic O
imaging O
( O
CT O
, O
MRI O
) O
. O

Functional O
imaging O
with O
( B
111 I
) I
Indium I
- O
octreotide O
with O
single O
photon O
emission O
computed O
tomography O
( O
octreo O
- O
SPECT O
or O
SPECT O
/ O
CT O
) O
, O
and O
( B
18 I
) I
fluorodeoxyglucose I
positron O
emission O
tomography O
/ O
CT O
( O
FDG O
- O
PET O
/ O
CT O
) O
were O
performed O
, O
followed O
by O
anatomic O
imaging O
( O
CT O
, O
MRI O
) O
. O

High O
T O
( O
g O
) O
bio O
- O
based O
aliphatic O
polyesters B
from O
bicyclic B
D I
- I
mannitol I
. O

Heracleifolinosides B
A I
- I
F I
, O
new O
triterpene B
glycosides I
from O
Cimicifuga O
heracleifolia O
, O
and O
their O
inhibitory O
activities O
against O
hypoxia O
and O
reoxygenation O
. O

Six O
new O
9 B
, I
19 I
- I
cycloartane I
triterpene I
glycosides I
, O
heracleifolinosides B
A I
- I
F I
( O
1 O
- O
6 O
) O
, O
and O
one O
new O
chromone O
, O
norkhelloside B
( O
7 O
) O
, O
were O
isolated O
from O
the O
rhizome O
of O
Cimicifuga O
heracleifolia O
, O
together O
with O
15 O
known O
compounds O
( O
8 O
- O
22 O
) O
. O

Model O
for O
conformational O
relaxation O
of O
flexible O
conjugated O
polymers O
: O
application O
to O
p B
- I
phenylenevinylene I
trimers I
in O
nonpolar O
solvents O
. O

The O
model O
is O
able O
to O
account O
for O
the O
softening O
of O
solute O
- O
solvent O
interactions O
and O
its O
predictions O
are O
found O
to O
be O
in O
excellent O
agreement O
with O
the O
observed O
relaxation O
rate O
constants O
of O
a O
series O
of O
substituted O
p B
- I
phenylenevinylene I
trimers I
[ O
ChemPhysChem O
2009 O
, O
10 O
, O
448 O
- O
454 O
] O
on O
T O
, O
eta O
and O
the O
size O
of O
the O
side O
- O
chains O
. O

In O
general O
, O
antiproliferative O
activity O
is O
greatly O
enhanced O
by O
low O
levels O
of O
the O
glutathione B
synthase O
inhibitor O
l B
- I
buthionine I
sulfoxime I
. O

Metastable O
Cu B
( I
I I
) I
- O
niobate O
semiconductor O
with O
a O
low O
- O
temperature O
, O
nanoparticle O
- O
mediated O
synthesis O
. O

A O
nanoparticle O
synthetic O
strategy O
for O
the O
preparation O
of O
a O
new O
metastable O
Cu B
( I
I I
) I
- O
niobate B
is O
described O
, O
and O
that O
involves O
multipored O
Li B
3 I
NbO I
4 I
nanoparticles O
as O
a O
precursor O
. O

A O
nanoparticle O
synthetic O
strategy O
for O
the O
preparation O
of O
a O
new O
metastable O
Cu B
( I
I I
) I
- O
niobate B
is O
described O
, O
and O
that O
involves O
multipored O
Li B
3 I
NbO I
4 I
nanoparticles O
as O
a O
precursor O
. O

A O
hydrothermal O
reaction O
of O
HNbO B
3 I
and O
LiOH B
. I
H I
2 I
O I
in O
PEG200 B
and O
water O
at O
~ O
180 O
degrees O
C O
yields O
~ O
15 O
- O
40 O
nm O
Li B
3 I
NbO I
4 I
particles O
. O

These O
particles O
are O
subsequently O
used O
in O
a O
solvothermal O
copper B
( I
I I
) I
- O
exchange O
reaction O
with O
excess O
CuCl B
at O
150 O
degrees O
C O
. O

The O
compound O
thermally O
decomposes O
starting O
at O
~ O
250 O
degrees O
C O
and O
higher O
temperatures O
, O
depending O
on O
the O
particle O
sizes O
, O
owing O
to O
the O
loss O
of O
the O
weakly O
coordinated O
Cu B
( I
I I
) I
cations O
from O
the O
structure O
and O
a O
concurrent O
disproportionation O
reaction O
at O
its O
surfaces O
. O

Electronic O
structure O
calculations O
based O
on O
density O
functional O
theory O
show O
that O
the O
bandgap O
transition O
results O
from O
the O
excitation O
of O
electrons O
at O
the O
band O
edges O
between O
filled O
Cu B
( I
I I
) I
3d O
( O
1 O
) O
0 O
- O
orbitals O
and O
empty O
Nb B
( I
V I
) I
4d O
0 O
- O
orbitals O
, O
respectively O
. O

Electronic O
structure O
calculations O
based O
on O
density O
functional O
theory O
show O
that O
the O
bandgap O
transition O
results O
from O
the O
excitation O
of O
electrons O
at O
the O
band O
edges O
between O
filled O
Cu B
( I
I I
) I
3d O
( O
1 O
) O
0 O
- O
orbitals O
and O
empty O
Nb B
( I
V I
) I
4d O
0 O
- O
orbitals O
, O
respectively O
. O

These O
results O
demonstrate O
the O
general O
utility O
of O
reactive O
nanoscale O
precursors O
in O
the O
synthetic O
discovery O
of O
new O
Cu B
( I
I I
) I
- O
based O
semiconducting O
oxides B
and O
which O
also O
show O
promise O
for O
use O
in O
solar O
energy O
conversion O
applications O
. O

The O
structures O
of O
the O
C31 B
- I
C33 I
polyacetylenes I
( O
1 O
- O
9 O
) O
were O
determined O
on O
the O
basis O
of O
1D O
- O
and O
2D O
- O
NMR O
analysis O
, O
mass O
spectrometry O
, O
and O
comparison O
of O
specific O
rotation O
values O
. O

The O
molar O
SuA B
/ O
AzA B
ratio O
was O
varied O
from O
4 O
: O
1 O
to O
1 O
: O
4 O
, O
and O
the O
chemical O
structure O
and O
molecular O
characteristics O
of O
resulting O
( B
co I
) I
polyesters I
were O
characterized O
by O
NMR O
and O
SEC O
, O
whereas O
thermal O
properties O
and O
crystallinity O
were O
studied O
by O
differential O
scanning O
calorimetry O
( O
DSC O
) O
, O
dynamic O
mechanical O
thermal O
analyses O
( O
DMTA O
) O
, O
and O
X O
- O
ray O
diffraction O
( O
XRD O
) O
. O

With O
an O
increase O
in O
the O
amount O
of O
sodium B
bicarbonate I
, O
faster O
buoyancy O
was O
achieved O
due O
to O
the O
increased O
CO B
( I
2 I
) I
gas O
formation O
. O

Thiamine B
and O
benfotiamine B
are O
vitamin B
B1 I
and O
pro B
- I
vitamin I
B1 I
substances O
, O
respectively O
. O

All O
the O
synthesized O
derivatives O
were O
screened O
for O
anticancer O
activity O
against O
HT29 O
and O
MCF7 O
cancer O
cell O
lines O
using O
Sulfo B
- I
Rodamine I
B I
( O
SRB B
) O
standard O
method O
. O

The O
decay O
mechanism O
was O
found O
to O
involve O
the O
loss O
of O
Ag B
( I
+ I
) I
ions O
and O
silver B
glutathionates I
. O

Clusters O
could O
be O
stabilized O
by O
the O
addition O
of O
Ag B
( I
+ I
) I
ions O
and O
destabilized O
by O
either O
the O
addition O
of O
glutathione B
or O
the O
removal O
of O
Ag B
( I
+ I
) I
ions O
. O

Clusters O
could O
be O
stabilized O
by O
the O
addition O
of O
Ag B
( I
+ I
) I
ions O
and O
destabilized O
by O
either O
the O
addition O
of O
glutathione B
or O
the O
removal O
of O
Ag B
( I
+ I
) I
ions O
. O

Investigation O
of O
astatine B
( I
III I
) I
hydrolyzed O
species O
: O
experiments O
and O
relativistic O
calculations O
. O

AtO B
( I
+ I
) I
is O
the O
dominant O
species O
existing O
under O
oxidizing O
and O
acidic O
pH O
conditions O
. O

Batch O
- O
experiments O
using O
a O
competition O
method O
show O
the O
exchange O
of O
one O
proton O
indicating O
the O
formation O
of O
the O
AtO B
( I
OH I
) I
species O
. O

Here O
, O
we O
have O
perturbed O
vibrational O
motions O
in O
pentaerythritol B
tetranitrate I
reductase O
( O
PETNR O
) O
by O
isotopic O
substitution O
where O
all O
non O
- O
exchangeable O
atoms O
were O
replaced O
with O
the O
corresponding O
heavy O
isotope O
( O
( B
13 I
) I
C I
, O
( B
15 I
) I
N I
, O
and O
( B
2 I
) I
H I
) O
. O

Here O
, O
we O
have O
perturbed O
vibrational O
motions O
in O
pentaerythritol B
tetranitrate I
reductase O
( O
PETNR O
) O
by O
isotopic O
substitution O
where O
all O
non O
- O
exchangeable O
atoms O
were O
replaced O
with O
the O
corresponding O
heavy O
isotope O
( O
( B
13 I
) I
C I
, O
( B
15 I
) I
N I
, O
and O
( B
2 I
) I
H I
) O
. O

Here O
, O
we O
have O
perturbed O
vibrational O
motions O
in O
pentaerythritol B
tetranitrate I
reductase O
( O
PETNR O
) O
by O
isotopic O
substitution O
where O
all O
non O
- O
exchangeable O
atoms O
were O
replaced O
with O
the O
corresponding O
heavy O
isotope O
( O
( B
13 I
) I
C I
, O
( B
15 I
) I
N I
, O
and O
( B
2 I
) I
H I
) O
. O

5 B
- I
Nitropyrimidine I
analogs O
substituted O
with O
conformationally O
restricted O
azabicyclic B
amines I
and I
alcohols I
were O
prepared O
and O
evaluated O
their O
agonistic O
activity O
against O
human O
GPR119 O
. O

The O
structure O
of O
the O
alkaloid O
was O
elucidated O
by O
extensive O
use O
of O
NMR O
spectroscopy O
and O
the O
complete O
assignment O
of O
the O
( B
1 I
) I
H I
and O
( B
13 I
) I
C I
NMR O
spectra O
is O
reported O
. O

The O
structure O
of O
the O
alkaloid O
was O
elucidated O
by O
extensive O
use O
of O
NMR O
spectroscopy O
and O
the O
complete O
assignment O
of O
the O
( B
1 I
) I
H I
and O
( B
13 I
) I
C I
NMR O
spectra O
is O
reported O
. O

Prenatal O
developmental O
toxicity O
studies O
on O
diundecyl B
and I
ditridecyl I
phthalates I
in O
Sprague O
- O
Dawley O
rats O
. O

Absence O
of O
edge O
States O
in O
covalently O
bonded O
zigzag O
edges O
of O
graphene B
on O
ir B
( I
111 I
) I
. O

The O
zigzag O
edges O
of O
graphene B
on O
Ir B
( I
111 I
) I
are O
studied O
by O
ab O
initio O
simulations O
and O
low O
- O
temperature O
scanning O
tunneling O
spectroscopy O
, O
providing O
information O
about O
their O
structural O
, O
electronic O
, O
and O
magnetic O
properties O
. O

Nocapyrones B
H I
- I
J I
, O
3 B
, I
6 I
- I
Disubstituted I
alpha I
- I
Pyrones I
from O
the O
Marine O
Actinomycete O
Nocardiopsis O
sp O
. O

Three O
new O
3 B
, I
6 I
- I
disubstituted I
alpha I
- I
pyrones I
, O
nocapyrones B
H I
- I
J I
( O
1 O
- O
3 O
) O
, O
were O
isolated O
from O
the O
marine O
actinomycete O
Nocardiopsis O
sp O
. O

SnO B
( I
2 I
) I
- O
Based O
Nanomaterials O
: O
Synthesis O
and O
Application O
in O
Lithium B
- O
Ion O
Batteries O
. O

Among O
all O
the O
metal B
oxides I
, O
tin B
dioxide I
( O
SnO B
( I
2 I
) I
) O
is O
regarded O
as O
a O
promising O
candidate O
to O
serve O
as O
the O
anode O
material O
for O
LIBs O
due O
to O
its O
high O
theoretical O
capacity O
. O

Here O
, O
a O
thorough O
survey O
is O
provided O
of O
the O
synthesis O
of O
SnO B
( I
2 I
) I
- O
based O
nanomaterials O
with O
various O
structures O
and O
chemical O
compositions O
, O
and O
their O
application O
as O
negative O
electrodes O
for O
LIBs O
. O

It O
covers O
SnO B
( I
2 I
) I
with O
different O
morphologies O
ranging O
from O
1D O
nanorods O
/ O
nanowires O
/ O
nanotubes O
, O
to O
2D O
nanosheets O
, O
to O
3D O
hollow O
nanostructures O
. O

Nanocomposites O
consisting O
of O
SnO B
( I
2 I
) I
and O
different O
carbonaceous O
supports O
, O
e O
. O
g O
. O
, O
amorphous O
carbon B
, O
carbon B
nanotubes O
, O
graphene B
, O
are O
also O
investigated O
. O

The O
aim O
of O
this O
review O
is O
to O
provide O
an O
in O
- O
depth O
and O
rational O
understanding O
such O
that O
the O
electrochemical O
properties O
of O
SnO B
( I
2 I
) I
- O
based O
anodes O
can O
be O
effectively O
enhanced O
by O
making O
proper O
nanostructures O
with O
optimized O
chemical O
composition O
. O

By O
focusing O
on O
SnO B
( I
2 I
) I
, O
the O
hope O
is O
that O
such O
concepts O
and O
strategies O
can O
be O
extended O
to O
other O
potential O
metal B
oxides I
, O
such O
as O
titanium B
dioxide I
or O
iron B
oxides I
, O
thus O
shedding O
some O
light O
on O
the O
future O
development O
of O
high O
- O
performance O
metal B
- I
oxide I
based O
negative O
electrodes O
for O
LIBs O
. O

Reversible O
inhibition O
of O
4 B
- I
nitrophenyl I
acetate I
hydrolysis O
by O
the O
acyl B
glucuronides I
was O
also O
studied O
. O

Four O
new O
germacranes B
[ O
heyneanones B
A I
- I
D I
( O
1 O
- O
4 O
) O
] O
, O
three O
new O
guaianes B
[ O
4 B
, I
10 I
- I
epizedoarondiol I
( O
5 O
) O
, O
15 B
- I
hydroxyprocurcumenol I
( O
6 O
) O
, O
12 B
- I
hydroxycurcumenol I
( O
7 O
) O
] O
, O
and O
two O
new O
spirolactones B
[ O
curcumanolides B
C O
( O
8 O
) O
and O
D O
( O
9 O
) O
] O
were O
isolated O
from O
the O
rhizomes O
of O
Curcuma O
heyneana O
together O
with O
13 O
known O
sesquiterpenes B
and O

The O
c O
( O
RGDfK O
) O
on O
the O
surface O
of O
the O
micelle O
was O
confirmed O
by O
( B
1 I
) I
H I
NMR O
analysis O
and O
cell O
affinity O
with O
human O
glioblastoma O
- O
astrocytoma O
cells O
( O
U87MG O
) O
. O

The O
herein O
presented O
complete O
structure O
of O
the O
core O
oligosaccharide O
of O
lipopolysaccharide O
( O
LPS O
) O
P O
. O
shigelloides O
Polish O
Collection O
of O
Microorganisms O
( O
PCM O
) O
2231 O
( O
serotype O
O17 O
) O
was O
investigated O
by O
( B
1 I
) I
H I
, O
( B
13 I
) I
C I
NMR O
spectroscopy O
, O
mass O
spectrometry O
, O
chemical O
analyses O
and O
serological O
methods O
. O

The O
herein O
presented O
complete O
structure O
of O
the O
core O
oligosaccharide O
of O
lipopolysaccharide O
( O
LPS O
) O
P O
. O
shigelloides O
Polish O
Collection O
of O
Microorganisms O
( O
PCM O
) O
2231 O
( O
serotype O
O17 O
) O
was O
investigated O
by O
( B
1 I
) I
H I
, O
( B
13 I
) I
C I
NMR O
spectroscopy O
, O
mass O
spectrometry O
, O
chemical O
analyses O
and O
serological O
methods O
. O

Six O
new O
casbane B
diterpenoids I
, O
named O
as O
sinularcasbanes B
A I
- I
F I
( O
1 O
- O
6 O
) O
, O
along O
with O
six O
known O
analogues O
7 O
- O
12 O
, O
were O
isolated O
from O
a O
South O
China O
Sea O
soft O
coral O
, O
Sinularia O
sp O
. O

Comparison O
of O
toxicity O
between O
the O
different O
- O
type O
TiO B
( I
2 I
) I
nanowires O
in O
vivo O
and O
in O
vitro O
. O

In O
this O
study O
, O
we O
compared O
their O
toxicity O
in O
vivo O
and O
in O
vitro O
based O
on O
the O
physicochemical O
properties O
of O
three O
different O
types O
of O
TiO B
( I
2 I
) I
nanowires O
, O
H B
( I
2 I
) I
Ti I
( I
3 I
) I
O I
( I
7 I
) I
nanowires O
( O
1HTO O
) O
, O
hydrothermal O
treatment O
( O
2HTO O
) O
, O
and O
calcination O
( O
3HTO O
) O
of O
1HTO O
. O

In O
vitro O
, O
three O
TiO B
( I
2 I
) I
nanowires O
( O
10 O
mu O
g O
/ O
ml O
) O
commonly O
induced O
the O
generation O
of O
cell O
debris O
in O
eight O
cell O
lines O
which O
may O
be O
the O
potential O
target O
organ O
of O
nanoparticles O
, O
especially O
by O
2HTO O
. O

Based O
on O
these O
results O
, O
we O
suggest O
that O
surface O
area O
may O
act O
as O
an O
important O
factor O
depends O
on O
the O
biological O
response O
by O
TiO B
( I
2 I
) I
nanowires O
. O

High O
K B
( I
+ I
) I
, O
noradrenaline B
( O
NA O
) O
, O
or O
acetylcholine B
( O
ACh B
) O
was O
applied O
with O
and O
without O
various O
antagonists O
and O
/ O
or O
inhibitors O
to O
examine O
the O
contractile O
signaling O
pathways O
. O

Combination O
of O
alpha O
- O
1 O
and O
muscarinic O
antagonists O
suppressed O
K B
( I
+ I
) I
depolarization O
- O
induced O
contraction O
potently O
in O
ventral O
rings O
, O
but O
slightly O
in O
anterior O
rings O
. O

At O
5 O
min O
after O
i O
. O
v O
. O
administration O
of O
the O
( B
14 I
) I
C I
compound O
, O
high O
levels O
of O
radioactivity O
were O
observed O
in O
the O
fundus O
of O
the O
stomach O
compared O
to O
blood O
and O
plasma O
and O
the O
rest O
of O
the O
stomach O
, O
indicating O
an O
active O
secretion O
of O
( B
14 I
) I
C I
material O
into O
the O
stomach O
. O

At O
5 O
min O
after O
i O
. O
v O
. O
administration O
of O
the O
( B
14 I
) I
C I
compound O
, O
high O
levels O
of O
radioactivity O
were O
observed O
in O
the O
fundus O
of O
the O
stomach O
compared O
to O
blood O
and O
plasma O
and O
the O
rest O
of O
the O
stomach O
, O
indicating O
an O
active O
secretion O
of O
( B
14 I
) I
C I
material O
into O
the O
stomach O
. O

The O
enzyme O
( O
TcCA O
) O
has O
a O
very O
high O
catalytic O
activity O
for O
the O
CO B
( I
2 I
) I
hydration O
reaction O
, O
being O
similar O
kinetically O
to O
the O
human O
( O
h O
) O
isoform O
hCA O
II O
, O
although O
it O
is O
devoid O
of O
the O
His64 B
proton O
shuttle O
. O

A O
large O
number O
of O
aromatic B
/ I
heterocyclic I
sulfonamides I
and O
some O
5 B
- I
mercapto I
- I
1 I
, I
3 I
, I
4 I
- I
thiadiazoles I
were O
investigated O
as O
TcCA O
inhibitors O
. O

RESULTS O
: O
Using O
an O
unbiased O
place O
conditioning O
procedure O
, O
we O
demonstrated O
that O
in O
Wistar O
rats O
, O
intra O
- O
VTA O
administration O
of O
furosemide B
, O
a O
Cl B
( I
- I
) I
cotransporter O
inhibitor O
, O
was O
able O
to O
promote O
a O
switch O
in O
the O
mechanisms O
underlying O
morphine B
' O
s O
motivational O
properties O
, O
one O
which O
is O
normally O
observed O
only O
after O
chronic O
opiate O
exposure O
. O

Four O
novel O
diterpenoids B
, O
including O
three O
tetracyclic B
diterpenes I
with O
isomerized O
isospongian B
skeletons O
, O
kravanhins B
A I
- I
C I
( O
1 O
- O
3 O
) O
, O
and O
kravanhin B
D I
( O
4 O
) O
, O
and O
three O
new O
labdane B
diterpenes I
( O
5 O
- O
7 O
) O
were O
isolated O
from O
the O
fruits O
of O
Amomum O
kravanh O
. O

Spectroscopic O
study O
and O
( B
1 I
) I
H I
NMR O
titration O
experiment O
revealed O
that O
the O
deprotonation O
of O
the O
hydrogen B
atom O
on O
the O
N B
position O
of O
uracil B
moiety O
by O
fluoride B
ions O
is O
responsible O
for O
the O
recognition O
events O
, O
evidenced O
by O
immediate O
transformation O
from O
the O
sol O
phase O
to O
the O
gel O
state O
upon O
adding O
a O
small O
amount O
of O
a O
proton O
solvent O
, O
methanol B
. O

Among O
all O
the O
aroma O
compounds O
, O
9 O
key O
ones O
were O
identified O
in O
all O
samples O
, O
including O
ethyl B
2 I
- I
methylbutanoate I
, O
butyl B
acetate I
, O
1 B
- I
butanol I
, O
ethyl B
hexanoate I
, O
1 B
- I
hexanol I
, O
butanoic B
acid I
, O
beta B
- I
damascenone I
, O
hexanoic B
acid I
, O
and O
octanoic B
acid I
. O

Ion O
- O
poor O
conditions O
led O
to O
increases O
in O
the O
expression O
of O
PRL O
receptor O
( O
prlra O
) O
, O
Na B
( I
+ I
) I
/ O
Cl B
( I
- I
) I
cotransporter O
( O
ncc O
; O
slc12a10 O
. O
2 O
) O
, O
Na B
( I
+ I
) I
/ O
H B
( I
+ I
) I
exchanger O
( O
nhe3b O
; O
slc9a3 O
. O
2 O
) O
, O
and O
epithelial O
Ca B
( I
2 I
+ I
) I
channel O
( O
ecac O
; O
trpv6 O
) O
transcripts O
within O
the O
gill O
. O

Ion O
- O
poor O
conditions O
led O
to O
increases O
in O
the O
expression O
of O
PRL O
receptor O
( O
prlra O
) O
, O
Na B
( I
+ I
) I
/ O
Cl B
( I
- I
) I
cotransporter O
( O
ncc O
; O
slc12a10 O
. O
2 O
) O
, O
Na B
( I
+ I
) I
/ O
H B
( I
+ I
) I
exchanger O
( O
nhe3b O
; O
slc9a3 O
. O
2 O
) O
, O
and O
epithelial O
Ca B
( I
2 I
+ I
) I
channel O
( O
ecac O
; O
trpv6 O
) O
transcripts O
within O
the O
gill O
. O

Ion O
- O
poor O
conditions O
led O
to O
increases O
in O
the O
expression O
of O
PRL O
receptor O
( O
prlra O
) O
, O
Na B
( I
+ I
) I
/ O
Cl B
( I
- I
) I
cotransporter O
( O
ncc O
; O
slc12a10 O
. O
2 O
) O
, O
Na B
( I
+ I
) I
/ O
H B
( I
+ I
) I
exchanger O
( O
nhe3b O
; O
slc9a3 O
. O
2 O
) O
, O
and O
epithelial O
Ca B
( I
2 I
+ I
) I
channel O
( O
ecac O
; O
trpv6 O
) O
transcripts O
within O
the O
gill O
. O

Ion O
- O
poor O
conditions O
led O
to O
increases O
in O
the O
expression O
of O
PRL O
receptor O
( O
prlra O
) O
, O
Na B
( I
+ I
) I
/ O
Cl B
( I
- I
) I
cotransporter O
( O
ncc O
; O
slc12a10 O
. O
2 O
) O
, O
Na B
( I
+ I
) I
/ O
H B
( I
+ I
) I
exchanger O
( O
nhe3b O
; O
slc9a3 O
. O
2 O
) O
, O
and O
epithelial O
Ca B
( I
2 I
+ I
) I
channel O
( O
ecac O
; O
trpv6 O
) O
transcripts O
within O
the O
gill O
. O

These O
results O
suggest O
that O
PRL O
signaling O
through O
PRL O
receptors O
in O
the O
gill O
regulates O
the O
expression O
of O
ncc O
, O
thereby O
linking O
this O
pituitary O
hormone O
with O
an O
effector O
of O
Cl B
( I
- I
) I
uptake O
in O
zebrafish O
for O
the O
first O
time O
. O

The O
modifications O
observed O
by O
( B
1 I
) I
H I
NMR O
, O
and O
the O
amounts O
of O
catabolites O
excreted O
by O
the O
parasites O
after O
treatment O
with O
the O
compounds O
, O
suggested O
that O
the O
catabolic O
mechanism O
could O
depend O
on O
the O
structure O
of O
the O
side O
chains O
linked O
to O
the O
aza B
- O
scorpiand O
macrocycles O
. O

Cellular O
- O
oxidation O
studies O
revealed O
reduction O
in O
glutathione B
dependent O
redox O
buffering O
along O
with O
depletion O
of O
enzymatic O
cellular O
antioxidants O
that O
might O
potentiate O
the O
nitrite B
( O
NO2 B
( I
- I
) I
) O
and O
superoxide B
anion O
( O
O2 B
( I
- I
) I
) O
mediated O
peroxynitrite B
( O
ONOO B
( I
- I
) I
) O
formation O
and O
irreversible O
protein O
nitration O
. O

Cellular O
- O
oxidation O
studies O
revealed O
reduction O
in O
glutathione B
dependent O
redox O
buffering O
along O
with O
depletion O
of O
enzymatic O
cellular O
antioxidants O
that O
might O
potentiate O
the O
nitrite B
( O
NO2 B
( I
- I
) I
) O
and O
superoxide B
anion O
( O
O2 B
( I
- I
) I
) O
mediated O
peroxynitrite B
( O
ONOO B
( I
- I
) I
) O
formation O
and O
irreversible O
protein O
nitration O
. O

Cellular O
- O
oxidation O
studies O
revealed O
reduction O
in O
glutathione B
dependent O
redox O
buffering O
along O
with O
depletion O
of O
enzymatic O
cellular O
antioxidants O
that O
might O
potentiate O
the O
nitrite B
( O
NO2 B
( I
- I
) I
) O
and O
superoxide B
anion O
( O
O2 B
( I
- I
) I
) O
mediated O
peroxynitrite B
( O
ONOO B
( I
- I
) I
) O
formation O
and O
irreversible O
protein O
nitration O
. O

Cationic B
Al I
- I
PAM I
was O
found O
to O
adsorb O
irreversibly O
and O
preferentially O
on O
tetrahedral O
silica B
basal O
planes O
of O
kaolinite B
. O

Strong O
effects O
of O
cluster O
size O
and O
air O
exposure O
on O
oxygen B
reduction O
and O
carbon B
oxidation O
electrocatalysis O
by O
size O
- O
selected O
Pt B
( I
n I
) I
( O
n O
< O
= O
11 O
) O
on O
glassy B
carbon I
electrodes O
. O

Model O
Pt B
( I
n I
) I
/ O
glassy B
carbon I
electrodes O
( O
Pt B
( I
n I
) I
/ O
GCE O
) O
were O
prepared O
by O
deposition O
of O
mass O
- O
selected O
Pt B
( I
n I
) I
( I
+ I
) I
( O
n O
< O
= O
11 O
) O
on O
GCE O
substrates O
in O
ultrahigh O
vacuum O
. O

Model O
Pt B
( I
n I
) I
/ O
glassy B
carbon I
electrodes O
( O
Pt B
( I
n I
) I
/ O
GCE O
) O
were O
prepared O
by O
deposition O
of O
mass O
- O
selected O
Pt B
( I
n I
) I
( I
+ I
) I
( O
n O
< O
= O
11 O
) O
on O
GCE O
substrates O
in O
ultrahigh O
vacuum O
. O

For O
other O
small O
Pt B
( I
n I
) I
on O
GCE O
, O
any O
ORR O
signal O
is O
overwhelmed O
by O
large O
oxidative O
currents O
attributed O
to O
catalysis O
of O
carbon B
oxidation O
by O
water O
. O

On O
8 O
visits O
, O
healthy O
women O
( O
n O
= O
8 O
) O
received O
intravaginal O
taggant O
( O
2 B
- I
butyl I
acetate I
, O
2 B
- I
pentyl I
acetate I
, O
isopropyl B
butyrate I
, O
or O
2 B
- I
pentyl I
butyrate I
; O
30 O
mg O
) O
formulated O
in O
hydroxyethylcellulos O
or O
tenofovir B
placebo O
gel O
. O

On O
8 O
visits O
, O
healthy O
women O
( O
n O
= O
8 O
) O
received O
intravaginal O
taggant O
( O
2 B
- I
butyl I
acetate I
, O
2 B
- I
pentyl I
acetate I
, O
isopropyl B
butyrate I
, O
or O
2 B
- I
pentyl I
butyrate I
; O
30 O
mg O
) O
formulated O
in O
hydroxyethylcellulos O
or O
tenofovir B
placebo O
gel O
. O

On O
8 O
visits O
, O
healthy O
women O
( O
n O
= O
8 O
) O
received O
intravaginal O
taggant O
( O
2 B
- I
butyl I
acetate I
, O
2 B
- I
pentyl I
acetate I
, O
isopropyl B
butyrate I
, O
or O
2 B
- I
pentyl I
butyrate I
; O
30 O
mg O
) O
formulated O
in O
hydroxyethylcellulos O
or O
tenofovir B
placebo O
gel O
. O

After O
vaginal O
administration O
, O
2 B
- I
butyl I
acetate I
, O
2 B
- I
pentyl I
acetate I
, O
and O
metabolites O
were O
observed O
in O
breath O
, O
whereas O
isopropyl B
butyrate I
, O
2 B
- I
pentyl I
butyrate I
, O
and O
metabolites O
were O
not O
. O

After O
vaginal O
administration O
, O
2 B
- I
butyl I
acetate I
, O
2 B
- I
pentyl I
acetate I
, O
and O
metabolites O
were O
observed O
in O
breath O
, O
whereas O
isopropyl B
butyrate I
, O
2 B
- I
pentyl I
butyrate I
, O
and O
metabolites O
were O
not O
. O

After O
vaginal O
administration O
, O
2 B
- I
butyl I
acetate I
, O
2 B
- I
pentyl I
acetate I
, O
and O
metabolites O
were O
observed O
in O
breath O
, O
whereas O
isopropyl B
butyrate I
, O
2 B
- I
pentyl I
butyrate I
, O
and O
metabolites O
were O
not O
. O

Stimulating O
microbial O
growth O
through O
the O
use O
of O
acetate O
injection O
wells O
at O
the O
former O
uranium O
mill O
site O
in O
Rifle O
, O
Colorado O
, O
USA O
, O
has O
been O
shown O
to O
decrease O
dissolved O
uranium B
( I
VI I
) I
concentrations O
through O
bacterial O
reduction O
to O
immobile O
uranium B
( I
IV I
) I
. O

Stimulating O
microbial O
growth O
through O
the O
use O
of O
acetate O
injection O
wells O
at O
the O
former O
uranium O
mill O
site O
in O
Rifle O
, O
Colorado O
, O
USA O
, O
has O
been O
shown O
to O
decrease O
dissolved O
uranium B
( I
VI I
) I
concentrations O
through O
bacterial O
reduction O
to O
immobile O
uranium B
( I
IV I
) I
. O

Upgradient O
samples O
, O
unexposed O
to O
acetate B
, O
showed O
low O
levels O
of O
arsenic B
( O
= O
~ O
1 O
mu O
M O
) O
, O
with O
greater O
than O
90 O
% O
as O
arsenate B
( O
As B
[ I
V I
] I
) O
and O
a O
small O
amount O
of O
arsenite B
( O
As B
[ I
III I
] I
) O
. O

Upgradient O
samples O
, O
unexposed O
to O
acetate B
, O
showed O
low O
levels O
of O
arsenic B
( O
= O
~ O
1 O
mu O
M O
) O
, O
with O
greater O
than O
90 O
% O
as O
arsenate B
( O
As B
[ I
V I
] I
) O
and O
a O
small O
amount O
of O
arsenite B
( O
As B
[ I
III I
] I
) O
. O

The O
compounds O
resulting O
from O
the O
cation O
exchange O
of O
the O
anions O
1 O
- O
9 O
to O
give O
TBA B
( O
a O
) O
and O
DMDOA B
( O
b O
) O
salts O
, O
and O
additionally O
for O
compounds O
1 O
, O
2 O
and O
3 O
, O
tetraphenylphosphoni B
( O
PPh B
( I
4 I
) I
) O
( O
c O
) O
salts O
, O
are O
explored O
at O
the O
air O
/ O
water O
interface O
using O
scanning O
force O
microscopy O
, O
showing O
a O
range O
of O
architectures O
including O
hexagonal O
structures O
, O
nanofibers O
and O
other O
supramolecular O
forms O
. O

The O
copolymers O
were O
degraded O
in O
a O
methanolic O
solution O
of O
1 B
, I
5 I
, I
7 I
- I
triaza I
- I
bicyclo I
[ I
4 I
. I
4 I
. I
0 I
] I
dec I
- I
5 I
- I
ene I
and O
the O
degradation O
was O
measured O
by O
( B
1 I
) I
H I
NMR O
spectroscopic O
and O
gel O
permeation O
chromatographic O
analyses O
. O

We O
studied O
well O
- O
characterized O
boehmite B
engineered O
NP O
[ O
aluminum B
oxide I
hydroxide I
, O
AlO B
( I
OH I
) I
] O
. O

The O
antibody O
was O
raised O
in O
rabbits O
against O
11 B
- I
KT I
- I
3 I
- I
CMO I
: O
bovine O
serum O
albumin O
with O
biotinylated B
11 I
- I
KT I
as O
a O
label O
. O

From O
this O
data O
, O
the O
authors O
conclude O
that O
11 B
- I
KT I
- O
like O
substances O
, O
specifically O
C19 B
O3 I
- I
androgens I
with O
a O
17 B
beta I
- I
hydroxy I
group O
, O
were O
present O
in O
the O
feces O
. O

From O
this O
data O
, O
the O
authors O
conclude O
that O
11 B
- I
KT I
- O
like O
substances O
, O
specifically O
C19 B
O3 I
- I
androgens I
with O
a O
17 B
beta I
- I
hydroxy I
group O
, O
were O
present O
in O
the O
feces O
. O

At O
the O
end O
of O
the O
study O
, O
malondialdehyde B
( O
MDA B
) O
and O
reduced B
glutathione I
( O
GSH B
) O
levels O
were O
measured O
in O
the O
whole O
blood O
; O
catalase O
( O
CAT O
) O
activity O
level O
was O
measured O
in O
erythrocytes O
; O
and O
nitrite B
( O
NO B
( I
2 I
) I
) O
and O
nitrate B
( O
NO B
( I
3 I
) I
) O
levels O
were O
measured O
in O
the O
serum O
. O

At O
the O
end O
of O
the O
study O
, O
malondialdehyde B
( O
MDA B
) O
and O
reduced B
glutathione I
( O
GSH B
) O
levels O
were O
measured O
in O
the O
whole O
blood O
; O
catalase O
( O
CAT O
) O
activity O
level O
was O
measured O
in O
erythrocytes O
; O
and O
nitrite B
( O
NO B
( I
2 I
) I
) O
and O
nitrate B
( O
NO B
( I
3 I
) I
) O
levels O
were O
measured O
in O
the O
serum O
. O

Serum O
NO B
( I
3 I
) I
concentrations O
in O
the O
diesel O
groups O
were O
found O
to O
be O
considerably O
different O
from O
those O
in O
the O
control O
and O
biodiesel O
groups O
. O

Serum O
NO B
( I
2 I
) I
concentrations O
in O
one O
of O
the O
diesel O
groups O
were O
significantly O
different O
from O
those O
in O
the O
control O
and O
biodiesel O
groups O
( O
p O
< O
0 O
. O
01 O
and O
p O
< O
0 O
. O
05 O
, O
respectively O
) O
. O

Abstract O
1 O
. O
Arsenic B
( O
As B
( I
III I
) I
) O
toxicity O
has O
received O
increasing O
attention O
as O
human O
exposure O
to O
arsenic B
is O
associated O
with O
pulmonary O
, O
hepatic O
and O
renal O
toxicities O
. O

Therefore O
, O
in O
the O
present O
study O
, O
we O
investigated O
the O
effect O
of O
acute O
As B
( I
III I
) I
treatment O
on O
pulmonary O
, O
hepatic O
and O
renal O
cytochrome O
( O
CYP O
) O
P450 O
- O
mediated O
arachidonic B
acid I
metabolism O
. O

2 O
. O
Our O
results O
demonstrated O
that O
acute O
As B
( I
III I
) I
treatment O
( O
12 O
. O
5 O
mg O
/ O
kg O
) O
altered O
CYP O
epoxygenases O
, O
CYP O
omega O
- O
hydroxylases O
and O
EPHX2 O
mRNA O
levels O
that O
were O
isozyme O
and O
tissue O
specific O
. O

3 O
. O
Furthermore O
, O
As B
( I
III I
) I
increased O
the O
formation O
of O
epoxyeicosatrienoic B
acids I
( O
EETs B
) O
in O
the O
kidney O
without O
affecting O
their O
levels O
in O
the O
lung O
or O
liver O
. O

In O
addition O
, O
acute O
As B
( I
III I
) I
treatment O
increased O
dihydroxyeicosatrien B
acid I
( O
DHETs B
) O
formation O
in O
the O
lung O
, O
while O
it O
did O
not O
affect O
liver O
DHETs B
formation O
and O
decreased O
kidney O
DHETs B
formation O
. O

4 O
. O
As B
( I
III I
) I
also O
increased O
total O
epoxygenases O
activity O
in O
the O
lung O
while O
it O
decreased O
its O
levels O
in O
the O
kidney O
and O
had O
no O
effect O
on O
the O
liver O
. O

Furthermore O
, O
As B
( I
III I
) I
increased O
20 B
- I
hydroxyeicosatetraen I
acid I
formation O
in O
the O
liver O
while O
it O
decreased O
its O
formation O
in O
the O
kidney O
. O

Furthermore O
, O
As B
( I
III I
) I
increased O
20 B
- I
hydroxyeicosatetraen I
acid I
formation O
in O
the O
liver O
while O
it O
decreased O
its O
formation O
in O
the O
kidney O
. O

5 O
. O
Lastly O
, O
As B
( I
III I
) I
increased O
soluble O
epoxide B
hydrolase O
activity O
in O
the O
lung O
, O
while O
it O
decreased O
its O
levels O
in O
the O
kidney O
and O
had O
no O
effect O
on O
the O
liver O
. O

In O
conclusion O
, O
this O
is O
the O
first O
demonstration O
that O
As B
( I
III I
) I
alters O
arachidonic B
acid I
metabolism O
in O
a O
tissue O
specific O
manner O
. O

A O
novel O
fluorogenic O
substrate O
for O
dinuclear O
Zn B
( I
II I
) I
- O
containing O
metallo O
- O
beta O
- O
lactamases O
. O

Sprague O
- O
Dawley O
rats O
were O
intraperitoneally O
given O
dimethyl B
n I
- I
nitrosamine I
( O
DMN B
) O
( O
10mg O
/ O
kg O
) O
3 O
days O
per O
week O
for O
4 O
weeks O
. O

Urine O
samples O
were O
analysed O
by O
( B
1 I
) I
H I
NMR O
, O
and O
untargeted O
multivariate O
analysis O
was O
applied O
to O
the O
data O
for O
comprehensive O
fingerprinting O
. O

Significantly O
( O
p O
< O
0 O
. O
05 O
) O
increased O
levels O
of O
polyphenol B
metabolites O
, O
hippuric B
acid I
and O
4 B
- I
hydroxyhippuric I
acid I
, O
and O
decreased O
creatinine B
and O
dimethylamine B
levels O
were O
the O
major O
explanations O
for O
the O
grouping O
of O
the O
postprandial O
samples O
after O
the O
different O
meals O
. O

The O
losses O
of O
ascorbic B
and I
chlorogenic I
acids I
were O
minimised O
with O
boiling O
and O
total O
anthocyanin B
levels O
retained O
the O
highest O
. O

Oral O
administration O
of O
APP O
at O
250 O
and O
500 O
mg O
/ O
kg O
bw O
in O
mice O
was O
shown O
to O
be O
as O
effective O
as O
AFP O
in O
lowering O
the O
CCl B
( I
4 I
) I
- O
caused O
increases O
of O
serum O
alanine B
aminotransferase O
, O
aspartate B
aminotransferase O
and O
lactic O
dehydrogenase O
activities O
, O
and O
hepatic O
malondialdehyde B
level O
, O
and O
antagonising O
the O
decreases O
in O
antioxidant O
superoxide B
dismutase O
and O
glutathione B
peroxidase O
activities O
caused O
by O
CCl B
( I
4 I
) I
( O
p O
< O
0 O
. O
05 O
) O
. O

Oral O
administration O
of O
APP O
at O
250 O
and O
500 O
mg O
/ O
kg O
bw O
in O
mice O
was O
shown O
to O
be O
as O
effective O
as O
AFP O
in O
lowering O
the O
CCl B
( I
4 I
) I
- O
caused O
increases O
of O
serum O
alanine B
aminotransferase O
, O
aspartate B
aminotransferase O
and O
lactic O
dehydrogenase O
activities O
, O
and O
hepatic O
malondialdehyde B
level O
, O
and O
antagonising O
the O
decreases O
in O
antioxidant O
superoxide B
dismutase O
and O
glutathione B
peroxidase O
activities O
caused O
by O
CCl B
( I
4 I
) I
( O
p O
< O
0 O
. O
05 O
) O
. O

Histopathological O
examinations O
further O
confirmed O
that O
both O
APP O
and O
AFP O
could O
protect O
the O
liver O
from O
CCl B
( I
4 I
) I
- O
induced O
histological O
alteration O
. O

Modelling O
the O
interactions O
between O
free O
phenols B
, O
L B
- I
ascorbic I
acid I
, O
apple O
polyphenoloxidase O
and O
oxygen B
during O
a O
thermal O
treatment O
. O

The O
kinetics O
of O
degradation O
of O
chlorogenic B
acid I
( O
CG O
) O
, O
( B
- I
) I
epicatechin I
( O
EPI B
) O
, O
L B
- I
ascorbic I
acid I
( O
AA O
) O
and O
polyphenoloxidase O
( O
PPO O
) O
activity O
from O
Marie O
- O
M O
e O
nard O
apple O
in O
pH O
3 O
. O
8 O
solutions O
at O
20 O
and O
50 O
degrees O
C O
were O
investigated O
to O
provide O
information O
on O
the O
impact O
of O
the O
presence O
of O
CG O
, O
EPI B
and O
/ O
or O
AA O
on O
PPO O
thermostability O
. O

The O
kinetics O
of O
degradation O
of O
chlorogenic B
acid I
( O
CG O
) O
, O
( B
- I
) I
epicatechin I
( O
EPI B
) O
, O
L B
- I
ascorbic I
acid I
( O
AA O
) O
and O
polyphenoloxidase O
( O
PPO O
) O
activity O
from O
Marie O
- O
M O
e O
nard O
apple O
in O
pH O
3 O
. O
8 O
solutions O
at O
20 O
and O
50 O
degrees O
C O
were O
investigated O
to O
provide O
information O
on O
the O
impact O
of O
the O
presence O
of O
CG O
, O
EPI B
and O
/ O
or O
AA O
on O
PPO O
thermostability O
. O

The O
evolution O
of O
the O
molar O
percentage O
of O
several O
kinds O
of O
acyl B
groups O
of O
extra O
virgin O
olive O
, O
sunflower O
and O
virgin O
linseed O
oils O
was O
monitored O
throughout O
heating O
at O
frying O
temperature O
by O
means O
of O
( B
1 I
) I
H I
nuclear O
magnetic O
resonance O
. O

In O
this O
way O
both O
molar O
percentage O
of O
acyl B
groups O
and O
percentage O
in O
weight O
of O
polar O
compounds O
can O
be O
obtained O
in O
a O
few O
minutes O
that O
registration O
of O
the O
( B
1 I
) I
H I
NMR O
spectrum O
of O
the O
oil O
takes O
, O
in O
addition O
to O
the O
rest O
of O
information O
provided O
by O
this O
technique O
. O

Rugosin B
D I
, O
rugosin B
A I
, O
rugosin B
A I
methyl I
ester I
( O
a O
novel O
compound O
) O
, O
and O
tellimagrandin B
II I
were O
the O
main O
components O
; O
these O
4 O
ellagitannins O
exhibited O
a O
non O
- O
competitive O
type O
of O
inhibition O
, O
with O
K O
( O
i O
) O
values O
of O
approximately O
0 O
. O
35 O
- O
1 O
mu O
M O
. O

Iron B
( I
III I
) I
was O
reduced O
to O
iron B
( I
II I
) I
by O
ascorbic B
acid I
and O
preconcentrated O
on O
a O
mini O
- O
column O
packed O
with O
polyurethane B
foam O
( O
PUF O
) O
functionalized O
with O
N B
, I
N I
- I
bis I
( I
salicylidene I
) I
- I
1 I
, I
3 I
- I
propanediamine I
( O
SPDA B
) O
. O

Iron B
( I
III I
) I
was O
reduced O
to O
iron B
( I
II I
) I
by O
ascorbic B
acid I
and O
preconcentrated O
on O
a O
mini O
- O
column O
packed O
with O
polyurethane B
foam O
( O
PUF O
) O
functionalized O
with O
N B
, I
N I
- I
bis I
( I
salicylidene I
) I
- I
1 I
, I
3 I
- I
propanediamine I
( O
SPDA B
) O
. O

The O
retained O
Fe B
( I
II I
) I
was O
eluted O
with O
hydrochloric B
acid I
and O
subsequently O
reacted O
to O
2 B
, I
4 I
, I
6 I
- I
tri I
( I
2 I
' I
- I
pyridyl I
) I
- I
1 I
, I
3 I
, I
5 I
- I
triazine I
( O
TPTZ B
) O
then O
measured O
at O
593 O
nm O
. O

The O
precision O
( O
RSD O
) O
was O
found O
to O
be O
5 O
. O
7 O
% O
and O
3 O
. O
1 O
% O
at O
concentration O
levels O
0 O
. O
1 O
and O
5 O
. O
0 O
mu O
g O
mL O
( O
- O
1 O
) O
iron B
( I
II I
) I
, O
respectively O
. O

In O
unheated O
parsley O
, O
apart O
from O
the O
major O
compound O
apiin B
, O
10 O
further O
phenolics B
were O
characterised O
including O
several O
p B
- I
coumaric I
acid I
derivatives O
which O
were O
newly O
detected O
. O

Based O
on O
the O
recommended O
dietary O
allowance O
of O
iron B
, O
maximum O
germination O
rate O
and O
gamma B
- I
aminobutyric I
acid I
, O
we O
recommend O
the O
brown O
rice O
fortified O
with O
0 O
. O
25 O
g O
/ O
L O
FeSO B
( I
4 I
) I
as O
a O
suitable O
fortification O
level O
to O
use O
in O
germination O
process O
. O

Based O
on O
the O
recommended O
dietary O
allowance O
of O
iron B
, O
maximum O
germination O
rate O
and O
gamma B
- I
aminobutyric I
acid I
, O
we O
recommend O
the O
brown O
rice O
fortified O
with O
0 O
. O
25 O
g O
/ O
L O
FeSO B
( I
4 I
) I
as O
a O
suitable O
fortification O
level O
to O
use O
in O
germination O
process O
. O

Dimethylarsinic B
acid I
( O
DMAs B
( I
V I
) I
) O
, O
the O
major O
urinary O
metabolite O
of O
inorganic O
arsenic B
, O
is O
weakly O
cytotoxic O
, O
whereas O
its O
reduced O
form O
, O
dimethylarsinous B
acid I
( O
DMAs B
( I
III I
) I
) O
, O
is O
highly O
toxic O
. O

Dimethylarsinic B
acid I
( O
DMAs B
( I
V I
) I
) O
, O
the O
major O
urinary O
metabolite O
of O
inorganic O
arsenic B
, O
is O
weakly O
cytotoxic O
, O
whereas O
its O
reduced O
form O
, O
dimethylarsinous B
acid I
( O
DMAs B
( I
III I
) I
) O
, O
is O
highly O
toxic O
. O

Although O
glutathione B
S B
- O
transferase O
omega O
1 O
( O
GSTO1 O
) O
and O
arsenic B
methyltransferase O
have O
been O
shown O
or O
thought O
to O
catalyze O
DMAs B
( I
V I
) I
reduction O
, O
their O
role O
in O
DMAs B
( I
V I
) I
reduction O
in O
vivo O
, O
or O
in O
cell O
extracts O
is O
uncertain O
. O

Although O
glutathione B
S B
- O
transferase O
omega O
1 O
( O
GSTO1 O
) O
and O
arsenic B
methyltransferase O
have O
been O
shown O
or O
thought O
to O
catalyze O
DMAs B
( I
V I
) I
reduction O
, O
their O
role O
in O
DMAs B
( I
V I
) I
reduction O
in O
vivo O
, O
or O
in O
cell O
extracts O
is O
uncertain O
. O

Therefore O
, O
the O
reduction O
of O
DMAs B
( I
V I
) I
to O
DMAs B
( I
III I
) I
in O
rats O
and O
in O
rat O
liver O
cytosol O
was O
studied O
to O
better O
understand O
its O
mechanism O
. O

Therefore O
, O
the O
reduction O
of O
DMAs B
( I
V I
) I
to O
DMAs B
( I
III I
) I
in O
rats O
and O
in O
rat O
liver O
cytosol O
was O
studied O
to O
better O
understand O
its O
mechanism O
. O

To O
assess O
DMAs B
( I
V I
) I
reduction O
in O
rats O
, O
a O
novel O
procedure O
was O
devised O
based O
on O
following O
the O
accumulation O
of O
red O
blood O
cell O
( O
RBC O
) O
- O
bound O
dimethylarsenic B
( O
DMAs B
) O
, O
which O
represents O
DMAs B
( I
III I
) I
, O
in O
the O
blood O
of O
DMAs B
( I
V I
) I
- O
injected O
anesthetized O
rats O
. O

To O
assess O
DMAs B
( I
V I
) I
reduction O
in O
rats O
, O
a O
novel O
procedure O
was O
devised O
based O
on O
following O
the O
accumulation O
of O
red O
blood O
cell O
( O
RBC O
) O
- O
bound O
dimethylarsenic B
( O
DMAs B
) O
, O
which O
represents O
DMAs B
( I
III I
) I
, O
in O
the O
blood O
of O
DMAs B
( I
V I
) I
- O
injected O
anesthetized O
rats O
. O

To O
assess O
DMAs B
( I
V I
) I
reduction O
in O
rats O
, O
a O
novel O
procedure O
was O
devised O
based O
on O
following O
the O
accumulation O
of O
red O
blood O
cell O
( O
RBC O
) O
- O
bound O
dimethylarsenic B
( O
DMAs B
) O
, O
which O
represents O
DMAs B
( I
III I
) I
, O
in O
the O
blood O
of O
DMAs B
( I
V I
) I
- O
injected O
anesthetized O
rats O
. O

These O
studies O
indicated O
that O
rats O
reduced O
DMAs B
( I
V I
) I
to O
DMAs B
( I
III I
) I
to O
a O
significant O
extent O
, O
as O
in O
90 O
min O
31 O
% O
of O
the O
injected O
50 O
mu O
mol O
/ O
kg O
DMAs B
( I
V I
) I
dose O
was O
converted O
to O
DMAs B
( I
III I
) I
that O
was O
sequestered O
by O
the O
circulating O
erythrocytes O
. O

These O
studies O
indicated O
that O
rats O
reduced O
DMAs B
( I
V I
) I
to O
DMAs B
( I
III I
) I
to O
a O
significant O
extent O
, O
as O
in O
90 O
min O
31 O
% O
of O
the O
injected O
50 O
mu O
mol O
/ O
kg O
DMAs B
( I
V I
) I
dose O
was O
converted O
to O
DMAs B
( I
III I
) I
that O
was O
sequestered O
by O
the O
circulating O
erythrocytes O
. O

These O
studies O
indicated O
that O
rats O
reduced O
DMAs B
( I
V I
) I
to O
DMAs B
( I
III I
) I
to O
a O
significant O
extent O
, O
as O
in O
90 O
min O
31 O
% O
of O
the O
injected O
50 O
mu O
mol O
/ O
kg O
DMAs B
( I
V I
) I
dose O
was O
converted O
to O
DMAs B
( I
III I
) I
that O
was O
sequestered O
by O
the O
circulating O
erythrocytes O
. O

These O
studies O
indicated O
that O
rats O
reduced O
DMAs B
( I
V I
) I
to O
DMAs B
( I
III I
) I
to O
a O
significant O
extent O
, O
as O
in O
90 O
min O
31 O
% O
of O
the O
injected O
50 O
mu O
mol O
/ O
kg O
DMAs B
( I
V I
) I
dose O
was O
converted O
to O
DMAs B
( I
III I
) I
that O
was O
sequestered O
by O
the O
circulating O
erythrocytes O
. O

Pretreatment O
of O
rats O
with O
glutathione B
( O
GSH B
) O
depletors O
( O
phorone B
or O
BSO B
) O
delayed O
the O
elimination O
of O
DMAs B
( I
V I
) I
and O
the O
accumulation O
of O
RBC O
- O
bound O
DMAs B
, O
whereas O
the O
indirect O
methyltransferase O
inhibitor O
periodate B
- O
oxidized O
adenosine B
was O
without O
effect O
. O

Assessment O
of O
DMAs B
( I
V I
) I
- O
reducing O
activity O
of O
rat O
liver O
cytosol O
revealed O
that O
reduction O
of O
DMAs B
( I
V I
) I
required O
cytosolic O
protein O
and O
GSH B
and O
was O
inhibited O
by O
thiol B
reagents O
, O
GSSG B
and O
dehydroascorbate B
. O

Assessment O
of O
DMAs B
( I
V I
) I
- O
reducing O
activity O
of O
rat O
liver O
cytosol O
revealed O
that O
reduction O
of O
DMAs B
( I
V I
) I
required O
cytosolic O
protein O
and O
GSH B
and O
was O
inhibited O
by O
thiol B
reagents O
, O
GSSG B
and O
dehydroascorbate B
. O

Although O
thioredoxin O
reductase O
( O
TRR O
) O
inhibitors O
( O
aurothioglucose B
and O
Sb B
( I
III I
) I
) O
inhibited O
cytosolic O
DMAs B
( I
V I
) I
reduction O
, O
recombinant O
rat O
TRR O
plus O
NADPH B
, O
alone O
or O
when O
added O
to O
the O
cytosol O
, O
failed O
to O
support O
DMAs B
( I
V I
) I
reduction O
. O

Although O
thioredoxin O
reductase O
( O
TRR O
) O
inhibitors O
( O
aurothioglucose B
and O
Sb B
( I
III I
) I
) O
inhibited O
cytosolic O
DMAs B
( I
V I
) I
reduction O
, O
recombinant O
rat O
TRR O
plus O
NADPH B
, O
alone O
or O
when O
added O
to O
the O
cytosol O
, O
failed O
to O
support O
DMAs B
( I
V I
) I
reduction O
. O

Although O
thioredoxin O
reductase O
( O
TRR O
) O
inhibitors O
( O
aurothioglucose B
and O
Sb B
( I
III I
) I
) O
inhibited O
cytosolic O
DMAs B
( I
V I
) I
reduction O
, O
recombinant O
rat O
TRR O
plus O
NADPH B
, O
alone O
or O
when O
added O
to O
the O
cytosol O
, O
failed O
to O
support O
DMAs B
( I
V I
) I
reduction O
. O

In O
summary O
, O
reduction O
of O
DMAs B
( I
V I
) I
to O
the O
highly O
toxic O
DMAs B
( I
III I
) I
in O
rats O
and O
rat O
liver O
cytosol O
is O
a O
GSH B
- O
dependent O
enzymatic O
process O
, O
yet O
its O
mechanism O
remains O
uncertain O
. O

In O
summary O
, O
reduction O
of O
DMAs B
( I
V I
) I
to O
the O
highly O
toxic O
DMAs B
( I
III I
) I
in O
rats O
and O
rat O
liver O
cytosol O
is O
a O
GSH B
- O
dependent O
enzymatic O
process O
, O
yet O
its O
mechanism O
remains O
uncertain O
. O

Chemical O
tagging O
of O
a O
drug O
target O
using O
5 B
- I
sulfonyl I
tetrazole I
. O

Here O
we O
report O
that O
receptor O
proteins O
can O
be O
chemically O
tagged O
using O
a O
5 B
- I
sulfonyl I
tetrazole I
probe O
. O

5 B
- I
Sulfonyl I
tetrazole I
easily O
accepted O
nucleophilic O
attack O
of O
thiol B
groups O
, O
while O
5 B
- I
sulfinyl I
tetrazole I
did O
not O
. O

5 B
- I
Sulfonyl I
tetrazole I
easily O
accepted O
nucleophilic O
attack O
of O
thiol B
groups O
, O
while O
5 B
- I
sulfinyl I
tetrazole I
did O
not O
. O

Cyclosporine B
A I
, O
an O
immunosuppressant O
produced O
by O
a O
microbe O
, O
was O
derivatized O
to O
possess O
5 B
- I
sulfonyl I
tetrazole I
and O
a O
tag O
group O
, O
which O
enabled O
chemical O
tagging O
of O
cyclophilin O
A O
, O
the O
cellular O
receptor O
of O
cyclosporine B
A I
. O

Cyclosporine B
A I
derivative O
possessing O
5 B
- I
sulfinyl I
tetrazole I
could O
not O
tag O
cyclophilin O
A O
. O

In O
this O
study O
, O
we O
present O
the O
signaling O
mechanisms O
of O
a O
newly O
developed O
LMW O
dihydropyridine B
agonist O
of O
the O
FSHR O
, O
Org B
214444 I
- I
0 I
. O

Org B
214444 I
- I
0 I
is O
shown O
to O
be O
a O
stereoselective O
, O
nanomolar O
potent O
FSHR O
agonist O
and O
selective O
over O
the O
structurally O
related O
LHR O
and O
TSHR O
. O

Org B
214444 I
- I
0 I
is O
an O
allosteric O
agonist O
interacting O
with O
the O
transmembrane O
region O
of O
the O
FSHR O
. O

When O
co O
- O
incubated O
with O
FSH O
, O
Org B
214444 I
- I
0 I
augments O
FSH O
' O
s O
potency O
in O
binding O
( O
6 O
. O
5 O
- O
fold O
) O
and O
adenylyl O
cyclase O
/ O
cAMP B
activation O
( O
3 O
. O
5 O
- O
fold O
) O
in O
a O
concentration O
- O
dependent O
manner O
. O

Like O
FSH O
, O
Org B
214444 I
- I
0 I
induces O
FSHR O
internalization O
and O
is O
only O
marginally O
effective O
in O
stimulating O
phospholipase O
C O
. O

Moreover O
, O
Org B
214444 I
- I
0 I
stimulates O
cAMP B
and O
estradiol B
production O
in O
human O
granulosa O
cells O
in O
culture O
and O
supports O
the O
follicular O
phase O
in O
mature O
female O
rats O
. O

We O
conclude O
that O
Org B
214444 I
- I
0 I
is O
a O
bonafide O
FSHR O
agonist O
. O

The O
naphthyl B
side O
chain O
was O
introduced O
via O
Wittig O
reaction O
and O
the O
aldehyde B
installed O
using O
directed O
ortho O
- O
metalation O
reaction O
of O
the O
substituted O
o B
- I
anisic I
acids I
. O

The O
second O
enzymatic O
system O
oxidizes O
nicotinamide B
to O
nicotinamide B
N I
- I
oxide I
. O

We O
have O
used O
human O
liver O
microsomes O
in O
combination O
with O
selective O
cytochrome O
P450 O
inhibitors O
, O
specific O
substrates O
, O
and O
antibodies O
to O
identify O
CYP2E1 O
as O
the O
main O
activity O
producing O
nicotinamide B
N I
- I
oxide I
. O

Our O
results O
suggest O
the O
potential O
use O
of O
nicotinamide B
N I
- I
oxide I
as O
a O
biomarker O
of O
CYP2E1 O
activity O
from O
urine O
or O
blood O
samples O
. O

Examples O
of O
sigma O
- O
bonds O
made O
of O
a O
single O
electron O
delocalized O
over O
two O
neighboring O
atoms O
were O
until O
recently O
found O
only O
in O
gas O
- O
phase O
cations O
such O
as O
H2 B
( I
+ I
) I
and O
Li2 B
( I
+ I
) I
and O
in O
highly O
unstable O
species O
generated O
in O
solid O
matrices O
. O

Examples O
of O
sigma O
- O
bonds O
made O
of O
a O
single O
electron O
delocalized O
over O
two O
neighboring O
atoms O
were O
until O
recently O
found O
only O
in O
gas O
- O
phase O
cations O
such O
as O
H2 B
( I
+ I
) I
and O
Li2 B
( I
+ I
) I
and O
in O
highly O
unstable O
species O
generated O
in O
solid O
matrices O
. O

Charge O
affects O
the O
oral O
toxicity O
of O
poly B
( I
amidoamine I
) I
dendrimers O
. O

Poly B
( I
amidoamine I
) I
( O
PAMAM B
) O
dendrimers O
have O
been O
evaluated O
for O
the O
influence O
of O
surface O
functionality O
and O
size O
on O
the O
epithelial O
barrier O
of O
the O
gut O
with O
the O
goal O
of O
identifying O
safe O
carriers O
that O
can O
be O
used O
for O
oral O
drug O
delivery O
. O

The O
amphiphilic O
character O
of O
GNSs O
allows O
the O
water O
solubility O
of O
insoluble O
hydrophobic O
cargos O
such O
as O
a O
perylene B
- I
bisimide I
derivative O
, O
[ B
60 I
] I
fullerene I
, O
or O
the O
anti O
- O
carcinogenic O
drug O
camptothecin B
( O
CPT B
) O
. O

Two O
new O
coumarin B
glycosides I
, O
namely O
nitensosides B
A I
- I
B I
( O
1 O
- O
2 O
) O
, O
together O
with O
six O
known O
compounds O
, O
scopolin B
( O
3 O
) O
, O
5 B
, I
6 I
, I
7 I
- I
trimethoxycoumarin I
( O
4 O
) O
, O
d B
- I
calycanthine I
( O
5 O
) O
, O
calycanthoside B
( O
6 O
) O
, O
xeroboside B
( O
7 O
) O
, O
and O
scopoletin B
( O
8 O
) O
, O
were O
isolated O
from O
Chimonanthus O
nitens O
. O

Comparisons O
are O
made O
to O
the O
known O
electronic O
states O
of O
CuF B
, O
CuCl B
, O
CuBr B
, O
and O
CuI B
, O
and O
it O
is O
argued O
that O
like O
these O
molecules O
, O
the O
CuCCH B
molecule O
is O
essentially O
ionic O
in O
both O
the O
ground O
and O
excited O
states O
, O
with O
the O
ground O
state O
correlating O
diabatically O
to O
Cu B
( I
+ I
) I
( O
3d O
( O
10 O
) O
, O
( O
1 O
) O
S O
) O
+ O
CCH B
( I
- I
) I
( O
X O
( O
1 O
) O
Sigma O
( O
+ O
) O
) O
and O
the O
excited O
states O
correlating O
diabatically O
to O
Cu B
( I
+ I
) I
( O
3d O
( O
9 O
) O
4s O

Comparisons O
are O
made O
to O
the O
known O
electronic O
states O
of O
CuF B
, O
CuCl B
, O
CuBr B
, O
and O
CuI B
, O
and O
it O
is O
argued O
that O
like O
these O
molecules O
, O
the O
CuCCH B
molecule O
is O
essentially O
ionic O
in O
both O
the O
ground O
and O
excited O
states O
, O
with O
the O
ground O
state O
correlating O
diabatically O
to O
Cu B
( I
+ I
) I
( O
3d O
( O
10 O
) O
, O
( O
1 O
) O
S O
) O
+ O
CCH B
( I
- I
) I
( O
X O
( O
1 O
) O
Sigma O
( O
+ O
) O
) O
and O
the O
excited O
states O
correlating O
diabatically O
to O
Cu B
( I
+ I
) I
( O
3d O
( O
9 O
) O
4s O

Comparisons O
are O
made O
to O
the O
known O
electronic O
states O
of O
CuF B
, O
CuCl B
, O
CuBr B
, O
and O
CuI B
, O
and O
it O
is O
argued O
that O
like O
these O
molecules O
, O
the O
CuCCH B
molecule O
is O
essentially O
ionic O
in O
both O
the O
ground O
and O
excited O
states O
, O
with O
the O
ground O
state O
correlating O
diabatically O
to O
Cu B
( I
+ I
) I
( O
3d O
( O
10 O
) O
, O
( O
1 O
) O
S O
) O
+ O
CCH B
( I
- I
) I
( O
X O
( O
1 O
) O
Sigma O
( O
+ O
) O
) O
and O
the O
excited O
states O
correlating O
diabatically O
to O
Cu B
( I
+ I
) I
( O
3d O
( O
9 O
) O
4s O

( O
1 O
) O
, O
( O
1 O
, O
3 O
) O
D O
) O
+ O
CCH B
( I
- I
) I
( O
X O
( O
1 O
) O
Sigma O
( O
+ O
) O
) O
. O

A O
solid O
solution O
series O
of O
lithium B
nickel I
metal I
oxides I
, O
Li B
[ I
Ni I
( I
1 I
- I
x I
) I
M I
( I
x I
) I
] I
O2 I
( O
with O
M O
= O
Co B
, O
Mn B
, O
and O
Al B
) O
have O
been O
investigated O
intensively O
to O
enhance O
the O
inherent O
structural O
instability O
of O
LiNiO2 B
. O

The O
structures O
of O
the O
new O
compounds O
were O
unambiguously O
elucidated O
by O
1D O
( O
( B
1 I
) I
H I
, O
( B
13 I
) I
C I
) O
, O
2D O
NMR O
( O
COSY O
, O
HSQC O
, O
and O
HMBC O
) O
and O
by O
mass O
spectroscopy O
. O

The O
structures O
of O
the O
new O
compounds O
were O
unambiguously O
elucidated O
by O
1D O
( O
( B
1 I
) I
H I
, O
( B
13 I
) I
C I
) O
, O
2D O
NMR O
( O
COSY O
, O
HSQC O
, O
and O
HMBC O
) O
and O
by O
mass O
spectroscopy O
. O

Previous O
studies O
demonstrate O
that O
the O
activity O
of O
the O
evolutionarily O
conserved O
NAD B
( I
+ I
) I
- O
dependent O
deacetylase O
SIRT1 O
declines O
with O
age O
and O
that O
pharmacological O
activators O
of O
SIRT1 O
confer O
significant O
anti O
- O
aging O
cardiovascular O
effects O
. O

Furthermore O
, O
the O
authors O
investigated O
the O
influence O
of O
Mg B
( I
2 I
+ I
) I
, O
Ca B
( I
2 I
+ I
) I
, O
Na B
( I
+ I
) I
, O
and O
Cl B
( I
- I
) I
on O
Ni B
toxicity O
to O
F O
. O
heteroclitus O
. O

Furthermore O
, O
the O
authors O
investigated O
the O
influence O
of O
Mg B
( I
2 I
+ I
) I
, O
Ca B
( I
2 I
+ I
) I
, O
Na B
( I
+ I
) I
, O
and O
Cl B
( I
- I
) I
on O
Ni B
toxicity O
to O
F O
. O
heteroclitus O
. O

Freshwater O
with O
up O
to O
120 O
mg O
/ O
L O
Ca B
( I
2 I
+ I
) I
as O
CaSO4 B
, O
250 O
mg O
/ O
L O
Mg B
( I
2 I
+ I
) I
as O
MgSO4 B
, O
or O
250 O
mg O
/ O
L O
Na B
( I
+ I
) I
as O
NaHCO3 B
did O
not O
provide O
protection O
against O
Ni B
toxicity O
. O

Alternatively O
, O
250 O
mg O
/ O
L O
Na B
( I
+ I
) I
, O
as O
NaCl B
, O
was O
protective O
against O
Ni B
toxicity O
; O
and O
the O
extent O
of O
protection O
was O
similar O
to O
that O
demonstrated O
from O
salt O
water O
with O
the O
same O
Cl B
( I
- I
) I
concentration O
. O

Alternatively O
, O
250 O
mg O
/ O
L O
Na B
( I
+ I
) I
, O
as O
NaCl B
, O
was O
protective O
against O
Ni B
toxicity O
; O
and O
the O
extent O
of O
protection O
was O
similar O
to O
that O
demonstrated O
from O
salt O
water O
with O
the O
same O
Cl B
( I
- I
) I
concentration O
. O

These O
results O
suggest O
that O
Cl B
( I
- I
) I
is O
the O
predominant O
ion O
responsible O
for O
reducing O
Ni B
toxicity O
to O
K O
. O
marmoratus O
and O
F O
. O
heteroclitus O
in O
higher O
salinity O
waters O
. O

The O
synthesis O
of O
the O
nanocomposite O
relies O
on O
loading O
zwitterionic O
polymer O
brushes O
with O
Ag B
( I
+ I
) I
precursor O
ions O
, O
followed O
by O
their O
in O
situ O
reduction O
to O
Ag B
nanoparticle O
by O
ultraviolet O
( O
UV O
) O
irradiation O
. O

Multiple O
- O
quantum O
( B
1 I
) I
H I
NMR O
spectroscopy O
has O
been O
finding O
a O
renewed O
interest O
for O
its O
possible O
applications O
in O
the O
analysis O
of O
mixtures O
of O
small O
molecules O
, O
due O
to O
its O
simplification O
properties O
. O

Evaluation O
of O
difluoromethyl B
ketones I
as O
agonists O
of O
the O
gamma B
- I
aminobutyric I
acid I
type O
B O
( O
GABAB O
) O
receptor O
. O

The O
N B
- I
heterocyclic I
amines I
and O
ligand O
backbone O
( O
Et O
vs O
Pr O
) O
are O
found O
to O
modulate O
structural O
and O
reactivity O
properties O
, O
and O
O B
- I
O I
bond O
activation O
is O
shown O
, O
both O
experimentally O
and O
theoretically O
, O
to O
track O
with O
metal O
ion O
Lewis O
acidity O
. O

The O
peroxo B
O I
- I
O I
bond O
is O
shown O
to O
gradually O
become O
more O
activated O
as O
the O
N B
- I
heterocyclic I
amines I
move O
closer O
to O
the O
metal O
ion O
causing O
a O
decrease O
in O
pi O
- O
donation O
from O
the O
peroxo O
pi O
v O
* O
( O
O B
- I
O I
) O
orbital O
. O

The O
peroxo B
O I
- I
O I
bond O
is O
shown O
to O
gradually O
become O
more O
activated O
as O
the O
N B
- I
heterocyclic I
amines I
move O
closer O
to O
the O
metal O
ion O
causing O
a O
decrease O
in O
pi O
- O
donation O
from O
the O
peroxo O
pi O
v O
* O
( O
O B
- I
O I
) O
orbital O
. O

Racemic B
IKM I
- I
159 I
was O
crystallized O
with O
the O
ligand O
- O
binding O
domain O
of O
GluA2 O
, O
and O
the O
structure O
revealed O
a O
complex O
containing O
( B
2R I
) I
- I
IKM I
- I
159 I
at O
the O
glutamate O
binding O
site O
. O

Metabolic O
Activation O
of O
Polycyclic B
Aromatic I
Hydrocarbons I
and O
Aryl B
and I
Heterocyclic I
Amines I
by O
Human O
Cytochromes O
P450 O
2A13 O
and O
2A6 O
. O

Guided O
by O
co O
- O
crystal O
structures O
of O
compounds O
15 O
, O
22 O
and O
30 O
, O
an O
SBDD O
approach O
led O
to O
the O
discovery O
of O
the O
6 B
- I
methyl I
pyridone I
series O
as O
a O
novel O
class O
of O
GKAs O
that O
potently O
activate O
GK O
in O
enzyme O
and O
cell O
assays O
. O

HW002 O
was O
constructed O
by O
deleting O
lpxM O
in O
HW001 O
and O
synthesizes O
only O
the O
pentaacylated B
monophosphoryl I
lipid I
A I
. O

Particularly O
, O
an O
increase O
in O
- O
pentadecenoic B
MUFA I
( O
15 O
: O
1 O
) O
, O
two O
n O
- O
3 O
PUFAs B
alpha B
- I
linolenic I
acid I
[ O
ALA B
: O
18 O
: O
3 O
n3 O
] O
and O
eicosapentaenoic B
acid I
[ O
EPA B
: O
20 O
: O
5 O
n O
- O
3 O
] O
and O
n O
- O
6 O
PUFA B
: O
arachidonic B
acid I
[ O
ARA B
: O
20 O
: O
4 O
n6 O
] O
, O
docosapentaenoic B
acid I
( O
DPA B
) O
by O
PFOA B
and O
PFOS B
were O
observed O
. O

Surface O
- O
enhanced O
Raman O
scattering O
( O
SERS O
) O
spectra O
of O
4 B
- I
mercaptobenzoic I
acid I
( O
4 B
- I
MBA I
) O
have O
been O
investigated O
on O
the O
surface O
of O
Cu2O B
nanospheres O
. O

6 B
' I
- I
Sulfonyloxy I
derivatives O
exhibited O
outstanding O
affinities O
to O
MAO O
- O
A O
( O
7 O
. O
0 O
nM O
< O
IC50 O
< O
49 O
nM O
, O
much O
higher O
than O
moclobemide B
) O
and O
a O
pronounced O
MAO O
- O
A O
/ O
B O
selectivity O
. O

The O
corresponding O
6 B
' I
- I
benzyloxy I
derivatives O
showed O
potent O
MAO O
- O
B O
inhibition O
and O
inverted O
selectivity O
profile O
. O

The O
known O
compounds O
were O
characterised O
as O
n B
- I
tetracosane I
, O
beta B
- I
sitosteryl I
stearate I
, O
eicosanoic B
acid I
, O
stigmasterol B
, O
beta B
- I
sitosterol I
, O
racemosol B
, O
octacosyl B
ferulate I
, O
de B
- I
O I
- I
methyl I
racemosol I
, O
lupeol B
and O
1 B
, I
7 I
, I
8 I
, I
12b I
- I
tetrahydro I
- I
2 I
, I
2 I
, I
4 I
- I
trimethyl I
- I
2H I
- I
benzo I
[ I
6 I
, I
7 I
] I
cyclohepta I
[ I
1 I
, I
2 I
, I
3 I
- I
de I
] I
[ I
1 I
] I

The O
formation O
of O
the O
well O
- O
known O
product O
Br3 B
( I
- I
) I
, O
observed O
in O
the O
steady O
- O
state O
radiolysis O
of O
highly O
concentrated O
Br B
( I
- I
) I
aqueous O
solutions O
, O
has O
now O
been O
directly O
observed O
at O
ultrashort O
times O
corresponding O
to O
the O
relaxation O
of O
the O
spur O
. O

The O
formation O
of O
the O
well O
- O
known O
product O
Br3 B
( I
- I
) I
, O
observed O
in O
the O
steady O
- O
state O
radiolysis O
of O
highly O
concentrated O
Br B
( I
- I
) I
aqueous O
solutions O
, O
has O
now O
been O
directly O
observed O
at O
ultrashort O
times O
corresponding O
to O
the O
relaxation O
of O
the O
spur O
. O

The O
transient O
absorption O
induced O
by O
picosecond O
pulse O
radiolysis O
of O
6 O
M O
Br B
( I
- I
) I
aqueous O
solution O
was O
probed O
simultaneously O
at O
260 O
nm O
with O
the O
third O
harmonic O
laser O
wave O
and O
from O
350 O
to O
750 O
nm O
with O
a O
supercontinuum O
generated O
by O
the O
fundamental O
laser O
wave O
. O

This O
approach O
allows O
several O
transient O
radiolytic O
species O
to O
be O
followed O
in O
parallel O
, O
particularly O
the O
solvated O
electron O
, O
BrOH B
( I
- I
* I
) I
, O
Br2 B
( I
- I
* I
) I
, O
and O
Br3 B
( I
- I
) I
. O

The O
kinetics O
measured O
within O
4 O
ns O
at O
260 O
and O
370 O
nm O
clearly O
exhibit O
that O
the O
decay O
of O
Br2 B
( I
* I
- I
) I
is O
correlated O
with O
the O
formation O
of O
Br3 B
( I
- I
) I
. O

In O
highly O
concentrated O
Br B
( I
- I
) I
solutions O
, O
the O
OH B
( I
* I
) I
radical O
is O
fully O
replaced O
by O
Br2 B
( I
* I
- I
) I
, O
and O
the O
spur O
kinetics O
of O
OH B
( I
* I
) I
radical O
in O
pure O
water O
is O
comparable O
with O
that O
of O
Br2 B
( I
- I
* I
) I
. O

In O
highly O
concentrated O
Br B
( I
- I
) I
solutions O
, O
the O
OH B
( I
* I
) I
radical O
is O
fully O
replaced O
by O
Br2 B
( I
* I
- I
) I
, O
and O
the O
spur O
kinetics O
of O
OH B
( I
* I
) I
radical O
in O
pure O
water O
is O
comparable O
with O
that O
of O
Br2 B
( I
- I
* I
) I
. O

In O
highly O
concentrated O
Br B
( I
- I
) I
solutions O
, O
the O
OH B
( I
* I
) I
radical O
is O
fully O
replaced O
by O
Br2 B
( I
* I
- I
) I
, O
and O
the O
spur O
kinetics O
of O
OH B
( I
* I
) I
radical O
in O
pure O
water O
is O
comparable O
with O
that O
of O
Br2 B
( I
- I
* I
) I
. O

Model O
calculations O
indicate O
that O
the O
main O
OH B
( I
* I
) I
radical O
combination O
product O
H2O2 B
in O
pure O
water O
has O
formation O
kinetics O
similar O
to O
that O
of O
Br3 B
( I
- I
) I
in O
6 O
M O
Br B
( I
- I
) I
solutions O
. O

Model O
calculations O
indicate O
that O
the O
main O
OH B
( I
* I
) I
radical O
combination O
product O
H2O2 B
in O
pure O
water O
has O
formation O
kinetics O
similar O
to O
that O
of O
Br3 B
( I
- I
) I
in O
6 O
M O
Br B
( I
- I
) I
solutions O
. O

Model O
calculations O
indicate O
that O
the O
main O
OH B
( I
* I
) I
radical O
combination O
product O
H2O2 B
in O
pure O
water O
has O
formation O
kinetics O
similar O
to O
that O
of O
Br3 B
( I
- I
) I
in O
6 O
M O
Br B
( I
- I
) I
solutions O
. O

Moreover O
, O
they O
point O
out O
that O
oxidation O
of O
Br B
( I
- I
) I
occurs O
within O
the O
electron O
pulse O
both O
by O
direct O
energy O
absorption O
and O
by O
scavenging O
of O
the O
water O
radical O
cation O
, O
H2O B
( I
* I
+ I
) I
. O

Strong O
fluorescence O
quenching O
was O
also O
observed O
with O
high O
redox O
potential O
metal O
ions O
such O
as O
Ag B
( I
+ I
) I
, O
Au B
( I
3 I
+ I
) I
, O
Cu B
( I
2 I
+ I
) I
and O
Hg B
( I
2 I
+ I
) I
, O
but O
not O
with O
low O
redox O
potential O
ions O
. O

Three O
new O
phenolic B
compounds O
, O
yunnanensins B
A I
- I
C I
( O
1 O
- O
3 O
) O
, O
together O
with O
fourteen O
known O
ones O
( O
4 O
- O
17 O
) O
, O
were O
isolated O
from O
the O
leaves O
and O
stems O
of O
Parakmeria O
yunnanensis O
. O

By O
using O
various O
isotope O
labeling O
systems O
, O
introduced O
by O
adding O
different O
( B
13 I
) I
C I
selectively O
labeled O
delta B
- I
aminolevulinic I
acid I
precursors O
in O
the O
growing O
medium O
of O
R O
. O
sphaeroides O
wild O
type O
( O
WT O
) O
, O
we O
were O
able O
to O
extract O
light O
- O
induced O
( B
13 I
) I
C I
NMR O
signals O
originating O
from O
the O
primary O
electron O
acceptor O
. O

By O
using O
various O
isotope O
labeling O
systems O
, O
introduced O
by O
adding O
different O
( B
13 I
) I
C I
selectively O
labeled O
delta B
- I
aminolevulinic I
acid I
precursors O
in O
the O
growing O
medium O
of O
R O
. O
sphaeroides O
wild O
type O
( O
WT O
) O
, O
we O
were O
able O
to O
extract O
light O
- O
induced O
( B
13 I
) I
C I
NMR O
signals O
originating O
from O
the O
primary O
electron O
acceptor O
. O

By O
using O
various O
isotope O
labeling O
systems O
, O
introduced O
by O
adding O
different O
( B
13 I
) I
C I
selectively O
labeled O
delta B
- I
aminolevulinic I
acid I
precursors O
in O
the O
growing O
medium O
of O
R O
. O
sphaeroides O
wild O
type O
( O
WT O
) O
, O
we O
were O
able O
to O
extract O
light O
- O
induced O
( B
13 I
) I
C I
NMR O
signals O
originating O
from O
the O
primary O
electron O
acceptor O
. O

Trimethylamine B
N I
- I
oxide I
reductase O
( O
TorA O
) O
is O
a O
model O
bacterial O
Tat O
substrate O
and O
is O
a O
molybdenum B
cofactor O
- O
dependent O
enzyme O
. O

In O
this O
study O
, O
we O
use O
( B
13 I
) I
C I
and O
( B
31 I
) I
P I
solid O
- O
state O
NMR O
and O
wide O
angle O
X O
- O
ray O
diffraction O
( O
WAXD O
) O
as O
tools O
to O
elucidate O
molecular O
protein O
structure O
of O
caddisfly O
larval O
silk O
from O
the O
species O
Hesperophylax O
consimilis O
. O

In O
this O
study O
, O
we O
use O
( B
13 I
) I
C I
and O
( B
31 I
) I
P I
solid O
- O
state O
NMR O
and O
wide O
angle O
X O
- O
ray O
diffraction O
( O
WAXD O
) O
as O
tools O
to O
elucidate O
molecular O
protein O
structure O
of O
caddisfly O
larval O
silk O
from O
the O
species O
Hesperophylax O
consimilis O
. O

( B
13 I
) I
C I
NMR O
data O
suggests O
that O
both O
phosphorylated B
serine I
and O
neighboring O
valine B
residues O
exist O
in O
a O
beta O
- O
sheet O
conformation O
while O
glycine B
and O
leucine B
residues O
common O
in O
GGX O
repeats O
likely O
reside O
in O
random O
coil O
conformations O
. O

Additionally O
, O
( B
31 I
) I
P I
chemical O
shift O
anisotropy O
( O
CSA O
) O
analysis O
indicates O
that O
the O
phosphates B
on O
phosphoserine B
residues O
are O
doubly O
ionized O
, O
and O
are O
charge O
- O
stabilized O
by O
divalent O
cations O
. O

These O
fatty B
acids I
included O
jacaric B
and I
punicic I
acid I
found O
in O
jacaranda O
and O
pomegranate O
seed O
oil O
, O
respectively O
, O
three O
octadecatrienoic O
geometric O
isomers O
( O
alpha B
- I
and I
beta I
- I
calendic I
and I
catalpic I
acid I
) O
and O
two O
mono B
- I
unsaturated I
C I
- I
18 I
fatty I
acids I
( O
trans B
- I
and I
cis I
- I
vaccenic I
acid I
) O
. O

The O
spatial O
conformation O
cis O
, O
trans O
, O
cis O
of O
jacaric B
and I
punicic I
acid I
was O
shown O
to O
play O
a O
key O
role O
in O
the O
increased O
potency O
and O
efficacy O
of O
these O
two O
fatty B
acids I
in O
comparison O
to O
the O
five O
other O
C B
- I
18 I
fatty I
acids I
tested O
. O

The O
beta B
- I
fluoroethoxy I
methylphosphonate I
analog O
( O
R B
= I
Me I
, I
Z I
= I
F I
, I
n I
= I
2 I
) O
was O
the O
most O
potent O
anti O
- O
AChE O
compound O
comparable O
( O
ki O
~ O
6 O
x O
10 O
( O
6 O
) O
M O
( O
- O
1 O
) O
min O
( O
- O
1 O
) O
) O
to O
paraoxon B
against O
EEAChE O
. O

The O
serum O
competitive O
study O
showed O
that O
the O
highly O
PEG B
- I
grafted I
PLL I
is O
better O
for O
preventing O
serum O
binding O
to O
the O
Photofrin B
/ O
PLL B
- I
g I
- I
PEG I
complex O
. O

Synthesis O
and O
biochemical O
activities O
of O
antiproliferative O
amino B
acid I
and O
phosphate B
derivatives O
of O
microtubule O
- O
disrupting O
beta B
- I
lactam I
combretastatins I
. O

The O
synthesis O
and O
biochemical O
activities O
of O
novel O
water O
- O
soluble O
beta B
- I
lactam I
analogues O
of O
combretastatin B
A I
- I
4 I
are O
described O
. O

This O
indicates O
that O
the O
beta B
- I
lactam I
amides I
did O
not O
require O
metabolic O
activation O
to O
have O
antiproliferative O
effects O
, O
in O
contrast O
to O
the O
phosphate B
series O
. O

The O
extracted O
DNA O
was O
hydrolyzed O
and O
2 B
' I
- I
deoxycytidine I
and O
5 B
- I
methyl I
- I
2 I
' I
- I
deoxycytidine I
were O
determined O
by O
HPLC O
- O
UV O
. O

Platinum B
( I
II I
) I
complexes O
with O
mono B
- I
aminophosphonate I
ester I
targeting O
group O
that O
induce O
apoptosis O
through O
G1 O
cell O
- O
cycle O
arrest O
: O
Synthesis O
, O
crystal O
structure O
and O
antitumour O
activity O
. O

Platinum B
( I
II I
) I
complexes O
with O
mono B
- I
aminophosphonate I
ester I
targeting O
group O
that O
induce O
apoptosis O
through O
G1 O
cell O
- O
cycle O
arrest O
: O
Synthesis O
, O
crystal O
structure O
and O
antitumour O
activity O
. O

Six O
new O
platinum B
( I
II I
) I
complexes O
with O
mono B
- I
aminophosphonate I
ester I
were O
synthesized O
and O
characterized O
by O
elemental O
analysis O
, O
( B
1 I
) I
H I
NMR O
, O
ESI O
- O
MS O
as O
well O
as O
single O
crystal O
X O
- O
ray O
diffraction O
analysis O
. O

Six O
new O
platinum B
( I
II I
) I
complexes O
with O
mono B
- I
aminophosphonate I
ester I
were O
synthesized O
and O
characterized O
by O
elemental O
analysis O
, O
( B
1 I
) I
H I
NMR O
, O
ESI O
- O
MS O
as O
well O
as O
single O
crystal O
X O
- O
ray O
diffraction O
analysis O
. O

Six O
new O
platinum B
( I
II I
) I
complexes O
with O
mono B
- I
aminophosphonate I
ester I
were O
synthesized O
and O
characterized O
by O
elemental O
analysis O
, O
( B
1 I
) I
H I
NMR O
, O
ESI O
- O
MS O
as O
well O
as O
single O
crystal O
X O
- O
ray O
diffraction O
analysis O
. O

Higher O
levels O
of O
serum O
25 B
- I
hydroxyvitamin I
D I
predicted O
decreases O
in O
trabecular O
network O
heterogeneity O
. O

One O
new O
flavonol B
, O
chlorflavonin B
A I
( O
1 O
) O
, O
four O
new O
diterpenoids B
, O
aspergiloids B
E I
- I
H I
( O
3 O
, O
5 O
- O
7 O
) O
, O
together O
with O
eight O
known O
compounds O
( O
2 O
, O
4 O
, O
8 O
- O
13 O
) O
were O
isolated O
from O
solid O
fermentation O
of O
Aspergillus O
sp O
. O

A O
chemical O
study O
of O
the O
alga O
Cystoseira O
usneoides O
has O
led O
to O
the O
isolation O
of O
six O
new O
meroterpenoids B
, O
cystodiones B
A I
- I
F I
( O
1 O
- O
6 O
) O
, O
together O
with O
six O
known O
related O
compounds O
( O
7 O
- O
12 O
) O
. O

Thioacetamide B
( O
TA O
) O
has O
long O
been O
known O
as O
a O
hepatotoxicant O
whose O
bioactivation O
requires O
S B
- O
oxidation O
to O
thioacetamide B
S I
- I
oxide I
( O
TASO B
) O
and O
then O
to O
the O
very O
reactive O
S B
, I
S I
- I
dioxide I
( O
TASO2 B
) O
. O

The O
structures O
of O
the O
target O
compounds O
have O
been O
characterized O
by O
( B
1 I
) I
H I
NMR O
, O
( B
13 I
) I
C I
NMR O
, O
IR O
, O
MS O
and O
HRMS O
. O

The O
structures O
of O
the O
target O
compounds O
have O
been O
characterized O
by O
( B
1 I
) I
H I
NMR O
, O
( B
13 I
) I
C I
NMR O
, O
IR O
, O
MS O
and O
HRMS O
. O

The O
long O
- O
term O
stability O
of O
3 B
- I
hydroxyazetidine I
amides I
is O
established O
at O
acidic O
and O
neutral O
pH O
and O
implies O
their O
value O
as O
non O
- O
proteinogenic O
amino B
acid I
components O
of O
peptides O
, O
providing O
medicinal O
chemists O
with O
a O
new O
class O
of O
peptide O
isosteres O
. O

An O
N B
- I
methylazetidine I
amide I
derivative O
is O
a O
specific O
inhibitor O
of O
beta O
- O
hexosaminidases O
at O
the O
micromolar O
level O
, O
and O
is O
only O
the O
second O
example O
of O
potent O
inhibition O
of O
any O
glycosidase O
by O
an O
amide B
of O
a O
sugar B
amino I
acid I
related O
to O
an O
iminosugar B
. O

Hybridization O
of O
Phenylthiolate B
- O
and O
Methylthiolate B
- O
Adatom O
Species O
at O
Low O
Coverage O
on O
the O
Au B
( I
111 I
) I
Surface O
. O

Using O
scanning O
tunneling O
microscopy O
we O
observed O
reaction O
products O
of O
two O
chemisorbed O
thiolate B
species O
, O
methylthiolate B
and O
phenylthiolate B
, O
on O
the O
Au B
( I
111 I
) I
surface O
. O

Preliminary O
screening O
of O
the O
compounds O
involved O
scavenging O
hydroxyl B
radicals O
and O
2 B
, I
2 I
- I
diphenyl I
- I
1 I
- I
picrylhydrazyl I
( O
DPPH B
( I
. I
) I
) O
, O
croton O
oil O
- O
induced O
ear O
edema O
in O
mice O
, O
and O
analysis O
of O
the O
mRNA O
expression O
of O
adhesion O
molecules O
in O
ECs O
. O

To O
further O
assess O
the O
etiology O
of O
his O
symptoms O
, O
he O
underwent O
a O
pharmacologic O
stress O
test O
with O
regadenoson B
followed O
by O
technetium B
99 I
m I
sestamibi I
. O

Catalysts O
based O
on O
iron B
( I
III I
) I
, O
bismuth B
( I
III I
) I
, O
and O
gold B
( I
III I
) I
show O
higher O
conversions O
for O
S B
- O
, O
C B
- O
, O
and O
N B
- O
centered O
nucleophiles O
, O
and O
Bi B
( I
III I
) I
was O
the O
most O
efficient O
catalyst O
in O
all O
combinations O
. O

Catalysts O
based O
on O
iron B
( I
III I
) I
, O
bismuth B
( I
III I
) I
, O
and O
gold B
( I
III I
) I
show O
higher O
conversions O
for O
S B
- O
, O
C B
- O
, O
and O
N B
- O
centered O
nucleophiles O
, O
and O
Bi B
( I
III I
) I
was O
the O
most O
efficient O
catalyst O
in O
all O
combinations O
. O

Catalysts O
based O
on O
iron B
( I
III I
) I
, O
bismuth B
( I
III I
) I
, O
and O
gold B
( I
III I
) I
show O
higher O
conversions O
for O
S B
- O
, O
C B
- O
, O
and O
N B
- O
centered O
nucleophiles O
, O
and O
Bi B
( I
III I
) I
was O
the O
most O
efficient O
catalyst O
in O
all O
combinations O
. O

Catalysts O
based O
on O
iron B
( I
III I
) I
, O
bismuth B
( I
III I
) I
, O
and O
gold B
( I
III I
) I
show O
higher O
conversions O
for O
S B
- O
, O
C B
- O
, O
and O
N B
- O
centered O
nucleophiles O
, O
and O
Bi B
( I
III I
) I
was O
the O
most O
efficient O
catalyst O
in O
all O
combinations O
. O

Catalysts O
based O
on O
rhenium B
( I
I I
) I
or O
rhenium B
( I
VII I
) I
, O
palladium B
( I
II I
) I
, O
and O
lanthanum B
( I
III I
) I
were O
the O
most O
efficient O
in O
performing O
the O
nucleophilic O
substitution O
on O
the O
various O
alcohols B
with O
the O
O B
- O
centered O
nucleophiles O
. O

Catalysts O
based O
on O
rhenium B
( I
I I
) I
or O
rhenium B
( I
VII I
) I
, O
palladium B
( I
II I
) I
, O
and O
lanthanum B
( I
III I
) I
were O
the O
most O
efficient O
in O
performing O
the O
nucleophilic O
substitution O
on O
the O
various O
alcohols B
with O
the O
O B
- O
centered O
nucleophiles O
. O

Catalysts O
based O
on O
rhenium B
( I
I I
) I
or O
rhenium B
( I
VII I
) I
, O
palladium B
( I
II I
) I
, O
and O
lanthanum B
( I
III I
) I
were O
the O
most O
efficient O
in O
performing O
the O
nucleophilic O
substitution O
on O
the O
various O
alcohols B
with O
the O
O B
- O
centered O
nucleophiles O
. O

Catalysts O
based O
on O
rhenium B
( I
I I
) I
or O
rhenium B
( I
VII I
) I
, O
palladium B
( I
II I
) I
, O
and O
lanthanum B
( I
III I
) I
were O
the O
most O
efficient O
in O
performing O
the O
nucleophilic O
substitution O
on O
the O
various O
alcohols B
with O
the O
O B
- O
centered O
nucleophiles O
. O

Detailed O
comparisons O
between O
the O
available O
experimental O
and O
computed O
AEA O
data O
at O
the O
B3LYP O
/ O
6 O
- O
311 O
+ O
G O
* O
level O
identified O
the O
electronic O
ground O
state O
of O
( O
5 O
) O
Delta O
for O
FeS B
, O
( O
4 O
) O
Delta O
for O
FeS B
( I
- I
) I
, O
( O
5 O
) O
B2 O
for O
FeS2 B
, O
( O
6 O
) O
A1 O
for O
FeS2 B
( I
- I
) I
, O
( O
1 O
) O
A1 O
for O
Fe2 B
S2 I
, O
( O
8 O
) O
A O
' O
for O
Fe2 B
S2 I
( I
- I
) I
, O
( O
5 O
) O
A O
' O
' O
for O
Fe3 B
S4 I
, O
( O
6 O
) O
A O
' O
' O
for O
Fe3 B
S4 I
( I
- I
) I
, O
( O

Detailed O
comparisons O
between O
the O
available O
experimental O
and O
computed O
AEA O
data O
at O
the O
B3LYP O
/ O
6 O
- O
311 O
+ O
G O
* O
level O
identified O
the O
electronic O
ground O
state O
of O
( O
5 O
) O
Delta O
for O
FeS B
, O
( O
4 O
) O
Delta O
for O
FeS B
( I
- I
) I
, O
( O
5 O
) O
B2 O
for O
FeS2 B
, O
( O
6 O
) O
A1 O
for O
FeS2 B
( I
- I
) I
, O
( O
1 O
) O
A1 O
for O
Fe2 B
S2 I
, O
( O
8 O
) O
A O
' O
for O
Fe2 B
S2 I
( I
- I
) I
, O
( O
5 O
) O
A O
' O
' O
for O
Fe3 B
S4 I
, O
( O
6 O
) O
A O
' O
' O
for O
Fe3 B
S4 I
( I
- I
) I
, O
( O

Enthalpies O
of O
dilution O
of O
aqueous O
solutions O
of O
aliphatic B
6 I
, I
12 I
- I
and I
12 I
, I
12 I
- I
ionene I
bromides I
and I
fluorides I
and O
enthalpies O
of O
mixing O
with O
low O
molecular O
- O
weight O
salts O
, O
such O
as O
sodium B
fluoride I
and I
bromide I
, O
are O
determined O
. O

We O
present O
a O
simple O
and O
straightforward O
method O
for O
the O
direct O
proton O
beam O
activation O
of O
synthetic O
or O
commercially O
available O
aluminum B
oxide I
NPs O
( O
Al2O3 B
NPs O
) O
via O
the O
( B
16 I
) I
O I
( O
p O
, O
alpha O
) O
( B
13 I
) I
N I
nuclear O
reaction O
in O
order O
to O
assess O
their O
biological O
fate O
using O
positron O
emission O
tomography O
( O
PET O
) O
. O

We O
present O
a O
simple O
and O
straightforward O
method O
for O
the O
direct O
proton O
beam O
activation O
of O
synthetic O
or O
commercially O
available O
aluminum B
oxide I
NPs O
( O
Al2O3 B
NPs O
) O
via O
the O
( B
16 I
) I
O I
( O
p O
, O
alpha O
) O
( B
13 I
) I
N I
nuclear O
reaction O
in O
order O
to O
assess O
their O
biological O
fate O
using O
positron O
emission O
tomography O
( O
PET O
) O
. O

The O
incorporation O
of O
radioactive O
( B
13 I
) I
N I
atoms O
in O
the O
Al2O3 B
NPs O
allowed O
the O
study O
of O
the O
biodistribution O
of O
the O
metal B
oxide I
NPs O
in O
rats O
after O
intravenous O
administration O
via O
PET O
. O

Despite O
the O
short O
half O
- O
life O
of O
( B
13 I
) I
N I
( O
9 O
. O
97 O
min O
) O
, O
the O
accumulation O
of O
NPs O
in O
different O
organs O
could O
be O
measured O
during O
the O
first O
68 O
min O
after O
administration O
. O

Sonochemical O
synthesis O
and O
characterization O
of O
nano O
- O
sized O
lead B
( I
II I
) I
3D O
coordination O
polymer O
: O
Precursor O
for O
the O
synthesis O
of O
lead B
( I
II I
) I
oxybromide I
nanoparticles O
. O

The O
supercritical O
CO2 B
extract O
from O
leaves O
was O
purified O
by O
chromatographic O
methods O
, O
yielding O
compounds O
( O
1 O
) O
, O
( O
4 O
) O
and O
( O
7 O
) O
, O
which O
were O
identified O
by O
( B
1 I
) I
H I
NMR O
and O
comparison O
with O
literature O
data O
. O

New O
series O
of O
[ B
1 I
, I
3 I
, I
4 I
] I
thiadiazolo I
[ I
3 I
, I
2 I
- I
a I
] I
pyrimidines I
, O
benzo B
[ I
h I
] I
[ I
1 I
, I
3 I
, I
4 I
] I
thiadiazolo I
[ I
2 I
, I
3 I
- I
b I
] I
quinazolines I
, O
benzothiadiazolotria B
, O
and O
imidazo B
[ I
2 I
, I
1 I
- I
b I
] I
[ I
1 I
, I
3 I
, I
4 I
] I
thiadiazoles I
have O
been O
synthesized O
and O
characterized O
by O
analytical O
and O
spectrometrical O
methods O
( O
IR O
, O
MS O
, O
( B
1 I
) I
H I
and O
( B
13 I
) I
C I
NMR O
) O
. O

New O
series O
of O
[ B
1 I
, I
3 I
, I
4 I
] I
thiadiazolo I
[ I
3 I
, I
2 I
- I
a I
] I
pyrimidines I
, O
benzo B
[ I
h I
] I
[ I
1 I
, I
3 I
, I
4 I
] I
thiadiazolo I
[ I
2 I
, I
3 I
- I
b I
] I
quinazolines I
, O
benzothiadiazolotria B
, O
and O
imidazo B
[ I
2 I
, I
1 I
- I
b I
] I
[ I
1 I
, I
3 I
, I
4 I
] I
thiadiazoles I
have O
been O
synthesized O
and O
characterized O
by O
analytical O
and O
spectrometrical O
methods O
( O
IR O
, O
MS O
, O
( B
1 I
) I
H I
and O
( B
13 I
) I
C I
NMR O
) O
. O

Characterization O
of O
all O
compounds O
was O
performed O
using O
one O
- O
dimensional O
NMR O
techniques O
( O
( B
1 I
) I
H I
, O
( B
13 I
) I
C I
- O
APT O
) O
, O
IR O
spectra O
, O
elemental O
analyses O
and O
high O
- O
resolution O
electrospray O
ionization O
mass O
spectrometry O
( O
HR O
- O
ESI O
- O
MS O
) O
. O

Characterization O
of O
all O
compounds O
was O
performed O
using O
one O
- O
dimensional O
NMR O
techniques O
( O
( B
1 I
) I
H I
, O
( B
13 I
) I
C I
- O
APT O
) O
, O
IR O
spectra O
, O
elemental O
analyses O
and O
high O
- O
resolution O
electrospray O
ionization O
mass O
spectrometry O
( O
HR O
- O
ESI O
- O
MS O
) O
. O

Monomethylarsonic B
acid I
( O
MMA B
) O
and O
As B
( I
V I
) I
were O
only O
detected O
in O
the O
whelk O
Drupa O
fiscella O
and O
the O
crab O
Heteropilumnus O
ciliatus O
, O
respectively O
. O

Arsenite B
[ O
As B
( I
III I
) I
] O
was O
not O
detected O
in O
any O
of O
the O
sampled O
specimens O
, O
but O
there O
were O
also O
unidentified O
other O
As B
species O
. O

For O
model O
development O
, O
we O
used O
plasma O
17 B
beta I
- I
estradiol I
( O
E2 O
) O
concentrations O
and O
ovarian O
cytochrome O
P450 O
( O
CYP O
) O
19A O
aromatase O
mRNA O
data O
from O
two O
time O
- O
course O
experiments O
, O
each O
of O
which O
included O
both O
an O
exposure O
and O
a O
depuration O
phase O
, O
and O
plasma O
E2 O
data O
from O
a O
third O
4 O
- O
day O
study O
. O

Polycalcium B
is O
a O
mixture O
of O
Polycan O
and O
calcium B
lactate I
- I
gluconate I
1 O
: O
9 O
( O
w O
/ O
w O
) O
with O
demonstrated O
antiosteoporosis O
activity O
in O
vitro O
and O
in O
vivo O
studies O
. O

The O
1 O
, O
3 O
- O
dipolar O
cycloaddition O
of O
diazomethane B
with O
trans B
- I
dibenzyl I
glutaconate I
yields O
a O
1 B
- I
pyrazoline I
, O
which O
may O
be O
reduced O
directly O
to O
the O
pyrazolidine B
. O

A O
scaffold O
bearing O
eight O
terminal O
alkyne B
groups O
was O
synthesized O
from O
sucrose B
, O
and O
copies O
of O
an O
azide B
- O
terminated O
Gd B
- I
DOTA I
complex O
were O
attached O
via O
copper B
( I
I I
) I
- O
catalyzed O
azide B
- I
alkyne I
cycloaddition O
. O

Five O
new O
eunicellin B
- O
based O
diterpenoids B
, O
krempfielins B
E I
- I
I I
( O
1 O
- O
5 O
) O
and O
seven O
known O
compounds O
( O
6 O
- O
12 O
) O
were O
isolated O
from O
the O
organic O
extract O
of O
a O
Taiwanese O
soft O
coral O
Cladiella O
krempfi O
. O

Hepatocyte O
uptake O
of O
[ B
( I
14 I
) I
C I
] I
sorafenib I
was O
not O
Na B
( I
+ I
) I
- O
dependent O
or O
influenced O
by O
the O
organic O
anion O
transporter O
2 O
( O
OAT2 O
) O
inhibitor O
ketoprofen B
. O

[ B
( I
14 I
) I
C I
] I
Sorafenib I
( O
0 O
. O
5 O
to O
5 O
mu O
M O
) O
uptake O
was O
significantly O
higher O
in O
hOCT1 O
- O
transfected O
CHO O
cells O
compared O
to O
mock O
cells O
, O
and O
inhibited O
by O
the O
general O
OCT O
inhibitor O
, O
MPP B
( I
+ I
) I
. O

RATIONALE O
: O
Treatment O
with O
a O
carbon B
monoxide I
- O
releasing O
molecule O
( O
tricarbonyldichloror B
( I
II I
) I
dimer O
, O
CORM B
- I
2 I
) O
or O
a O
classical O
heme O
oxygenase O
1 O
inducer O
( O
cobalt B
protoporphyrin I
IX I
, O
CoPP B
) O
has O
potent O
anti O
- O
inflammatory O
effects O
, O
but O
the O
role O
played O
by O
these O
treatments O
in O
the O
antinociceptive O
effects O
of O
morphine B
during O
acute O
and O
chronic O
pain O
was O
not O
evaluated O
. O

Embellicines B
A I
and I
B I
: O
Absolute O
Configuration O
and O
NF O
- O
kappa O
B O
Transcriptional O
Inhibitory O
Activity O
. O

Two O
new O
metabolites O
, O
embellicines B
A I
and I
B I
( O
1 O
and O
2 O
) O
, O
were O
isolated O
from O
the O
EtOAc B
extract O
of O
the O
fungus O
Embellisia O
eureka O
, O
an O
endophyte O
of O
the O
Moroccan O
plant O
Cladanthus O
arabicus O
( O
Asteraceae O
) O
. O

[ B
FeFe I
] I
- O
hydrogenases O
are O
the O
most O
effective O
of O
three O
such O
enzymes O
at O
catalyzing O
H B
( I
+ I
) I
reduction O
. O

Ionic O
liquid O
[ B
HMIM I
] I
HSO4 I
was O
found O
to O
be O
an O
efficient O
catalyst O
for O
the O
synthesis O
of O
N B
- I
substituted I
pyrroles I
through O
the O
reaction O
of O
2 B
, I
5 I
- I
hexanedione I
with O
amines B
under O
ultrasonic O
irradiation O
at O
room O
temperature O
. O

Ionic O
liquid O
[ B
HMIM I
] I
HSO4 I
was O
found O
to O
be O
an O
efficient O
catalyst O
for O
the O
synthesis O
of O
N B
- I
substituted I
pyrroles I
through O
the O
reaction O
of O
2 B
, I
5 I
- I
hexanedione I
with O
amines B
under O
ultrasonic O
irradiation O
at O
room O
temperature O
. O

Other O
migrants O
such O
as O
dipropylene B
glycol I
methyl I
ether I
or O
tributyl B
- I
o I
- I
acetylcitrate I
, O
both O
coming O
from O
the O
coating O
were O
also O
found O
, O
but O
none O
of O
them O
have O
potential O
adverse O
effects O
. O

Further O
analyses O
revealed O
that O
CdTe B
- O
QD O
exposure O
resulted O
in O
apoptosis O
, O
indicated O
by O
changes O
in O
levels O
of O
caspase O
- O
3 O
activity O
, O
poly B
ADP I
- I
ribose I
polymerase O
( O
PARP O
) O
cleavage O
and O
phosphatidylserine B
externalization O
. O

Stimulation O
of O
rat O
liver O
branched O
- O
chain O
alpha B
- I
keto I
acid I
dehydrogenase O
activity O
by O
low O
doses O
of O
bezafibrate B
. O

Synthesis O
, O
crystal O
structure O
and O
biological O
evaluation O
of O
a O
main O
group O
seven O
- O
coordinated O
bismuth B
( I
III I
) I
complex O
with O
2 B
- I
acetylpyridine I
N4 I
- I
phenylthiosemicarbaz I
. O

Up O
to O
now O
, O
bismuth B
( I
III I
) I
complexes O
with O
thiosemicarbazones B
have O
been O
comparatively O
rare O
. O

Here O
, O
a O
main O
group O
seven O
- O
coordinated O
bismuth B
( I
III I
) I
complex O
[ O
Bi B
( I
L I
) I
( I
NO3 I
) I
2 I
( I
CH3CH2OH I
) I
] O
( O
1 O
) O
( O
HL O
= O
2 B
- I
acetylpyridine I
N I
( I
4 I
) I
- I
phenylthiosemicarbaz I
) O
has O
been O
synthesized O
and O
characterized O
by O
elemental O
analysis O
, O
IR O
, O
( B
1 I
) I
H I
NMR O
and O
single O
- O
crystal O
X O
- O
ray O
diffraction O
studies O
. O

Here O
, O
a O
main O
group O
seven O
- O
coordinated O
bismuth B
( I
III I
) I
complex O
[ O
Bi B
( I
L I
) I
( I
NO3 I
) I
2 I
( I
CH3CH2OH I
) I
] O
( O
1 O
) O
( O
HL O
= O
2 B
- I
acetylpyridine I
N I
( I
4 I
) I
- I
phenylthiosemicarbaz I
) O
has O
been O
synthesized O
and O
characterized O
by O
elemental O
analysis O
, O
IR O
, O
( B
1 I
) I
H I
NMR O
and O
single O
- O
crystal O
X O
- O
ray O
diffraction O
studies O
. O

Ureido O
- O
derivatized O
polymers O
, O
such O
as O
poly B
( I
allylurea I
) I
( O
PU O
) O
and O
poly B
( I
L I
- I
citrulline I
) I
derivatives O
, O
exhibited O
upper O
critical O
solution O
temperature O
( O
UCST O
) O
behavior O
under O
physiological O
buffer O
conditions O
as O
we O
previously O
reported O
. O

In O
the O
small O
intestine O
, O
peptide O
transporter O
1 O
( O
PEPT1 O
) O
plays O
a O
role O
in O
the O
transport O
of O
di B
- I
and I
tripeptides I
. O

In O
this O
study O
, O
gamma B
- I
glutamyl I
transpeptidase O
( O
GGT O
) O
and O
l B
- I
cysteine I
sulphoxide I
lyase O
( O
C O
- O
S O
lyase O
) O
were O
purified O
from O
the O
fruiting O
body O
of O
Lentinula O
edodes O
in O
three O
steps O
and O
then O
characterised O
. O

Intermediate O
- O
conductance O
calcium B
- O
activated O
K B
( I
+ I
) I
channels O
( O
KCa3 O
. O
1 O
channels O
) O
have O
important O
roles O
in O
cell O
proliferation O
. O

The O
lowest O
levels O
of O
peroxide B
value O
( O
PV O
) O
, O
thiobarbituric B
acid I
reactive O
substances O
( O
TBARs O
) O
, O
cholesterol B
oxidation O
products O
( O
COPs O
) O
and O
the O
highest O
level O
of O
polyunsaturated B
fatty I
acids I
( O
PUFAs B
) O
content O
, O
especially O
PUFA B
n I
- I
3 I
, O
were O
found O
in O
the O
untreated O
sardines O
( O
time O
zero O
) O
. O

A O
series O
of O
novel O
2 B
- I
ferrocenyl I
- I
7 I
- I
hydroxy I
- I
5 I
- I
phenethyl I
- I
5 I
, I
6 I
, I
7 I
, I
8 I
- I
tetrahydro I
- I
4H I
- I
pyrazolo I
[ I
1 I
, I
5 I
- I
a I
] I
[ I
1 I
, I
4 I
] I
diazepin I
- I
4 I
- I
one I
derivatives O
with O
optical O
activity O
( O
2 O
) O
was O
synthesized O
in O
the O
microwave O
- O
assisted O
condition O
and O
characterized O
by O
means O
of O
IR O
, O
( B
1 I
) I
H I
NMR O
and O
mass O
spectroscopy O
, O
and O
furthermore O
confirmed O
by O
X O
- O
ray O
analysis O
of O
a O
representative O
compound O
( O
R O
) O
- O
2a O
. O

A O
comparison O
of O
the O
constituents O
in O
the O
nine O
commercial O
products O
of O
Dang O
- O
shen O
showed O
that O
compounds O
codonopyrrolidum B
A I
, I
B I
and O
codonoside B
A I
only O
exist O
in O
C O
. O
tangshen O
, O
but O
not O
in O
C O
. O
pilosula O
var O
. O
modesta O
and O
C O
. O
pilosula O
. O

Transition O
to O
Reinforced O
State O
by O
Percolating O
Domains O
of O
Intercalated O
Brush O
- O
Modified O
Cellulose O
Nanocrystals O
and O
Poly B
( I
butadiene I
) I
in O
Cross O
- O
Linked O
Composites O
Based O
on O
Thiol B
- I
ene I
Click O
Chemistry O
. O

Composite O
films O
with O
0 O
- O
80 O
wt O
% O
of O
such O
modified O
CNCs O
( O
mCNCs O
) O
within O
a O
poly B
( I
butadiene I
) I
( O
PBD B
) O
rubber O
matrix O
were O
prepared O
via O
cross O
- O
linking O
by O
UV O
- O
light O
initiated O
thiol B
- I
ene I
click O
reaction O
. O

LC O
- O
MS O
/ O
MS O
Determination O
of O
Isoprostanes B
in O
Plasma O
Samples O
Collected O
from O
Mice O
Exposed O
to O
Doxorubicin B
or O
Tert B
- I
Butyl I
Hydroperoxide I
. O

The O
applicability O
of O
the O
proposed O
approach O
has O
been O
verified O
by O
the O
assessment O
of O
changes O
in O
isoprostane B
levels O
in O
plasma O
samples O
derived O
from O
mice O
exposed O
to O
tert B
- I
butyl I
hydroperoxide I
( O
TBHP B
) O
, O
a O
model O
inducer O
of O
oxidative O
stress O
, O
or O
to O
antitumor O
drug O
doxorubicin B
( O
DOX B
) O
known O
for O
potent O
stimulation O
of O
redox O
cycling O
. O

DOX B
- I
omega I
- I
3 I
FA I
group O
was O
given O
as O
omega B
- I
3 I
FAs I
at O
the O
dose O
of O
400 O
mg O
/ O
kg O
daily O
by O
intragastric O
gavage O
for O
30 O
days O
and O
received O
DOX B
at O
the O
dose O
of O
30 O
mg O
/ O
kg O
intraperitoneally O
on O
day O
28 O
. O

In O
addition O
, O
a O
significant O
decrease O
in O
MDA B
levels O
was O
observed O
in O
rats O
when O
a O
dose O
of O
omega B
- I
3 I
FAs I
was O
given O
with O
DOX B
and O
a O
significant O
increase O
was O
determined O
in O
the O
levels O
of O
GSH B
, O
SOD O
and O
GSH B
- O
Px O
activities O
in O
serum O
, O
liver O
and O
kidney O
tissues O
, O
when O
compared O
with O
DOX B
group O
. O

We O
concluded O
that O
omega B
- I
3 I
FA I
had O
favorable O
effects O
in O
rat O
liver O
and O
kidney O
tissues O
by O
preventing O
oxidative O
damage O
. O

We O
report O
the O
isolation O
and O
structure O
elucidation O
of O
a O
new O
cheilanthane B
sesterterpene B
from O
the O
roots O
of O
Aletris O
farinosa O
that O
possesses O
an O
unusual O
malonate B
half I
- I
ester I
functional O
group O
. O

Biological O
activity O
of O
Pd B
( I
II I
) I
complexes O
with O
mono B
- I
and I
disubstituted I
pyridines I
- O
Experimental O
and O
theoretical O
studies O
. O

Due O
to O
the O
similarity O
between O
Pd B
and O
Pt B
, O
the O
complexes O
of O
palladium B
( I
II I
) I
can O
be O
considered O
as O
potential O
anticancer O
agents O
. O

Obtained O
results O
were O
discussed O
and O
compared O
with O
the O
activation O
parameters O
calculated O
for O
the O
hydrolysis O
of O
PdCl2 B
( I
XnPy I
) I
2 I
, O
indicating O
a O
correlation O
between O
viability O
of O
MCF7 O
and O
CCRF O
- O
SB O
cells O
and O
rates O
of O
hydrolysis O
of O
the O
Pd B
( I
II I
) I
complexes O
. O

The O
Androgen B
Metabolite O
, O
5 B
alpha I
- I
Androstane I
- I
3 I
beta I
, I
17 I
beta I
- I
Diol I
( O
3 B
beta I
- I
Diol I
) O
, O
Activates O
the O
Oxytocin B
Promoter O
Through O
an O
Estrogen B
Receptor O
- O
beta O
Pathway O
. O

The O
dihydrotestosterone B
metabolite O
, O
5 B
alpha I
- I
androstane I
- I
3 I
beta I
, I
17 I
beta I
- I
diol I
( O
3 B
beta I
- I
diol I
) O
, O
binds O
and O
activates O
estrogen B
receptor O
- O
beta O
( O
ER O
- O
beta O
) O
, O
the O
predominant O
ER O
in O
the O
PVN O
. O

Therefore O
, O
we O
tested O
the O
hypothesis O
that O
3 B
beta I
- I
diol I
regulates O
OT O
expression O
through O
ER O
- O
beta O
activation O
. O

Treatment O
of O
ovariectomized O
rats O
with O
estradiol B
benzoate I
or O
3 B
beta I
- I
diol I
for O
4 O
days O
increased O
OT O
mRNA O
selectively O
in O
the O
midcaudal O
, O
but O
not O
rostral O
PVN O
compared O
with O
vehicle O
- O
treated O
controls O
. O

3 B
beta I
- I
Diol I
treatment O
also O
increased O
OT O
mRNA O
in O
the O
hypothalamic O
N38 O
cell O
line O
in O
vitro O
. O

The O
functional O
interactions O
between O
3 B
beta I
- I
diol I
and O
ER O
- O
beta O
with O
the O
human O
OT O
promoter O
were O
examined O
using O
an O
OT O
promoter O
- O
luciferase O
reporter O
construct O
( O
OT O
- O
luc O
) O
. O

In O
a O
dose O
- O
dependent O
manner O
, O
3 B
beta I
- I
diol I
treatment O
increased O
OT O
- O
luc O
activity O
when O
cells O
were O
cotransfected O
with O
ER O
- O
beta O
, O
but O
not O
ER O
- O
alpha O
. O

The O
3 B
beta I
- I
diol I
- O
induced O
OT O
- O
luc O
activity O
was O
reduced O
by O
deletion O
of O
the O
promoter O
region O
containing O
the O
composite O
hormone O
response O
element O
( O
cHRE O
) O
. O

Point O
mutations O
of O
the O
cHRE O
also O
prevented O
OT O
- O
luc O
activation O
by O
3 B
beta I
- I
diol I
. O

These O
results O
indicate O
that O
3 B
beta I
- I
diol I
induces O
OT O
promoter O
activity O
via O
ER O
- O
beta O
- O
cHRE O
interactions O
. O

Specifically O
, O
at O
least O
two O
alkaloids O
isolated O
from O
the O
plant O
Mitragyna O
speciosa O
, O
mitragynine B
( O
( B
E I
) I
- I
2 I
- I
[ I
( I
2S I
, I
3S I
) I
- I
3 I
- I
ethyl I
- I
8 I
- I
methoxy I
- I
1 I
, I
2 I
, I
3 I
, I
4 I
, I
6 I
, I
7 I
, I
12 I
, I
12b I
- I
octahydroindolo I
[ I
3 I
, I
2 I
- I
h I
] I
quinolizin I
- I
2 I
- I
yl I
] I
- I
3 I
- I
methoxyprop I
- I
2 I
- I
enoic I
acid I
methyl I
ester I
; O
9 B
- I
methoxy I
coryantheidine I
; O
MG O
) O
and O

The O
synthesized O
compounds O
were O
characterized O
on O
the O
basis O
of O
their O
spectral O
( O
IR O
, O
( B
13 I
) I
C I
and O
( B
1 I
) I
H I
NMR O
) O
data O
and O
evaluated O
for O
biological O
activities O
. O

The O
synthesized O
compounds O
were O
characterized O
on O
the O
basis O
of O
their O
spectral O
( O
IR O
, O
( B
13 I
) I
C I
and O
( B
1 I
) I
H I
NMR O
) O
data O
and O
evaluated O
for O
biological O
activities O
. O

High O
electrochemical O
cycling O
stability O
, O
chloride B
( O
Cl B
( I
- I
) I
) O
tolerance O
and O
good O
selectivity O
are O
also O
obtained O
for O
the O
Pt B
NP O
@ O
PPy B
NF O
structure O
, O
as O
the O
electrode O
showed O
no O
obvious O
response O
to O
the O
common O
interfering O
agents O
, O
such O
as O
ascorbic B
acid I
( O
AA O
) O
, O
uric B
acid I
( O
UA O
) O
, O
and O
4 B
- I
acetamidophenol I
( O
AP O
) O
. O

Mole O
fractions O
of O
structural O
fragments O
( O
kappa O
exp O
) O
responsible O
for O
the O
polar O
interactions O
within O
polyurethane B
chains O
were O
calculated O
by O
( B
1 I
) I
H I
NMR O
method O
. O

We O
created O
hydrolytically O
degradable O
hydrogel O
/ O
bioceramic O
biocomposites O
, O
comprising O
poly B
( I
2 I
- I
hydroxyethyl I
methacrylate I
) I
( O
pHEMA B
) O
hydrogels O
and O
50 O
wt O
% O
biphasic O
hydroxyapatite B
/ O
beta B
- I
tricalcium I
phosphate I
( O
60 O
/ O
40 O
) O
through O
in O
situ O
polymerization O
. O

To O
vary O
degradability O
, O
a O
co O
- O
monomer O
, O
acrylic B
acid I
( O
AA O
) O
or O
2 B
- I
hydroxypropyl I
methacrylamide I
( O
HPMA B
) O
, O
was O
introduced O
, O
coupled O
with O
altering O
the O
concentration O
of O
the O
cross O
- O
linker O
and O
of O
the O
bioceramic O
. O

One O
of O
them O
that O
resulted O
from O
the O
oxidation O
of O
2 B
- I
oxo I
- I
prasugrel I
by O
human O
liver O
microsomes O
in O
the O
presence O
of O
ethanolamine B
and O
CPDH B
was O
isolated O
and O
completely O
characterized O
by O
( B
1 I
) I
H I
and O
( B
13 I
) I
C I
NMR O
spectroscopy O
in O
addition O
to O
MS O
and O
MS O
( O
2 O
) O
spectrometry O
. O

One O
of O
them O
that O
resulted O
from O
the O
oxidation O
of O
2 B
- I
oxo I
- I
prasugrel I
by O
human O
liver O
microsomes O
in O
the O
presence O
of O
ethanolamine B
and O
CPDH B
was O
isolated O
and O
completely O
characterized O
by O
( B
1 I
) I
H I
and O
( B
13 I
) I
C I
NMR O
spectroscopy O
in O
addition O
to O
MS O
and O
MS O
( O
2 O
) O
spectrometry O
. O

( B
18 I
) I
O I
isotope O
exchange O
depth O
profiling O
with O
ToF O
- O
SIMS O
was O
employed O
to O
simultaneously O
measure O
the O
tracer O
surface O
exchange O
coefficient O
k O
* O
and O
the O
tracer O
diffusion O
coefficient O
D O
* O
in O
the O
temperature O
range O
280 O
- O
475 O
degrees O
C O
. O

We O
tested O
associations O
of O
circulating O
vitamin B
D I
metabolite O
concentrations O
with O
subclinical O
atherosclerosis O
among O
1 O
, O
193 O
participants O
with O
type O
1 O
diabetes O
in O
the O
DCCT O
/ O
EDIC O
study O
. O
RESEARCH O
DESIGN O
AND O
METHODSWe O
measured O
plasma O
concentrations O
of O
25 B
- I
hydroxyvitamin I
D I
[ O
25 B
( I
OH I
) I
D I
] O
, O
1 B
, I
25 I
- I
dihydroxyvitamin I
D I
, O
and O
24 B
, I
25 I
- I
dihydroxyvitamin I
D I
by O
mass O
spectrometry O
at O
the O
end O
of O
the O
DCCT O
. O

For O
instance O
, O
in O
a O
fully O
adjusted O
multinomial O
logistic O
model O
, O
a O
25 O
nmol O
/ O
L O
lower O
25 B
- I
hydroxyvitamin I
D I
was O
associated O
with O
a O
0 O
. O
8 O
- O
fold O
decrease O
in O
the O
odds O
of O
having O
higher O
CAC O
( O
95 O
% O
CI O
0 O
. O
68 O
- O
0 O
. O
96 O
, O
P O
= O
0 O
. O
01 O
) O
. O

We O
synthesized O
complexes O
of O
Ni B
( I
II I
) I
with O
dithiocarbamate B
ligands O
derived O
from O
the O
ortho O
and O
para O
isomers O
of O
sulforhodamine B
B I
fluorophores O
and O
demonstrated O
they O
are O
highly O
selective O
in O
reactions O
with O
nitrogen B
dioxide I
( O
NO2 B
) O
. O

Compared O
with O
the O
para O
isomer O
, O
the O
ortho O
isomer O
showed O
a O
much O
greater O
fluorescence O
increase O
upon O
reaction O
with O
NO2 B
, O
which O
led O
to O
oxidation O
and O
decomplexation O
of O
the O
dithiocarbamate B
ligand O
from O
Ni B
( I
II I
) I
. O

( B
1 I
) I
H I
NMR O
spectral O
analysis O
was O
used O
to O
determine O
the O
structures O
and O
content O
of O
ricinoleic B
acid I
containing O
oligomeric O
chains O
present O
in O
the O
degraded O
polymer O
. O

The O
Protective O
Effects O
of O
alpha B
- I
Lipoic I
Acid I
on O
Kidneys O
in O
Type O
2 O
Diabetic O
Goto O
- O
Kakisaki O
Rats O
via O
Reducing O
Oxidative O
Stress O
. O

To O
evaluate O
the O
protective O
effects O
of O
alpha B
- I
lipoic I
acid I
on O
the O
kidneys O
of O
Goto O
- O
Kakisaki O
( O
GK O
) O
diabetic O
rats O
, O
ten O
GK O
diabetic O
rats O
were O
randomly O
divided O
into O
a O
diabetic O
control O
group O
and O
a O
lipoic B
acid I
- O
treated O
diabetic O
group O
with O
alpha B
- I
lipoic I
acid I
35 O
mg O
. O
Kg O
- O
1 O
intraperitoneal O
injections O
. O

To O
evaluate O
the O
protective O
effects O
of O
alpha B
- I
lipoic I
acid I
on O
the O
kidneys O
of O
Goto O
- O
Kakisaki O
( O
GK O
) O
diabetic O
rats O
, O
ten O
GK O
diabetic O
rats O
were O
randomly O
divided O
into O
a O
diabetic O
control O
group O
and O
a O
lipoic B
acid I
- O
treated O
diabetic O
group O
with O
alpha B
- I
lipoic I
acid I
35 O
mg O
. O
Kg O
- O
1 O
intraperitoneal O
injections O
. O

All O
the O
parameters O
above O
were O
improved O
in O
the O
alpha B
- I
lipoic I
acid I
- O
treated O
diabetic O
group O
. O

alpha B
- I
lipoic I
acid I
can O
protect O
renal O
function O
in O
diabetic O
rats O
via O
its O
antioxidant O
activity O
. O

Analysis O
of O
visible O
- O
light O
- O
active O
Sn B
( I
ii I
) I
- O
TiO2 B
photocatalysts O
. O

The O
influence O
of O
Sn B
( I
ii I
) I
species O
on O
TiO2 B
is O
investigated O
. O

This O
prominent O
red O
- O
shift O
is O
attributed O
to O
the O
interaction O
of O
Sn B
( I
ii I
) I
5s O
orbitals O
with O
the O
TiO2 B
decreasing O
the O
band O
gap O
of O
TiO2 B
by O
raising O
its O
valence O
band O
. O

We O
performed O
chemical O
modifications O
of O
ifenprodil B
at O
the O
benzylic B
position O
and O
on O
the O
phenol B
ring O
by O
introducing O
secondary B
amine I
or I
amide I
functions O
and O
evaluated O
alkyl O
chains O
from O
two O
to O
20 O
bonds O
either O
including O
or O
not O
including O
secondary B
amide I
functions O
as O
spacers O
. O

Further O
evidence O
for O
involvement O
of O
the O
dorsal O
hippocampus O
serotonergic O
and O
gamma B
- I
aminobutyric I
acid I
( O
GABA B
) O
ergic O
pathways O
in O
the O
expression O
of O
contextual O
fear O
conditioning O
in O
rats O
. O

Thus O
, O
the O
purpose O
of O
the O
present O
study O
was O
to O
investigate O
the O
role O
of O
DH O
serotonergic O
and O
gamma B
- I
aminobutyric I
acid I
( O
GABA B
) O
ergic O
mechanisms O
in O
the O
expression O
of O
contextual O
fear O
24 O
h O
after O
conditioning O
, O
reflected O
by O
fear O
- O
potentiated O
startle O
( O
FPS O
) O
and O
freezing O
behavior O
. O

Influence O
of O
oily O
vehicles O
on O
fetal O
testis O
and O
lipid O
profile O
of O
rats O
exposed O
to O
di B
- I
butyl I
phthalate I
. O

In O
the O
present O
study O
, O
the O
influence O
of O
different O
oily O
vehicles O
on O
di B
- I
butyl I
phthalate I
( O
DBP B
) O
- O
induced O
testicular O
toxicity O
and O
lipid O
profile O
was O
investigated O
. O

For O
two O
of O
them O
, O
viz O
. O
, O
3 B
' I
, I
4 I
' I
- I
dimethoxywogonin I
and O
4 B
' I
- I
hydroxywogonin I
, O
such O
data O
have O
not O
been O
reported O
in O
literature O
. O

These O
compounds O
were O
characterised O
on O
the O
basis O
of O
their O
spectral O
data O
, O
mainly O
one O
- O
dimension O
( O
1D O
; O
( B
1 I
) I
H I
, O
( B
13 I
) I
C I
, O
APT O
) O
and O
two O
- O
dimension O
( O
2D O
; O
( B
1 I
) I
H I
- O
( B
1 I
) I
H I
- O
COSY O
, O
HMQC O
and O
HMBC O
) O
nuclear O
magnetic O
resonance O
( O
NMR O
) O
and O
HR O
- O
ESI O
- O
MS O
, O
and O
comparison O
with O
values O
in O
the O
literature O
. O

These O
compounds O
were O
characterised O
on O
the O
basis O
of O
their O
spectral O
data O
, O
mainly O
one O
- O
dimension O
( O
1D O
; O
( B
1 I
) I
H I
, O
( B
13 I
) I
C I
, O
APT O
) O
and O
two O
- O
dimension O
( O
2D O
; O
( B
1 I
) I
H I
- O
( B
1 I
) I
H I
- O
COSY O
, O
HMQC O
and O
HMBC O
) O
nuclear O
magnetic O
resonance O
( O
NMR O
) O
and O
HR O
- O
ESI O
- O
MS O
, O
and O
comparison O
with O
values O
in O
the O
literature O
. O

These O
compounds O
were O
characterised O
on O
the O
basis O
of O
their O
spectral O
data O
, O
mainly O
one O
- O
dimension O
( O
1D O
; O
( B
1 I
) I
H I
, O
( B
13 I
) I
C I
, O
APT O
) O
and O
two O
- O
dimension O
( O
2D O
; O
( B
1 I
) I
H I
- O
( B
1 I
) I
H I
- O
COSY O
, O
HMQC O
and O
HMBC O
) O
nuclear O
magnetic O
resonance O
( O
NMR O
) O
and O
HR O
- O
ESI O
- O
MS O
, O
and O
comparison O
with O
values O
in O
the O
literature O
. O

These O
compounds O
were O
characterised O
on O
the O
basis O
of O
their O
spectral O
data O
, O
mainly O
one O
- O
dimension O
( O
1D O
; O
( B
1 I
) I
H I
, O
( B
13 I
) I
C I
, O
APT O
) O
and O
two O
- O
dimension O
( O
2D O
; O
( B
1 I
) I
H I
- O
( B
1 I
) I
H I
- O
COSY O
, O
HMQC O
and O
HMBC O
) O
nuclear O
magnetic O
resonance O
( O
NMR O
) O
and O
HR O
- O
ESI O
- O
MS O
, O
and O
comparison O
with O
values O
in O
the O
literature O
. O

Both O
compounds O
1 O
and O
2 O
were O
found O
to O
promote O
early O
infection O
events O
in O
HIV O
, O
likely O
by O
inhibiting O
the O
enzyme O
indolamine B
2 O
, O
3 O
- O
dioxygenase O
( O
IDO O
) O
and O
preventing O
tryptophan B
depletion O
. O

These O
protective O
effects O
were O
abolished O
by O
glucocorticoid O
receptor O
( O
GR O
) O
antagonist O
RU486 B
or O
p O
- O
ERK O
inhibitor O
U0126 B
rather O
than O
estrogen B
receptor O
alpha O
antagonist O
ICI B
82 I
, I
780 I
. O

The O
reported O
compounds O
herein O
are O
: O
4 B
- I
aminothienopyrimidin I
derivatives O
4a O
, O
b O
and O
their O
4 B
- I
substituted I
phenylamino I
analogues O
8a O
, O
b O
; O
4 B
- I
thienopyrimidin I
- I
4 I
- I
ones I
5a O
, O
b O
; O
N B
- I
alkyl I
thienopyrimidin I
- I
4 I
- I
ones I
6a O
- O
g O
; O
4 B
- I
chlorothienopyrimidi I
7a O
, O
b O
; O
and O
thienopyrimidoquinaz B
9a O
, O
b O
which O
are O
the O
structural O
mimics O
of O
8a O
, O
b O
. O

In O
vitro O
, O
lipid O
transfers O
were O
evaluated O
by O
incubation O
of O
plasma O
samples O
( O
37 O
degrees O
C O
, O
1h O
) O
with O
a O
donor O
lipid O
nanoemulsion O
labeled O
with O
3H B
- I
triglycerides I
( O
TG O
) O
and O
14C B
- O
unesterified O
cholesterol B
( O
UC O
) O
or O
with O
3H B
- I
cholesteryl I
ester I
( O
EC O
) O
and O
14C B
- O
phospholipids O
( O
PL O
) O
. O

Synthesis O
of O
the O
conjugates O
was O
achieved O
via O
selective O
nucleophilic O
monofunctionalizatio O
of O
5 B
, I
10 I
, I
15 I
, I
20 I
- I
tetrahydroxyphenylpo I
with O
propargyl B
bromide I
followed O
by O
Cu B
( I
I I
) I
mediated O
cycloaddition O
with O
bile B
acid I
azides I
in O
good O
yields O
. O

A O
new O
series O
of O
fluoro B
substituted I
pyrazoline I
derivatives O
5a O
- O
g O
and O
6a O
- O
g O
were O
synthesized O
in O
good O
to O
excellent O
yield O
from O
the O
corresponding O
pyrazole B
chalcones I
, O
4a O
- O
g O
, O
by O
using O
polyethylene B
glycol I
- I
400 I
( O
PEG B
- I
400 I
) O
as O
an O
alternative O
reaction O
medium O
. O

A O
custom O
- O
designed O
bench O
- O
top O
framework O
comprising O
a O
model O
of O
a O
single O
drug O
- O
eluting O
stent O
strut O
and O
a O
poly B
- I
vinyl I
alcohol I
- O
based O
hydrogel O
as O
a O
model O
tissue O
bed O
simulated O
fluid O
flow O
and O
drug O
transport O
under O
fully O
apposed O
strut O
settings O
. O

The O
ethylene B
bis I
- I
dithiocarbamate I
fungicide O
Mancozeb B
activates O
voltage O
- O
gated O
KCNQ2 O
potassium B
channel O
. O

We O
previously O
reported O
that O
oroxylin B
A I
, O
a O
gamma B
- I
aminobutyric I
acid I
A O
( O
GABAA O
) O
receptor O
antagonist O
, O
ameliorates O
drugs O
- O
induced O
memory O
impairments O
. O

In O
an O
in O
vitro O
study O
, O
DMPC B
( O
20 O
mu O
M O
) O
inhibited O
intracellular O
Cl B
( I
- I
) I
influx O
induced O
by O
muscimol B
, O
a O
selective O
GABAA O
receptor O
agonist O
. O

Tryptanthrin B
showed O
a O
variety O
of O
intriguing O
biological O
properties O
such O
as O
antibacterial O
, O
antifungal O
, O
antiprotozoal O
, O
and O
antiparasitic O
activities O
, O
inhibitory O
activities O
against O
COX O
- O
2 O
, O
5 O
- O
LOX O
, O
NO B
synthase O
and O
PGE B
( I
2 I
) I
expression O
, O
as O
well O
as O
cytotoxic O
and O
antitumor O
activities O
. O

Self O
- O
diffusion O
coefficient O
measurements O
were O
performed O
for O
pure O
n B
- I
alkyl I
ketone I
liquids O
using O
the O
pulsed O
field O
gradient O
NMR O
spin O
- O
echo O
technique O
. O

The O
data O
for O
the O
pure O
ketones B
and O
ketone B
- O
based O
electrolytes O
are O
compared O
with O
analogous O
data O
for O
pure O
n B
- I
alkyl I
acetates I
and O
n B
- I
alkyl I
acetate I
- O
based O
electrolytes O
. O

The O
data O
for O
the O
pure O
ketones B
and O
ketone B
- O
based O
electrolytes O
are O
compared O
with O
analogous O
data O
for O
pure O
n B
- I
alkyl I
acetates I
and O
n B
- I
alkyl I
acetate I
- O
based O
electrolytes O
. O

Six O
new O
cyclic O
peptides O
, O
gypsophin B
A I
- I
F I
( O
1 O
- O
6 O
) O
, O
were O
isolated O
from O
Gypsophila O
oldhamiana O
. O

A O
Coupling O
of O
Benzamides B
and O
Donor O
/ O
Acceptor O
Diazo B
Compounds O
To O
Form O
gamma B
- I
Lactams I
via O
Rh B
( I
III I
) I
- O
Catalyzed O
C B
- I
H I
Activation O
. O

The O
effects O
of O
exogenous O
thiocyanate B
( O
SCN B
( I
- I
) I
) O
on O
amino B
acids I
composition O
, O
content O
of O
mineral O
nutrients O
and O
antioxidative O
systems O
in O
plants O
were O
investigated O
. O

Mineral O
nutrients O
and O
free O
amino B
acids I
in O
rice O
seedlings O
were O
also O
measured O
to O
determine O
metabolic O
responses O
to O
SCN B
( I
- I
) I
exposure O
. O

The O
content O
of O
nutrient O
elements O
in O
rice O
seedlings O
exposed O
to O
exogenous O
SCN B
( I
- I
) I
was O
variable O
, O
while O
the O
effects O
were O
more O
evident O
at O
the O
highest O
SCN B
- O
treatment O
( O
p O
< O
0 O
. O
05 O
) O
. O

Although O
the O
change O
of O
total O
free O
amino B
acids I
in O
shoots O
of O
SCN B
- O
exposed O
seedlings O
was O
negligible O
( O
p O
> O
0 O
. O
05 O
) O
, O
responses O
of O
different O
amino B
acids I
to O
SCN B
( I
- I
) I
application O
were O
quite O
different O
. O

Among O
fifteen O
free O
amino B
acids I
detected O
, O
serine B
( O
Ser B
) O
, O
proline B
( O
Pro B
) O
, O
and O
methionine B
( O
Met B
) O
increased O
, O
while O
asparagine B
( O
Asp B
) O
decreased O
with O
an O
increase O
of O
the O
doses O
of O
SCN B
( I
- I
) I
supplied O
. O

Phyto O
- O
transport O
of O
SCN B
( I
- I
) I
was O
apparent O
and O
the O
removal O
rates O
were O
positively O
correlated O
to O
the O
doses O
, O
suggesting O
that O
phyto O
- O
assimilation O
of O
SCN B
( I
- I
) I
is O
an O
enzymatic O
process O
through O
a O
potentially O
un O
- O
identified O
degradation O
pathway O
. O

Phyto O
- O
transport O
of O
SCN B
( I
- I
) I
was O
apparent O
and O
the O
removal O
rates O
were O
positively O
correlated O
to O
the O
doses O
, O
suggesting O
that O
phyto O
- O
assimilation O
of O
SCN B
( I
- I
) I
is O
an O
enzymatic O
process O
through O
a O
potentially O
un O
- O
identified O
degradation O
pathway O
. O

Eight O
new O
cycloartane B
triterpenoids I
( O
1 O
- O
8 O
) O
, O
named O
carinatins B
A I
- I
H I
, O
and O
the O
known O
compounds O
secaubryolide B
( O
9 O
) O
and O
dikamaliartane B
D I
( O
10 O
) O
were O
isolated O
from O
the O
leaves O
and O
twigs O
of O
Gardenia O
carinata O
. O

The O
aqueous O
phase O
contains O
alkali B
- I
metal I
chlorides I
, O
including O
LiCl B
, O
NaCl B
, O
RbCl B
, O
or O
CsCl B
, O
and O
the O
organic O
phase O
is O
a O
1 B
, I
2 I
- I
dichloroethane I
solution O
of O
bis B
( I
triphenylphosphor I
anylidene I
) I
ammonium I
tetrakis I
( I
pentafluorophenyl I
) I
borate I
( O
BTPPATPFB B
) O
. O

Selected O
data O
for O
a O
subset O
of O
electric O
potential O
differences O
are O
analyzed O
to O
determine O
the O
potentials O
of O
mean O
force O
for O
Li B
( I
+ I
) I
, O
Rb B
( I
+ I
) I
, O
Cs B
( I
+ I
) I
, O
BTPPA B
( I
+ I
) I
, O
and O
TPFB B
( I
- I
) I
. O

Selected O
data O
for O
a O
subset O
of O
electric O
potential O
differences O
are O
analyzed O
to O
determine O
the O
potentials O
of O
mean O
force O
for O
Li B
( I
+ I
) I
, O
Rb B
( I
+ I
) I
, O
Cs B
( I
+ I
) I
, O
BTPPA B
( I
+ I
) I
, O
and O
TPFB B
( I
- I
) I
. O

Selected O
data O
for O
a O
subset O
of O
electric O
potential O
differences O
are O
analyzed O
to O
determine O
the O
potentials O
of O
mean O
force O
for O
Li B
( I
+ I
) I
, O
Rb B
( I
+ I
) I
, O
Cs B
( I
+ I
) I
, O
BTPPA B
( I
+ I
) I
, O
and O
TPFB B
( I
- I
) I
. O

Selected O
data O
for O
a O
subset O
of O
electric O
potential O
differences O
are O
analyzed O
to O
determine O
the O
potentials O
of O
mean O
force O
for O
Li B
( I
+ I
) I
, O
Rb B
( I
+ I
) I
, O
Cs B
( I
+ I
) I
, O
BTPPA B
( I
+ I
) I
, O
and O
TPFB B
( I
- I
) I
. O

Selected O
data O
for O
a O
subset O
of O
electric O
potential O
differences O
are O
analyzed O
to O
determine O
the O
potentials O
of O
mean O
force O
for O
Li B
( I
+ I
) I
, O
Rb B
( I
+ I
) I
, O
Cs B
( I
+ I
) I
, O
BTPPA B
( I
+ I
) I
, O
and O
TPFB B
( I
- I
) I
. O

Comparison O
of O
X O
- O
ray O
reflectivity O
data O
for O
strongly O
hydrated O
alkali B
- I
metal I
ions O
( O
Li B
( I
+ I
) I
and O
Na B
( I
+ I
) I
) O
, O
for O
which O
ion O
pairing O
to O
TPFB B
( I
- I
) I
ions O
across O
the O
interface O
is O
not O
expected O
, O
to O
data O
for O
weakly O
hydrated O
alkali B
- I
metal I
ions O
( O
Rb B
( I
+ I
) I
and O
Cs B
( I
+ I
) I
) O
indicates O
that O
the O
Gibbs O
energy O
of O
adsorption O
due O
to O
ion O
pairing O
at O
the O
interface O
must O
be O
small O
( O
< O
1 O
kBT O
per O
ion O
pair O
) O
for O
both O
the O
CsCl B
and O
RbCl B
samples O
. O

Comparison O
of O
X O
- O
ray O
reflectivity O
data O
for O
strongly O
hydrated O
alkali B
- I
metal I
ions O
( O
Li B
( I
+ I
) I
and O
Na B
( I
+ I
) I
) O
, O
for O
which O
ion O
pairing O
to O
TPFB B
( I
- I
) I
ions O
across O
the O
interface O
is O
not O
expected O
, O
to O
data O
for O
weakly O
hydrated O
alkali B
- I
metal I
ions O
( O
Rb B
( I
+ I
) I
and O
Cs B
( I
+ I
) I
) O
indicates O
that O
the O
Gibbs O
energy O
of O
adsorption O
due O
to O
ion O
pairing O
at O
the O
interface O
must O
be O
small O
( O
< O
1 O
kBT O
per O
ion O
pair O
) O
for O
both O
the O
CsCl B
and O
RbCl B
samples O
. O

Comparison O
of O
X O
- O
ray O
reflectivity O
data O
for O
strongly O
hydrated O
alkali B
- I
metal I
ions O
( O
Li B
( I
+ I
) I
and O
Na B
( I
+ I
) I
) O
, O
for O
which O
ion O
pairing O
to O
TPFB B
( I
- I
) I
ions O
across O
the O
interface O
is O
not O
expected O
, O
to O
data O
for O
weakly O
hydrated O
alkali B
- I
metal I
ions O
( O
Rb B
( I
+ I
) I
and O
Cs B
( I
+ I
) I
) O
indicates O
that O
the O
Gibbs O
energy O
of O
adsorption O
due O
to O
ion O
pairing O
at O
the O
interface O
must O
be O
small O
( O
< O
1 O
kBT O
per O
ion O
pair O
) O
for O
both O
the O
CsCl B
and O
RbCl B
samples O
. O

Comparison O
of O
X O
- O
ray O
reflectivity O
data O
for O
strongly O
hydrated O
alkali B
- I
metal I
ions O
( O
Li B
( I
+ I
) I
and O
Na B
( I
+ I
) I
) O
, O
for O
which O
ion O
pairing O
to O
TPFB B
( I
- I
) I
ions O
across O
the O
interface O
is O
not O
expected O
, O
to O
data O
for O
weakly O
hydrated O
alkali B
- I
metal I
ions O
( O
Rb B
( I
+ I
) I
and O
Cs B
( I
+ I
) I
) O
indicates O
that O
the O
Gibbs O
energy O
of O
adsorption O
due O
to O
ion O
pairing O
at O
the O
interface O
must O
be O
small O
( O
< O
1 O
kBT O
per O
ion O
pair O
) O
for O
both O
the O
CsCl B
and O
RbCl B
samples O
. O

Comparison O
of O
X O
- O
ray O
reflectivity O
data O
for O
strongly O
hydrated O
alkali B
- I
metal I
ions O
( O
Li B
( I
+ I
) I
and O
Na B
( I
+ I
) I
) O
, O
for O
which O
ion O
pairing O
to O
TPFB B
( I
- I
) I
ions O
across O
the O
interface O
is O
not O
expected O
, O
to O
data O
for O
weakly O
hydrated O
alkali B
- I
metal I
ions O
( O
Rb B
( I
+ I
) I
and O
Cs B
( I
+ I
) I
) O
indicates O
that O
the O
Gibbs O
energy O
of O
adsorption O
due O
to O
ion O
pairing O
at O
the O
interface O
must O
be O
small O
( O
< O
1 O
kBT O
per O
ion O
pair O
) O
for O
both O
the O
CsCl B
and O
RbCl B
samples O
. O

Here O
we O
demonstrate O
that O
the O
boron B
nitride I
nanomesh O
, O
a O
corrugated O
single O
layer O
of O
hexagonal O
boron B
nitride I
( O
h B
- I
BN I
) O
with O
a O
3 O
. O
2 O
nm O
honeycomb O
superstructure O
formed O
on O
a O
Rh B
( I
111 I
) I
surface O
, O
can O
trap O
individual O
argon B
atoms O
at O
distinct O
subsurface O
sites O
at O
room O
temperature O
. O

This O
work O
addresses O
structural O
and O
nonequilibrium O
effects O
of O
the O
interactions O
between O
well O
- O
defined O
cationic O
poly B
( I
amidoamine I
) I
PAMAM B
dendrimers O
of O
generations O
4 O
and O
8 O
and O
the O
anionic O
surfactant O
sodium B
dodecyl I
sulfate I
( O
SDS B
) O
at O
the O
hydrophilic O
silica B
- O
water O
interface O
. O

The O
following O
surfactants O
were O
used O
in O
the O
experiments O
: O
cationic O
dodecyltrimethylammo B
bromide I
( O
DTAB B
) O
, O
anionic O
sodium B
dodecyl I
sulfate I
( O
SDS B
) O
, O
anionic O
Pantene O
shampoo O
which O
primarily O
contains O
sodium B
lauryl I
sulfate I
, O
nonionic O
tetraethylene B
glycol I
monooctyl I
ether I
( O
C8E4 B
) O
, O
and O
nonionic O
Pluronic B
( I
P I
- I
123 I
) I
surfactants O
at O
different O
concentrations O
. O

Global O
gene O
expression O
analysis O
reveals O
pathway O
differences O
between O
teratogenic O
and O
non O
- O
teratogenic O
exposure O
concentrations O
of O
bisphenol B
A I
and O
17 B
beta I
- I
estradiol I
in O
embryonic O
zebrafish O
. O

Exposure O
concentrations O
were O
selected O
and O
anchored O
to O
the O
positive O
control O
, O
17 B
beta I
- I
estradiol I
( O
E2 O
) O
, O
based O
on O
previously O
determined O
behavioral O
or O
teratogenic O
phenotypes O
. O

Storable O
sunshine O
, O
reusable O
rays O
: O
A O
solar O
rechargeable O
redox O
flow O
battery O
is O
proposed O
based O
on O
the O
photoregeneration O
of O
I3 B
( I
- I
) I
/ O
I B
( I
- I
) I
and O
[ B
Fe I
( I
C10 I
H15 I
) I
2 I
] I
( I
+ I
) I
/ O
Fe B
( I
C10 I
H15 I
) I
2 I
soluble O
redox O
couples O
, O
which O
can O
be O
regenerated O
by O
flowing O
from O
a O
discharged O
redox O
flow O
battery O
( O
RFB O
) O
into O
a O
dye O
- O
sensitized O
solar O
cell O
( O
DSSC O
) O
and O
then O
stored O
in O
tanks O
for O
subsequent O
RFB O
applications O
This O
technology O
enables O
effective O
solar O
- O
to O
- O
chemical O
energy O
conversion O
. O

Storable O
sunshine O
, O
reusable O
rays O
: O
A O
solar O
rechargeable O
redox O
flow O
battery O
is O
proposed O
based O
on O
the O
photoregeneration O
of O
I3 B
( I
- I
) I
/ O
I B
( I
- I
) I
and O
[ B
Fe I
( I
C10 I
H15 I
) I
2 I
] I
( I
+ I
) I
/ O
Fe B
( I
C10 I
H15 I
) I
2 I
soluble O
redox O
couples O
, O
which O
can O
be O
regenerated O
by O
flowing O
from O
a O
discharged O
redox O
flow O
battery O
( O
RFB O
) O
into O
a O
dye O
- O
sensitized O
solar O
cell O
( O
DSSC O
) O
and O
then O
stored O
in O
tanks O
for O
subsequent O
RFB O
applications O
This O
technology O
enables O
effective O
solar O
- O
to O
- O
chemical O
energy O
conversion O
. O

Nine O
phenolic B
acids I
, O
protocatechuic B
acid I
, O
p B
- I
hydroxybenzoic I
acid I
, O
ferulic B
acid I
, O
chlorogenic B
acid I
, O
vanillic B
acid I
, O
caffeic B
acid I
, O
vanillin B
, O
ortho B
- I
and I
para I
- I
coumaric I
acids I
, O
were O
identified O
and O
quantified O
. O

The O
three O
major O
phenolic B
acids I
identified O
in O
all O
four O
ber O
species O
were O
p B
- I
coumaric I
acid I
, O
vanillin B
and O
ferulic B
acids I
. O

Cyanidin B
3 I
- I
glucoside I
, O
and O
quercetin B
and O
its O
glycosides O
were O
only O
found O
in O
the O
pulp O
powder O
, O
while O
proanthocyanidins B
were O
only O
present O
in O
the O
flour O
( O
3 O
. O
5g O
/ O
100g O
, O
mean O
degree O
of O
polymerisation O
3 O
) O
. O

To O
enhance O
the O
( B
13 I
) I
C I
- O
enrichment O
and O
yields O
of O
labelled O
lycopene B
from O
the O
hp O
- O
1 O
tomato O
cell O
line O
, O
cultures O
were O
first O
grown O
in O
( B
13 I
) I
C I
- I
glucose I
media O
for O
three O
serial O
batches O
and O
produced O
increasing O
proportions O
of O
uniformly O
labelled O
lycopene B
( O
14 O
. O
3 O
+ O
/ O
- O
1 O
. O
2 O
% O
, O
39 O
. O
6 O
+ O
/ O
- O
0 O
. O
5 O
% O
, O
and O
48 O
. O
9 O
+ O
/ O
- O
1 O
. O
5 O
% O
) O
with O
consistent O
yields O
( O
from O
5 O
. O
8 O
to O
9mg O
/ O
L O
) O
. O

An O
optimised O
9 O
- O
day O
- O
long O
( B
13 I
) I
C I
- O
loading O
and O
18 O
- O
day O
- O
long O
labelling O
strategy O
developed O
based O
on O
glucose B
utilisation O
and O
lycopene B
yields O
, O
yielded O
( B
13 I
) I
C I
- I
lycopene I
with O
93 O
% O
( B
13 I
) I
C I
isotopic O
purity O
, O
and O
55 O
% O
of O
isotopomers O
were O
uniformly O
labelled O
. O

An O
optimised O
9 O
- O
day O
- O
long O
( B
13 I
) I
C I
- O
loading O
and O
18 O
- O
day O
- O
long O
labelling O
strategy O
developed O
based O
on O
glucose B
utilisation O
and O
lycopene B
yields O
, O
yielded O
( B
13 I
) I
C I
- I
lycopene I
with O
93 O
% O
( B
13 I
) I
C I
isotopic O
purity O
, O
and O
55 O
% O
of O
isotopomers O
were O
uniformly O
labelled O
. O

Selenocystine B
was O
detected O
at O
low O
concentrations O
while O
Se B
- O
( B
Methyl I
) I
selenocysteine I
and O
inorganic O
selenium B
species O
( O
selenite B
and O
selenate B
) O
were O
not O
detected O
in O
the O
dialyzate O
. O

This O
transport O
was O
completely O
inhibited O
by O
MPP B
( I
+ I
) I
, O
a O
common O
OCT3 O
and O
MATE1 O
inhibitor O
. O

Furthermore O
, O
we O
observed O
that O
the O
oppositely O
directed O
H B
( I
+ I
) I
- O
gradient O
can O
drive O
the O
secretion O
of O
metformin B
from O
placenta O
to O
maternal O
circulation O
, O
confirming O
apical O
efflux O
of O
metformin B
from O
trophoblast O
by O
MATE1 O
. O

Bioreducible O
alginate O
- O
poly B
( I
ethylenimine I
) I
nanogels O
as O
an O
antigen O
- O
delivery O
system O
robustly O
enhance O
vaccine O
- O
elicited O
humoral O
and O
cellular O
immune O
responses O
. O

The O
influx O
of O
AC O
was O
temperature O
- O
, O
pH O
- O
and O
Na B
( I
+ I
) I
- O
dependent O
. O

However O
, O
the O
efflux O
of O
AC O
was O
temperature O
- O
and O
pH O
- O
dependent O
, O
but O
Na B
( I
+ I
) I
- O
independent O
. O

DNA O
- O
binding O
, O
photocleavage O
, O
cytotoxicity O
in O
vitro O
, O
apoptosis O
and O
cell O
cycle O
arrest O
studies O
of O
symmetric O
ruthenium B
( I
II I
) I
complexes O
. O

Two O
novel O
ruthenium B
( I
II I
) I
complexes O
[ B
Ru I
( I
dmb I
) I
2 I
( I
addppn I
) I
] I
( I
ClO4 I
) I
2 I
( O
1 O
) O
and O
[ B
Ru I
( I
bpy I
) I
2 I
( I
addppn I
) I
] I
( I
ClO4 I
) I
2 I
( O
2 O
) O
were O
synthesized O
. O

Herein O
, O
we O
report O
the O
antioxidant O
properties O
of O
some O
selected O
substituted O
2 B
- I
indolyl I
carbohydrazides I
( O
JL34 B
, O
JL40 B
, O
JL71 B
, O
JL87 B
, O
JL317 B
, O
JL432 B
, O
JL436 B
) O
, O
the O
substituted O
3 B
- I
indolyl I
carbohydrazide I
JL344 B
, O
3 B
- I
( I
3 I
- I
hydrazinylpropyl I
) I
- I
1H I
- I
indole I
( O
JL72 B
) O
and O
3 B
- I
( I
1H I
- I
indol I
- I
3 I
- I
yl I
) I

Herein O
, O
we O
report O
the O
antioxidant O
properties O
of O
some O
selected O
substituted O
2 B
- I
indolyl I
carbohydrazides I
( O
JL34 B
, O
JL40 B
, O
JL71 B
, O
JL87 B
, O
JL317 B
, O
JL432 B
, O
JL436 B
) O
, O
the O
substituted O
3 B
- I
indolyl I
carbohydrazide I
JL344 B
, O
3 B
- I
( I
3 I
- I
hydrazinylpropyl I
) I
- I
1H I
- I
indole I
( O
JL72 B
) O
and O
3 B
- I
( I
1H I
- I
indol I
- I
3 I
- I
yl I
) I

Reactions O
of O
Hydrocarbon B
Radicals I
and I
Biradicals I
. O

Ion O
impacts O
on O
graphene B
/ O
ir B
( I
111 I
) I
: O
interface O
channeling O
, O
vacancy O
funnels O
, O
and O
a O
nanomesh O
. O

By O
combining O
ion O
beam O
experiments O
and O
atomistic O
simulations O
we O
study O
the O
production O
of O
defects O
in O
graphene B
on O
Ir B
( I
111 I
) I
under O
grazing O
incidence O
of O
low O
energy O
Xe B
ions O
. O

Detection O
of O
Nitrogen B
- O
Protonated B
Nitrous I
Oxide I
( O
HNNO B
( I
+ I
) I
) O
by O
Rotational O
Spectroscopy O
. O

The O
rotational O
spectrum O
of O
nitrogen B
- O
protonated B
nitrous I
oxide I
( O
HNNO B
( I
+ I
) I
) O
, O
an O
isomer O
whose O
existence O
was O
first O
inferred O
from O
kinetic O
studies O
more O
than O
30 O
years O
ago O
, O
has O
now O
been O
detected O
by O
Fourier O
transform O
microwave O
spectroscopy O
, O
guided O
by O
new O
high O
- O
level O
coupled O
- O
cluster O
calculations O
of O
its O
molecular O
structure O
. O

HNNO B
( I
+ I
) I
is O
found O
to O
be O
2 O
- O
4 O
times O
less O
abundant O
than O
NNOH B
( I
+ I
) I
under O
a O
range O
of O
experimental O
conditions O
, O
as O
might O
be O
expected O
because O
this O
metastable O
isomer O
is O
known O
to O
be O
only O
~ O
6 O
kcal O
mol O
( O
- O
1 O
) O
less O
stable O
than O
ground O
- O
state O
NNOH B
( I
+ I
) I
from O
kinetic O
measurements O
by O
Ferguson O
and O
co O
- O
workers O
. O

HNNO B
( I
+ I
) I
is O
found O
to O
be O
2 O
- O
4 O
times O
less O
abundant O
than O
NNOH B
( I
+ I
) I
under O
a O
range O
of O
experimental O
conditions O
, O
as O
might O
be O
expected O
because O
this O
metastable O
isomer O
is O
known O
to O
be O
only O
~ O
6 O
kcal O
mol O
( O
- O
1 O
) O
less O
stable O
than O
ground O
- O
state O
NNOH B
( I
+ I
) I
from O
kinetic O
measurements O
by O
Ferguson O
and O
co O
- O
workers O
. O

HNNO B
( I
+ I
) I
is O
found O
to O
be O
2 O
- O
4 O
times O
less O
abundant O
than O
NNOH B
( I
+ I
) I
under O
a O
range O
of O
experimental O
conditions O
, O
as O
might O
be O
expected O
because O
this O
metastable O
isomer O
is O
known O
to O
be O
only O
~ O
6 O
kcal O
mol O
( O
- O
1 O
) O
less O
stable O
than O
ground O
- O
state O
NNOH B
( I
+ I
) I
from O
kinetic O
measurements O
by O
Ferguson O
and O
co O
- O
workers O
. O

The O
biological O
activities O
of O
6 B
- I
DHSG I
were O
attenuated O
by O
sulfhydryl B
antioxidants O
such O
as O
glutathione B
( O
GSH B
) O
or O
N B
- I
acetyl I
cysteine I
( O
NAC B
) O
, O
but O
not O
ascorbic B
acid I
( O
ASC B
) O
. O

Determination O
of O
alpha B
- I
keto I
acids I
in O
pork O
meat O
and O
Iberian O
ham O
via O
tandem O
mass O
spectrometry O
. O

An O
analytical O
method O
which O
offers O
accurate O
determination O
and O
identification O
of O
eight O
alpha B
- I
keto I
acids I
( O
alpha B
- I
ketoglutaric I
acid I
, O
pyruvic B
acid I
, O
4 B
- I
hydroxyphenylpyruvic I
acid I
, O
3 B
- I
methyl I
- I
2 I
- I
oxobutyric I
acid I
, O
alpha B
- I
keto I
- I
gamma I
- I
methylthiobutyric I
acid I
, O
4 B
- I
methyl I
- I
2 I
- I
oxovaleric I
acid I
, O
3 B
- I
methyl I
- I
2 I
- I
oxovaleric I
acid I
, O
and O
phenylpyruvic B
acid I
) O
in O
pork O
meat O
and O
Iberian O
ham O
samples O
is O
reported O
. O

An O
analytical O
method O
which O
offers O
accurate O
determination O
and O
identification O
of O
eight O
alpha B
- I
keto I
acids I
( O
alpha B
- I
ketoglutaric I
acid I
, O
pyruvic B
acid I
, O
4 B
- I
hydroxyphenylpyruvic I
acid I
, O
3 B
- I
methyl I
- I
2 I
- I
oxobutyric I
acid I
, O
alpha B
- I
keto I
- I
gamma I
- I
methylthiobutyric I
acid I
, O
4 B
- I
methyl I
- I
2 I
- I
oxovaleric I
acid I
, O
3 B
- I
methyl I
- I
2 I
- I
oxovaleric I
acid I
, O
and O
phenylpyruvic B
acid I
) O
in O
pork O
meat O
and O
Iberian O
ham O
samples O
is O
reported O
. O

An O
analytical O
method O
which O
offers O
accurate O
determination O
and O
identification O
of O
eight O
alpha B
- I
keto I
acids I
( O
alpha B
- I
ketoglutaric I
acid I
, O
pyruvic B
acid I
, O
4 B
- I
hydroxyphenylpyruvic I
acid I
, O
3 B
- I
methyl I
- I
2 I
- I
oxobutyric I
acid I
, O
alpha B
- I
keto I
- I
gamma I
- I
methylthiobutyric I
acid I
, O
4 B
- I
methyl I
- I
2 I
- I
oxovaleric I
acid I
, O
3 B
- I
methyl I
- I
2 I
- I
oxovaleric I
acid I
, O
and O
phenylpyruvic B
acid I
) O
in O
pork O
meat O
and O
Iberian O
ham O
samples O
is O
reported O
. O

The O
analytical O
method O
is O
simple O
( O
although O
the O
chemical O
derivatisation O
of O
the O
alpha B
- I
keto I
acids I
with O
dansylhydrazine B
is O
required O
) O
, O
precise O
( O
< O
18 O
% O
RSD O
) O
, O
accurate O
( O
90 O
- O
110 O
% O
) O
, O
sensitive O
( O
0 O
. O
01 O
- O
0 O
. O
34mg O
/ O
kg O
of O
defatted O
and O
freeze O
- O
dried O
meat O
depending O
on O
the O
alpha B
- I
keto I
acid I
) O
and O
linear O
( O
R O
> O
0 O
. O
99 O
) O
over O
several O
orders O
of O
magnitude O
( O
until O
0 O
. O
01 O
- O
146 O
. O
1mg O
/ O
kg O
of O
defatted O
and O
freeze O
- O
dried O
meat O
depending O
on O
the O
alpha B
- I
keto I
acid I
) O
. O

The O
analytical O
method O
is O
simple O
( O
although O
the O
chemical O
derivatisation O
of O
the O
alpha B
- I
keto I
acids I
with O
dansylhydrazine B
is O
required O
) O
, O
precise O
( O
< O
18 O
% O
RSD O
) O
, O
accurate O
( O
90 O
- O
110 O
% O
) O
, O
sensitive O
( O
0 O
. O
01 O
- O
0 O
. O
34mg O
/ O
kg O
of O
defatted O
and O
freeze O
- O
dried O
meat O
depending O
on O
the O
alpha B
- I
keto I
acid I
) O
and O
linear O
( O
R O
> O
0 O
. O
99 O
) O
over O
several O
orders O
of O
magnitude O
( O
until O
0 O
. O
01 O
- O
146 O
. O
1mg O
/ O
kg O
of O
defatted O
and O
freeze O
- O
dried O
meat O
depending O
on O
the O
alpha B
- I
keto I
acid I
) O
. O

The O
analytical O
method O
is O
simple O
( O
although O
the O
chemical O
derivatisation O
of O
the O
alpha B
- I
keto I
acids I
with O
dansylhydrazine B
is O
required O
) O
, O
precise O
( O
< O
18 O
% O
RSD O
) O
, O
accurate O
( O
90 O
- O
110 O
% O
) O
, O
sensitive O
( O
0 O
. O
01 O
- O
0 O
. O
34mg O
/ O
kg O
of O
defatted O
and O
freeze O
- O
dried O
meat O
depending O
on O
the O
alpha B
- I
keto I
acid I
) O
and O
linear O
( O
R O
> O
0 O
. O
99 O
) O
over O
several O
orders O
of O
magnitude O
( O
until O
0 O
. O
01 O
- O
146 O
. O
1mg O
/ O
kg O
of O
defatted O
and O
freeze O
- O
dried O
meat O
depending O
on O
the O
alpha B
- I
keto I
acid I
) O
. O

Using O
this O
methodology O
, O
alpha B
- I
keto I
acids I
were O
found O
to O
be O
present O
in O
pork O
meat O
to O
a O
low O
extent O
, O
and O
their O
concentration O
increased O
when O
they O
were O
determined O
in O
Iberian O
ham O
. O

This O
is O
the O
first O
report O
of O
the O
presence O
of O
alpha B
- I
keto I
acids I
in O
both O
pork O
meats O
and O
Iberian O
hams O
. O

In O
fruits O
, O
10 O
phenolics B
were O
detected O
, O
whereas O
rutin B
, O
a O
dicaffeic B
acid I
derivative O
and O
two O
feruloylquinic B
and I
caffeoylquinic I
acid I
isomers O
were O
newly O
detected O
. O

Though O
the O
phosphoryloxymethyle B
carbamates I
( O
3 O
, O
4 O
, O
and O
5 O
) O
and O
alpha B
- I
aminoacyloxymethylen I
carbamates I
( O
22 O
, O
23 O
, O
and O
26 O
) O
were O
found O
unstable O
at O
neutral O
pH O
values O
, O
fumaric B
acid I
derived O
acyloxymethylene B
carbamates I
( O
2 O
, O
28 O
, O
and O
31 O
) O
were O
highly O
stable O
under O
both O
acidic O
and O
neutral O
conditions O
. O

Effect O
of O
N B
- I
acetyl I
cysteine I
( O
NAC B
) O
, O
an O
organosulfur B
compound O
from O
Allium O
plants O
, O
on O
experimentally O
induced O
hepatic O
prefibrogenic O
events O
in O
wistar O
rat O
. O

Moreover O
, O
exposure O
to O
the O
OP O
pesticides O
resulted O
in O
increased O
7 B
- I
methylguanine I
, O
ribothymidine B
, O
cholic B
acid I
, O
4 B
- I
pyridoxic I
acid I
, O
kynurenine B
and O
indoxyl B
sulfate I
levels O
, O
as O
well O
as O
decreased O
hippuric B
acid I
, O
creatinine B
, O
uric B
acid I
, O
gentisic B
acid I
, O
C18 B
- I
dihydrosphingosine I
, O
phytosphingosine B
, O
suberic B
acid I
and O
citric B
acid I
. O

This O
paper O
analyzes O
surface O
chemistry O
effects O
to O
stably O
pattern O
aqueous O
two O
- O
phase O
system O
( O
ATPS O
) O
droplets O
on O
chemically O
modified O
poly B
( I
dimethylsiloxane I
) I
( O
PDMS B
) O
. O

Simonols B
A I
and I
B I
, O
two O
novel O
sesqui B
- I
neolignans I
from O
the O
fruits O
of O
Illicium O
simonsii O
. O

We O
examined O
the O
ability O
of O
ICI B
182 I
, I
780 I
( O
ICI B
) O
to O
block O
uterine O
cell O
proliferation O
via O
protein O
kinase O
b O
/ O
AKT O
pathway O
in O
the O
uterus O
of O
the O
rat O
during O
the O
estrous O
cycle O
. O

Skin O
penetration O
enhancing O
properties O
of O
the O
plant O
N B
- I
alkylamide I
spilanthol I
. O

Moreover O
, O
as O
plants O
are O
frequently O
contaminated O
with O
toxic O
environmental O
substances O
, O
the O
mutual O
influence O
on O
the O
transdermal O
behavior O
between O
spilanthol B
and O
six O
model O
mycotoxins O
( O
aflatoxin B
B1 I
, O
ochratoxin B
A I
, O
fumonisin B
B1 I
, O
citrinin B
, O
zearalenone B
, O
T B
- I
2 I
toxin I
) O
was O
investigated O
. O

Photocytotoxicity O
of O
copper B
( I
II I
) I
complexes O
of O
curcumin B
and O
N B
- I
ferrocenylmethyl I
- I
l I
- I
amino I
acids I
. O

Copper B
( I
II I
) I
complexes O
[ B
Cu I
( I
Fc I
- I
aa I
) I
( I
cur I
) I
] I
( O
1 O
- O
3 O
) O
of O
curcumin B
( O
Hcur B
) O
and O
N B
- I
ferrocenylmethyl I
- I
l I
- I
amino I
acids I
( O
Fc B
- I
aa I
) O
, O
viz O
. O
, O
ferrocenylmethyl B
- I
l I
- I
tyrosine I
( O
Fc B
- I
TyrH I
) O
, O
ferrocenylmethyl B
- I
l I
- I
tryptophan I
( O
Fc B
- I
TrpH I
) O
and O
ferrocenylmethyl B
- I
l I
- I
methionine I

Related O
homogeneous O
ligand O
L B
( I
t I
) I
( I
Bu I
) I
and O
its O
Ni B
( I
II I
) I
complexes O
, O
[ B
Ni I
( I
L I
( I
t I
) I
( I
Bu I
) I
) I
( I
OAc I
) I
2 I
( I
H2 I
O I
) I
] I
( I
L I
( I
t I
) I
( I
Bu I
) I
/ I
Ni I
) I
and O
[ B
Ni I
( I
L I
( I
t I
) I
( I
Bu I
) I
) I
2 I
] I
BF4 I
( I
2 I
L I
( I
t I
) I
( I
Bu I
) I
/ I
Ni I
) I
, O
have O
been O
synthesized O
. O

SBA O
* O
- O
L O
- O
x O
/ O
Ni B
has O
been O
applied O
to O
the O
catalytic O
oxidation O
of O
cyclohexane B
with O
m B
- I
chloroperbenzoic I
acid I
( O
mCPBA B
) O
. O

As O
a O
result O
, O
we O
determined O
that O
a O
fosK O
- O
encoded O
cytochrome O
P450 O
monooxygenase O
is O
responsible O
for O
C O
- O
18 O
hydroxylation O
, O
formation O
of O
an O
unsaturated B
lactone I
is O
dependent O
upon O
FosM O
, O
and O
the O
fosG O
gene O
product O
is O
involved O
in O
hydroxylation O
at O
C O
- O
4 O
after O
the O
action O
of O
FosM O
to O
yield O
PD B
113 I
, I
271 I
from O
FST B
. O

Nocardiamides B
A I
and I
B I
, O
Two O
Cyclohexapeptides B
from O
the O
Marine O
- O
Derived O
Actinomycete O
Nocardiopsis O
sp O
. O

Bromate B
( O
BrO3 B
( I
- I
) I
) O
, O
a O
by O
- O
product O
of O
ozonation O
of O
drinking O
water O
, O
induces O
nephrotoxicity O
in O
male O
rats O
at O
much O
lower O
doses O
than O
in O
female O
rats O
. O

Microarray O
analysis O
of O
male O
and O
female O
rats O
treated O
with O
BrO3 B
( I
- I
) I
at O
low O
doses O
( O
125 O
mg O
/ O
L O
KBrO3 B
) O
displayed O
marked O
sex O
- O
dependent O
changes O
in O
renal O
gene O
expression O
. O

Similarly O
, O
BrO3 B
( I
- I
) I
treatment O
increased O
clusterin O
and O
Kim O
- O
1 O
staining O
in O
the O
proximal O
tubules O
; O
however O
, O
staining O
for O
these O
proteins O
did O
not O
differ O
appreciably O
between O
males O
and O
females O
. O

These O
data O
demonstrate O
both O
qualitative O
and O
quantitative O
differences O
in O
the O
response O
of O
male O
versus O
female O
kidneys O
to O
BrO3 B
( I
- I
) I
- O
treatment O
. O

These O
sex O
- O
dependent O
effects O
likely O
contribute O
to O
renal O
carcinogenesis O
of O
BrO3 B
( I
- I
) I
in O
the O
male O
rat O
. O

Background O
: O
The O
presented O
method O
is O
able O
to O
determine O
6 B
- I
mercaptopurine I
( O
6 B
- I
MP I
) O
, O
6 B
- I
thioguanine I
, O
6 B
- I
mercaptopurine I
riboside I
and O
6 B
- I
thioguanine I
riboside I
in O
urine O
, O
and O
is O
thereby O
dedicated O
to O
control O
of O
thiopurine B
therapy O
of O
children O
with O
acute O
lymphoblastic O
leukemia O
. O

Background O
: O
The O
presented O
method O
is O
able O
to O
determine O
6 B
- I
mercaptopurine I
( O
6 B
- I
MP I
) O
, O
6 B
- I
thioguanine I
, O
6 B
- I
mercaptopurine I
riboside I
and O
6 B
- I
thioguanine I
riboside I
in O
urine O
, O
and O
is O
thereby O
dedicated O
to O
control O
of O
thiopurine B
therapy O
of O
children O
with O
acute O
lymphoblastic O
leukemia O
. O

LOD O
and O
LOQ O
are O
0 O
. O
3 O
, O
0 O
. O
4 O
, O
0 O
. O
3 O
, O
0 O
. O
8 O
and O
0 O
. O
4 O
, O
0 O
. O
6 O
, O
0 O
. O
5 O
and O
0 O
. O
9 O
nmol O
/ O
ml O
of O
urine O
for O
6 B
- I
MP I
, O
6 B
- I
thioguanine I
, O
6 B
- I
mercaptopurine I
riboside I
and O
6 B
- I
thioguanine I
riboside I
, O
respectively O
. O

LOD O
and O
LOQ O
are O
0 O
. O
3 O
, O
0 O
. O
4 O
, O
0 O
. O
3 O
, O
0 O
. O
8 O
and O
0 O
. O
4 O
, O
0 O
. O
6 O
, O
0 O
. O
5 O
and O
0 O
. O
9 O
nmol O
/ O
ml O
of O
urine O
for O
6 B
- I
MP I
, O
6 B
- I
thioguanine I
, O
6 B
- I
mercaptopurine I
riboside I
and O
6 B
- I
thioguanine I
riboside I
, O
respectively O
. O

pH O
- O
Responsive O
Aggregation O
States O
of O
Chiral O
Polymerizable O
Amphiphiles O
from O
l B
- I
Tyrosine I
and O
l B
- I
Phenyl I
Alanine I
in O
Water O
. O

Phenanthroimidazole B
- O
based O
thiobenzamide B
as O
an O
effective O
sensor O
for O
highly O
selective O
detection O
of O
mercury B
( I
II I
) I
. O

Complexes O
of O
mono O
- O
, O
bi O
- O
( O
RB O
) O
, O
and O
tridentate O
( O
RT O
) O
receptors O
with O
a O
range O
of O
anions O
( O
Cl B
( I
- I
) I
, O
Br B
( I
- I
) I
, O
I B
( I
- I
) I
, O
NO3 B
( I
- I
) I
, O
H2PO4 B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
, O
and O
tosylate B
( O
TsO B
( I
- I
) I
) O
) O
have O
been O
studied O
in O
the O
gas O
phase O
by O
both O
experimental O
and O
theoretical O
methods O
. O

Complexes O
of O
mono O
- O
, O
bi O
- O
( O
RB O
) O
, O
and O
tridentate O
( O
RT O
) O
receptors O
with O
a O
range O
of O
anions O
( O
Cl B
( I
- I
) I
, O
Br B
( I
- I
) I
, O
I B
( I
- I
) I
, O
NO3 B
( I
- I
) I
, O
H2PO4 B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
, O
and O
tosylate B
( O
TsO B
( I
- I
) I
) O
) O
have O
been O
studied O
in O
the O
gas O
phase O
by O
both O
experimental O
and O
theoretical O
methods O
. O

Complexes O
of O
mono O
- O
, O
bi O
- O
( O
RB O
) O
, O
and O
tridentate O
( O
RT O
) O
receptors O
with O
a O
range O
of O
anions O
( O
Cl B
( I
- I
) I
, O
Br B
( I
- I
) I
, O
I B
( I
- I
) I
, O
NO3 B
( I
- I
) I
, O
H2PO4 B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
, O
and O
tosylate B
( O
TsO B
( I
- I
) I
) O
) O
have O
been O
studied O
in O
the O
gas O
phase O
by O
both O
experimental O
and O
theoretical O
methods O
. O

Complexes O
of O
mono O
- O
, O
bi O
- O
( O
RB O
) O
, O
and O
tridentate O
( O
RT O
) O
receptors O
with O
a O
range O
of O
anions O
( O
Cl B
( I
- I
) I
, O
Br B
( I
- I
) I
, O
I B
( I
- I
) I
, O
NO3 B
( I
- I
) I
, O
H2PO4 B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
, O
and O
tosylate B
( O
TsO B
( I
- I
) I
) O
) O
have O
been O
studied O
in O
the O
gas O
phase O
by O
both O
experimental O
and O
theoretical O
methods O
. O

Complexes O
of O
mono O
- O
, O
bi O
- O
( O
RB O
) O
, O
and O
tridentate O
( O
RT O
) O
receptors O
with O
a O
range O
of O
anions O
( O
Cl B
( I
- I
) I
, O
Br B
( I
- I
) I
, O
I B
( I
- I
) I
, O
NO3 B
( I
- I
) I
, O
H2PO4 B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
, O
and O
tosylate B
( O
TsO B
( I
- I
) I
) O
) O
have O
been O
studied O
in O
the O
gas O
phase O
by O
both O
experimental O
and O
theoretical O
methods O
. O

Complexes O
of O
mono O
- O
, O
bi O
- O
( O
RB O
) O
, O
and O
tridentate O
( O
RT O
) O
receptors O
with O
a O
range O
of O
anions O
( O
Cl B
( I
- I
) I
, O
Br B
( I
- I
) I
, O
I B
( I
- I
) I
, O
NO3 B
( I
- I
) I
, O
H2PO4 B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
, O
and O
tosylate B
( O
TsO B
( I
- I
) I
) O
) O
have O
been O
studied O
in O
the O
gas O
phase O
by O
both O
experimental O
and O
theoretical O
methods O
. O

Complexes O
of O
mono O
- O
, O
bi O
- O
( O
RB O
) O
, O
and O
tridentate O
( O
RT O
) O
receptors O
with O
a O
range O
of O
anions O
( O
Cl B
( I
- I
) I
, O
Br B
( I
- I
) I
, O
I B
( I
- I
) I
, O
NO3 B
( I
- I
) I
, O
H2PO4 B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
, O
and O
tosylate B
( O
TsO B
( I
- I
) I
) O
) O
have O
been O
studied O
in O
the O
gas O
phase O
by O
both O
experimental O
and O
theoretical O
methods O
. O

Temperature O
dependent O
blackbody O
infrared O
radiative O
dissociation O
( O
BIRD O
) O
experiments O
were O
performed O
on O
complexes O
of O
C8F17I B
with O
Br B
( I
- I
) I
and O
I B
( I
- I
) I
, O
RB O
with O
I B
( I
- I
) I
, O
NO3 B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
, O
H2PO4 B
( I
- I
) I
, O
and O
TsO B
( I
- I
) I
, O
and O
RT O
with O
I B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
and O
TsO B
( I
- I
) I
and O
the O
observed O
Arrhenius O
parameters O
are O
reported O
here O
. O

Temperature O
dependent O
blackbody O
infrared O
radiative O
dissociation O
( O
BIRD O
) O
experiments O
were O
performed O
on O
complexes O
of O
C8F17I B
with O
Br B
( I
- I
) I
and O
I B
( I
- I
) I
, O
RB O
with O
I B
( I
- I
) I
, O
NO3 B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
, O
H2PO4 B
( I
- I
) I
, O
and O
TsO B
( I
- I
) I
, O
and O
RT O
with O
I B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
and O
TsO B
( I
- I
) I
and O
the O
observed O
Arrhenius O
parameters O
are O
reported O
here O
. O

Temperature O
dependent O
blackbody O
infrared O
radiative O
dissociation O
( O
BIRD O
) O
experiments O
were O
performed O
on O
complexes O
of O
C8F17I B
with O
Br B
( I
- I
) I
and O
I B
( I
- I
) I
, O
RB O
with O
I B
( I
- I
) I
, O
NO3 B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
, O
H2PO4 B
( I
- I
) I
, O
and O
TsO B
( I
- I
) I
, O
and O
RT O
with O
I B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
and O
TsO B
( I
- I
) I
and O
the O
observed O
Arrhenius O
parameters O
are O
reported O
here O
. O

Temperature O
dependent O
blackbody O
infrared O
radiative O
dissociation O
( O
BIRD O
) O
experiments O
were O
performed O
on O
complexes O
of O
C8F17I B
with O
Br B
( I
- I
) I
and O
I B
( I
- I
) I
, O
RB O
with O
I B
( I
- I
) I
, O
NO3 B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
, O
H2PO4 B
( I
- I
) I
, O
and O
TsO B
( I
- I
) I
, O
and O
RT O
with O
I B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
and O
TsO B
( I
- I
) I
and O
the O
observed O
Arrhenius O
parameters O
are O
reported O
here O
. O

Temperature O
dependent O
blackbody O
infrared O
radiative O
dissociation O
( O
BIRD O
) O
experiments O
were O
performed O
on O
complexes O
of O
C8F17I B
with O
Br B
( I
- I
) I
and O
I B
( I
- I
) I
, O
RB O
with O
I B
( I
- I
) I
, O
NO3 B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
, O
H2PO4 B
( I
- I
) I
, O
and O
TsO B
( I
- I
) I
, O
and O
RT O
with O
I B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
and O
TsO B
( I
- I
) I
and O
the O
observed O
Arrhenius O
parameters O
are O
reported O
here O
. O

Temperature O
dependent O
blackbody O
infrared O
radiative O
dissociation O
( O
BIRD O
) O
experiments O
were O
performed O
on O
complexes O
of O
C8F17I B
with O
Br B
( I
- I
) I
and O
I B
( I
- I
) I
, O
RB O
with O
I B
( I
- I
) I
, O
NO3 B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
, O
H2PO4 B
( I
- I
) I
, O
and O
TsO B
( I
- I
) I
, O
and O
RT O
with O
I B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
and O
TsO B
( I
- I
) I
and O
the O
observed O
Arrhenius O
parameters O
are O
reported O
here O
. O

Temperature O
dependent O
blackbody O
infrared O
radiative O
dissociation O
( O
BIRD O
) O
experiments O
were O
performed O
on O
complexes O
of O
C8F17I B
with O
Br B
( I
- I
) I
and O
I B
( I
- I
) I
, O
RB O
with O
I B
( I
- I
) I
, O
NO3 B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
, O
H2PO4 B
( I
- I
) I
, O
and O
TsO B
( I
- I
) I
, O
and O
RT O
with O
I B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
and O
TsO B
( I
- I
) I
and O
the O
observed O
Arrhenius O
parameters O
are O
reported O
here O
. O

Temperature O
dependent O
blackbody O
infrared O
radiative O
dissociation O
( O
BIRD O
) O
experiments O
were O
performed O
on O
complexes O
of O
C8F17I B
with O
Br B
( I
- I
) I
and O
I B
( I
- I
) I
, O
RB O
with O
I B
( I
- I
) I
, O
NO3 B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
, O
H2PO4 B
( I
- I
) I
, O
and O
TsO B
( I
- I
) I
, O
and O
RT O
with O
I B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
and O
TsO B
( I
- I
) I
and O
the O
observed O
Arrhenius O
parameters O
are O
reported O
here O
. O

Temperature O
dependent O
blackbody O
infrared O
radiative O
dissociation O
( O
BIRD O
) O
experiments O
were O
performed O
on O
complexes O
of O
C8F17I B
with O
Br B
( I
- I
) I
and O
I B
( I
- I
) I
, O
RB O
with O
I B
( I
- I
) I
, O
NO3 B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
, O
H2PO4 B
( I
- I
) I
, O
and O
TsO B
( I
- I
) I
, O
and O
RT O
with O
I B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
and O
TsO B
( I
- I
) I
and O
the O
observed O
Arrhenius O
parameters O
are O
reported O
here O
. O

Temperature O
dependent O
blackbody O
infrared O
radiative O
dissociation O
( O
BIRD O
) O
experiments O
were O
performed O
on O
complexes O
of O
C8F17I B
with O
Br B
( I
- I
) I
and O
I B
( I
- I
) I
, O
RB O
with O
I B
( I
- I
) I
, O
NO3 B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
, O
H2PO4 B
( I
- I
) I
, O
and O
TsO B
( I
- I
) I
, O
and O
RT O
with O
I B
( I
- I
) I
, O
HSO4 B
( I
- I
) I
and O
TsO B
( I
- I
) I
and O
the O
observed O
Arrhenius O
parameters O
are O
reported O
here O
. O

The O
relative O
binding O
energies O
of O
ions O
were O
generally O
consistent O
with O
the O
ordering O
previously O
reported O
from O
solution O
phase O
experiments O
; O
however O
, O
the O
relatively O
strong O
binding O
of O
H2PO4 B
( I
- I
) I
to O
the O
bidentate O
receptor O
contrasted O
the O
solution O
phase O
observation O
of O
oxoanions B
having O
weaker O
interactions O
when O
compared O
to O
halides B
. O

Structural O
observations O
of O
the O
transition O
of O
TiO B
2 I
nanopores O
into O
nanotubes O
by O
increasing O
the O
OH B
( I
- I
) I
concentration O
in O
the O
electrolyte O
challenge O
the O
validity O
of O
existing O
formation O
mechanisms O
of O
anodic O
TiO B
2 I
nanotubes O
. O

UV O
, O
IR O
, O
MS O
, O
( B
1 I
) I
H I
NMR O
and O
( B
13 I
) I
C I
NMR O
spectra O
were O
employed O
to O
identify O
phyllanthin B
. O

UV O
, O
IR O
, O
MS O
, O
( B
1 I
) I
H I
NMR O
and O
( B
13 I
) I
C I
NMR O
spectra O
were O
employed O
to O
identify O
phyllanthin B
. O

Moreover O
, O
wide O
- O
angle O
X O
- O
ray O
diffraction O
and O
( B
1 I
) I
H I
NMR O
studies O
revealed O
that O
the O
genistein B
molecules O
, O
successfully O
incorporated O
in O
the O
blends O
, O
remained O
chemically O
stable O
after O
electrospinning O
. O

They O
were O
identified O
as O
homologous O
beta B
- I
galactopyranosylcera I
composed O
of O
2 B
- I
amino I
- I
( I
6E I
) I
- I
octadec I
- I
6 I
- I
en I
- I
1 I
, I
3 I
, I
4 I
- I
triol I
, O
and O
the O
major O
one O
, O
axidjiferoside B
- I
A I
( O
around O
60 O
% O
) O
, O
contained O
2 B
- I
hydroxytetracosanoic I
acid I
. O

Catalysis O
of O
Cope O
- O
type O
rearrangements O
of O
bis B
- I
homoallylic I
hydroxylamines I
is O
demonstrated O
using O
chiral O
thiourea O
derivatives O
. O

Flavone B
C I
- I
glycosides I
from O
the O
flowers O
of O
Trollius O
chinensis O
and O
their O
anti O
- O
complementary O
activity O
. O

Phytochemical O
investigation O
of O
ethanol B
extract O
from O
the O
flowers O
of O
Trollius O
chinensis O
Bunge O
resulted O
in O
the O
isolation O
of O
two O
new O
flavone B
C I
- I
glycosides I
( O
1 O
- O
2 O
) O
, O
along O
with O
10 O
known O
compounds O
( O
3 O
- O
12 O
) O
. O

The O
content O
of O
other O
nutrients O
, O
like O
vitamins B
E I
and I
A I
, O
are O
also O
depending O
on O
the O
type O
of O
feed O
. O

Like O
Artemis O
, O
Metnase O
efficiently O
trimmed O
overhangs O
terminated O
in O
3 B
' I
- I
phosphoglycolates I
( O
PGs B
) O
, O
and O
in O
some O
cases O
the O
presence O
of O
3 B
' I
- I
PG I
stimulated O
cleavage O
and O
altered O
its O
specificity O
. O

Like O
Artemis O
, O
Metnase O
efficiently O
trimmed O
overhangs O
terminated O
in O
3 B
' I
- I
phosphoglycolates I
( O
PGs B
) O
, O
and O
in O
some O
cases O
the O
presence O
of O
3 B
' I
- I
PG I
stimulated O
cleavage O
and O
altered O
its O
specificity O
. O

In O
in O
vitro O
end O
- O
joining O
systems O
based O
on O
human O
cell O
extracts O
, O
addition O
of O
Artemis O
, O
but O
not O
Metnase O
, O
effected O
robust O
trimming O
of O
an O
unligatable O
3 B
' I
- I
PG I
overhang O
, O
resulting O
in O
a O
dramatic O
stimulation O
of O
ligase O
IV O
- O
and O
XLF O
- O
dependent O
end O
joining O
. O

The O
tumoural O
radioactivity O
uptake O
was O
most O
often O
high O
and O
specific O
even O
at O
early O
time O
points O
( O
12 O
. O
1 O
- O
18 O
. O
3 O
% O
ID O
/ O
g O
at O
3 O
h O
p O
. O
i O
. O
for O
[ O
( B
125 I
) I
I I
] O
39 O
- O
42 O
) O
and O
a O
fast O
clearance O
from O
the O
non O
- O
target O
organs O
was O
observed O
. O

Also O
, O
calculated O
effective O
doses O
that O
could O
be O
delivered O
to O
tumours O
when O
using O
corresponding O
[ O
( B
131 I
) I
I I
] O
- O
labelled O
analogues O
were O
generally O
higher O
than O
100 O
cGy O
/ O
MBq O
injected O
( O
98 O
. O
9 O
- O
150 O
. O
5 O
cGy O
/ O
MBq O
for O
[ O
( B
131 I
) I
I I
] O
39 O
- O
42 O
) O
. O

Also O
, O
calculated O
effective O
doses O
that O
could O
be O
delivered O
to O
tumours O
when O
using O
corresponding O
[ O
( B
131 I
) I
I I
] O
- O
labelled O
analogues O
were O
generally O
higher O
than O
100 O
cGy O
/ O
MBq O
injected O
( O
98 O
. O
9 O
- O
150 O
. O
5 O
cGy O
/ O
MBq O
for O
[ O
( B
131 I
) I
I I
] O
39 O
- O
42 O
) O
. O

Prostagrandin O
( B
PG I
) I
E2 I
production O
stimulated O
by O
arachidonic B
acid I
was O
suppressed O
by O
SAL B
- I
2 I
. O

Here O
, O
a O
new O
and O
simple O
method O
based O
on O
controlled O
polymerization O
of O
2 B
- I
methacryloyloxyethyl I
phosphorylcholine I
( O
MPC B
) O
on O
the O
surface O
of O
styrene B
- I
block I
- I
( I
ethylene I
- I
co I
- I
butylene I
) I
- I
block I
- I
styrene I
( O
SEBS B
) O
is O
shown O
. O

MATERIALS O
AND O
METHODS O
: O
Acetone B
extract O
and O
its O
sub O
- O
fractions O
of O
Acacia O
ferruginea O
stem O
bark O
were O
subjected O
to O
assess O
their O
antioxidant O
potential O
using O
various O
in O
vitro O
systems O
such O
as O
DPPH B
( I
* I
) I
, O
ABTS B
( I
* I
+ I
) I
scavenging O
, O
FRAP O
and O
phosphomolybdenum B
reduction O
activities O
. O

Ovx O
mice O
were O
replaced O
with O
vehicle O
( O
sesame O
oil O
) O
or O
17 B
beta I
- I
estradiol I
( O
E2 O
) O
for O
2 O
days O
or O
30 O
min O
prior O
to O
a O
cocaine B
challenge O
to O
investigate O
the O
time O
course O
of O
E2 O
' O
s O
effects O
. O

Resumption O
of O
menstruation O
and O
pituitary O
response O
to O
gonadotropin B
- I
releasing I
hormone I
in O
functional O
hypothalamic O
amenorrhea O
undertaking O
estrogen B
replacement O
therapy O
. O

Aim O
: O
To O
explore O
factors O
affecting O
the O
menstrual O
resumption O
and O
to O
evaluate O
the O
pituitary O
response O
to O
gonadotropin B
- I
releasing I
hormone I
( O
GnRH B
) O
in O
FHA O
. O

So O
simple O
: O
The O
in O
situ O
synthesis O
of O
an O
aryldiazonium B
salt I
and O
an O
azo B
- I
aryldiazonium I
salt I
by O
azo B
coupling O
from O
sulfanilic B
acid I
and O
aniline B
is O
reported O
. O

In O
this O
work O
, O
the O
design O
and O
synthesis O
of O
biodegradable O
PSQ B
particles O
with O
extremely O
high O
payloads O
of O
paramagnetic O
Gd B
( I
III I
) I
centers O
is O
explored O
, O
for O
use O
as O
efficient O
contrast O
agents O
for O
magnetic O
resonance O
imaging O
( O
MRI O
) O
. O

Two O
new O
bis B
( I
trialkoxysilyl I
) I
derivatives O
of O
Gd B
( I
III I
) I
diethylenetriamine I
pentaacetate I
( O
Gd B
- I
DTPA I
) O
containing O
disulfide B
linkages O
are O
synthesized O
and O
used O
to O
form O
biodegradable O
Gd B
- I
PSQ I
particles O
by O
base O
- O
catalyzed O
condensation O
reactions O
in O
reverse O
microemulsions O
. O

The O
Gd B
- I
PSQ I
particles O
are O
readily O
degradable O
to O
release O
the O
constituent O
Gd B
( I
III I
) I
chelates O
in O
the O
presence O
of O
endogenous O
reducing O
agents O
such O
as O
cysteine B
and O
glutathione B
. O

The O
structures O
of O
the O
isolated O
compounds O
were O
assigned O
on O
the O
basis O
of O
their O
( B
1 I
) I
H I
and O
( B
13 I
) I
C I
NMR O
spectra O
including O
two O
- O
dimensional O
NMR O
techniques O
such O
as O
HMQC O
, O
HMBC O
, O
and O
NOESY O
experiments O
and O
comparison O
with O
the O
literature O
data O
. O

The O
structures O
of O
the O
isolated O
compounds O
were O
assigned O
on O
the O
basis O
of O
their O
( B
1 I
) I
H I
and O
( B
13 I
) I
C I
NMR O
spectra O
including O
two O
- O
dimensional O
NMR O
techniques O
such O
as O
HMQC O
, O
HMBC O
, O
and O
NOESY O
experiments O
and O
comparison O
with O
the O
literature O
data O
. O

The O
abundance O
of O
serotonin B
and O
5 B
- I
hydroxyindoleacetic I
acid I
in O
brain O
of O
Tg O
- O
2D6 O
is O
higher O
than O
in O
WT O
mice O
, O
either O
basal O
levels O
or O
after O
harmaline B
induction O
. O

Caffeic B
Acid I
Phenethyl I
Ester I
Suppresses O
Proliferation O
and O
Survival O
of O
TW2 O
. O
6 O
Human O
Oral O
Cancer O
Cells O
via O
Inhibition O
of O
Akt O
Signaling O
. O

Caffeic B
acid I
phenethyl I
ester I
( O
CAPE B
) O
is O
a O
bioactive O
component O
extracted O
from O
honeybee O
hive O
propolis O
. O

Self O
- O
assembled O
monolayers O
of O
meso B
- I
5 I
, I
10 I
, I
15 I
, I
20 I
- I
tetrakis I
( I
undecyl I
) I
porphyrin I
copper I
( I
ii I
) I
on O
a O
graphite B
/ O
1 B
- I
octanoic I
acid I
interface O
have O
been O
studied O
by O
Scanning O
Tunnelling O
Microscopy O
. O

High O
- O
Accuracy O
Estimates O
for O
the O
Vinylidene B
- O
Acetylene B
Isomerization O
Energy O
and O
the O
Ground O
State O
Rotational O
Constants O
of O
: B
C I
= I
CH2 I
. O

Highly O
accurate O
calculations O
are O
reported O
for O
properties O
of O
vinylidene B
( O
H2C B
= I
C I
: I
) O
, O
specically O
the O
position O
of O
its O
zero O
- O
point O
vibrational O
level O
relative O
to O
that O
of O
acetylene B
and O
its O
equilibrium O
structure O
and O
ground O
state O
rotational O
constants O
. O

In O
addition O
, O
the O
thermochemical O
calculations O
presented O
here O
also O
allow O
a O
determination O
of O
the O
: B
C I
= I
CH2 I
bond O
energy O
of O
the O
vinyl B
radical O
at O
the O
HEAT O
- O
345 O
( O
Q O
) O
level O
of O
theory O
, O
which O
is O
77 O
. O
70 O
. O
3 O
kcal O
mol1 O
. O

We O
were O
able O
to O
achieve O
the O
direct O
observation O
of O
the O
interfacial O
band O
alignments O
at O
the O
donor O
( O
P3HT B
) O
- O
acceptor O
( O
PCBM B
) O
interfaces O
and O
at O
the O
interfaces O
between O
the O
photoactive O
P3HT B
: O
PCBM B
blends O
and O
the O
poly B
( I
3 I
, I
4 I
- I
ethylenedioxythiophe I
) I
poly B
( I
styrenesulfonate I
) I
( O
PEDOT B
: O
PSS B
) O
anode O
modification O
layer O
with O
an O
atomic O
- O
scale O
spatial O
resolution O
. O

Nine O
new O
triterpene B
derivatives O
, O
yunnanterpenes B
A I
- I
F I
( O
1 O
- O
6 O
) O
, O
15 B
, I
16 I
- I
seco I
- I
cimiterpenes I
A I
and I
B I
( O
7 O
, O
8 O
) O
, O
and O
cimilactone B
C I
( O
9 O
) O
, O
and O
15 O
known O
analogues O
( O
10 O
- O
24 O
) O
were O
isolated O
from O
the O
aerial O
parts O
of O
Cimicifuga O
yunnanensis O
. O

Compound O
1 O
, O
a O
dimer O
composed O
of O
benzylisoquinoline B
and O
seco B
- I
aristolactam I
units O
, O
represents O
a O
new O
type O
of O
bisbenzylisoquinolin B
alkaloid I
, O
while O
compounds O
3 O
- O
6 O
are O
bisbenzylisoquinolin B
N I
- I
oxides I
. O

The O
action O
of O
piperine B
( O
the O
pungent O
component O
of O
pepper O
) O
and O
its O
derivative O
SCT B
- I
66 I
( B
( I
2E I
, I
4E I
) I
- I
5 I
- I
( I
1 I
, I
3 I
- I
benzodioxol I
- I
5 I
- I
yl I
) I
) I
- I
N I
, I
N I
- I
diisobutyl I
- I
2 I
, I
4 I
- I
pentadienamide I
) I
on O
different O
gamma B
- I
aminobutyric I
acid I
( O
GABA B
) O
type O
A O
( O
GABAA O
) O
receptors O
, O
transient O
- O
receptor O
- O
potential O
- O
vanilloid O
- O
1 O
( O
TRPV1 O
) O
receptors O
and O
behavioral O
effects O
were O
investigated O
. O

The O
average O
daily O
dose O
of O
calcium B
acetate I
or I
carbonate I
prescribed O
in O
the O
randomised O
controlled O
trials O
to O
control O
hyperphosphataemia O
in O
dialysis O
patients O
ranges O
between O
1 O
. O
2 O
and O
2 O
. O
3 O
g O
of O
elemental O
calcium B
. O

Mechanistic O
Aspects O
of O
hSOD1 O
Maturation O
from O
the O
Solution O
Structure O
of O
Cu B
( I
I I
) I
- O
Loaded O
hCCS O
Domain O
1 O
and O
Analysis O
of O
Disulfide B
- O
Free O
hSOD1 O
Mutants O
. O

The O
NMR O
solution O
structure O
of O
the O
copper B
( I
I I
) I
- O
loaded O
form O
of O
hCCSD1 O
reported O
here O
contributes O
further O
to O
characterization O
of O
the O
copper O
- O
transfer O
mechanism O
to O
hSOD1 O
. O

Interactions O
between O
solid O
surfaces O
with O
pre O
- O
adsorbed O
poly B
( I
ethylenimine I
) I
( O
PEI B
) O
layers O
: O
effect O
of O
unadsorbed O
free O
PEI B
chains O
. O

Poly B
( I
ethylenimine I
) I
( O
PEI B
) O
polyelectrolytes O
have O
been O
widely O
used O
to O
tune O
the O
stability O
, O
rheology O
, O
or O
adhesion O
properties O
of O
colloidal O
suspensions O
due O
to O
their O
strong O
tendency O
to O
adsorb O
to O
solid O
surfaces O
. O

The O
cause O
of O
the O
disease O
is O
still O
unknown O
despite O
accumulating O
in O
vivo O
and O
in O
vitro O
evidence O
of O
massive O
epidermal O
oxidative O
stress O
via O
H2O2 B
and O
peroxynitrite B
( O
ONOO B
( I
- I
) I
) O
in O
affected O
individuals O
. O

We O
here O
asked O
the O
question O
whether O
ROS O
and O
possibly O
ONOO B
( I
- I
) I
could O
be O
players O
in O
the O
pathogenesis O
of O
SSV O
. O

Moreover O
, O
we O
show O
epidermal O
ONOO B
( I
- I
) I
accumulation O
. O

Basic O
evidence O
for O
epidermal O
H2O2 B
/ O
ONOO B
( I
- I
) I
- O
mediated O
oxidation O
/ O
nitration O
in O
segmental O
vitiligo O
is O
supported O
by O
repigmentation O
of O
skin O
and O
eyelashes O
after O
reduction O
of O
epidermal O
H2O2 B
with O
topical O
NB O
- O
UVB O
- O
activated O
pseudocatalase O
PC O
- O
KUS O
. O

New O
series O
of O
pyrrolidine B
mercaptosulfide I
, O
2 B
- I
mercaptocyclopentane I
arylsulfonamide I
, O
and O
3 B
- I
mercapto I
- I
4 I
- I
arylsulfonamido I
pyrrolidine I
matrix O
metalloproteinase O
inhibitors O
( O
MMPIs O
) O
were O
designed O
, O
synthesized O
, O
and O
evaluated O
. O

Aminoalkenes B
are O
catalytically O
cyclized O
in O
the O
presence O
of O
cyclopentadienylbis B
( I
oxazolinyl I
) I
borato I
group O
4 O
complexes O
{ B
PhB I
( I
C5H4 I
) I
( I
Ox I
( I
R I
) I
) I
2 I
} I
M I
( I
NMe2 I
) I
2 I
( O
M O
= O
Ti B
, O
Zr B
, O
Hf B
; O
Ox B
( I
R I
) I
= O
4 B
, I
4 I
- I
dimethyl I
- I
2 I
- I
oxazoline I
, O
4S B
- I
isopropyl I
- I
5 I
, I
5 I
- I
dimethyl I
- I
2 I
- I
oxazoline I
, O
4S B
- I

Elucidation O
of O
the O
biochemical O
basis O
for O
a O
clinical O
drug O
- O
drug O
interaction O
between O
atorvastatin B
and O
5 B
- I
( I
N I
- I
( I
4 I
- I
( I
( I
4 I
- I
ethylbenzyl I
) I
thio I
) I
phenyl I
) I
sulfamoyl I
) I
- I
2 I
- I
methyl I
benzoic I
acid I
( O
CP B
- I
778 I
875 I
) O
, O
a O
subtype O
selective O
agonist O
of O
the O
peroxisome O
proliferator O
- O
activated O
receptor O
alpha O
. O

Abstract O
1 O
. O
5 B
- I
( I
N I
- I
( I
4 I
- I
( I
( I
4 I
- I
ethylbenzyl I
) I
thio I
) I
phenyl I
) I
sulfamoyl I
) I
- I
2 I
- I
methyl I
benzoic I
acid I
( O
CP B
- I
778 I
875 I
) O
, O
an O
agonist O
of O
the O
peroxisome O
proliferator O
- O
activated O
receptor O
alpha O
, O
has O
been O
evaluated O
in O
the O
clinic O
to O
treat O
dyslipidemia O
and O
type O
2 O
diabetes O
mellitus O
. O

Herein O
, O
we O
investigate O
the O
effect O
of O
CP B
- I
778 I
875 I
on O
the O
pharmacokinetics O
of O
atorvastatin B
acid I
and O
its O
metabolites O
in O
humans O
. O

Group O
A O
was O
designed O
to O
estimate O
the O
effects O
of O
multiple O
doses O
of O
CP B
- I
778 I
875 I
on O
the O
single O
dose O
pharmacokinetics O
of O
atorvastatin B
. O

Subjects O
in O
group O
A O
( O
n O
= O
26 O
) O
received O
atorvastatin B
( O
40 O
mg O
) O
on O
days O
1 O
and O
9 O
and O
CP B
- I
778 I
875 I
( O
1 O
. O
0 O
mg O
QD O
) O
on O
days O
5 O
- O
12 O
. O

Group O
B O
was O
designed O
to O
examine O
the O
effects O
of O
multiple O
doses O
of O
atorvastatin B
on O
the O
single O
dose O
pharmacokinetics O
of O
CP B
- I
778 I
875 I
. O

Subjects O
in O
group O
B O
( O
n O
= O
29 O
) O
received O
CP B
- I
778 I
875 I
( O
0 O
. O
3 O
mg O
) O
on O
days O
1 O
and O
9 O
and O
atorvastatin B
( O
40 O
mg O
QD O
) O
on O
days O
5 O
- O
12 O
. O

3 O
. O
Mean O
maximum O
serum O
concentration O
( O
Cmax O
) O
and O
area O
under O
the O
curve O
of O
atorvastatin B
were O
increased O
by O
45 O
% O
and O
20 O
% O
, O
respectively O
, O
upon O
co O
- O
administration O
with O
CP B
- I
778 I
875 I
. O

Statistically O
significant O
increases O
in O
the O
systemic O
exposure O
of O
ortho B
- I
and I
para I
- I
hydroxyatorvastatin I
were O
also O
observed O
upon O
concomitant O
dosing O
with O
CP B
- I
778 I
875 I
. O

CP B
- I
778 I
875 I
pharmacokinetics O
, O
however O
, O
were O
not O
impacted O
upon O
concomitant O
dosing O
with O
atorvastatin B
. O

4 O
. O
Inhibition O
of O
organic O
anion O
transporting O
polypeptide O
1B1 O
by O
CP B
- I
778 I
875 I
( O
IC50 O
= O
2 O
. O
14 O
+ O
/ O
- O
0 O
. O
40 O
mu O
M O
) O
could O
be O
the O
dominant O
cause O
of O
the O
pharmacokinetic O
interaction O
as O
CP B
- I
778 I
875 I
did O
not O
exhibit O
significant O
inhibition O
of O
cytochrome O
P450 O
3A4 O
/ O
3A5 O
, O
multidrug O
resistant O
protein O
1 O
or O
breast O
cancer O
resistant O
protein O
, O
which O
are O
also O
involved O
in O
the O
hepatobiliary O
disposition O
of O
atorvastatin B
. O

4 O
. O
Inhibition O
of O
organic O
anion O
transporting O
polypeptide O
1B1 O
by O
CP B
- I
778 I
875 I
( O
IC50 O
= O
2 O
. O
14 O
+ O
/ O
- O
0 O
. O
40 O
mu O
M O
) O
could O
be O
the O
dominant O
cause O
of O
the O
pharmacokinetic O
interaction O
as O
CP B
- I
778 I
875 I
did O
not O
exhibit O
significant O
inhibition O
of O
cytochrome O
P450 O
3A4 O
/ O
3A5 O
, O
multidrug O
resistant O
protein O
1 O
or O
breast O
cancer O
resistant O
protein O
, O
which O
are O
also O
involved O
in O
the O
hepatobiliary O
disposition O
of O
atorvastatin B
. O

In O
addition O
, O
the O
level O
of O
8 B
- I
Gua I
( O
guanine B
) O
, O
a O
product O
of O
DNA O
damage O
, O
was O
1 O
. O
7 O
+ O
/ O
- O
0 O
. O
12 O
8 B
- I
hydroxyl I
guanine I
( O
8 B
- I
OH I
Gua I
) O
/ O
105 O
Gua B
in O
brain O
tissue O
in O
the O
control O
group O
receiving O
cisplatin B
, O
compared O
with O
0 O
. O
97 O
+ O
/ O
- O
0 O
. O
03 O
8 O
- O
OH O
Gua B
/ O
105 O
Gua B
in O
the O
thiamine B
pyrophosphate I
( O
20 O
mg O
/ O
kg O
) O
group O
and O
1 O
. O
55 O
+ O
/ O
- O
0 O
. O
11 O
8 B
- I
OH I
Gua I
/ O
105 O
Gua B
in O
the O

In O
addition O
, O
the O
level O
of O
8 B
- I
Gua I
( O
guanine B
) O
, O
a O
product O
of O
DNA O
damage O
, O
was O
1 O
. O
7 O
+ O
/ O
- O
0 O
. O
12 O
8 B
- I
hydroxyl I
guanine I
( O
8 B
- I
OH I
Gua I
) O
/ O
105 O
Gua B
in O
brain O
tissue O
in O
the O
control O
group O
receiving O
cisplatin B
, O
compared O
with O
0 O
. O
97 O
+ O
/ O
- O
0 O
. O
03 O
8 O
- O
OH O
Gua B
/ O
105 O
Gua B
in O
the O
thiamine B
pyrophosphate I
( O
20 O
mg O
/ O
kg O
) O
group O
and O
1 O
. O
55 O
+ O
/ O
- O
0 O
. O
11 O
8 B
- I
OH I
Gua I
/ O
105 O
Gua B
in O
the O

In O
addition O
, O
the O
level O
of O
8 B
- I
Gua I
( O
guanine B
) O
, O
a O
product O
of O
DNA O
damage O
, O
was O
1 O
. O
7 O
+ O
/ O
- O
0 O
. O
12 O
8 B
- I
hydroxyl I
guanine I
( O
8 B
- I
OH I
Gua I
) O
/ O
105 O
Gua B
in O
brain O
tissue O
in O
the O
control O
group O
receiving O
cisplatin B
, O
compared O
with O
0 O
. O
97 O
+ O
/ O
- O
0 O
. O
03 O
8 O
- O
OH O
Gua B
/ O
105 O
Gua B
in O
the O
thiamine B
pyrophosphate I
( O
20 O
mg O
/ O
kg O
) O
group O
and O
1 O
. O
55 O
+ O
/ O
- O
0 O
. O
11 O
8 B
- I
OH I
Gua I
/ O
105 O
Gua B
in O
the O

Using O
Mn B
( I
II I
) I
or O
Zn B
( I
II I
) I
to O
activate O
HsMetAP1 O
, O
we O
found O
that O
1 O
- O
4 O
could O
only O
effectively O
inhibit O
purified O
HsMetAP1 O
in O
the O
presence O
of O
physiologically O
unachievable O
concentrations O
of O
Co B
( I
II I
) I
. O

Using O
Mn B
( I
II I
) I
or O
Zn B
( I
II I
) I
to O
activate O
HsMetAP1 O
, O
we O
found O
that O
1 O
- O
4 O
could O
only O
effectively O
inhibit O
purified O
HsMetAP1 O
in O
the O
presence O
of O
physiologically O
unachievable O
concentrations O
of O
Co B
( I
II I
) I
. O

Using O
Mn B
( I
II I
) I
or O
Zn B
( I
II I
) I
to O
activate O
HsMetAP1 O
, O
we O
found O
that O
1 O
- O
4 O
could O
only O
effectively O
inhibit O
purified O
HsMetAP1 O
in O
the O
presence O
of O
physiologically O
unachievable O
concentrations O
of O
Co B
( I
II I
) I
. O

In O
an O
effort O
to O
seek O
Co B
( I
II I
) I
- O
independent O
inhibitors O
, O
a O
novel O
structural O
class O
containing O
a O
2 B
- I
( I
pyridin I
- I
2 I
- I
yl I
) I
quinazoline I
core O
has O
been O
discovered O
. O

Many O
compounds O
in O
this O
class O
potently O
and O
selectively O
inhibited O
HsMetAP1 O
without O
Co B
( I
II I
) I
. O

The O
novel O
( B
68 I
) I
Ga I
labeled O
tracer O
showed O
an O
improved O
in O
vivo O
stability O
and O
could O
therefore O
be O
used O
for O
selective O
non O
- O
invasive O
imaging O
of O
necrotic O
cell O
death O
using O
PET O
. O

Indoxyl B
3 I
- I
sulfate I
stimulates O
Th17 O
differentiation O
enhancing O
phosphorylation O
of O
c O
- O
Src O
and O
STAT3 O
to O
worsen O
experimental O
autoimmune O
encephalomyelitis O
. O

In O
the O
present O
study O
, O
using O
in O
vitro O
Th17 O
differentiation O
model O
, O
we O
examined O
effects O
of O
AhR O
activation O
by O
indoxyl B
3 I
- I
sulfate I
( O
I3S B
) O
, O
a O
uremic O
toxin O
, O
on O
Th17 O
differentiation O
and O
investigated O
underlying O
mechanisms O
. O

C12 B
- O
, O
( B
C12 I
) I
2 I
- O
and O
cholesteryl B
- I
sperminex I
- O
siRNA O
were O
capable O
of O
luciferase O
knockdown O
at O
nanomolar O
concentrations O
without O
vectorization O
( O
i O
. O
e O
. O
one O
to O
two O
orders O
of O
magnitude O
more O
potent O
than O
commercially O
available O
cholesteryl B
siRNA O
) O
. O

From O
the O
rhizomes O
of O
Polygonatum O
odoratum O
( O
Mill O
. O
) O
Druce O
, O
six O
homoisoflavonoids B
( O
1 O
- O
6 O
) O
and O
one O
dihydrochalcone B
( O
7 O
) O
were O
isolated O
, O
and O
the O
structures O
of O
polygonatones B
A I
- I
D I
( O
4 O
- O
7 O
) O
were O
elucidated O
by O
various O
spectroscopic O
analyses O
. O

Antifouling O
zwitterionic O
SS O
- O
PMPC O
surface O
was O
prepared O
by O
thiol B
- O
ene O
photopolymerization O
of O
2 B
- I
methacryloyloxyethyl I
phosphorylcholine I
( O
MPC B
) O
from O
the O
SS O
- O
thiol B
surface O
. O

distolasterosides B
D1 I
- I
D3 I
( O
4 O
- O
6 O
) O
from O
the O
starfish O
Distolasterias O
nipon O
were O
analyzed O
using O
the O
mouse O
neuroblastoma O
( O
NB O
) O
C O
- O
1300 O
cell O
line O
and O
an O
organotypic O
rat O
hippocampal O
slice O
culture O
( O
OHSC O
) O
. O

